0001753926-23-000213.txt : 20230228 0001753926-23-000213.hdr.sgml : 20230228 20230228162601 ACCESSION NUMBER: 0001753926-23-000213 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 105 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTER PARFUMS INC CENTRAL INDEX KEY: 0000822663 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 133275609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16469 FILM NUMBER: 23685884 BUSINESS ADDRESS: STREET 1: 551 FIFTH AVE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 BUSINESS PHONE: 2129832640 MAIL ADDRESS: STREET 1: 551 FIFTH AVENUE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 FORMER COMPANY: FORMER CONFORMED NAME: JEAN PHILIPPE FRAGRANCES INC DATE OF NAME CHANGE: 19920703 10-K 1 g083417_10k.htm 10-K
0000822663 false --12-31 2022 FY NASDAQ P5Y P15Y P1Y P12Y P7Y P50Y P10Y 7000000 P8Y P14Y P2Y P14Y P3Y P20Y 2023-12-15 132902 P5Y9M18D P4Y P5Y P5Y P4Y P5Y P5Y P0Y11M15D P2Y0M15D P3Y0M0D P5Y10M6D P2Y7M13D P1Y10M17D P3Y 31859417 31835408 194219 151019 69349 0000822663 2022-01-01 2022-12-31 0000822663 2022-06-30 0000822663 2023-02-28 0000822663 2022-12-31 0000822663 2021-12-31 0000822663 2021-01-01 2021-12-31 0000822663 2020-01-01 2020-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:CommonStockMember 2020-12-31 0000822663 us-gaap:CommonStockMember 2019-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2020-12-31 0000822663 us-gaap:RetainedEarningsMember 2019-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000822663 us-gaap:TreasuryStockMember 2021-12-31 0000822663 us-gaap:TreasuryStockMember 2020-12-31 0000822663 us-gaap:TreasuryStockMember 2019-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2020-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2019-12-31 0000822663 2020-12-31 0000822663 2019-12-31 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000822663 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000822663 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0000822663 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0000822663 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:TreasuryStockMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:MontblancMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:MontblancMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:MontblancMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:JimmyChooMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:JimmyChooMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:JimmyChooMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:CoachMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:CoachMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:CoachMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:GUESSMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:GUESSMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:ProductSalesConcentrationRiskMember ipar:GUESSMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2021-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2021-01-01 2021-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 ipar:EmanuelUngarMember 2022-01-01 2022-12-31 0000822663 ipar:DonnaKaranAndDKNYMember 2022-01-01 2022-12-31 0000822663 ipar:RochasFashionMember 2022-01-01 2022-12-31 0000822663 ipar:RochasFashionMember 2021-01-01 2021-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2021-04-30 0000822663 us-gaap:LandMember 2022-01-01 2022-12-31 0000822663 us-gaap:BuildingMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember 2022-01-01 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 us-gaap:ProductMember 2022-01-01 2022-12-31 0000822663 us-gaap:ProductMember 2021-01-01 2021-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2022-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2021-12-31 0000822663 us-gaap:BuildingMember 2022-12-31 0000822663 us-gaap:BuildingMember 2021-12-31 0000822663 us-gaap:EquipmentMember 2022-12-31 0000822663 us-gaap:EquipmentMember 2021-12-31 0000822663 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000822663 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0000822663 us-gaap:FiniteLivedIntangibleAssetsMember 2022-12-31 0000822663 us-gaap:LicensingAgreementsMember 2022-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000822663 ipar:SubtotalMember 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-12-31 0000822663 us-gaap:FiniteLivedIntangibleAssetsMember 2021-12-31 0000822663 us-gaap:LicensingAgreementsMember 2021-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000822663 ipar:SubtotalMember 2021-12-31 0000822663 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0000822663 us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-01-01 2021-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember ipar:RochasFashionBusinessMember 2022-01-01 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0000822663 ipar:DomesticSubsidiariesMember 2022-12-31 0000822663 ipar:LondonInterbankOfferedRateMember ipar:DomesticSubsidiariesMember 2022-01-01 2022-12-31 0000822663 ipar:LondonInterbankOfferedRateMember ipar:DomesticSubsidiariesMember 2022-12-31 0000822663 ipar:ForeignSubsidiariesMember 2022-12-31 0000822663 ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember srt:MinimumMember 2022-01-01 2022-12-31 0000822663 ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember srt:MaximumMember 2022-01-01 2022-12-31 0000822663 ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember 2022-12-31 0000822663 us-gaap:LoansPayableMember 2022-12-31 0000822663 us-gaap:LoansPayableMember 2022-01-01 2022-12-31 0000822663 us-gaap:LoansPayableMember 2021-12-31 0000822663 ipar:LoansPayableOneMember 2022-12-31 0000822663 ipar:LoansPayableOneMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableOneMember 2021-12-31 0000822663 ipar:LoansPayableTwoMember 2022-12-31 0000822663 ipar:LoansPayableTwoMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableTwoMember 2021-12-31 0000822663 ipar:LoansPayableThreeMember 2022-12-31 0000822663 ipar:LoansPayableThreeMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableThreeMember 2021-12-31 0000822663 ipar:LoansPayableOneMember 2021-04-30 0000822663 ipar:LoansPayableOneMember 2021-04-01 2021-04-30 0000822663 ipar:OperatingLeaseMember 2022-12-31 0000822663 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000822663 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0000822663 us-gaap:StockOptionMember 2022-12-31 0000822663 ipar:StockOptionOneMember 2022-12-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-06-27 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSAMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-12-31 0000822663 2019-10-01 2019-10-31 0000822663 2019-10-31 0000822663 srt:BoardOfDirectorsChairmanMember 2021-02-28 0000822663 us-gaap:SubsequentEventMember 2023-03-31 0000822663 us-gaap:OperatingIncomeLossMember 2022-01-01 2022-12-31 0000822663 us-gaap:OperatingIncomeLossMember 2021-01-01 2021-12-31 0000822663 us-gaap:OperatingIncomeLossMember 2020-01-01 2020-12-31 0000822663 srt:MinimumMember ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeOneMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeTwoMember 2022-01-01 2022-12-31 0000822663 ipar:ExercisePriceRangeThreeMember 2022-12-31 0000822663 ipar:ExercisePriceRangeThreeMember 2022-01-01 2022-12-31 0000822663 ipar:ExercisePriceRangeFourMember 2022-12-31 0000822663 ipar:ExercisePriceRangeFourMember 2022-01-01 2022-12-31 0000822663 country:US 2022-01-01 2022-12-31 0000822663 country:US 2021-01-01 2021-12-31 0000822663 country:US 2020-01-01 2020-12-31 0000822663 srt:EuropeMember 2022-01-01 2022-12-31 0000822663 srt:EuropeMember 2021-01-01 2021-12-31 0000822663 srt:EuropeMember 2020-01-01 2020-12-31 0000822663 ipar:EliminationsMember 2022-01-01 2022-12-31 0000822663 ipar:EliminationsMember 2021-01-01 2021-12-31 0000822663 ipar:EliminationsMember 2020-01-01 2020-12-31 0000822663 country:US 2022-12-31 0000822663 country:US 2021-12-31 0000822663 country:US 2020-12-31 0000822663 srt:EuropeMember 2022-12-31 0000822663 srt:EuropeMember 2021-12-31 0000822663 srt:EuropeMember 2020-12-31 0000822663 ipar:EliminationsMember 2022-12-31 0000822663 ipar:EliminationsMember 2021-12-31 0000822663 ipar:EliminationsMember 2020-12-31 0000822663 srt:NorthAmericaMember 2022-01-01 2022-12-31 0000822663 srt:NorthAmericaMember 2021-01-01 2021-12-31 0000822663 srt:NorthAmericaMember 2020-01-01 2020-12-31 0000822663 srt:AsiaMember 2022-01-01 2022-12-31 0000822663 srt:AsiaMember 2021-01-01 2021-12-31 0000822663 srt:AsiaMember 2020-01-01 2020-12-31 0000822663 us-gaap:MiddleEastMember 2022-01-01 2022-12-31 0000822663 us-gaap:MiddleEastMember 2021-01-01 2021-12-31 0000822663 us-gaap:MiddleEastMember 2020-01-01 2020-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2022-01-01 2022-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2021-01-01 2021-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2020-01-01 2020-12-31 0000822663 ipar:OtherSegmentCountryMember 2022-01-01 2022-12-31 0000822663 ipar:OtherSegmentCountryMember 2021-01-01 2021-12-31 0000822663 ipar:OtherSegmentCountryMember 2020-01-01 2020-12-31 0000822663 ipar:UnitedStatesMember 2022-01-01 2022-12-31 0000822663 ipar:UnitedStatesMember 2021-01-01 2021-12-31 0000822663 ipar:UnitedStatesMember 2020-01-01 2020-12-31 0000822663 ipar:FranceMember 2022-01-01 2022-12-31 0000822663 ipar:FranceMember 2021-01-01 2021-12-31 0000822663 ipar:FranceMember 2020-01-01 2020-12-31 0000822663 ipar:RussiaMember 2022-01-01 2022-12-31 0000822663 ipar:RussiaMember 2021-01-01 2021-12-31 0000822663 ipar:RussiaMember 2020-01-01 2020-12-31 0000822663 ipar:UnitedKingdomMember 2022-01-01 2022-12-31 0000822663 ipar:UnitedKingdomMember 2021-01-01 2021-12-31 0000822663 ipar:UnitedKingdomMember 2020-01-01 2020-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2022-01-01 2022-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2021-01-01 2021-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2020-01-01 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2021-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2019-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2022-01-01 2022-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2021-01-01 2021-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2020-01-01 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2022-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2021-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2022-01-01 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2020-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2019-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2021-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2022-01-01 2022-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2022-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2020-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2021-01-01 2021-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2019-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2020-01-01 2020-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2021-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2022-01-01 2022-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2022-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2020-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2021-01-01 2021-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2019-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2020-01-01 2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:EUR ipar:Number

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark one)

 

☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the fiscal year ended December 31, 2022

 

or

 

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from ________to _______.

 

Commission file no. 0-16469

 

Inter Parfums, Inc.

 

(Exact name of registrant as specified in its charter)

 

Delaware   13-3275609
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
551 Fifth Avenue, New York, New York   10176
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 212.983.2640

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Name of exchange on which registered
Common Stock, $.001 par value per share   The Nasdaq Stock Market

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Name of exchange on which registered
None   None

 

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $1,274,342,976 of voting equity and $-0- of non-voting equity.

 

Indicate the number of shares outstanding of the registrant’s $.001 par value common stock as of the close of business on the latest practicable date February 28, 2023: 32,109,360.

 

Documents Incorporated by Reference: None.

 

 

 

 

TABLE OF CONTENTS

 

  Page
Forward Looking Statements ii
   
PART I   1
     
Item 1. Business 1
     
Item 1A. Risk Factors 29
     
Item 1B. Unresolved Staff Comments 37
     
Item 2. Properties 38
     
Item 3. Legal Proceedings 38
     
Item 4. Mine Safety Disclosures 38
     
PART II    39
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 39
     
Item 6. RESERVED 40
     
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 41
     
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 52
     
Item 8. Financial Statements and Supplementary Data 52
     
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 52
     
Item 9A. Controls and Procedures 52
     
Item 9B. Other Information 53
     
PART III    54
     
Item 10. Directors, Executive Officers and Corporate Governance  54
     
Item 11. Executive Compensation  61
     
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters  76
     
Item 13. Certain Relationships and Related Transactions, and Director Independence  77
     
Item 14. Principal Accountant Fees and Services  78
     
PART IV    80
     
Item 15. Exhibits and Financial Statement Schedules 80
     
Item 16. Form 10-K Summary 80
     
FINANCIAL STATEMENTS F-1
   
SIGNATURES  

  

i

 

 

FORWARD LOOKING STATEMENTS

 

This report includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, and if incorporated by reference into a registration statement under the Securities Act of 1933, as amended, within the meaning of Section 27A of such act. When used in this report, the words “anticipate,” “believe,” “estimate,” “will,” “should,” “could,” “may,” “intend,” “expect,” “plan,” “predict,” “potential,” or “continue” or similar expressions identify certain forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved.

 

Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this report. Important factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report, including under the heading “Risk Factors”. Such factors include: The effects of; our inability to successfully integrate or manage any future acquisitions; continuation and renewal of existing licenses and similar agreements; potential inability to obtain new licensing, arrangements or agreements for additional brands; potential reduction in sales of our fragrance products due to reduced consumer confidence as the result of a prolonged economic downturn, recession or terrorist attack in the United States, Europe or any of the other countries in which we do significant business; inflation; uncertainties and deterioration in global credit markets could negatively impact suppliers, customers and consumers; re-emergence of COVID-19 and related governmental mandates, or outbreak of other disease, epidemic or pandemic, or similar public health threat,; inability to protect our intellectual property rights; our business could be negatively impacted by social impact and sustainability matters; potential liability for infringement of third party brand names; product liability claims; effectiveness of our sales and marketing efforts and product acceptance by consumers; our dependence upon third party manufacturers and distributors; our dependence upon existing management; competition in the fragrance industry; risks related to our foreign operations, currency fluctuation and international tariff and trade barriers; compliance with governmental regulation; changing political conditions could adversely impact our business and financial results; potential hacking and outages of our global information systems; seasonal variability of our business; our ability to operate our business without infringing, and misappropriating or otherwise violating the intellectual property rights of other parties.

 

These factors are not intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic factors and business strategies, may be significant, and the factors set forth herein may affect us to a greater extent than indicated. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth in this report. Except as may be required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

ii

 

 

PART I

 

Item 1. Business

 

General Business Development

 

Founded in 1982, we operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrance, and fragrance related products. Our worldwide headquarters and the office of our wholly-owned United States subsidiaries, Jean Philippe Fragrances, LLC and Interparfums, USA LLC, are located at 551 Fifth Avenue, New York, New York 10176, and our telephone number is 212.983.2640. We also have wholly-owned subsidiaries in Italy, subsidiary, Interparfums Italia Srl and Hong Kong, Inter Parfums USA Hong Kong Limited.

 

Our consolidated wholly-owned subsidiary, Inter Parfums Holdings, S.A., and its majority owned subsidiary, Interparfums SA, maintain executive offices at 10 rue de Solférino, 75007 Paris, France. Our telephone number in Paris is 331.5377.0000. Interparfums SA is the sole owner of Interparfums Luxury Brands, Inc., a Delaware corporation, for distribution of prestige brands in the United States. Interparfums SA is also the majority owner of Parfums Rochas Spain, SL, a Spanish limited liability company, which specializes in the distribution of Rochas fragrances. In addition, Interparfums SA is also the sole owner of Interparfums (Suisse) Sarl, a company formed to hold and manage certain brand names, and Interparfums Asia Pacific Pte., Ltd., an Asian sales and marketing office.

 

Our common stock is listed on The Nasdaq Global Select Market under the trading symbol “IPAR”. The common shares of our subsidiary, Interparfums SA, are traded on the Euronext.

 

The Securities and Exchange Commission (“SEC”) maintains an internet site at http://www.sec.gov that contains financial reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. We maintain our internet website at www.interparfumsinc.com, which is linked to the SEC internet site. You can obtain through our website, free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q, interactive data files, current reports on Form 8-K, beneficial ownership reports (Forms 3, 4 and 5) and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934 as soon as reasonably practicable after they have been electronically filed with or furnished to the SEC.

 

The following information is qualified in its entirety by and should be read together with the more detailed information and audited financial statements, including the related notes, contained or incorporated by reference in this report.

 

General

 

We operate in the fragrance business and manufacture, market and distribute a wide array of fragrance and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the Euronext.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are either received and stored directly at our third-party fillers or received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

1

 

 

Our fragrance products focus on prestige brands, each with a devoted following. By concentrating in markets where the brands are best known, we have had many successful product launches. We typically launch new fragrance families for our brands every few years, and more frequently seasonal and limited edition fragrances are introduced as well.

 

The creation and marketing of each product family is intimately linked with the brand’s name, its past and present positioning, customer base and, more generally, the prevailing market atmosphere. Accordingly, we generally study the market for each proposed family of fragrance products for almost a full year before we introduce any new product into the market. This study is intended to define the general position of the fragrance family and more particularly its scent, bottle, packaging and appeal to the buyer. In our opinion, the unity of these four elements of the marketing mix makes for a successful product.

 

As with any business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments in fast-growing markets and channels to grow market share. We discuss in greater detail risk factors relating to our business in Item 1A of this Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and the reports that we file from time to time with the SEC.

 

European Operations

 

We produce and distribute our fragrance products primarily under license agreements with brand owners, and fragrance product sales through our European operations represented approximately 68% of net sales for 2022. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. European operations will also become the exclusive worldwide licensee for Lacoste fragrances on January 1, 2024.

 

United States Operations

 

Prestige brand fragrance products are also produced and marketed through our United States operations, and represented approximately 32% of net sales for the year ended December 31, 2022. These fragrance products are sold under trademarks owned by us or pursuant to license or other agreements with the owners of brands, which include Abercrombie & Fitch, Anna Sui, Dunhill, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Ungaro.

 

Recent Developments

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted to Interparfums SA for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

2

 

 

Salvatore Ferragamo

 

In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.

 

With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition.

 

Emanuel Ungaro

 

In October 2021, we also entered into a 10-year exclusive global licensing agreement with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective on July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Fragrance Products

 

General

 

We are the owner of the Rochas brand, and the Lanvin brand name and trademark for our class of trade. In addition, we have built a portfolio of licensed prestige brands whereby we produce and distribute our prestige fragrance products under license agreements with brand owners. Under license agreements, we obtain the right to use the brand name, create new fragrances and packaging, determine positioning and distribution, and market and sell the licensed products, in exchange for the payment of royalties. Our rights under license agreements are also generally subject to certain minimum sales requirements and advertising expenditures as are customary in our industry.

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%

 

3

 

 

Our licenses expire on the following dates:

 

Brand Name   Expiration Date
Abercrombie & Fitch   Extends until either party terminates on 3 years’ notice
Anna Sui   December 31, 2026, plus one 5-year optional term
bebe Stores   June 30, 2023
Boucheron   December 31, 2025, plus a 5-year optional term if certain sales targets are met
Coach   June 30, 2026
DKNY   December 31, 2032, plus a 5-year optional term if certain sales targets are met
Donna Karan   December 31, 2032, plus a 5-year optional term if certain sales targets are met
Dunhill   September 30, 2023
Emanuel Ungaro   December 31, 2031, plus a 5-year optional term if certain sales targets are met
French Connection   December 31, 2027, plus a 10-year optional term if certain sales targets are met
Graff   December 31, 2026, plus 3 optional 3-year terms if certain sales targets are met
GUESS   December 31, 2033
Hollister   Extends until either party terminates on 3 years’ notice
Kate Spade   June 30, 2030
Jimmy Choo   December 31, 2031
Karl Lagerfeld   October 31, 2032
Lacoste*   December 31, 2038
MCM   December 31, 2030, plus 4 option years
Moncler   December 31, 2026, plus a 5-year optional term if certain conditions are met
Montblanc  

December 31, 2030

Oscar de la Renta   December 31, 2031, plus a 5-year optional term if certain sales targets are met
Ferragamo   December 31, 2031, plus a 5-year optional term if certain sales targets are met
S.T. Dupont   December 31, 2023
Van Cleef & Arpels   December 31, 2024

*The Lacoste license commences on January 1, 2024.

 

In connection with the acquisition of the Lanvin brand names and trademarks for our class of trade, we granted the seller the right to repurchase the brand names and trademarks on July 1, 2027 for €70 million (approximately $79 million) in accordance with an amendment signed in 2021. In connection with such amendment, we also granted a license to the seller to develop and sell cosmetics other than fragrances.

 

Fragrance Portfolio

 

Abercrombie & Fitch— In 2014, we entered into a worldwide license to create, produce and distribute new fragrances and fragrance related products under the Abercrombie & Fitch brand name. We distribute these fragrances in specialty stores, department stores and duty free shops, and in the U.S., in select Abercrombie & Fitch retail stores. Our initial men’s scent, First Instinct was launched in 2016 followed by a women’s version in 2017. Since that time, we unveiled several new fragrances most notably the Authentic and Away duos as well as brand extensions. 

 

4

 

 

Abercrombie & Fitch Co. is a leading, global, omnichannel specialty retailer of apparel and accessories for men, women and kids. The iconic Abercrombie & Fitch brand was born in 1892 and aims to make every day feel as exceptional as the start of a long weekend.

 

Anna Sui—In 2011, we entered into an exclusive worldwide fragrance license to create, produce and distribute fragrances and fragrance related products under the Anna Sui brand. Anna Sui is one of New York’s most accomplished fashion designers known for creating contemporary clothing inspired by vintage style that capture the brand’s very sweet feminine girly aspect, combined with a touch of hipness and rock-and-roll. Today, Anna Sui has over 50 boutiques and her collection and products are sold in 300 stores in over 30 countries, but her brand is by far most popular and well received throughout Asia. Over the past decade, we have worked in partnership with Anna Sui and her creative team to build upon the brand’s customer appeal and develop and market a family of fragrances including Fantasia, Sui Dreams and the newest scent, Sky, which was ranked as the second best perfume launch of 2021 by WWD Japan.

 

Boucheron— In 2010, we entered into an exclusive 15-year worldwide license agreement for the creation, development and distribution of fragrances and fragrance related products under the Boucheron brand. For over a century, since becoming the first jeweler to open a boutique on Place Vendôme in 1893, Boucheron has embodied very high-end creation, luxury and French know-how. The mysterious and seductive collection of Boucheron fragrances unquestionably continues this prestigious line of creations.

 

Boucheron’s legacy scents, Femme and Homme, and the legendary Jaipur perfume form the foundation of brand sales. Our team has enriched the portfolio with Quatre for men and women, along with several special editions, a growing collection of unique scents aptly named, La Collection, and Serpent Bohème. During 2022, we introduced a new men’s fragrance, Boucheron Singulier, as well as still another addition to our Boucheron Collection. Currently, Boucheron operates through several boutiques worldwide as well as an e-commerce site.

 

Coach— In 2015, we entered into an exclusive 11-year worldwide license to create, produce and distribute new men’s and women’s fragrances and fragrance related products under the Coach brand name. We distribute these fragrances globally to department stores, specialty stores and duty free shops, as well as in Coach retail stores.

 

Founded in 1941, Coach is the ultimate American leather goods brand and has always been renowned for its quality craftsmanship. Now the luxury brand that best embodies New York’s casual elegance, Coach also offers collections of ready-to-wear, lifestyle accessories and fragrances. Its contemporary approach to luxury combines authenticity and innovation, exported worldwide thanks to its thoroughly American non-conformist vision.

 

In 2016, we launched our first Coach fragrance, a women’s signature scent, and in 2017, a men’s scent, both of which became and remain top selling prestige fragrances. Subsequent flankers and extensions have enlarged the Coach fragrance enterprise as have entirely new collections, including Coach Dreams which debuted in early 2020, and its sister scent, Dreams Sunset, which debuted in 2021. For 2022, we unveiled Coach Wild Rose, and Coach Open Road, a new fragrance for men. Coach is part of the Tapestry house of brands.

 

Donna Karan/DKNY— In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands, which took effect on July 1, 2022. The Donna Karan and DKNY brands, which draw from the energy and attitude of New York City, are powerhouses in fashion and fragrance. These global lifestyle brands will make excellent additions to our portfolio. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. Upon joining our portfolio, these brands now rank among our largest. We are planning to launch new fragrances under these brands in 2024. Donna Karan and DKNY are part of the G-III house of brands.

 

5

 

 

Dunhill— Since 2012, we have been the exclusive fragrance licensee whereby we create, produce and distribute fragrances and fragrance related products under the Dunhill brand. Our rights under this license terminate on September 30, 2023.

 

Emanuel Ungaro— In October 2021, we also entered into a 10-year exclusive global licensing agreement with Emanuel Ungaro for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Founded in 1965 in Paris, the house of Emanuel Ungaro is an icon of French refinement and haute couture. Its unique style is expressed through unquestioning sensuality, purity of silhouette, flamboyant prints, and exquisite attention to details. Season after season, Emanuel Ungaro dared to be different, combining unexpected yet sensual clashes of bright colors and prints with beautiful draping. Today Ungaro fragrances uphold the same values of audacity and elegance, and the brand is best known and most prized internationally, and such presence will remain our sales focus as we continue to produce and distribute the brand’s legacy scents, notably Diva. Beginning in 2023, we plan to unveil a Diva brand extension.

 

Graff— In 2018, we entered into an exclusive, 8-year worldwide license agreement with London-based Graff for the creation, development and distribution of fragrances under the Graff brand. The agreement has three 3-year automatic renewal options, potentially extending the license until December 31, 2035.

 

Since Laurence Graff OBE founded the company in 1960, Graff has been dedicated to sourcing and crafting diamonds and gemstones of untold beauty and rarity and transforming them into spectacular pieces of jewelry that move the heart and stir the soul. Throughout its rich history, Graff has become the world leader for diamonds of rarity, magnitude and distinction. Each jewelry creation is designed and manufactured in Graff’s London atelier, where master craftsmen employ techniques to emphasize the beauty of each individual stone. The company remains a family business, overseen by Francois Graff, Chief Executive Officer.

 

For Graff, a six-scent collection for women, Lesedi La Rona, debuted exclusively at Harrods beginning in March 2020, which we further extended through 2020 as a result of the mandatory store closings throughout that year. In 2021, a select market rollout began in the Middle East, with limited luxury distribution to only the most exclusive, upmarket retail outlets. In 2021 and 2022, we added two new scents to the Lesedi La Rona collection.

 

GUESS— In 2018, we entered into an exclusive, 15-year worldwide license agreement with GUESS, Inc. for the creation, development and distribution of fragrances under the GUESS brand.

 

Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand. GUESS, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, footwear and other related consumer products. GUESS products are distributed through branded GUESS stores as well as better department and specialty stores around the world. 

 

We began selling GUESS legacy scents in 2018. In 2019 the GUESS brand quickly became the largest within our U.S. operations, with legacy fragrances dominating the sales mix. In 2019, we began shipments of 1981 Los Angeles and Seductive Noir, both flankers of established scents, which accelerated brand growth.

 

Nearly three years in the making, our first new blockbuster scent, Bella Vita, debuted for the GUESS brand both domestically and internationally in 2021. In addition, Effect, a new men’s grooming line and fragrance collection was launched in 2021. Uomo, a new men’s fragrance for GUESS, came to market in 2022 with a flanker debuting in 2023.

 

Hollister— In 2014, we entered into a worldwide license to create, produce and distribute new fragrances and fragrance related products under the Hollister brand name. We distribute these fragrances in specialty stores, department stores and duty free shops, as well as select Hollister retail stores in the U.S. In 2016 we launched our first men’s and women’s fragrance duo, Wave which led to flankers and extensions as did subsequent fragrance families Festival and Canyon Escape. We have a new pillar debuting in 2023, Feelin’ Good.

 

6

 

 

The quintessential apparel brand of the global teen consumer, Hollister celebrates the liberating spirit of the endless summer inside everyone. Inspired by California’s laidback attitude, Hollister’s clothes are designed to be lived in and made your own, for wherever life takes you.

 

Jimmy Choo— In 2009, we entered into an exclusive 12-year worldwide license agreement for the creation, development and distribution of fragrances and fragrance related products under the Jimmy Choo brand, and in 2017, we extended the license agreement which now runs through December 31, 2031.

 

Jimmy Choo encompasses a complete luxury accessories brand. Women’s shoes remain the core of the product offering, alongside handbags, small leather goods, scarves, eyewear, belts, fragrance and men’s shoes. Jimmy Choo has a global store network encompassing more than 200 stores and is present in the most prestigious department and specialty stores worldwide. Jimmy Choo is part of the Capri Holdings Limited luxury fashion group.

 

Our initial Jimmy Choo fragrance was launched in 2011, a signature scent for women. In the decade that followed, Jimmy Choo has grown to become our second largest brand with new pillars and flankers debuting regularly, both for men and women. Our newest women’s fragrance pillar, I Want Choo, was launched in 2021 and for 2022, two flankers debuted, Jimmy Choo Man Aqua and I Want Choo Forever. For 2023, Jimmy Choo Rose Passion is scheduled to be unveiled.

 

Karl Lagerfeld— In 2012, we entered into a 20-year worldwide license agreement with Karl Lagerfeld B.V., the internationally renowned haute couture fashion house, to create, produce and distribute fragrances under the Karl Lagerfeld brand.

 

Under the creative direction of the late Karl Lagerfeld, one of the world’s most influential and iconic designers, the Lagerfeld Portfolio represents a modern approach to distribution, an innovative digital strategy and a global 360 degree vision that reflects the designer’s own style and soul. Karl Lagerfeld created the first fragrance that bears his name in 1978, and that legacy has expanded to include several growing multi-scent collections, Les Parfums Matières and more recently, Karl Cities, a new collection featuring entries for New York, Paris, Hamburg, Tokyo and Vienna was unveiled.

 

Kate Spade— In 2019, we entered into an exclusive, 11-year worldwide license agreement with Kate Spade to create, produce and distribute new perfumes and fragrance related products under the Kate Spade brand which we distribute globally to department and specialty stores and duty free shops, as well as in Kate Spade retail stores. Our first original scent, Kate Spade New York, debuted in January 2021 and for 2022, we added a flanker to our line, Kate Spade Sparkle. Kate Spade Cherie debuted in early 2023.

 

Since its launch in 1993 with a collection of six essential handbags, Kate Spade has always stood for optimistic femininity. Today, the brand is a global life and style house with handbags, ready-to-wear, jewelry, footwear, gifts, home décor and more. Polished ease, thoughtful details and a modern, sophisticated use of color—Kate Spade’s founding principles define a unique style synonymous with joy. Under the vision of its creative director, the brand continues to celebrate confident women with a youthful spirit. Kate Spade is part of the Tapestry house of brands.

 

Lanvin— In 2007, we acquired the worldwide rights to the Lanvin brand names and international trademarks listed in Class 3, our class of trade. A synonym of luxury and elegance, the Lanvin fashion house, founded in 1889 by Jeanne Lanvin, expanded into fragrances in the 1920s.

 

Lanvin fragrances occupy an important position in the selective distribution market in France, Eastern Europe and Asia, and we have several lines currently in distribution, including Éclat d’Arpège, Lanvin L’Homme, Jeanne Lanvin, Modern Princess and A Girl in Capri. The Éclat d’Arpège line accounts for almost 50% of brand sales. Les Fleurs de Lanvin, a new floral fragrance collection, was released during the second half of 2021. For 2022, we unveiled a new extension to our Éclat d’Arpège line, Mon Éclat.

 

7

 

 

MCM— In 2019, we entered into an exclusive, 10-year worldwide license agreement with German luxury fashion house MCM for the creation, development and distribution of fragrances and fragrance related products under the MCM brand. The agreement has a 4-year automatic renewal option, potentially extending the license until December 31, 2034.

 

MCM is a luxury lifestyle goods and fashion house founded in 1976 with an attitude defined by the cultural Zeitgeist and its German heritage with a focus on functional innovation, including the use of cutting-edge techniques. Today, through its association with music, art, travel and technology, MCM embodies the bold, rebellious and aspirational. Always with an eye on the disruptive, the driving force behind MCM centers on revolutionizing classic design with futuristic materials. MCM’s millennial and Gen Z audience is genderless, ageless, empowered and unconstrained by rules and boundaries.

 

Following through on our plan to develop extraordinary fragrances that capture the creative spirit of MCM, our first new fragrance, MCM, was released during the first quarter of 2021 to great, and somewhat unexpected success. We released a flanker in 2022, along with a limited edition called Graffiti. Our distribution strategy encompasses MCM stores, high-end department stores and prestige beauty retailers, with a geographic focus on Asia, the Americas and Europe. Our first ever men’s scent for the brand is debuting in 2023.

 

Moncler— In June 2020, we entered into an exclusive, 5-year worldwide license agreement with a potential 5-year extension with Moncler for the creation, development and distribution of fragrances under the Moncler brand. Moncler was founded at Monestier-de-Clermont, Grenoble, France, in 1952 and is currently headquartered in Italy. Over the years, the brand has combined style with constant technological research assisted by experts in activities linked to the world of the mountain. The Moncler outerwear collections marry the extreme demands of nature with those of city life.

 

Our first fragrance for the Moncler brand has a revolutionary LED design, and the flask-shaped bottles of Moncler Pour Femme and Moncler Pour Homme forge a powerful bond with the House Moncler’s alpine roots and pioneering spirit. This playful and unique innovation enables its owner to write a personalized note that scrolls in red letters on the screen of the mirror bottle. Our first fragrance was pre-launched in 250 select outlets in the second half of 2021, and was met with an excellent response. The rollout to approximately 3,000 doors took place during 2022. Moncler will also launch a new collection in Q1 2023.

 

Montblanc—In 2010, we entered into an exclusive license agreement to create, develop and distribute fragrances and fragrance related products under the Montblanc brand. In 2015, we extended the agreement which now runs through December 31, 2025.

 

Montblanc has achieved a world-renowned position in the luxury segment and has become a purveyor of exclusive products, which reflect today’s exacting demands for timeless design, tradition and master craftsmanship. Through its leadership positions in writing instruments, watches and leather goods, promising growth outlook in women’s jewelry, international retail footprint through its network of more than 600 boutiques, high standards of product design and quality, Montblanc has grown to be our largest fragrance brand.

 

In 2011, we launched our first new Montblanc fragrance, Legend, which quickly became our best-selling men’s line and has given rise to a plethora of flankers including Legend Night and Legend Spirit. In 2014, we launched our second men’s line, Emblem and like its predecessor, Emblem gave rise to brand extensions. In 2019, we unveiled Montblanc Explorer, which has added flankers, most recently Montblanc Explorer Ultra Blue. The Legend continues, as in 2022, we introduced a new flanker, Montblanc Legend Red. For 2023, extensions for the Montblanc signature scent for women and Explorer line for men are in the pipeline.

 

8

 

 

Oscar de la Renta— In 2013, we entered into an exclusive worldwide license to create, produce and distribute fragrances and fragrance related products under the Oscar de la Renta brand. In 2019, the agreement was extended through December 31, 2031, with an additional five-year option potentially extending the agreement through December 31, 2036. After taking over distribution of the brand’s legacy fragrances in 2014, we introduced Extraordinary the following year. Oscar de la Renta Bella Blanca debuted in 2018, followed by Bella Rosa and Bella Essence and soon to join them, Bella Bouquet. Debuting in 2021 was an entirely new fragrance pillar, Alibi which welcomed a sister scent in 2022, Alibi Eau de Toilette.

 

Oscar de la Renta is one of the world’s leading luxury goods firms. The New York-based company was established in 1965, and encompasses a full line of women’s accessories, bridal, children’s wear, fragrance, beauty and home goods, in addition to its internationally renowned signature women’s ready to wear collection. Oscar de la Renta products are sold globally in fine department and specialty stores, www.oscardelarenta.com and through wholesale channels.

 

Rochas— In 2015, we acquired the Rochas brand from The Procter & Gamble Company. Founded by Marcel Rochas in 1925, the brand began as a fashion house and expanded into perfumery in the 1950s under Hélène Rochas’ direction.

 

Our first new fragrance for Rochas, Mademoiselle Rochas, had a successful launch in 2017 in its traditional markets of France and Spain. Over the next few years, we debuted flankers for legacy scents Eau de Rochas and Mademoiselle Rochas, plus others, and in 2018 we launched our first new men’s line, Rochas Moustache. Byzance debuted in early 2020 and Rochas Girl in 2021, and the first flanker for both came to market in 2022 as well as one for L’Homme Rochas. Flankers for many of these pillars debuted in 2022 with more to come in 2023.

 

Ferragamo— In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide 10-year license was granted for the production and distribution of Ferragamo brand perfumes, with a 5-year optional term if certain conditions are met. Salvatore Ferragamo S.p.A. is the parent company of the Salvatore Ferragamo Group, one of the world’s leaders in the luxury industry and whose origins date back to 1927. Named after its founder, the brand still represents and lives by the original values of Salvatore Ferragamo. The uniqueness and exclusivity of its creations, along with the perfect blend of style, creativity and innovation enriched by the quality and superior craftsmanship of the ‘Made in Italy’ tradition, have always been the hallmarks of the Salvatore Ferragamo’s products notably shoes, leather goods, apparel, silk products and other accessories for men and women.

 

The current fragrance lineup includes Storie di Seta, a collection of four refined, luminous olfactory works of art. Each fragrance is made with rare, sustainable raw materials, and can be worn alone or in combination, creating a personalized multifaceted scent. The genderless collection is comprised of four fragrances in four colors. Four exclusive motifs drawn from the House’s textile heritage adorn each flacon. Established scents in the Ferragamo portfolio include Ferragamo, a collection of fragrances for men, Signoria, a collection of fragrances for women, the Tuscan Creations series, the Amo series and the Uomo series. New flankers are in the works for 2023 and 2024 with a major new pillar in the works for 2025.

 

S.T. Dupont— In 1997, we signed an exclusive worldwide license agreement with S.T. Dupont for the creation, manufacture and distribution of S.T. Dupont fragrances. The license agreement had been renewed several times and is now renewed annually, without any material changes in terms and conditions. S.T. Dupont is a French luxury goods house founded in 1872, which is known for its fine writing instruments, lighters and leather goods. S.T. Dupont fragrances include S.T. Dupont pour Femme, S.T. Dupont pour Homme, Pure and S.T. Dupont Collection.

 

Van Cleef & Arpels— In 2018, we renewed its license agreement for an additional six years with Van Cleef & Arpels for the creation, development, and distribution of fragrance products through December 2024. Our initial 12-year license agreement with Van Cleef & Arpels was signed in 2006.

 

9

 

 

Van Cleef & Arpels fragrances in current distribution include: First and Collection Extraordinaire. Sales of the Collection Extraordinaire line have experienced continued growth since its debut. We continue to introduce new additions to the Van Cleef & Arpels Collection Extraordinaire assortment annually, including Oud Blanc, in 2020 and Rêve de Matiere in 2021. Patchouli Blanc is the new addition to the Collection Extraordinaire, released in 2022 with further additions coming in 2023. Founded in 1896, Van Cleef & Arpels is a French luxury jewelry company owned by Richemont Holdings Limited.

 

Business Strategy

 

Focus on prestige beauty brands. Prestige beauty brands are expected to contribute significantly to our growth. We focus on developing and launching quality fragrances utilizing internationally renowned brand names. By identifying and concentrating in the most receptive market segments and territories where our brands are known, and executing highly targeted launches that capture the essence of the brand, we have had a history of successful launches. Certain fashion designers and other licensors choose us as a partner, because our Company’s size enables us to work more closely with them in the product development process as well as our successful track record.

 

Grow portfolio brands through new product development and marketing. We grow through the creation of fragrance family extensions within the existing brands in our portfolio. We regularly create a new family of fragrances for each brand in our portfolio. We frequently introduce seasonal and limited edition fragrances as well. With new introductions, we leverage our ability and experience to gauge trends in the market and further leverage the brand name into different product families in order to maximize sales and profit potential. We have had success in introducing new fragrance families (sub-brands, flanker brands or flankers) within our brand franchises. Furthermore, we promote the performance of our prestige fragrance operations through knowledge of the market, detailed analysis of the image and potential of each brand name, and a highly professional approach to international distribution channels.

 

Continue to add new brands to our portfolio, through new licenses or acquisitions. Prestige brands are the core of our business, and we intend to add new prestige beauty brands to our portfolio. Over the past 35 years, we have built our portfolio of well-known prestige brands through acquisitions and new license agreements. We intend to further build on our success in prestige fragrances and pursue new licenses and acquire new brands to strengthen our position in the prestige beauty market. To that end, in 2020, we signed a new license for the Moncler brand. We also acquired a minority interest in Divabox, which owns the Origines-parfums online platform. As a website of reference for all selective fragrance brands, Origines-parfums is a key French player in the online beauty market recognized for its customer relationship expertise. This acquisition enhances the introduction of dedicated fragrance lines and products designed to address a specific consumer demand for this distribution channel and accelerate our digital development. During 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. In 2021, we also entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. This exclusive license became effective in July 2022. During 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted to Interparfums SA for the production and distribution of Lacoste brand perfumes and cosmetics. As of December 31, 2022, we had cash, cash equivalents and short-term investments of approximately $256 million, which we believe should assist us in entering new brand licenses or outright acquisitions. We identify prestige brands that can be developed and marketed into a full and varied product families and, with our technical knowledge and practical experience gained over time, take licensed brand names through all phases of concept, development, manufacturing, marketing and distribution.

 

Expand existing portfolio into new categories. We selectively broaden our product offering beyond the fragrance category and offer other fragrance related products and personal care products under some of our existing brands. We believe such product offerings meet customer needs, generate trial and further strengthen customer loyalty.

 

10

 

 

Continue to build global distribution footprint. Our business is a global business, and we intend to continue to build our global distribution footprint. In order to adapt to changes in the environment and our business, in addition to our arrangements with third party distributors globally, we are operating distribution subsidiaries or divisions in the major markets of the United States, France, Italy and Spain for distribution of prestige fragrances. We may look into future joint arrangements or acquire distribution companies within other key markets to distribute certain of our prestige brands. While building a global distribution footprint is part of our long-term strategy, we may need to make certain decisions based on the short-term needs of the business. We believe that in certain markets, vertical integration of our distribution network may be one of the keys to future growth of our Company, and ownership of such distribution should enable us to better serve our customers’ needs in local markets and adapt more quickly as situations may determine.

 

Production and Supply

 

The stages of the development and production process for all fragrances are as follows:

 

  ● Simultaneous discussions with perfume designers and creators (includes analysis of esthetic and olfactory trends, target clientele and market communication approach)
     
  ● Concept choice
     
  ● Produce mock-ups for final acceptance of bottles and packaging
     
  ● Receive bids from component suppliers (glass makers, plastic processors, printers, etc.) and packaging companies
     
  ● Choose suppliers
     
  ● Schedule production and packaging

 

  ● Issue component purchase orders

 

  ● Follow quality control procedures for incoming components; and

 

  ● Follow packaging and inventory control procedures.

 

Suppliers who assist us with product development include, but are not limited to:

 

  ● Independent perfumery design companies (Aesthete, Carré Basset, PI Design, Cent Degres)

 

  ● Perfumers (IFF, Givaudan, Firmenich, Robertet, Takasago, Mane) who create a fragrance consistent with our expectations and, that of the fragrance designers and creators
     
  ● Fillers (Voyant, CPFPI, Omega Packaging, Societe de Diffusion de Produits de Parfumerie, TSM Brands, ICR, Cosmint, Tatra, Arcade Beauty)

 

  ●

Bottle manufacturers (Pochet du Courval, Verescence, Verreries Brosse, Bormioli Luigi, Stoelzle Masnières, Heinz), caps (Qualipac, ALBEA, RPC, Codiplas, LF Beauty, Texen Group, S.A.R.L. J3P SBG Packaging Group), Pumps (Silgan Dispensing Systems Thomaston Corp, Aptar, Rexam) or boxes (Autajon, Diamond Packaging, TPC Printing) 

 

  ● Logistics (Bansard and Bolloré Logistics for storage, order preparation and shipment)

 

11

 

 

Suppliers’ accounts for our European operations are primarily settled in euro and for our United States operations, suppliers’ accounts are primarily settled in U.S. dollars. For our European operations components for our prestige fragrances are purchased from many suppliers around the world and are primarily manufactured in France.

 

For United States operations, components for our prestige fragrances are sourced from many suppliers around the world and are primarily manufactured in the United States and Italy. Additionally, we occasionally utilize third party manufacturers in China and Turkey.

 

Environmental, Social & Governance

 

Both our U.S. operations and our European operations are good corporate citizens and take our responsibilities seriously. We comply with all applicable laws, rules and regulations in general, and in particular with regard to chemicals and hazardous materials. Throughout our supply chain, from procurement of components to distribution of finished products, we act responsibly and monitor and comply with all legal requirements. While we do not own our manufacturing facilities, we set a high bar with our industrial partners by placing an emphasis on quality, the use of good manufacturing practices and innovation, and encouraging them to build strong ESG programs of their own. Like many of our industry competitors, we are applying a multifunctional and comprehensive approach in addressing the issues of corporate, environmental and social responsibility and transparency, building off the UN Sustainable Development Goals. Our European Operations have led the way on this initiative, but our US operations are actively catching up.

 

European Operations

 

Interparfums SA, our European operations with their headquarters in Paris, has made further progress in the areas of environmental, social, and corporate governance (ESG) based on the results of the 2022 campaign of the rating agency Gaïa Research1 which ranks the top performing companies in this area.

 

Campaign for Fiscal Year 2020 for Fiscal 2019 2021 for Fiscal 2020 2022 for Fiscal Year 2021
ESG Rating 69/100 76/100 81/100

 

This score is calculated on the basis of 140 criteria divided into 4 pillars: Environmental, Social, Governance and External Stakeholders.

 

Interparfums SA applies a comprehensive approach in addressing the issues of corporate, environmental and social responsibility and transparency. It has developed from one year to the next its corporate social responsibility (“CSR”) policy, implemented by its Operational and Support Departments by involving all personnel, and has identified issues to be addressed in three key areas: its responsibilities toward operational stakeholders, staff and the company. Social and societal values have been an important component of Interparfums SA’s development for a number of years, exemplified notably by an attractive policy of employee benefits and solid relations with its partners.

 

In October 2022, Interparfums SA announced that it had retained the services of Muriel Buiatti, as its CSR Project Manager to assist the CSR Executive Committee in achieving its goals. A graduate of the French Engineering School, Ecole Polytechnique, Ms. Buiatti exercised various responsibilities, including research and development, at L’Oréal for 13 years. After completing her Master’s Degree in Sustainable Development, she founded Commenterre, which specializes in helping companies address their CSR issues.

 

 

1 Gaïa Research, a member of the EthiFinance Group is an extra-financial rating agency specializing in rating the ESG performance of small and midsize companies and mid-cap companies listed on European markets.

 

12

 

 

To support its strategy, at the beginning of 2021 and at the initiative of management, Interparfums SA created an CSR Executive Committee, consisting of members of the Operations & Supply Chain, Human Resources, Legal Affairs and Communications teams, tasked with formalizing the company’s CSR strategy focusing on the following priorities, aligned with the UN Sustainable Development Goals:

 

-reinforce its status as a responsible employer, by notably creating a “Responsible Employer Charter” and strengthening the employee training plan;

-reduce its environmental footprint, notably by adopting environmentally optimized design specifications to reduce packaging and the introduction of recycled and recyclable materials for each product developed;

-strengthen its sustainable development approach by formalizing a code of business conduct and ethics that is enforceable against operational stakeholders.

 

Environmental

 

Interparfums SA does not own its own manufacturing facilities, having chosen to support its industrial partners by placing an emphasis on quality, the use of good manufacturing practices and innovation. The construction of a high quality environmentally certified warehouse in 2011 and sourcing in Europe more than 80% of its needs highlight the efforts undertaken in recent years. In addition, reflecting the stakes in terms of protecting the planet, Interparfums SA now intends to also exercise an increasingly active role in contributing to the environment.

 

As part of its CSR strategy, Interparfums SA has partnered with EcoVadis to assess the CSR performance of its supply chain and suppliers. EcoVadis operates a global platform to assess corporate social responsibility and share performance data using their assessment method based on international CSR standards.

 

In 2022, 119 suppliers were evaluated or were in the process of being evaluated, representing over 68% of Interparfums SA’s procurement activity. As part of a continuous improvement process, Interparfums SA’s objective will be to monitor and encourage the CSR performance of its suppliers in four major areas: the environment, social and human rights, ethics and responsible procurement.

 

EcoVadis assessment results:

 

Number of suppliers evaluated Average EcoVadis score Average Environmental score Average Labor and Human Rights score Average Ethics score Average Sustainable Procurement score
91 66.7 69.5 66.9 60.7 65.3

 

In addition, in 2022, Interparfums SA has calculated its total carbon footprint in accordance with international standards, and namely the Green House Gas Protocol (GHG Protocol) for the conversion of all emission sources into tons of CO2 equivalent and the Base Carbone®, a public database of emission factors made available by the French Agency for Ecological Transition (ADEME).

 

2021 Carbon footprint: 174,930 tCO2e

-2021 Carbon intensity: 312 KgCO2e per € thousand of revenue (in the low range of our industry)

 

13

 

 

In tons CO2 equivalent  2021   Weight 
Scope 1 (gas and fuel energy consumption)   226    0,1%
Scope 2 (electricity consumption)   29    0,0%
Scope 3 (other indirect emissions)   174,675    99,9%
Total   174,930    100,0%

 

(GRAPHIC) 

 

This first measurement is a crucial step before determining a low carbon trajectory in accordance with the European green deal regulation which aims to be climate-neutral by 2050.

 

Moreover, Interparfums SA complies with IS 22716, International Standards for Good Manufacturing Practices, with all aspects of the manufacturing process, including receiving of raw materials and packaging materials, production and quality control. In this regulatory environment, regular audit campaigns are carried out for all packaging plants by the quality department based on the ISO 22716 standard in place. The ultimate purpose of these audits is to ensure that packaging service providers maintain a good level of traceability for their activities. All plant activities were reviewed: receiving process for raw materials and packaging materials, manufacturing, packaging and quality controls. These reports demonstrated that Interparfums SA’s subcontractors comply with ISO 22716 Good Manufacturing Practices and in particular, traceability requirements for all perfume production operations. It is also in compliance with the EU directive entitled Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”), which governs and regulates the safe use of chemicals. Although not a manufacturer, per se, Interparfums SA has taken the initiative and monitors its suppliers for compliance with REACH, and has commitments from each of them concerning “Substances of Very High Concern” as listed in appendix XIV of REACH. No supplier of Interparfums SA has advised it of any such hazardous materials in any of its products to date.

 

Interparfums SA monitors the outsourcing of the entire production process of its manufacturing partners with expertise and accountable leadership in their respective areas. These include producers of juice, glass, caps and cardboard boxes and packaging companies. We take environmental issues into account at each of these phases, and in particular regarding the choice of materials used for components, waste management and reducing the carbon footprint. Moreover, all the alcohol used by Interparfums SA is from vegetal origin (essentially from beets).

 

14

 

 

Proposing environmentally and socially responsible packaging
  2021 2022 Target Year
Monitor: Monitor the EcoVadis scores of our suppliers Average score 65/100 Average score 66.7/100 Average score >70/100  2025
Increase: Increase the PCR glass part of our packaging 47 % 46 % 60 % 2025
Initiating a low-carbon trajectory

Reduce: Reduce scope 1, 2, 3 greenhouse gases emission intensity

 -3%/year   Neutrality 2040
Contribute Define the appropriate regenerative agriculture program One 5 years program defined    

 

 

Sustainability & The Environment

 

At every stage of the purchasing process, Interparfums SA seeks to determine the precise needs and considers the requirement of limiting sources of unnecessary costs and a waste of resources:

 

-reducing waste, in particular at the phases of production, consumption and the end of the product life;

 

-recycling flawed production, notably at the production phase;

 

-repairing palettes to increase their lifespan.

 

Interparfums SA regularly monitors energy and water consumption indicators to assess possibilities for improving energy efficiencies in the area of lighting, heating and air-conditioning for the entire warehousing site, for example by adjusting ventilation flows and using a program that reduces heating and ventilation over weekends.

 

With this objective, measures are planned to automatically turn off lights in the warehouse when employees are taking outside breaks and maintain the warehouse temperature at 11°C (51°Fahrenheit). These energy savings initiatives include measures providing for managing the hours for reloading the electric forklifts during non-peak hours during the night, requiring low consumption for a maximum of 280,000 kW instead of 600,000 kW during the day. Monthly reports on electricity consumption are prepared, allowing the company to analyze the causes for overconsumption, when applicable, in order to take corrective actions as applicable. The measurement of energy consumption highlighted stable levels for electricity and gas over the last four years, whereas water consumption has on average declined marginally. Finally, in the spirit of contributing to protecting the environment, the company has installed parking places at the logistic site for bicycles and electric recharging stations for cars.

 

By strategically locating its warehouse at the crossroads for its subcontractors, Interparfums SA has reduced distances for shipments of finished products.

 

Measures undertaken in collaboration with the warehouse and trade goods shipping manager, within the framework of the improvement and optimization of shipments between production sites and the logistics platform have contributed to reducing the number of back-and-forth trips for trucks.

 

15

 

 

In the area of transport to distributors, Interparfums SA uses road transport for France and Europe and maritime transport for the Americas, Asia and the Middle East. Use of air transport is very limited and reserved only for urgent situations where no other solutions are available. Certain promotional materials manufactured in Asia are shipped directly to American distributors without being imported and stored in France.

 

In addition, in 2018 Interparfums SA put into service a new warehouse located in Singapore to promote the use of short channels within the Asia Pacific region. This warehouse makes it possible to maintain a permanent inventory in this region and, in this way, encourages the use of maritime transport for goods shipped from France to Asia.

 

Measures to prevent environmental risks and pollution involve firstly the choice of techniques and materials.

 

To reduce the impacts of its activities, a water-soluble solution in part biodegradable that does not harm the environment is used in the coloring of some of its bottles. For the remainder of the product lines, the coating process provides for the gradual elimination of solvent-based coatings and the progressive adoption of hydro-coating for all the company’s products, in compliance with the law of 2005 for reducing emissions of Volatile Organic Compounds (VOC) in the air. In addition, certain sub-contractors for glass making have electrostatic air filters to reduce dust and smoke emissions in addition to wastewater recycling.

 

Interparfums SA has, in addition, eliminated thermosetting plastics from its line of bath and body care products in favor of recyclable plastic.

 

To balance product quality and aesthetics with environmental considerations, Interparfums SA takes care to reduce packaging volumes and select the appropriate materials at each stage of production to ensure optimal conditions for their recycling or disposal.

 

The manufacture of recyclable glass bottles includes a system for the recovery, crushing and remolding the waste. Indicators in place since 2013 for tracking wastage have improved Interparfums SA’s ability to monitor wastage rates by glass bottle decorators. Its first objective is to apply a continuous improvement approach and reduce rates of wastage over the long term. The second objective is to succeed in reducing this wastage and reintroduce bottles back into the manufacturing cycle.

 

In addition, Interparfums SA has adopted procedures for recovering waste from subcontractors originating from surplus production or components of discontinued products. The recovered waste is then sorted for the purpose of their elimination.

 

Interparfums SA has also revised the bulk and secondary packaging (product boxes and perfume sets) in order to optimize the palletizing process, reduce the purchase of cardboard packaging materials and reduce volumes transported by decreasing the amount of empty space. The company henceforth requires a minimum number of palettes per truck.

 

Finally, cardboard packaging materials for testers are 100% recyclable.

 

Social

 

Donations and sponsorship initiatives:

 

-Interparfums SA contributes to volunteer-sector organizations intervening in the areas of solidarity, childhood, combating exclusion and promoting health, by providing financial assistance to support their projects and initiatives.

 

-Since 2018, through the Givaudan Foundation,

 

-Interparfums provided support to five schools for the management of their libraries.

 

16

 

 

-In 2021, the program for the installation of school libraries continued in Sulawesi with a new library in Moramo (South East Sulawesi), benefiting 1,040 children and 66 school teachers, and providing a total of 5,180 books.

 

-In 2021, €136,000 of charitable initiatives and donations were made by Interparfums SA.

 

-Educational establishments:

 

-As part of its desire to share its experience and train future generations, Interparfums SA is a regular contributor, particularly in the fields of marketing and finance, at different leading schools (business schools, Sciences Po, École supérieure de parfumerie).

 

-Interparfums SA also regularly welcomes and trains interns at Interparfums SA offices as well as work-study contract beneficiaries.

 

Assisting Local Economies

 

-Production facilities of Interparfums SA’s subcontractors as well as warehousing facilities for finished products are located primarily in the Haute Normandie region of France. These activities contribute to developing the local economy.

 

-Interparfums SA provides support for patchouli-producing communities in Indonesia.

 

Sustainable Development Goals

 

In line with Interparfums SA’s Corporate Social Responsibility strategy, the main goals set by Interparfums SA are presented in the following table.

 

Social Initiatives Current Situation Expected performance Deadline   
Attracting, supporting and developing all talents

Attract:

 Write a Responsible Employer Charter Share the Responsible Employer Charter 2023
Develop: Strengthen training 50% of the employees      70% of the employees 2025
Develop : CSR training for employees - 80% in 2 years 2023

Diversify: Raising employee             awareness about  disabilities

 Once a year Once a year          

 

Governance

 

-Interparfums SA only engages in recognized ethical practices.

 

-It has adopted the Middlenext Corporate Governance Code since 2010, which was revised in September 2016 and September 2021 to ensure effective governance.

 

-Board of Directors – Interparfums SA has a Board of Directors consisting of 11 members, with 5 members being independent. It also intends to set up a committee of shareholders.

 

17

 

 

○Director Ethics - in accordance with the new Middlenext Code Recommendation 2 reinforcing the management of conflicts of interest, each Director declares before each meeting any potential conflicts of interest and, on an annual basis, any actual or potential conflicts of interest between their obligations to Interparfums SA and their private interests, in particular with respect to their other offices and functions.

 

○In any event, the members of the Board shall refrain from participating in the proceedings and voting on any matter in which they would be in a situation of real or potential conflict of interest.

 

-Existence of a CSR Executive Committee

 

-Audit committee consisting of 5 independent directors.

 

United States Operations

 

In the U.S. we are also a good corporate citizen. Like our French subsidiary, Interparfums USA also retained Muriel Buiatti to advise and guide us on our path to become a better corporate citizen, as we attempt to increase our efforts in ESG. Also, like our French subsidiary, we are also not a true manufacturer, but we regularly monitor our subcontractors, suppliers and fillers for their compliance. In addition, our subcontractors and fillers are subject to inspection and audit from our various licensors for compliance with all aspects of law.

 

Environmental

 

In connection with a new product launch in 2023, Hollister Feelin’ Good, this new fragrance highlights our ESG efforts we made in 2022:

●Glass containing 10% PCR (post-consumer recycled) glass, and is 100% recyclable.

●Our folding cartons meet the requirements of SFI, the Sustainable Forestry Initiative, and are 100% recyclable.

●Liners are 100% recyclable.

●All components sourced from North/South America – closer supply chain for Hollister brand fragrances and are filled and warehoused in the United States.

 

In addition, all folding cartons for all licensed brands in United States operations now consist of FSC, the Forest Stewardship Council, or SFI certified paper. We are also making efforts to regionally source components to filling and warehousing locations where practicable in order to lessen shipping and thereby lower energy costs. For 2023 most giftsets will be reduced in format and size, and we have eliminated plastic from the following branded gift sets completely, Abercrombie & Fitch, Donna Karan, DKNY, Hollister, MCM and Oscar de la Renta.

 

Our largest filler in the United States has been awarded Bronze status in 2022 from EcoVadis. One of our largest pump manufacturers is the recipient of a 2021 Gold Medal from EcoVadis for Sustainability and a 2020 Bronze Medal from EcoVadis for its corporate social responsibility rating, and a large glass bottle manufacturer was awarded gold metals from EcoVadis for its corporate social responsibility rating two years in a row. In addition in 2021, a large glass bottle manufacturer that we utilize received an “A” rating for leadership in corporate sustainability by CDP, a global environmental non-profit group, ranking ‘A’ for tackling water security and ‘A-’ for leading effort against climate change.

 

In our U.S. operations, we do not use any banned ingredients or components and use sustainable ingredients where practicable. Some componentry (glass/folding cartons) is also recyclable where practicable. For example, our Abercrombie & Fitch Away fragrance uses glass and folding cartons that are 100% recyclable, and the carton liner is 100% recyclable and biodegradable.

 

Lastly, our product development team works with our fragrance houses – all very sustainable in their own right – to incorporate sustainably sourced ingredients in the fragrance oils used.

 

18

 

 

In addition to our production operations complying with applicable law, our managers, supervisors and traffic coordinators in our New Jersey distribution center undergo training in order for us to comply with Dangerous Goods Regulations. Compliance requires training and certification to deal in hazardous materials to prevent damage to the environment. The two main certifications are:

 

International Maritime Dangerous Goods (IMDG) Dangerous Goods Training – 3 year Certification for Ocean Shipment and International Air Transport Association (IATA) Dangerous Goods Training – 2 year Certification for Global Air Shipments.

 

Further, our distribution center in New Jersey has in-rack sprinklers to accommodate our hazardous material products. Our fragrances, Class 9 – Consumer Commodity ID8000, are registered with American Chemistry Council, Inc. (known in the chemicals industry as Chemtrec). Chemtrec has a 24/7 hazardous materials emergency communications center, which provides immediate assistance for incidents involving hazardous materials of any kind.

 

Social & Governance

 

We have an Ethical Code of Conduct, which governs our behavior in the following subject matters:

 

CSR & Governance

Employer Values

Social Values

Corporate Governance

Brand Initiatives

The Environment

Dangerous Goods Regulations

 

CSR & Governance

 

Introduction

 

●Responsible employment, corporate citizenship and governance practices have been an integral part of our values from day one
●In our recent past, environmental practices were mainly based on Good Manufacturing Practices and U.S. sourcing.
 ●Today, our aim is to elevate the issue of environmental responsibility

Practices recognized in the areas of responsible employment, social responsibility and governance

●Employer values: A responsible employer

○An “Interparfums spirit” cultivating a sense of belonging #OneIP #OneTeam #OneDream

○A proactive employee relations policy

●Social values: Long-standing practices

○Ethical conduct

○Close relations with our partners

●Governance values: Long-proven practices

○Quality of profiles, balance between independent/non-independent board members

○Following Inter Parfums, Inc. Board of Directors’ Diversity Policy

 

Interparfums USA contributes to protecting the environment

●Application of Good Manufacturing Practices

●Audits of packaging service providers

●U.S. sourcing: 64%

 

19

 

 

A value chain from design to distribution

●Approximately 40.5 million bottles were shipped in 2022 throughout the globe

●Approximately 2.5 million gift sets are to be shipped per year, throughout the globe

●Working with U.S. packaging sites:

○6 fragrance filling and assembly sites

○About 20 packaging component sites

●A 150,000 sq. ft. warehouse and distribution facility in Dayton, New Jersey

●Points of sale all around the world

 

Targets

 

●Reinforcing our status as socially engaged and responsible employer

●Reinforcing our corporate governance practices

●Become an active contributor to protecting the environment

 

Recent Actions

 

Creation of working groups to integrate an “optimized eco-design” component in products over their entire lifecycle

●Use of environmentally responsible materials

●Reducing weight and size of glass, cardboard and plastics

●Strengthening relations with design houses (natural products, sourcing, traceability)

 

Employer values

 

Current situation: A proactive employee relations policy

 

Long-standing fundamentals

●A family-style management culture built on fostering close relations

●An “Interparfums spirit” promoting a sense of belonging

●Ethical values based notably on respecting people

●Welcoming and sharing new ideas

●Job preservation

●Paid time off for vacation, sick days and personal days

 

Workplace Quality of life

●Positions that encourage responsibility and autonomy

●Respecting a proper balance between business and private life

●Managing talent (appraisal interviews, training)

●A commitment to combating all forms of discrimination

●Paid sick leave benefits, including maternity leave and caring for a family member with a serious health condition

 

A motivating compensation policy

●Compensation levels in line with market practice

●Savings plans in the form of 401K

●Available health insurance programs with multiple coverage options

●Stock option plans available for certain officers and high-level employees

 

20

 

 

Targets

●Formalizing employee relations practices through an employee Workplace Safety Committee


Social Values

 

Current situation: Recognized business ethics

 

Relations with brands under license agreements

●A focus on developing genuine partnerships through close and regular relations with the management of each brand

●Developing products that respect the codes of each brand

●Dedicated Interparfums USA marketing teams

 

Relations with customers

●Long (or very long-term) relationships with distributors

●Taking into account the specific characteristics of each market and country

●Developing products in some cases specifically adapted to demands

●Sharing projects at a very early stage

 

Relations with industrial partners

●Long or very long-term relationships with manufacturers in the sector

●Implementing guidelines on “Good Manufacturing Practices”

●Supporting innovation

●Financial support (2020 pandemic)

 

Targets

●Raising awareness of our partners about CSR challenges

 

Corporate governance

 

Current situation: Long-proven practices

 

Board of Directors

●10 members: 6 independent directors (60%)

 

Audit Committee, Executive Compensation Committee and Nominating Committee

●3 members: 3 independent directors (100%)

 

Important Business Policies

●Prohibition on fraud, bribes, kickbacks and other benefits to suppliers and customers

●Prohibition on trading in the company’s securities on the basis of non-public material information

●Requirement of Company-wide confidentiality for non-public sensitive or proprietary information

●Prohibition on sexual harassment

●Prohibition on use of child labor and slave labor

 

Targets

●Consolidating our existing corporate governance practices

●Strengthening alignment with Inter Parfums, Inc. Board Diversity Policy

 

21

 

 

Brand initiatives

 

MCM

 

MCM EAU DE PARFUM PACKAGING SUSTAINABILITY

●Outer packaging is 100% recyclable and Forest Stewardship Council (FSC) certified

○FSC sets standards for responsible forest management

○FSC is the gold standard in forest certification

●Glass bottle is made from post-industrial recycled materials

●Only environmentally friendly ink and colorants were used for the bottle and carton

 

HOLLISTER

 

HOLLISTER CANYON ESCAPE named “GOOD FOR VEGAN” by Sephora

●Hollister Canyon Escape For Him and Hollister Canyon Escape For Her meet the following criteria:

○Do not contain substances of animal origin (i.e., carmine, beeswax, honey, royal jelly, marine collagen, lanolin, fish extract, musk, silk, gelatin, milk, keratin, etc.)

○Formula has not been tested on animals

○Do not contain raw materials that have been tested on animals since March 11, 2009 for cosmetic purposes

 

ABERCROMBIE & FITCH

 

ABERCROMBIE & FITCH AWAY PACKAGING SUSTAINABILITY

●Uses glass and folding cartons that are 100% recyclable

●Carton liner is 100% recyclable and biodegradable

 

The Environment

 

Focus of 2022 work

 

Today, Interparfums USA is pursuing an environmental approach in the following areas

●Manufacturing of components

●The design of fragrances (juice)

●Industrial packaging

 

Production of components

●Glass bottles: Reducing consumption of glass and systematic use of recycled glass for launches

●Packaging: Reducing consumption of cardboard, use of sustainable FSC-certified cardboard

●Gift sets: Use of FSC cardboard

 

Design of fragrances (“juice”)

●Continue close collaboration with fragrance houses to incorporate sustainably sourced ingredients in the fragrance oils used

 

Industrial packaging

●Continue to work in close collaboration with EcoVadis Award Winning packaging service providers

○Our largest filler in the United States has been awarded Bronze status in 2022 from EcoVadis. One of our largest pump manufacturers is the recipient of a 2021 Gold Medal from EcoVadis for Sustainability and a 2020 Bronze Medal from EcoVadis for its corporate social responsibility rating, and a large glass bottle manufacturer was awarded gold metals from EcoVadis for its corporate social responsibility rating two years in a row.

 

22

 

 

EcoVadis

●A platform used by the main perfumes & cosmetics industry players

●4 pillars:

○The environment

○Social & Human Rights

○Ethics

○Responsible sourcing

 

Targets

●Become an active contributor to protecting the environment as well as through our business partners

 

As we continue in our endeavors of responsible employment, corporate citizenship and governance practices, and continue to elevate the issue of environmental responsibility, we will update our policies and procedures accordingly. As such, this Ethical Code of Conduct will be updated from time to time.

 

Marketing and Distribution

 

Our products are distributed in over 120 countries around the world through a selective distribution network. For our international distribution, we either contract with independent distribution companies specializing in luxury goods or distribute prestige products through our distribution subsidiaries. In each country, we designate anywhere from one to three distributors on an exclusive basis for one or more of our name brands. We also distribute our products through a variety of duty free operators, such as airports and airlines and select vacation destinations.

 

As our business is a global one, we intend to continue to build our global distribution footprint. For the distribution of brands within our European based operations, we operate through our distribution subsidiaries or divisions in the major markets of the United States, France, Italy and Spain, in addition to our arrangements with third party distributors globally. Our third party distributors vary in size depending on the number of competing brands they represent. This extensive and diverse network together with our own distribution subsidiaries provides us with a significant presence in over 120 countries around the world.

 

Over 50% of our European based prestige fragrance net sales are denominated in U.S. dollars. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

The business of our European operations has become increasingly seasonal due to the timing of shipments by our distribution subsidiaries and divisions to their customers, which are weighted to the second half of the year.

 

For our United States operations, we distribute products to retailers and distributors in the United States as well as internationally, including duty free and other travel-related retailers. We utilize our in-house sales team to reach our third party distributors and customers outside the United States. In addition, the business of our United States operations has become increasingly seasonal as shipments are weighted toward the second half of the year.

 

Competition

 

The market for prestige fragrance products is highly competitive and sensitive to changing preferences and demands. The prestige fragrance industry is highly concentrated around certain major players with resources far greater than ours. We compete with an original strategy, regular and methodical development of quality fragrances for a growing portfolio of internationally renowned brand names.

 

23

 

 

Inventory

 

We purchase raw materials and component parts from suppliers based on internal estimates of anticipated need for finished goods, which enables us to meet production requirements for finished goods. We generally ship products to customers within 72 hours of the receipt of their orders. Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers or directly to one of those third party fillers, which manufacture the finished products for us and then deliver them to one of our distribution centers.

 

Product Liability

 

Our United States operations maintain product liability coverage in an amount of $10.0 million, and our European operations maintain product liability coverage in an amount of €20 million (approximately $21 million). Based on our experience, we believe this coverage is adequate and covers substantially all of the exposure we may have with respect to our products. We have never been the subject of any material product liability claims.

 

Government Regulation

 

Under the Federal Food, Drug and Cosmetic Act, fragrance products are regulated as cosmetics, and fragrances include perfumes, colognes and aftershave. They must meet the same requirements for safety as other cosmetic ingredients. Compliance required of fragrance ingredients include being safe for consumers when they are used according to labeled directions or as consumers customarily use them.

 

Under the Fair Packaging and Labelling Act, companies and individuals who manufacture or market cosmetics have the legal responsibility to ensure the products are safe and labelled according to the Act.

 

Our fragrance products that are manufactured and marketed in Europe are also regulated as cosmetics and subject to EU Regulation 1223/2009, and after Brexit, the United Kingdom regulation of The UK Schedule 34 to the Product Safety and Metrology Regulation 2019. As of the date of this report, IP products are in compliance with these regulations.

 

Trademarks

 

The market for our products depends to a significant extent upon the value associated with our trademarks and brand names. We have licenses or other rights to use, or own, the material trademark and brand name rights used in connection with the packaging, marketing and distribution of our major products both in the United States and in other countries where such products are principally sold. Therefore, trademark and brand name protection are important to our business. Although most of the brand names we license, use or own are registered in the United States and in certain foreign countries in which we operate, we may not be successful in asserting trademark or brand name protection. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. The costs required to protect our trademarks and brand names may be substantial.

 

Under various licenses and other agreements, we have the right to use certain registered trademarks throughout the world for fragrance products. These registered trademarks include:

 

  ● Abercrombie & Fitch
  ● Anna Sui
  ● bebe
  ● Boucheron
  ● Coach

 

24

 

 

  ● Donna Karan and DKNY
  ● Dunhill
  ● Emanuel Ungaro
  ● French Connection
  ● Graff
  ● GUESS
  ● Hollister
  ● Jimmy Choo
  ● Kate Spade
  ● Karl Lagerfeld
  ● MCM
  ● Moncler
  ● Montblanc
  ● Oscar de la Renta
  ● Ferragamo
  ● S.T. Dupont
  ● Van Cleef & Arpels

 

In addition, we are the registered owner of several trademarks for fragrance and beauty products, including:

 

  ● Rochas
  ● Lanvin
  ● Intimate
  ● Aziza

 

Human Capital

 

General

 

As of December 31, 2022, we had 527 full-time employees worldwide. Of these, 306 are full-time employees of our European operations and its subsidiaries, with 186 employees engaged in sales activities and 120 in administrative, production and marketing activities. Our United States operations have 175 full-time employees, and of these, 51 are engaged in sales activities and 124 in administrative, production and marketing activities. In addition, Interparfums Italia Srl, our wholly-owned subsidiary, has 46 full-time employees, with 21 engaged in sales activities and 25 in administrative, production and marketing activities. Other than for the employees of Interparfums Italia Srl, we do not have collective bargaining agreements relating to any of our employees, and we believe the collective bargaining agreement for our employees of Interparfums Italia Srl will not have a material adverse effect on our operations. We strive to maintain an inclusive environment free from discrimination of any kind, including sexual or other discriminatory harassment and, believe that our relationship with our employees is good.

 

Goals for our employees Company-wide are

 

-developing a team spirit and cross-functional collaboration;

-maintaining a high level of expertise;

-cultivating a culture that promotes our values of entrepreneurship, commitment, creativity and passion;

-developing a respectful and inclusive work environment;

-ensuring equal opportunity employment;

-empowering employees to develop their skills and grow their careers;

-promoting dialogue between employees and management;

-offering quality working conditions;

-preserving the health and safety of all;

-maintaining a proper balance between professional and private life.

 

25

 

 

United States Operations

 

Our employees are one of our most valuable assets, and fostering long-term relationships are beneficial to the continuity of our business. After experience and expertise in the respective fields of employment, we look for dedication and loyalty among our employees, as we believe having long-term staff members benefits our Company. All of our executive senior officers have been with us for more than twenty years (other than our CFO who just joined our company in September 2022), and we have several senior and upper-level staff members, who have also been with us long-term. These long-term executives and employees believe that our Company and their co-workers are an extended family and share the same values of entrepreneurship, commitment, creativity and passion. Their efforts and dedication are what allow our Company to prosper.

 

Every year, United States operations organizes two seminars over several days for all its global sales staff. This seminar provides an opportunity to present all the Company’s brands and products and marketing strategies.

 

The safety of our employees is of paramount importance to us. In the early stages of the COVID-19 pandemic, we experienced brief closures at all of our locations, and adapted to working remotely. Upon reopening, we implemented prevention protocols to minimize the spread of COVID-19 in our workplaces. These protocols, which remain in place, are in compliance with the Centers for Disease Control guidelines and state requirements.

 

As part of our increasing benefits of working at our United States operations, we provide a comprehensive benefits package (medical, dental, vision, long-term disability, accidental death and dismemberment insurance and life insurance, 401-K, commuter benefits), allow Friday remote working arrangements for our employees, have shorter hours on Fridays during the summer months, offer various gifts and “goodie bags” during various times of the year, have made available food choices for purchase in our lunchroom in New York from the “Fraîche fridge,” and hold quarterly presentations showing financial results, updates on all departments, existing product lines, as well as the development and launches of new products for all of our brands for all employees and consultants worldwide of United States operations so that all are made aware of our operations, and invite comments from those in attendance at the presentations.

 

Interparfums Italia Srl

 

The employees of our wholly-owned Italian subsidiary, Interparfums Italia Srl, receive both benefits required under Italian law and certain additional benefits that it provides. Below are employee benefits provided as required by law.

 

○ Health insurance for employees and family coverage

○ Supplementary voluntary severance plan

○ Parental leave

○ Study leave

○ Training in health and safety at work

○ Paid time off

○ Implementation of Covid anti-contagion measures and protocol

 

Interparfums Italia also provides these additional benefits for its employees:

 

○ Working remotely 2 days per week

○ Flexible working hours (different start and end times for employees’ workday)

○ Onboarding Process – Welcome day (includes training on Company’s history and values, meeting with all teams, a gift and dinner with the new hire’s team)

 

26

 

 

○ Welfare Plan – €500 per year to each employee that can be used through a dedicated platform that encompasses a broad range of benefits and services (transportation, education, health, culture and leisure time, supplementary pension, other fringe benefits)

○ Paid time off for medical checkups - 10 hours per year

○ Restaurant voucher to cover lunch expenses (value of €8 per each day worked)

○ Mobile phone and unlimited internet connection for specific category of employees (based on role)

 

The following additional benefits are also provided:

 

○ Event celebrations to actively promote and build a sense of belonging

○ New office set up including dining area to socialize and relax (free coffee, tea and biscuits)

○ Easter - Chocolate eggs gift for charity purpose (AIL - Italian Association against Leukemia Lymphoma and Myeloma)

○ Christmas – Greeting cards and gift sets baskets for charity purpose (ANT – Medical care at home for cancer patients)

 

European Operations

 

Interparfums SA’s employees constitute its most important contributor for creating value. For that reason, their professional fulfillment and motivation are indispensable drivers for our development.

 

With a family-style management culture that is close to its employees, everyone is free to share their ideas in a manner that respects the company’s values. Management attaches great importance to ensuring that each employee fully understands and supports Interparfums SA’s strategy.

 

Through weekly memos and regular information meetings on business developments and trends, employees are kept up-to-date on expectations of management and the market. The organization’s flexibility largely made up of small teams facilitates its continuous adaptation to all changes or evolving external conditions.

 

This sharing of the “Interparfums” spirit, also entails a commitment to and understanding of its ethical values by each employee, the fulfillment of employees at work and compliance with good working conditions. This ethical commitment is formalized by a “Code of Good Conduct” to which each employee subscribes, and that is focused in particular on health, safety, discipline, risk management, preventing harassment, respecting individual freedoms, sensitive transactions, fraud and business confidentiality.

 

In 2017, Interparfums SA adopted a Charter relating to the right to disconnect from digital devices that was accepted by each employee.

 

Every two to three years, Interparfums SA organizes a seminar over several days for all its distributors from throughout the world. This seminar provides an opportunity to present all the company’s brands and products, meet with all distributors and involve them in Interparfums SA’s development while giving the distributors an opportunity to meet with staff with whom they work closely on a daily basis.

 

The Human Resources Department pays particular attention to ensuring equal opportunity and non-discrimination for each recruitment. Only skills, experience, qualifications and the personality of the candidates are taken into account in the selection process for new employees. This diversity in terms of profiles, culture, age and gender constitutes a decisive strength of its teams, the company’s most important asset.

 

27

 

 

Women account for 72% of Interparfums’ workforce and 52% of management positions are occupied by women in 2021.

 

Since 2019, Interparfums SA has organized an annual disability awareness raising campaign. In 2021, employees were given an opportunity to participate role-playing workshop designed to give them a first-hand perspective of a person with a disability (hearing, visual, psychological, motor). Thanks to these opportunities for exchange, employees were able to talk about their all possible impediments and share their views and experiences.

 

Through these awareness-raising campaigns and local support from the Human Resources teams, two employees were accorded the status of employees with disabilities through a specific procedure available in France for that purpose (Reconnaissance de la Qualité de Travailleur Handicapé or RQTH).

 

Interparfums SA also participates indirectly in promoting the employment of persons with disabilities and combating exclusion discrimination. The company has chosen to use a sheltered work enterprise to package its perfume boxes and a global communications agency called “Les Papillons de Jour” to organize the European Week for the Employment of People with Disabilities (EWPD).

 

In 2021, the total cost for these services amounted to €974,094.

 

In addition, Interparfums SA has adopted action plans promoting the employment of seniors and equal opportunity between men and women.

 

Compensation and wage increases

 

Interparfums SA has a compensation policy as well as a system of job classifications and performance evaluations applied to all employees. These procedures guarantee the principle of fairness as well as equal treatment of men and women employees. All employees benefit from a combination of fixed and variable incentive compensation benefits linked to Interparfums SA’s performance.

 

Profit-sharing

 

As required by French law, a statutory employee profit-sharing agreement was implemented in 2001. In April 2015, this agreement was amended to provide more advantageous terms to employees, representing an important component of compensation and motivation for all staff and reviewed every year.

 

Savings plan and pension plan

 

All employees of Interparfums SA benefit from a company savings plan which proposes several types of funds corresponding to the specific projects of each. Since 2017, it has adapted its plan by proposing an Interparfums stock ownership fund allowing employees to take advantage of the growth of Interparfums’ shares under favorable tax conditions. The amounts employees pay into this fund are supplemented by an important contribution by the company.

 

In addition, a group retirement savings plan (Plan d’Epargne Retraite Collectif or PERCOL) is available to employees as a vehicle for preparing for their retirement and to which the company contributes significantly. Employees also can transfer a portion of their unused annual vacation days into the Interparfums SA retirement savings plan.

 

Supplemental defined contribution retirement plan contract (Article 83)

 

Management employees benefit from a supplemental defined-contribution retirement plan. Participation in this plan is mandatory. This individual plan is funded by monthly employee and employer contributions, with the breakdown of these latter contributions freely determined. Interparfums SA has decided to assist its employees in financing this supplemental retirement benefit, by assuming an important percentage of these contributions itself.

 

28

 

 

Item 1A. Risk Factors.

 

You should carefully consider these material risk factors before you decide to purchase or sell shares of our common stock. These factors could cause our future results to differ materially from those expressed or implied in forward-looking statements made by us. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment.

 

● Fragrance Business, Brand Names and Intellectual Property

 

We are dependent upon the continuation and renewal of various licenses and other agreements for a significant portion of our sales, and the loss of one or more licenses or agreements could have a material adverse effect on us.

 

All of our rights relating to prestige fragrance brands, other than Lanvin and Rochas, are derived from licenses or other agreements from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses and other agreements on terms favorable to us. Each license or agreement is for a specific term and may have additional optional terms. Generally, each license is subject to us making required royalty payments (which are subject to certain minimums), minimum advertising and promotional expenditures and meeting minimum sales requirements. Other agreements are generally subject to meeting minimum sales requirements. Just as the loss of a license or other significant agreement may have a material adverse effect on us, a renewal on less favorable terms may also negatively impact us.

 

If we are unable to acquire or license additional brands or obtain the required financing for these agreements and arrangements, then the growth of our business could be impaired.

 

Our future expansion through acquisitions or new product licenses or distribution arrangements, if any, will depend upon the capital resources and working capital available to us. Further, we may be unable to obtain financing or credit that we may require for additional licenses, acquisitions or other transactions. We may be unsuccessful in identifying, negotiating, financing and consummating such acquisitions or arrangements on terms acceptable to us, or at all, which could hinder our ability to increase revenues and build our business. Just as the loss of a license or other significant agreement may have a material adverse effect on us, our failure to acquire rights to new brands may also negatively impact us.

 

We may engage in future acquisitions that we may not be able to successfully integrate or manage. These acquisitions may dilute our stockholders and cause us to incur debt and assume contingent liabilities.

 

We continuously review acquisition prospects that would complement our current product offerings, increase our size and geographic scope of operations or otherwise offer growth and operating efficiency opportunities. The financing, if available, for any of these acquisitions could significantly dilute our stockholders and/or result in an increase in our indebtedness. We may acquire or make investments in businesses or products in the future, and such acquisitions may entail numerous integration risks and impose costs on us, including:

 

  ● difficulties in assimilating acquired operations or products, including the loss of key employees from acquired businesses
     
  ● diversion of management’s attention from our core business
     
  ● adverse effects on existing business relationships with suppliers and customers
     

 

29

 

 

  ● risks of entering markets in which we have no or limited prior experience
     
  ● dilutive issuances of equity securities
     
  ● incurrence of substantial debt
     
  ● assumption of contingent liabilities
     
  ● incurrence of significant amortization expenses related to intangible assets and the potential impairment of acquired assets and
     
  ● incurrence of significant immediate write-offs.

 

Our failure to successfully complete the integration of any acquired business could have a material adverse effect on our business, financial condition and operating results.

 

Joint arrangements or strategic alliances in geographic markets in which we have limited, or no prior experience may expose us to additional risks.

 

We review, and from time to time may establish, arrangements and strategic alliances that we believe would complement our current product offerings, increase the size and geographic scope of our operations or otherwise offer growth and operating efficiency opportunities. These business relationships may require us to rely on the local expertise of our partners with respect to market development, sales, local regulatory compliance and other matters. Further, there may be challenges with ensuring that such arrangements or strategic alliances implement the appropriate internal controls to ensure compliance with the various laws and regulations applicable to us as a U.S. public company. Accordingly, in addition to commercial and operational risk, these arrangements and strategic alliances may entail risks such as reputational risk and regulatory compliance risk. In addition, there can be no assurance that we will be able to identify suitable alliances or candidates, that we will be able to consummate any such alliances or arrangements on favorable terms, or that we will realize the anticipated benefits of entering into any such alliances or arrangements.

 

If we are unable to protect our intellectual property rights, specifically trademarks and brand names, our ability to compete could be negatively impacted.

 

The market for our products depends to a significant extent upon the value associated with trademarks and brand names that we license, use or own. We have licenses or other rights to use, or own the material trademark and brand name rights in connection with the packaging, marketing and distribution of our major products both in the United States and in other countries where such products are principally sold. Therefore, trademark and brand name protection are important to our business. Although most of the brand names we license, use or own are registered in the United States and in certain foreign countries in which we operate, we may not be successful in asserting trademark or brand name protection. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. The costs required to protect our trademarks and brand names may be substantial.

 

If our intangible assets, such as trademarks and licenses, become impaired, we may be required to record a significant non-cash charge to earnings which would negatively impact our results of operations.

 

Under United States generally accepted accounting principles, we review our intangible assets, including our trademarks and licenses, for impairment annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate the carrying value of our intangible assets may not be fully recoverable. The carrying value of our intangible assets may not be recoverable due to factors such as reduced estimates of future cash flows, including those associated with the specific brands to which intangibles relate, or slower growth rates in our industry. Estimates of future cash flows are based on a long-term financial outlook of our operations and the specific brands to which the intangible assets relate. However, actual performance in the near-term or long-term could be materially different from these forecasts, which could impact future estimates and the recorded value of the intangibles. Any significant impairment to our intangible assets would result in a significant charge to earnings in our financial statements during the period in which the impairment is determined to exist.

 

30

 

 

The illegal distribution and sale by third parties of counterfeit versions of the Company’s products or the unauthorized diversion by third parties of the Company’s products could have an adverse effect on the Company’s revenues and a negative impact on the Company’s reputation and business.

 

Third parties may illegally distribute and sell counterfeit versions of the Company’s products. These counterfeit products may be inferior in terms of quality and other characteristics compared to the Company’s authentic products and/or the counterfeit products could pose safety risks that the Company’s authentic products would not otherwise present to consumers. Consumers could confuse counterfeit products with the Company’s authentic products, which could damage or diminish the image, reputation and/or value of the Company’s brands and cause consumers to refrain from purchasing the Company’s products in the future. In addition, the sale of the Company’s prestige products through non-authorized “grey market” channels could damage or diminish the image, reputation and/or value of the Company’s brands and could adversely affect the Company’s revenues and have a negative impact on the Company’s reputation.

 

Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary rights of other parties.

 

Our commercial success depends at least in part on our ability to operate without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of others. However, we cannot be certain that the conduct of our business does not and will not infringe, misappropriate or otherwise violate such rights. Many companies have employed intellectual property litigation as a way to gain a competitive advantage, and to the extent we gain greater visibility and market exposure, we may also face a greater risk of being the subject of such litigation. For these and other reasons, third parties may allege that our products, services or activities infringe, misappropriate or otherwise violate their trademark, patent, copyright or other proprietary rights. Defending against allegations and litigation could be expensive, take significant time, divert management’s attention from other business concerns, and delay getting our products to market. In addition, if we are found to be infringing, misappropriating or otherwise violating third party trademark, patent, copyright or other proprietary rights, we may need to obtain a license, which may not be available on commercially reasonable terms or at all, or redesign or rebrand our products, which may not be possible. We may also be required to pay substantial damages or be subject to a court order prohibiting us and our customers from selling certain products or engaging in certain activities. Our inability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary rights of others could therefore have a material adverse effect on our business, financial condition and results of operations.

 

31

 

 

● COVID-19 Pandemic and Economic Downturn

 

Although in both 2022 and 2021 we weathered the COVID-19 pandemic and its effects to date, if the pandemic reemerges, it may have a material adverse effect on our business, results of operations, financial condition and cash flows.

 

The public health crisis caused by the COVID-19 pandemic, its variants and the measures being taken by governments, businesses, including us, our suppliers, our distributors, retailers and the public, to limit COVID-19’s spread, have had and we expect will continue to have, certain negative impacts on our business including, but not limited to, the following:

 

  ● Deteriorating economic and political conditions in certain of our major markets affected by the COVID-19 pandemic, such as increased unemployment, decreases in disposable income, declines in consumer confidence, or economic slowdowns could cause a decrease in demand for our products.
     
  ● We may be required to record significant impairment charges with respect to noncurrent assets, including trademarks, licenses and other intangible assets whose fair values may be negatively affected by the effects of re-emergence of the COVID-19 pandemic on our operations.
     
  ● Considerable uncertainty remains regarding the potential re-emergence of COVID-19 variants, including potential reinstatement of measures by various authorities and others in response to any such re-emergence. As we continue to monitor potential COVID-19 variant developments, including the impacts on our consumers, customers and suppliers, we take further measures as necessary to protect our business and our employees. Some of the actions we take could adversely impact our business, and there is no certainty that our actions will be sufficient to mitigate the risks and the impacts of a re-emergence of COVID-19 variants.
     
  ● Actions we may take, or decisions on potential actions that we did not take, as a consequence of a resurgence of a COVID-19 variant pandemic may result in claims or litigation against us.
     

Consumers may reduce discretionary purchases of our products as a result of a general economic downturn.

 

We believe that a high degree of global economic uncertainty could have a further negative effect on consumer confidence, demand and spending. In addition, we believe that consumer spending on beauty products is influenced by general economic conditions and the availability of discretionary income. Accordingly, we may experience sustained periods of declines in sales during periods of economic downturn as it may affect consumer purchasing patterns. In addition, a further general economic downturn may result in further reduced traffic in our customers’ stores which may, in turn, result in reduced net sales to our retail store customers. Any further material reduction in our sales could have a material adverse effect on our business, financial condition and operating results.

 

An outbreak of any other disease, epidemic or pandemic, or similar public health threat on the scope of COVID-19, could have a material adverse impact on the Company’s business, operating results and financial condition.

 

An outbreak of disease, epidemic or pandemic, or similar public threat on the scope of COVID-19, or fear of such an event, that negatively impacts consumer spending on our products could have a material adverse impact on the Company’s business, financial condition and operating results. The extent and potential short and long-term impact of any other pandemic on the Company’s operational and financial performance will depend on future developments, including the duration and spread of the outbreak, our customers’ willingness to travel and purchase our products, and the impact on our supply chain and the financial markets, all of which are highly uncertain and cannot be predicted.

 

32

 

 

● Global Operations

 

We are subject to risks related to our foreign operations, and a disruption in our operations or supply chain could adversely affect our business and financial results.

 

We operate on a global basis, with a substantial portion of our net sales and net income generated outside the United States, and we anticipate for the foreseeable future that a substantial portion of our net sales and net income will be generated outside the United States. A substantial portion of our cash, cash equivalents and short-term investments that result from these earnings remain outside the United States. As a company engaged in manufacturing and distribution on a global scale, we are subject to many risks and uncertainties, including:

 

  ● changes in foreign laws, regulations and policies, including restrictions on trade, import and export license requirements, and tariffs and taxes, as well as changes in United States laws and regulations relating to foreign trade and investment; and
     
  ● industrial accidents, environmental events, strikes and other labor disputes, disruptions in supply chain or information technology, loss or impairment of key manufacturing sites or suppliers, product quality control, safety, as well as natural disasters, adverse weather conditions, social, economic and geopolitical conditions, such as terrorist attacks, war or other military action and other external factors over which we have no control.

 

These risks could have a material adverse effect on our business, prospects, results of operations and financial condition.

 

Terrorist attacks, acts of war or military actions, other civil unrest or natural disasters may adversely affect territories in which we operate, and therefore affect our business, financial condition and operating results.

 

Terrorist attacks such as those that have previously occurred in Paris, France where we have our European headquarters, amongst other locations, and attempted terrorist attacks, military responses to terrorist attacks, other military actions, or governmental action in response to or in anticipation of a terrorist attack, or civil unrest as occurring in the Middle East, Ukraine and Africa or natural disasters, may adversely affect prevailing economic conditions. These events could result in work stoppages, reduced consumer spending or reduced demand for our products. These developments subject our worldwide operations to increased risks and, depending on their magnitude, could reduce net sales and therefore could have a material adverse effect on our business, financial condition and operating results.

 

The loss of or disruption in our distribution facilities could have a material adverse effect on our business, financial condition and operating results.

 

We currently have several distribution facilities in Europe, China and the United States. The loss of any of those facilities, as well as the inventory stored in those facilities, would require us to find replacement facilities and assets. In addition, acts of God, such as extreme weather conditions, natural disasters and the like or terrorist attacks, could disrupt our distribution operations. If we cannot replace our distribution capacity and inventory in a timely, cost-efficient manner, then such failure could have a material adverse effect on our business, financial condition and operating results.

 

Changes in foreign tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows.

 

In addition to being subject to taxation in the United States, we are subject to income and other taxes in other foreign jurisdictions. Our effective tax rate in the future could be adversely affected by changes to our operating structure, changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws and the discovery of new information in the course of our tax return preparation process. From time to time, tax proposals are introduced or considered by the United States Congress or the legislative bodies in foreign jurisdictions that could also affect our tax rate, the carrying value of our deferred tax assets, or our other tax liabilities. Our tax liabilities are also affected by the amounts we charge for inventory, services, licenses, funding, cross-jurisdictional transfer pricing, and other items in intercompany transactions. A negative determination or ultimate disposition in any tax audit, changes in tax laws or tax rates, or the ability to utilize our deferred tax assets could materially affect our tax provision, net income and cash flows in future periods.

 

33

 

 

The international character of our business renders us subject to fluctuation in foreign currency exchange rates and international trade tariffs, barriers and other restrictions.

 

A substantial portion of our European operations’ net sales (over 50%) are sold in U.S. dollars. In an effort to reduce our exposure to foreign currency exchange fluctuations, we engage in a controlled program of risk management that includes the use of derivative financial instruments for all major currencies with which we operate. Despite such actions, fluctuations in foreign currency exchange rates for the U.S. dollar, particularly with respect to the euro, could have a material adverse effect on our operating results. Possible import, export, tariff and other trade barriers, which could be imposed by the United States, the European Union or other countries might also have a material adverse effect on our operating results.

 

Changing political conditions could adversely impact our business and financial results.

 

Changes in the political conditions in markets in which we manufacture, sell or distribute our products may be difficult to predict and may adversely affect our business and financial results. In addition, results of elections, referendums or other political processes in certain markets in which our products are manufactured, sold or distributed could create uncertainty regarding how existing governmental policies, laws and regulations may change, including with respect to sanctions, taxes, the movement of goods, services, capital and people between countries and other matters. The potential implications of such uncertainty, which include, among others, exchange rate fluctuations, tariffs, trade barriers and market contraction, could adversely affect the Company’s business and financial results.

 

● Operational Risks

 

We are dependent upon Messrs. Jean Madar and Philippe Benacin, and the loss of their services could harm our business.

 

Jean Madar, our Chairman and Chief Executive Officer, and Philippe Benacin, our President, and Chief Executive Officer of Interparfums SA, are responsible for day-to-day operations as well as major decisions. Termination of their relationships with us, whether through death, incapacity or otherwise, could have a material adverse effect on our operations, and we cannot assure you that qualified replacements can be found.

 

Our reliance on third party manufacturers could have a material adverse effect on us.

 

We rely on outside sources to manufacture our fragrances and cosmetics. The failure of such third party manufacturers to deliver either compliant, quality components or finished goods on a timely basis could have a material adverse effect on our business. Although we believe there are alternate manufacturers available to supply our requirements, we cannot assure you that current or alternative sources will be able to supply all of our demands on a timely basis. We do not intend to develop our own manufacturing capacity. As these are third parties over whom we have little or no control, the failure of such third parties to provide components or finished goods on a timely basis could have a material adverse effect on our business, financial condition and operating results.

 

Our reliance on third party distributors could have a material adverse effect on us.

 

We sell a substantial percentage of our prestige fragrances through independent distributors specializing in luxury goods. Given the growing importance of distribution, we have modified our distribution model by owning a controlling interest in certain of our distributors within key markets. However, we have little or no control over third party distributors and the failure of such third parties to provide services on a timely basis could have a material adverse effect on our business, financial condition and operating results. In addition, if we replace existing third party distributors with new third party distributors or with our own distribution arrangements, then transition issues could have a material adverse effect on our business, financial condition and operating results.

 

34

 

 

Our business is subject to governmental regulation, which could impact our operations.

 

Under the Federal Food, Drug and Cosmetic Act, fragrance products are regulated as cosmetics, and fragrances include perfumes, colognes and aftershave. They must meet the same requirements for safety as other cosmetic ingredients. Compliance required of fragrance ingredients include being safe for consumers when they are used according to labelled directions or as consumers customarily use them.

 

Under the Fair Packaging and Labelling Act, companies and individuals who manufacture or market cosmetics have the legal responsibility to ensure the products are safe and labelled according to the Act.

 

Our fragrance products that are manufactured and marketed in Europe are also regulated as cosmetics and subject to EU Regulation 1223/2009, and after Brexit, the United Kingdom regulation of The UK Schedule 34 to the Product Safety and Metrology Regulation 2019. As of the date of this report, IP products are in compliance with these regulations.

 

However, we cannot assure you that, should we use proscribed ingredients in our fragrance products that we develop or market, or develop or market fragrance products with different ingredients, or should existing regulations or requirements be revised, we would not in the future experience difficulty in complying with such requirements, which could have a material adverse effect on our results of operations.

 

Our business could be negatively impacted by social impact and sustainability matters.

 

There continues to be an increased focus from certain investors, customers, consumers, employees, and other stakeholders concerning social impact and environmental matters. We are spending considerable time addressing social impact and sustainability matters, which are becoming more prominent issues for certain of our institutional shareholders. From time to time, we may announce certain initiatives, including goals and commitments, regarding environmental matters, packaging, responsible sourcing and corporate social responsibility. We could fail, or be perceived to fail, in our achievement of such initiatives, or in accurately reporting our progress on such initiatives. Such failures could be due to changes in distribution channels, new licenses or other acquisitions. Moreover, the standards by which corporate social responsibility are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. In addition, we could be criticized for the scope of our initiatives or goals or perceived as not acting responsibly in connection with these matters. Any of such matters could have a material adverse effect on our business.

 

Our business is subject to seasonal variability.

 

Our business is somewhat seasonal due to the timing of shipments to our customers, which are weighted to the second half of the year. Accordingly, our financial performance, sales, working capital requirements, cash flow and borrowings generally experience variability during the third and fourth quarters.

 

Our business is subject to inflationary pressures.

 

Despite significant inflationary pressures that started during 2022 affecting many aspects of our business, especially increase component costs and shipping, we were able to offset the effects of inflation during 2022 by increasing the prices of our products. Although we believe inflation will continue to be a major factor in 2023, a further increase in sales prices should help to mitigate its impact to some degree. However, we may not be able to continue increasing our prices indefinitely without causing a reduction in the number of consumers with sufficient disposable income to buy our certain of our fragrance products, which could have a material adverse effect on our business.

 

35

 

 

● Fragrance Markets

 

The success of our products is dependent on public taste.

 

Our revenues are substantially dependent on the success of our products, which depends upon, among other matters, pronounced and rapidly changing public tastes, factors which are difficult to predict and over which we have little, if any, control. In addition, we have to develop successful marketing, promotional and sales programs in order to sell our fragrances and fragrance related products. If we are not able to develop successful marketing, promotional and sales programs, then such failure will have a material adverse effect on our business, financial condition and operating results.

 

We are subject to extreme competition in the fragrance industry.

 

The market for fragrance products is highly competitive and sensitive to changing market preferences and demands. Many of our competitors in this market are larger than we are and have greater financial resources than are available to us, potentially allowing them greater operational flexibility. Our success in the prestige fragrance industry is dependent upon our ability to continue to generate original strategies and develop quality products that are in accord with ongoing changes in the market.

 

If there is insufficient demand for our existing fragrance products, or if we do not develop future strategies and products that withstand competition or if we are unsuccessful in competing on price terms, then we could experience a material adverse effect on our business, financial condition and operating results.

 

Changes in laws, regulations and policies that affect our business could adversely affect our financial results.

 

Our business is subject to numerous laws, regulations and policies. Changes in the laws, regulations and policies, including the interpretation or enforcement thereof, that affect, or will affect, our business, including changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, or increased cosmetics regulation, and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result could adversely affect our financial results.

 

● General Risk Factors

 

Our success depends, in part, on the quality and safety of our products.

 

Our success depends, in part, on the quality and safety of our products. If our products are found to be defective or unsafe, or if they otherwise fail to meet our consumers’ standards, then our relationships with customers or consumers could suffer, the appeal of one or more of our brands could be diminished, and we could lose sales and/or become subject to liability claims, any of which could result in a material adverse effect on our business, results of operations and financial condition.

 

Our failure to protect our reputation, or the failure of our partners to protect their reputations, could have a material adverse effect on our brand images.

 

Our ability to maintain our reputation is critical to our various brand images. Our reputation could be jeopardized if we fail to maintain high standards for merchandise quality and integrity or if we, or the third parties with whom we do business, do not comply with regulations or accepted practices. Any negative publicity about these types of concerns may reduce demand for our merchandise. Failure to comply with ethical, social, product, labor and environmental standards, or related political considerations, such as animal testing, could also jeopardize our reputation and potentially lead to various adverse consumer actions, including boycotts. Failure to comply with local laws and regulations, including applicable U.S. trade sanctions, to maintain an effective system of internal controls or to provide accurate and timely financial statement information could also hurt our reputation. We are also dependent on the reputations of our brand partners and licensors, which can be affected by matters outside of our control. Damage to our reputation or the reputations of our brand partners or licensors or loss of consumer confidence for any of these or other reasons could have a material adverse effect on our results of operations, financial condition and cash flows, as well as require additional resources to rebuild our reputation.

 

36

 

 

Our information systems and websites may be susceptible to outages, hacking and other risks.

 

We have information systems that support our business processes, including product development, production, marketing, order processing, sales, distribution, finance and intra-company communications. We also have Internet websites in the United States and Europe. These systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, hacking and similar events. Despite the implementation of network security measures, our systems may be vulnerable to computer viruses, hacking and similar disruptions from unauthorized tampering. The occurrence of these or other events could disrupt or damage our information systems and adversely affect our business and results of operations.

 

The trading prices of our securities periodically may rise or fall based on the accuracy of predictions of our earnings or other financial performance.

 

Our business planning process is designed to maximize our long-term strength, growth and profitability, not to achieve an earnings target in any particular fiscal quarter. We believe that this longer-term focus is in the best interests of our Company and our stockholders. At the same time, however, we recognize that it may be helpful to provide investors with guidance as to our forecast of annual net sales and diluted earnings per share. Accordingly, we provide guidance as to our expected annual net sales, and diluted earnings per share, which is updated as appropriate throughout the year. While we generally provide updates to our guidance when we report our results each fiscal quarter if called for, we assume no responsibility to update any of our forward-looking statements at such times or otherwise. In addition, longer-term guidance that we may from time to time provide is based on goals that we believe, at the time guidance is given, are reasonably attainable.

 

In all of our public statements when we make, or update, a forward-looking statement about our sales and/or earnings expectations or expectations regarding other initiatives, we accompany such statements directly, or by reference to a public document, with a list of factors that could cause our actual results to differ materially from those we expect. Such a list is included, among other places, in our earnings press releases (by reference to our periodic filings with the Securities and Exchange Commission) and in our periodic filings with the Securities and Exchange Commission (e.g., in our reports on Form 10-K and Forms 10-Q). These and other factors may make it difficult for outside observers, such as research analysts, to predict what our earnings will be in any given fiscal quarter or year.

 

Outside analysts and investors have the right to make their own predictions of our financial results for any future period. Outside analysts, however, have access to no more material information about our results or plans than any other public investor, and we do not endorse or adopt their predictions as to our future performance. Nor do we assume any responsibility to correct the predictions of outside analysts or others when they differ from our own internal expectations. If and when we announce actual results that differ from those that outside analysts or others have been predicting, the market price of our securities could be affected. Investors who rely on the predictions of outside analysts or others when making investment decisions with respect to our securities do so at their own risk. We take no responsibility for any losses suffered as a result of such changes in the prices of our securities.

 

Item 1B. Unresolved Staff Comments.

 

None.

 

37

 

 

Item 2. Properties

 

United States Operations

 

We maintain our corporate headquarters and United States operations in approximately 32,000 square feet with a term that expires on December 31, 2029, and have been at the same location in New York City since 1992. We also have a 140,000 square foot distribution center in New Jersey, and this lease expires on October 31, 2025. In addition, we maintain office space in Hong Kong with a lease that expires in June 2023, as well as a small leased distribution center in Hong Kong through December 2023. In October 2021 we leased office space in Florence, Italy for a 6-year term with an option for an additional 6 years for Interparfums Italia Srl.

 

European Operations

 

Since March 2022, our European operations have maintained their corporate headquarters at 10 rue de Solférino in the 7th arrondissement of Paris. This is an office complex combining three buildings connected by two inner courtyards and consists of approximately 40,000 total sq. ft. United States distribution operations for European operations maintain their headquarters in New York City, with a lease that expires in May 2029. During 2022, we also purchased several small apartments at 96 rue de l’Université, Paris adjacent to the main office complex and have started the process of converting them into additional offices. A small office is located Singapore for Asia-Pacific distribution by European operations.

 

In addition, European operations maintain an approximately 37,000 square meters (approximately 398,265 square feet) distribution center located in Criquebeuf sur Seine, France, with a seven year term that expires May 2027 and an option to extend the term for an additional two years. Interparfums SA also has several agreements for warehousing and distribution services which are renewed on an annual basis, as well as a one with a service provider that expires in 2024. Fees payable are partially calculated based upon a percentage of sales, which is customary in the industry.

 

We believe our office and warehouse facilities are satisfactory for our present needs and those for the foreseeable future.

 

Item 3. Legal Proceedings

 

We are not a party to any material lawsuits.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

38

 

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

The Market for Our Common Stock

 

Our Company’s common stock, $.001 par value per share, is traded on The Nasdaq Global Select Market under the symbol “IPAR”. The following table sets forth in dollars, the range of high and low closing prices for the past two fiscal years for our common stock.

 

Fiscal 2022 High Closing Price Low Closing Price
Fourth Quarter 99.35 74.26
Third Quarter 86.78 70.02
Second Quarter 89.45 64.74
First Quarter 106.82 80.22

 

Fiscal 2021 High Closing Price Low Closing Price
Fourth Quarter 106.90 75.89
Third Quarter 79.42 67.55
Second Quarter 77.95 69.96
First Quarter 76.75 59.17

 

As of February 8, 2023, the number of record holders, which include brokers and broker nominees, etc., of our common stock was 28. We believe there are approximately 32,436 beneficial owners of our common stock.

 

Corporate Performance Graph

 

The following graph compares the performance for the periods indicated in the graph of our common stock with the performance of the Nasdaq Market Index and the average performance of a group of the Company’s peer corporations consisting of: CCA Industries, Inc., Colgate-Palmolive Co., Estée Lauder Companies, Inc., Inter Parfums, Inc., Kimberly Clark Corp., Natural Health Trends Corp., Procter & Gamble Co., Stephan Co., Summer Infant, Inc. and United Guardian, Inc. The graph assumes that the value of the investment in our common stock and each index was $100 at the beginning of the period indicated in the graph, and that all dividends were reinvested.

 

39

 

 

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Inter Parfums, Inc., the NASDAQ Composite Index,
and a Peer Group

 

 

 

*$100 invested on 12/31/17 in stock or index, including reinvestment of dividends. Fiscal year ending December 31.

 

 

Below is the list of the data points for each year that corresponds to the lines on the above graph.

 

    12/17 12/18 12/19 12/20 12/21 12/22
               
Inter Parfums, Inc.   100.00 153.33 172.84 144.75 259.11 239.94
NASDAQ Composite   100.00 97.16 132.81 192.47 235.15 158.65
Peer Group   100.00 99.33 136.46 159.01 192.02 171.79

 

Dividends

 

In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share. Just recently, in February 2023 the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on March 31, 2023 to shareholders of record on March 15, 2023.

 

Item 6. [RESERVED]

 

40

 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext.

 

We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 68%, 75% and 78% of net sales for 2022, 2021 and 2020, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world.

 

Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 32%, 25% and 22% of net sales in 2022, 2021 and 2020, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Ungaro brands.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names.

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%

 

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France and the United States.

 

We grow our business and expand our shares in two distinct ways. First, by adding new brands to our portfolio, either through new licenses or other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling, as well as by phasing out underperforming products, so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. The introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are either received and stored directly at our third-party fillers or received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

41

 

 

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share.

 

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because over 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments, and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

Impact of COVID-19 Pandemic

 

A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain classes of workers from reporting to work. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.

 

Business significantly improved in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in several jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. We remain confident that travel retail will once again be a source of growth over the long-term. Lastly, the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.

 

Recent Important Events

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

42

 

 

Salvatore Ferragamo

 

In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.

 

With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition.

 

Emanuel Ungaro

 

In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective on July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Future Headquarters in Paris

 

In April 2021, Interparfums SA, our 73% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price includes the complete renovation of the site. As of December 31, 2022, $148.1 million of the purchase price, including approximately $4.4 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022. The purchase price has been allocated approximately $61.1 million to land and $87.0 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $3.4 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022.

 

The acquisition was financed by a 10-year €120 million (approximately $128.0 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.

 

Discussion of Critical Accounting Policies

 

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Management of the Company has discussed the selection of significant accounting policies and the effect of estimates with the Audit Committee of the Board of Directors.

 

Long-Lived Assets

 

We evaluate indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more likely than not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.80%. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

 

43

 

 

We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.

 

At December 31, 2022 indefinite-lived intangible assets aggregated $105.0 million. The following table presents the impact a change in the following significant assumptions would have had on the calculated fair value in 2022 assuming all other assumptions remained constant:

 

$ in millions   Change    Increase (decrease) to fair value 
           
Weighted average cost of capital   +10%   $(7.2)
Weighted average cost of capital   -10%   $8.1 
Future sales levels   +10%   $9.7 
Future sales levels   -10%   $(9.7)

 

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. In those cases where we determine that the useful life of long-lived assets should be shortened, we would amortize the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable.

 

In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3. The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. “Any legal, regulatory, or contractual provisions that may limit the useful life.” The existence of a repurchase option originally in 2025 and amended to 2027, may limit the useful life of the Lanvin brand names and trademarks to the Company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our Company and their useful life would be considered to be indefinite.

 

With respect to the application of ASC topic 350-30-35-8, the Lanvin brand names and trademarks would only have a finite life to our Company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8, we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the Company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (residual value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.

 

44

 

 

Quantitative Analysis

 

During the three-year period ended December 31, 2022, we have not made any material changes in our assumptions underlying these critical accounting policies or to the related significant estimates. The results of our business underlying these assumptions have not differed significantly from our expectations.

 

While we believe the estimates we have made are proper and the related results of operations for the period are presented fairly in all material respects, other assumptions could reasonably be justified that would change the amount of reported net sales, cost of sales, and selling, general and administrative expenses as they relate to the provisions for anticipated sales returns, allowance for doubtful accounts and inventory obsolescence reserves. For 2022, had these estimates been changed simultaneously by 5% in either direction, our reported gross profit would have increased or decreased by approximately $0.8 million and selling, general and administrative expenses would have changed by approximately $0.1 million. The collective impact of these changes on 2022 operating income, net income attributable to Inter Parfums, Inc., and net income attributable to Inter Parfums, Inc. per diluted share would be an increase or decrease of approximately $0.8 million, $0.5 million and $0.02, respectively.

 

Results of Operations

 

Net Sales 

Years ended December 31, 

 
(in millions) 

2022 

  

% Change 

  

2021 

  

% Change 

  

2020

 
European based product sales   $744.0    12%   $663.2    57%   $422.9 
United States based product sales    342.7    58%    216.4    86%    116.1 
Total net sales   $1,086.7    24%   $879.6    63%   $539.0 

 

Net sales rebounded significantly in 2021, as compared to 2020 for both European and United States based operations and continued to increase in 2022. At comparable foreign currency exchange rates, net sales increased 30% in 2022, as compared to 2021. Net sales in 2020 reflected the negative impacts of the COVID-19 pandemic on the beauty industry. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill in early 2020. In the second half of 2020, business began rebounding thanks to retail stores reopening and a robust e-commerce business conducted by our retail customers.

 

For European based operations, our largest brands, Montblanc, Jimmy Choo and Coach grew 2022 sales by 15%, 23% and 18%, respectively, as compared to 2021. There were also significant gains made by our mid-sized brands, including Van Cleef & Arpels and Karl Lagerfeld. The year-over-year gains, in both euro and dollars, are all the more impressive considering our new product pipeline was dominated by flankers and extensions. However, we did bring to market several entirely new lines, including our first ever Moncler duo, Kate Spade Sparkle, Singulier by Boucheron and Open Road and Wild Rose by Coach.

 

In 2021, GUESS became our fourth brand with sales exceeding $100 million. Strong momentum on GUESS continued in 2022 with brand sales increasing another 24% as compared to 2021. There were also significant gains made by our mid-sized brands, especially Abercrombie & Fitch, Hollister and Oscar de la Renta. Additionally, 2022 saw the first full year of sales of Ferragamo products and in the second half of 2022, we also welcomed first time sales of our newest brands, Donna Karan/DKNY. Together, these new brands contributed to 38% growth of our US operations.

 

45

 

 

We are confident in our future as 2023 has many exciting developments for the Company. We have transitioned to a new modern enterprise resource planning system (ERP) for our US operations which will enable us to operate more efficiently and offer more scale to absorb our newer brands We have a solid line-up of new product launches in the pipeline for many of our brands. This includes the roll out of the Moncler Collection in the first quarter and a Duo flanker in the third quarter, a launch of GUESS Uomo Acqua in the second quarter, as well as Bella Vita Paradiso in the fourth quarter. Extensions of the Montblanc Legend, Jimmy Choo Man and Jimmy Choo’s I Want Choo, debut in the first, second and third quarters, respectively. Also, in the third quarter, we will unveil new men’s lines for Coach and Boucheron. Brand extensions and flankers are in the works for MCM, Abercrombie & Fitch, Hollister, Anna Sui, and Oscar de la Renta. In sum, 2023 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably inflation and supply chain disruptions. Lastly, we have recently announced the license agreement with Lacoste which will offer us another sizable building block of growth in 2024. 

 

As in the past, we hope to benefit from our strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. However, we have no certainty that any new license or acquisition agreements will be consummated.

 

Net Sales to Customers by Region

 

  

Years ended December 31,

 
  

2022

  

2021

  

2020

 
   (in millions) 
     
North America  $431.9   $354.1   $193.5 
Western Europe   259.2    202.0    147.1 
Asia   152.7    128.0    79.7 
Middle East   87.8    61.0    46.8 
Eastern Europe   74.2    69.7    33.1 
Central and South America   69.9    56.4    32.5 
Other   11.0    8.4    6.3 
   $1,086.7   $879.6   $539.0 

 

Our largest market, North America achieved sales growth of 22% in 2022 compared to 2021, while Western Europe and Asia grew sales by 28% and 19% in 2022, respectively, compared to 2021. Latin America and the Middle East also achieved top line growth of 24% and 44% in 2022, respectively compared to 2021. Eastern Europe saw only moderate top line growth of 6% as compared to 2021 largely related to the war in Ukraine.

 

Gross Margins

 

   Years ended December 31, 
   2022  

2021

  

2020

 
   (in millions) 
European operations:               
Net sales  $744.0   $663.2   $422.9 
Cost of sales   236.9    221.2    152.3 
Gross margin  $507.1   $442.0   $270.6 
Gross margin, as a percent of net sales   68.2%   66.6%   64.0%
                
United States operations:               
Net sales  $342.7   $216.4   $116.1 
Cost of sales   155.4    101.5    56.0 
Gross margin  $187.3   $114.9   $60.1 
Gross margin, as a percent of net sales   54.7%   53.1%   51.8%

 

46

 

 

For European based operations, gross profit margin as a percentage of net sales was 68.2%, 66.6% and 64.0% in 2022, 2021 and 2020, respectively. Distribution in the United States for European based operations is handled by a 100% owned subsidiary of Interparfums SA based in the United States. Therefore, sales are made at a wholesale price rather than at an ex-factory price, resulting in higher gross margins. Net sales of our U.S. based distribution subsidiary increased 16% in 2022, as compared to 2021, leading to favorable mix and giving rise to the increase in gross margin in 2022 over both 2021 and 2020. We carefully monitor movements in foreign currency exchange rates as over 50% of our European based operations net sales is denominated in U.S. dollars, while most of our costs are incurred in euro. From a margin standpoint, a strong U.S. dollar has a positive effect on our gross margin while a weak U.S. dollar has a negative effect. The average dollar/euro exchange rate was 1.05 in 2022, 1.18 in 2021, and 1.15 in 2020. Pricing action also enabled us to offset inflationary pressures.

 

For United States operations, gross profit margin was 54.7%, 53.1% and 51.8% in 2022, 2021 and 2020, respectively. With a decline in sales in 2020, certain expenses such as depreciation of tools and molds together with the distribution of point-of-sale materials exaggerated the decline in gross margin for the year as a percentage of sales. The scale benefits coming from our significant growth in 2021 and 2022, combined with pricing actions and favorable channel/brand mix, have enabled us to more than offset the impacts of inflation and thus expand gross margin by 130 bps in 2021 and another 160 bps in 2022.

 

Costs relating to purchase with purchase and gift with purchase promotions are reflected in cost of sales, and aggregated $43.1 million, $36.9 million and $26.4 million in 2022, 2021 and 2020, respectively, and represented 4.0%, 4.2% and 4.9% of net sales, respectively.

 

Generally, we do not bill customers for shipping and handling costs and such costs, which aggregated $15.8 million, $10.0 million and $5.0 million in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross margins may not be comparable to other companies, which may include these expenses as a component of cost of goods sold.

 

Selling, General & Administrative Expenses

 

  

Years ended December 31,

 
  

2022

  

2021

  

2020

 
   (in millions) 
European Operations               
Selling, general & administrative expenses  $358.3   $327.5   $210.6 
Selling, general & administrative expenses as a percent of net sales   48.2%   49.4%   49.8%
United States Operations               
Selling, general & administrative expenses  $134.0   $79.0   $50.1 
Selling, general & administrative expenses as a percent of net sales   39.1%   36.5%   43.1%

 

For European operations, selling, general and administrative expenses increased 9% and 55% in 2022 and 2021, respectively, as compared to the corresponding prior year period, and represented 48.2%, 49.4% and 49.8% of sales in 2022, 2021 and 2020, respectively as we were able to leverage our scale. As discussed in more detail below, these fluctuations, which are in line with the fluctuations in sales for European operations, are primarily from variations in promotion and advertising expenditures. For United States operations, selling, general and administrative expenses increased 70% and 58% in 2022 and 2021, respectively, as compared to the corresponding prior year period and represented 39.1%, 36.5% and 43.1% of sales in 2022, 2021 and 2020, respectively. As discussed in more detail below, the increased selling, general and administrative expenses as a percentage of net sales are primarily the result of increases in promotion and advertising expenditures. Additionally, the US based operations increased expenses related to salaries and benefits as we build the organization and infrastructure to support our new brands and future growth.

 

47

 

 

Promotion and advertising included in selling, general and administrative expenses aggregated $212.4 million, $171.1 million and $91.7 million in 2022, 2021 and 2020, respectively. Promotion and advertising as a percentage of sales represented 19.5%, 19.5% and 17.0% of net sales in 2022, 2021 and 2020, respectively. Promotion and advertising programs were cut significantly in 2020 in response to market conditions. Promotion and advertising are integral parts of our industry, and we continue to invest heavily in promotional spending to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on online net sales, causing then to continue to grow strongly on a global basis. All of our brands have benefitted from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts, the way brick-and-mortar stores and a business’ online operations work in tandem, and compelling content to deliver an integrated consumer experience. We anticipated that on a full year basis, future promotion and advertising expenditures will aggregate approximately 21% of net sales, which is in line with pre-COVID historical averages.

 

Royalty expense included in selling, general and administrative expenses aggregated $87.0 million, $68.9 million and $41.1 million in 2022, 2021 and 2020, respectively. Royalty expense as a percentage of sales represented 8.0%, 7.8% and 7.6% of net sales in 2022, 2021 and 2020, respectively. The increases in 2022 and 2021, as a percentage of sales, are directly related to new licenses and increased royalty-based product sales. As a result of the COVID-19 pandemic, we reached agreements with most of our licensors to waive or significantly reduce minimum guaranteed royalties for 2020.

 

Service fees, which are fees paid within our European operations to third parties relating to the activities of our distribution subsidiaries, aggregated $7.9 million, $9.4 million and $6.8 million in 2022, 2021 and 2020, respectively. The 2022 and 2021 amounts are in line with and directly related to fluctuations in sales within our U.S. distribution subsidiary.

 

Income from Operations

 

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 17.9%, 16.8% and 13.1% for the years ended December 31, 2022, 2021 and 2020, respectively.

 

Other Income and Expenses

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a $53.3 million (€50 million) four-year loan agreement. The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. Additionally, in April 2021, we completed the acquisition of the future headquarters of Interparfums SA. The acquisition was financed by a 10-year €120 million (approximately $128 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately €80 million of the variable rate debt was swapped for fixed interest rate debt. Long-term debt including current maturities aggregated $186.8 million, $148.8 million and $24.7 million as of December 31, 2022, 2021 and 2020, respectively.

 

We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Due to the sizable swings in currency rates during 2022, we went from recognizing a gain of $2.3 million in 2021 to a loss of $1.9 million in 2022. This accounts for most of our fluctuation within Other income and expenses.

 

Interest and investment income represents interest earned on cash and cash equivalents and short-term investments. In 2022, short-term investments include approximately $19.9 million of marketable equity securities of other companies in the luxury goods sector. Interest and investment income includes approximately $3.1 million of unrealized gains on marketable equity securities. Given our strong balance sheet and cash position, the increase in interest rates had a favorable impact on interest and investment income.

 

Income Taxes

 

Our effective income tax rate was 22.2%, 27.1% and 27.9% in 2022, 2021 and 2020, respectively.

 

48

 

 

Income tax expense represents U.S. federal, foreign, state and local income taxes. The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of share-based compensation and the taxation of foreign income including tax settlements. Our effective tax rate will change from year-to-year based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, the tax impact of share-based compensation, the interaction of various global tax strategies and the impact from certain acquisitions.

 

Our effective income tax rate for European operations was 25.2%, 30.6% and 29.7% in 2022, 2021 and 2020, respectively, as the French Prime Minister reduced the French corporate income tax rate from approximately 33% to 25% over a three-year period.

 

Our effective income tax rate for U.S. operations was 13.8%, 15.6% and 16.7% in 2022, 2021 and 2020, respectively.

 

Our effective tax rate differs from the 21% statutory rate due to state, local and foreign taxes, offset by benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income. Additionally, in the third quarter of 2022, our U.S. operations recognized a one-time tax benefit of $2.5 million associated with the 2021 Salvatore Ferragamo acquisition. At the time of the acquisition, we had not recognized deferred tax benefits as there were uncertainties concerning its potential recoverability; however, as of September 30, 2022, the recoverability was deemed likely.

 

The Company has determined that it has no tax liability related global intangible low-taxed income (“GILTI”) as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of its foreign derived intangible income (“FDII”) and recorded a tax benefit of $1.5 million, $0.6 million and $0.3 million as of December 31, 2022, 2021 and 2020, respectively. Share-based compensation resulted in a discrete tax benefit of $0.8 million, $1.3 million and $0.4 million in 2022, 2021 and 2020, respectively.

 

Net Income

 

   Year ended December 31, 
   2022   2021   2020 
   (In thousands) 
             
Net income attributable to European operations  $107,292   $80,670   $41,990 
Net income attributable to United States operations   43,745    29,357    7,978 
Net income   151,037    110,027    49,968 
Less: Net income attributable to the noncontrolling interest   30,099    22,616    11,749 
Net income attributable to Inter Parfums, Inc.  $120,938   $87,411   $38,219 
                

Net income attributable to European operations was $107.3 million, $80.7 million and $42.0 million in 2022, 2021 and 2020, respectively, while net income attributable to United States operations was $43.7 million, $29.4 million and $8.0 million in 2022, 2021 and 2020, respectively. The fluctuations in net income for both European operations and United States operations are directly related to the previous discussions concerning changes in sales, gross profit margins, selling, general and administrative expenses, most of which were caused by the effects of the COVID-19 pandemic beginning in 2020 and the recovery in 2021 and 2022.

 

The noncontrolling interest arises primarily from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations and aggregated 27.9%, 28.0% and 28.1% of European operations net income in 2022, 2021 and 2020, respectively. Net margins attributable to Inter Parfums, Inc. aggregated 11.1%, 9.9% and 7.1% in 2022, 2022 and 2020, respectively.

 

Liquidity and Capital Resources

 

Our conservative financial tradition has enabled us to amass significant cash balances. As of December 31, 2022, we had $256 million in cash, cash equivalents and short-term investments, most of which are held in euro by our European operations and are readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of December 31, 2022, short-term investments include approximately $19.9 million of marketable equity securities.

 

49

 

 

As of December 31, 2022, working capital aggregated $443 million, and we had a working capital ratio of 2.3 to 1. Approximately 80% of the Company’s total assets are held by European operations including approximately $249 million of trademarks, licenses and other intangible assets.

 

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in this annual report on Form 10-K. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

 

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Lacoste brand. This new license takes effect January 2024.

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. The exclusive license became effective on July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions. With respect to the management and coordination of activities related to the license agreement, the Company is operating through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition. The total cost of the assets acquired net of liabilities assumed aggregated approximately $35.8 million. In connection with this acquisition, we agreed to pay $17.0 million in equal annual installments of $1.7 million including interest imputed at 2.0%.

 

Opportunities for external growth are regularly examined, with the priority of maintaining the quality and homogeneous nature of our portfolio. However, we cannot assure you that any new license or acquisition agreements will be consummated.

 

Cash provided by operating activities aggregated $115.2 million, $119.6 million, and $65.0 million in 2022, 2021 and 2020, respectively. In 2022, working capital items used $65.6 million in cash from operating activities, as compared to $13.7 million in 2021 and $7.3 million in 2020. Although, from a cash flow perspective, accounts receivable is up approximately 37% from year-end 2021, the balance is reasonable based upon fourth quarter 2022 record sales levels and reflects strong collection activity as day’s sales outstanding increased slightly to 64 days in 2022, as compared to 61 days in 2022 and decreased significantly as compared to 86 days in 2020. From a cash flow perspective, inventory levels are up 49% from year-end 2021. Inventory days on hand increased to 231 days in 2022, as compared to 208 days in 2021, and 277 days in 2020 as we chose to protect service level in light of the COVID driven supply chain disruptions.

 

Cash flows used in investing activities reflect the purchase and sales of short-term investments. These investments consist of certificates of deposit with maturities greater than three months marketable equity securities and other contracts. At December 31, 2022, approximately $39 million of certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

 

50

 

 

Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we generally spend less than $5.0 million on capital expenditures including tools and molds needed to support our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

 

In December 2022, to finance Interparfums SA’s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (€50 million) four-year loan agreement. The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.

 

In April 2021, Interparfums SA completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The $142 million purchase price is in line with market value and includes the complete renovation of the site. As of December 31, 2021, $136.1 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in building, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2021. Approximately $8.8 million of cash held in escrow is included in other assets on the accompanying balance sheet as of December 31, 2021. In 2022 this cash was released from escrow and there is no longer any balance of cash outside of cash and cash equivalents on the accompanying balance sheet as of December 31, 2022. In addition, the Company borrowed $17.0 million pursuant to a short-term loan equal to the VAT credit, and in July 2021, the $17.0 million VAT credit was reimbursed by the French Tax Authorities and the loan was repaid.

 

The acquisition was financed by a 10-year €120 million (approximately $136 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.

 

In June 2020, the Company and Divabox, owner of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment pursuant to which we acquired 25% of Divabox capital for $14 million through a capital increase. In connection with the acquisition, the Company entered into a $13.4 million term loan, which was repaid in full in February 2021.

 

Our short-term financing requirements are expected to be met by available cash on hand at December 31, 2022, cash generated by operations and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2022 consist of a $20.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $20 million in credit lines provided by a consortium of international financial institutions. There were no balances due from short-term borrowings as of December 31, 2022 and 2021.

 

In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the quarterly cash dividend. In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly and in February 2022, our Board authorized a 100% increase in the annual dividend to $2.00 per share. In February 2023 the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on March 31, 2023, to shareholders of record on March 15, 2023. Dividends paid, including dividends paid once per year to noncontrolling stockholders of Interparfums SA, aggregated $79.8 million, $41.5 million and $21.1 million for the years ended December 31, 2022, 2021 and 2020, respectively. The cash dividends to be paid in 2023 are not expected to have any significant impact on our financial position.

 

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

 

51

 

 

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the year ended December 31, 2022 as they were either offset by price increases we passed onto our respective customers or operating efficiencies.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

General

 

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

 

Foreign Exchange Risk Management

 

A general discussion relating to our policies on foreign exchange risk management can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our annual report on Form 10-K for the year ended December 2020.

 

As of December 31, 2022, we had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $36.5 million which all have maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

 

Interest Rate Risk Management

 

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.

 

Item 8. Financial Statements and Supplementary Data

 

The required financial statements commence on page F-1.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this annual report on Form 10-K (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company’s disclosure controls and procedures were effective.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

The management of Inter Parfums, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13(a)-15(f) under the Securities Exchange Act of 1934. With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control – Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2022.

 

52

 

 

Our independent auditor, Mazars USA LLP, a registered public accounting firm, has issued its report on its audit of our internal control over financial reporting. This report appears on page F-2.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the fourth quarter of 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Item 9B.Other Information.

 

None.

 

53

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Executive Officers and Directors

 

As of the date of this report, our executive officers and directors were as follows:

 

Name   Position
Jean Madar   Chairman of the Board, Chief Executive Officer of Inter Parfums, Inc. and Director General of Interparfums SA
Philippe Benacin   Vice Chairman of the Board, President of Inter Parfums, Inc. and Chief Executive Officer of Interparfums SA
Michel Atwood   Director and Chief Financial Officer
Philippe Santi   Director, Executive Vice President and Chief Financial Officer, Interparfums SA
François Heilbronn   Director
Robert Bensoussan   Director
Patrick Choël   Director
Michel Dyens   Director
Veronique Gabai-Pinsky   Director
Gilbert Harrison   Director
Frederic Garcia-Pelayo   Executive Vice President and Chief Operating Officer of Interparfums SA

 

Our directors will serve until the next annual meeting of stockholders and thereafter until their successors shall have been elected and qualified. Messrs. Jean Madar and Philippe Benacin have a verbal agreement or understanding to vote their shares and the shares of their respective holding companies in a like manner.

 

With the exception of Mr. Benacin, the officers are elected annually by the directors and serve at the discretion of the board of directors. There are no family relationships between executive officers or directors of our Company.

 

Board of Directors

 

Our board of directors has the responsibility for establishing broad corporate policies and for the overall performance of our Company. Although certain directors are not involved in day-to-day operating details, members of the board of directors are kept informed of our business by various reports and documents made available to them. Our board of directors held 18 meetings (or executed consents in lieu thereof), including meetings of committees of the full board of directors during 2022, and all of the directors attended at least 75% of the meetings (or executed consents in lieu thereof) of the full board of directors and committees of which they were a member. Our board of directors presently consists of ten (10) directors.

 

We have adopted a Code of Business Conduct that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, as well as other persons performing similar functions, and we agree to provide to any person without charge, upon request, a copy of our Code of Business Conduct. Any person who requests a copy of our Code of Business Conduct should provide their name and address in writing to: Inter Parfums, Inc., 551 Fifth Avenue, New York, NY 10176, Att.: Shareholder Relations. In addition, our Code of Conduct is also maintained on our website, at www.interparfumsinc.com.

 

During 2022, our board of directors had the following standing committees:

 

  ● Audit Committee – The Audit Committee has the sole authority and is directly responsible for, the appointment, compensation and oversight of the work of the independent accountants employed by our company which prepare or issue audit reports for our company. During 2022, this committee consisted of Messrs. Heilbronn and Choël, and Ms. Gabai-Pinsky. The charter of the Audit Committee is posted on our Company’s website.

 

54

 

 

The Company does not have an “audit committee financial expert” within the definition of the applicable Securities and Exchange Commission rules. Finding qualified nominees to serve as a director of a public company without the comparable financial resources of other larger, more established companies has been challenging. In addition, despite the applicable Securities and Exchange Commission rule which states that being named as the audit committee financial expert does not impose any greater duty, obligation or liability, our company has been met with resistance from both present and former directors to being named as such, primarily due to potential additional personal liability. However, as the result of the background, education and experience of the members of the Audit Committee, our board of directors believes that such committee members are fully qualified to fulfill their obligations as members of the Audit Committee. The Chair of the Audit Committee, Mr. François Heilbronn, is a graduate of Harvard Business School with a Master of Business Administration degree and is currently the managing partner of the consulting firm of M.M. Friedrich, Heilbronn & Fiszer which is specialized in business strategy and complex financial operations and investments.

 

  ● Executive Compensation and Stock Option Committee – The Executive Compensation and Stock Option Committee oversees the compensation of our Company’s executives and administers our company’s stock option plans. During 2022, this committee consisted of Messrs. Heilbronn and Choël, and Ms. Gabai-Pinsky. The charter of the Executive Compensation and Stock Option Committee is posted on our company’s website.

 

  ● Nominating Committee – During 2022, this committee consisted of Messrs. Heilbronn and Choël, and Ms. Gabai-Pinsky. The purpose of the Nominating Committee is to determine and recommend qualified persons to the Board of Directors who will be put forth as management’s slate of directors for vote of the Corporation’s stockholders, as well as to fill vacancies in the Board of Directors. The charter of the Nominating Committee is posted on our Company’s website.

 

We have adopted a board diversity policy, which provides that the selection of candidates for appointment to our board will be based on an overriding emphasis on merit, but the Nominating Committee will seek to fill board vacancies by considering candidates that bring a diversity of background and industry or related expertise to our board. The Nominating Committee is to consider an appropriate level of diversity having regard for factors such as skills, business and other experience, education, gender, age, ethnicity and geographic location. A copy of the board diversity policy is posted on our company’s website. In addition, Nasdaq has adopted a Board Diversity Rule, which requires Nasdaq listed companies to publicly disclose board-level diversity statistics using a standardized template during 2022. By the 2025 annual meeting, we will be required to disclose whether or not we have two directors that are diverse under the applicable Nasdaq rule, and if not, then why not. We do not foresee any issue in complying with Nasdaq Board Diversity Rule at this time.

 

55

 

 

Nasdaq Board Diversity

 

As required by the the Nasdaq Diversity Rule, the board of directors of our company presently has one (1) member who self-identifies as a female and one (1) member who identifies as Hispanic, which is in compliance with the Nasdaq Board Diversity rule. Below is the Nasdaq Board Diversity Matrix, which shows the gender identity and demographic background of our board of directors as they have self-identified.

 

Board Diversity Matrix for                                                           INTER PARFUMS INC.

 

As of February 28, 2023

 

 
Total Number of Directors 10
Part I: Gender Identity Female Male Non-Binary Did Not Disclose Gender
Directors 1 9 0 0
Part II: Demographic Background
African American or Black 0 0 0 0
Alaskan Native or American Indian 0 0 0 0
Asian 0 0 0 0
Hispanic or Latinx 0 1 0 0
Native Hawaiian or Pacific Islander 0 0 0 0
White 1 8 0 0
Two or More Races or Ethnicities 0 0 0 0
LGBTQ+ 0
Did Not Disclose Demographic Background 0

 

Business Experience

 

The following sets forth biographical information as to the business experience of each executive officer and director of our company for at least the past five years.

 

Jean Madar

 

Jean Madar, age 62, a Director, has been the Chairman of the Board since our Company’s inception, and is a co-founder of our Company with Mr. Philippe Benacin. From inception until December 1993 he was the President of our Company; in January 1994, he became Director General of Interparfums SA, our Company’s subsidiary; and in January 1997, he became Chief Executive Officer of our Company. Mr. Madar was previously the managing director of Interparfums SA, from September 1983 until June 1985. At such subsidiary, he had the responsibility of overseeing the marketing operations of its foreign distribution, including market research analysis and actual marketing campaigns. Mr. Madar graduated from The French University for Economic and Commercial Sciences (ESSEC) in 1983. We believe that Mr. Madar’s skills in guiding, leading and determining the strategic direction of our company since its inception together with Mr. Benacin, in addition to his contacts in the fragrance and cosmetic industry, render him qualified to serve as a member of our board of directors.

 

Philippe Benacin

 

Mr. Benacin, age 64, a Director, is President of our Company and the Chief Executive Officer of Interparfums SA, has been the Vice Chairman of the Board since September 1991, and is a co-founder of our Company with Mr. Madar. He was elected the Executive Vice President in September 1991, Senior Vice President in April 1993, and President of the Company in January 1994. In addition, he has been the President of our Company and Chief Executive Officer of Interparfums SA for more than the past five years. Mr. Benacin graduated from The French University for Economic and Commercial Sciences (ESSEC) in 1983. In June 2014 Mr. Benacin was elected as a member of the Supervisory Board of Vivendi, and Chairman of its Corporate Governance, Nominations and Remuneration Committee. We believe that Mr. Benacin’s skills in guiding, leading and determining the strategic direction of our company since its inception together with Mr. Madar, in addition to his contacts in the fragrance and cosmetic industry, render him qualified to serve as a member of our board of directors.

 

56

 

 

Michel Atwood

 

Mr. Atwood, age 53, became our Chief Financial Officer on September 6, 2022, succeeding Mr. Russell Greenberg, the former Chief Financial Officer, who retired on that same date. Mr. Atwood was first elected to our Board of Directors at the 2022 Annual Meeting held in September 2022.

 

From September 2018 through March 2022 while at Estée Lauder, Mr. Atwood had strategic oversight for the fragrance category across that company and operational accountability for several of its fragrance brands. He also had senior level merger and acquisition (“M&A”) duties, including acquisition integration and brand divestitures/discontinuations. Over his nearly four years at Estée Lauder, he also drove cross-brand synergies across research and development and supply chain for the fragrance category. From February 2017 to August 2018, he was an independent consultant as an M&A advisor on multiple fragrance license acquisitions and also acted as a private investor. 

 

From 1995 to 2017, Mr. Atwood has held several executive positions at Procter & Gamble (“P&G”) in France, Switzerland, Italy and Germany. His final title at P&G was Divisional CFO of Global Prestige Fragrances, leading a 90 member team, and ultimately spearheading the divestiture of that division to Coty. Earlier he was CFO Global Markets – Prestige Fragrances, a business generating over $2 billion in sales, where he headed a globally dispersed team of 60 people supporting the go-to-market organization (affiliates, Travel Retail and distributors) of the Prestige Division. Before that, he was Global Prestige Director of Strategic Planning, Licensing and Acquisition shaping and executing the overall business direction and licensing and acquisition strategy of P&G’s Global Fragrance and Premium skin and cosmetics businesses.

 

Michel Atwood holds a Master’s degree in Software Engineering from the Institut National des Sciences Appliquées of Lyon, and a Master’s in International Finance from HEC Paris, the prestigious French business school. He also earned the designation of Certified Management Accountant from the Institute of Management Accountants. He has a truly international background, working/living in France, Switzerland, the U.S., Canada, Turkey and Italy. We believe that Mr. Atwood’s skills and experience in accounting, international tax, mergers and acquisitions, as well as his knowledge of the fragrance industry, render him qualified to serve as a member of our board of directors.

 

Philippe Santi

 

Philippe Santi, age 61, and a Director since December 1999, is the Executive Vice President and Chief Financial Officer of Interparfums SA. Mr. Santi, who is a Certified Accountant and Statutory Auditor in France, has been the Chief Financial Officer of Interparfums SA since February 1995. Prior to February 1995, Mr. Santi was the Chief Financial Officer for Stryker France and an Audit Manager for Ernst and Young. We believe that Mr. Santi’s skills in accounting and tax, as well as his knowledge of the fragrance industry and our Company’s European operations, render him qualified to serve as a member of our board of directors.

 

Francois Heilbronn

 

Mr. Heilbronn, age 61, a Director since 1988, an independent director and a member of the Audit Committee, Nominating Committee and the Executive Compensation and Stock Option Committee, is a graduate of Harvard Business School with a Master of Business Administration degree and is currently the managing partner of the consulting firm of M.M. Friedrich, Heilbronn & Fiszer. He was formerly employed by The Boston Consulting Group, Inc. from 1988 through 1992 as a manager. Mr. Heilbronn graduated from Institut d’ Etudes Politiques de Paris in June 1983. From 1984 to 1986, he worked as a financial analyst for Lazard Freres & Co. In addition, during 2009, Mr. Heilbronn became an Associate Professor in Business Strategy at Sciences Po, Paris, France. As the result of his business and financial acumen, as well as his experience as managing partner of a business consulting firm in the area of mergers and acquisitions of large international companies in retail, consumer goods and consumer services throughout the world, we believe Mr. Heilbronn is qualified to serve as a member of our board of directors.

 

57

 

 

Robert Bensoussan

 

Robert Bensoussan, age 65, has been a Director since March 1997, and is also an independent director. Mr. Bensoussan is the founder of Sirius Equity Consultants, a retail and branded luxury goods investment company. To date, Mr. Bensoussan remains as an investor in Hapy Sweet Bee Ltd, natural health food products,

 

He was previously Chairman of Camaïeu, the French retail conglomerate, a board member of Celio International, the French retail conglomerate and Vivarte representing the GLG hedge fund. In the latter part of 2019, Mr. Bensoussan resigned after 6 years as the only non-North American board member of lululemon athletica Inc. Following the successful sale in 2021, Mr. Bensoussan stepped down from the board of Feelunique.com, one of Europe’s largest online beauty retailers after serving 9 years.

 

He is a member of the Advisory Board of Pictet Bank Premium Brands Fund and sits on the board of Pronovias, the worldwide leader of wedding dresses. Yonderland, Europe’s largest premium outdoor retailer and SNS, a prominent aspirational streetwear and entertainment hub.

 

Previously Mr. Bensoussan was as director of, and had an indirect ownership interest in, J. Choo Limited until July 2011, and was CEO from 2001 to 2007, and was a member of the Board of Jimmy Choo Ltd, from 2001 to 2011, which had been a privately held luxury shoe wholesaler and retailer.

 

We believe Mr. Bensoussan is qualified to serve as a member of our board of directors due to his business and financial acumen, as well as his experience in the retail and branded luxury goods market.

 

Patrick Choël

 

Mr. Choël, age 79, was appointed to the board of directors in June 2006 as an independent director, and is a member of the Audit Committee, Nominating Committee and the Executive Compensation and Stock Option Committee. Mr. Choël is a director of our majority-owned subsidiary, Interparfums SA, a publicly held company, and Christian Dior a privately held company. For approximately 10 years, through March 2004, Mr. Choël was the President and CEO of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., first Parfums Christian Dior, a leading world-wide prestige beauty/fragrances business, and later, the LVMH Perfumes and Cosmetics Division, which included such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy, among others. Prior to such time, for approximately 30 years, he held various executive positions at Unilever, including President and CEO of Elida Fabergé France and President and CEO of Chesebrough Pond’s USA. Because of this experience, especially in the prestige beauty business, we believe that Mr. Choël is qualified to serve as a member of our board of directors.

 

Michel Dyens

 

Michel Dyens, age 82 and an independent director, is the Founder, Chairman and Chief Executive Officer of Michel Dyens & Co., which he founded over 25 years ago. With headquarters in New York and Paris, Michel Dyens & Co. is a leading independent investment banking firm focused on mergers and acquisitions. Michel Dyens & Co. has vast experience in luxury goods, beauty, spirits and other premium branded consumer goods in which it has concluded numerous landmark deals. Michel Dyens & Co. has advised in such deals as the sale of the Grey Goose ultra-premium vodka brand to Bacardi, the acquisition of the luxury Swiss watchmaker Hublot by LVMH, the sale of the Harry Winston to Aber Diamond Corporation and Boucheron to Kering. Michel Dyens & Co. represented the owners of Liaigre, the luxury furniture brand, in the sale to Symphony International and Navis Capital, and Casa Dragones, the ultra-premium tequila, in the sale to BDT Partners (Byron Trott).

 

In 2021, Michel Dyens & Co. represented the owners of Buly, the luxury French fragrance and beauty brand, in the sale to LVMH and the owners of Blissim, the French leader in beauty subscription e-commerce, and online beauty retail for an investment by Raise Investissement. In addition, he has just sold We11done, the Korean contemporary fashion and lifestyle brand, to Sequoia Capital.

 

58

 

 

Michel Dyens & Co. was the exclusive advisor to Creed in the sale of the ultra-luxury fragrance company Creed BlackRock Long Term Private Capital, and represented Mr. Chin Wook Lee, the founder and CEO of Dr. Jart+, in the sale of Have & Be Co. Ltd. to The Estée Lauder Companies. Michel Dyens & Co. also advised the owner of the ultra-luxury fragrance brand By Kilian, in the sale to Estée Lauder. Michel Dyens & Co. advised the shareholders of the largest independent hair color and hair care company in Brazil, Niely Cosmeticos in the sale of the company to L’Oréal, as well as the owner of the super-premium liqueur St-Germain in the sale of the brand to Bacardi, the Colomer Group (American Crew and CND/Shellac brands) in its sale to Revlon, and Sidney Frank Importing Company in the sale of the company to Jaegermeister. Other transactions include the sale of the Essie cosmetics business to L’Oréal, the sale of TIGI (BedHead and Catwalk brands) to Unilever, the luxury hair care brand Christophe Robin to The Hut Group, the thinning hair brand NIOXIN Research Laboratories to Procter & Gamble, John Frieda Professional Hair Care and Molton Brown to the Kao Corporation, the Svedka vodka brand to Constellation Brands and Chambord liqueur to Brown-Forman.

 

In the mission-driven field, Michel Dyens & Co. recently represented ClimateCare, a prominent UK carbon-offset business, in the sale to Averna Capital and represented the founders of Caboo Paper Products a Vancouver, Canada-based tree-free household paper products brand, for an investment by sustainability-focused venture capital firm Renewal Funds. Among other recent transactions, Michel Dyens & Co. recently represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz, and as well as Alter Eco Americas, a leading organic chocolate brand, which we sold to NextWorld Evergreen.

 

In healthy and premium food, Michel Dyens & Co. represented the Fairtrade and organic coffee brand Ethical Bean Coffee in the sale to Kraft Heinz, and as well as Alter Eco Americas, a leading organic chocolate brand, which it sold to NextWorld Evergreen.

 

From April 2004 to September 2014, Mr. Dyens was an independent director of Interparfums SA. We believe Mr. Dyens is qualified to serve as a member of our board of directors thanks to his knowledge of our Company’s luxury business, his business and financial acumen, as well as his experience in the luxury goods market.

 

Veronique Gabai-Pinsky

 

Ms. Gabai-Pinsky, age 57, was elected for the first time to our board in September 2017. She became a director of Interparfums SA in April 2017. She is currently operating a startup specialty fragrance business, and a director of Lifetime Brands (Nasdaq: LCUT), which is in the home goods business. She was President of Vera Wang Group from January 2016 through June 2018, after a year of consulting with the company and she oversaw all product categories and markets. Prior to joining Vera Wang, from 2006 to December 2014, Ms. Gabai-Pinsky was the Global President for Aramis and Designers Fragrances as well as Beauty Bank and Idea Bank at The Estée Lauder Companies, reporting to the Chief Executive Officer of such company. During her tenure, Ms. Gabai-Pinsky developed and ensured the growth of several beauty and skin care brands, including Lab Series for Men. She was highly instrumental in the evolution of the fragrance category for such company, as she improved its overall business model, globally grew brands such as Donna Karan and Michael Kors, evolved and harmonized the portfolio, divested dilutive brands and brought in Tory Burch, Zegna and Marni under licenses. She ultimately actively participated in the acquisitions of Le Labo, Frederic Malle, and By Kilian and assisted in the transformation of the long-term strategic direction of such company.

 

In the earlier years of her career, Ms. Gabai-Pinsky served as Vice President of Marketing and Communication for Guerlain, a division of LVMH Moet Hennessy Louis Vuitton S.A., where she led the successful re-launch of Shalimar, the introduction of Aqua Allegoria, and contributed to the re-focus of the beauty category around its pillars, Terracotta, Meteorites and Issima, while redesigning all communication strategies and content. She started her career at L’Oréal, and was also Vice President of Marketing for Giorgio Armani, where she was instrumental in the overall development of its fragrance business by developing the successful Acqua di Gio for men and introducing the Emporio Armani franchise. A graduate from ESSEC Business School in Paris, France, she has received several awards, including Marketer of the Year by Women’s Wear Daily in December 2013.

 

59

 

 

Ms. Gabai-Pinksy is an independent director, and is a member of the Audit Committee, Executive Compensation and Stock Option Committee and the Nominating Committee of our Company. We believe Ms. Gabi-Pinsky is qualified to serve as a member of our board of directors due to her more than 25 years of experience in the luxury, fashion, beauty and fragrance fields, success as a brand builder, creative thinker, business acumen, and a broad understanding of consumers, brands and business models.

 

Gilbert Harrison

 

Mr. Harrison, age 82, an independent director, was appointed to our board in April 2018. Mr. Harrison has more than 50 years of experience in corporate finance and strategic transactions, specializing in the consumer products space. He began his career in 1965 practicing corporate and securities law in New York and Philadelphia. In 1971 he founded Financo, which he grew to become one of the leading independent middle market transaction firms in the country. In 1985, Financo was acquired by Lehman Brothers, where the firm’s primary efforts were focused on increasing its expertise in retail, apparel and other merchandising transactions of all types. At Lehman, Mr. Harrison was Chairman of the Merchandising Group and on the firm’s Investment Banking Operating Committee while continuing as Chairman of Financo, which was renamed the Middle Market Group of Lehman. In 1989, he re-acquired Financo from Lehman, re-establishing Financo as one of the leading investment banking firms handling transactions and providing strategic advice in connection with merchandising companies. Mr. Harrison retired as Chairman of Financo in December of 2017, after which he formed the Harrison Group, a firm that provides consulting and financial advisory services to merchandising and products companies.

 

Mr. Harrison’s other activities include his membership on the Advisory Council of the World Retail Congress, Shoptalk and the Financial Times Business of Luxury Summit. Additionally, he has created a course on mergers and acquisitions at The Wharton School and has published various articles and academic studies on the state of retailing and mergers and acquisitions, including a chapter in the book entitled, “The Mergers and Acquisitions Handbook.” Mr. Harrison lectures throughout the country, including chairing seminars for Retail Week as well as for the International Council of Shopping Centers, the National Retail Federation, Young President’s Center, The Wharton Aresty Institute of Executive Education and The President’s Association of the American Management Association. He also appears frequently on Bloomberg TV and CNBC as an expert on retail and apparel.

 

Mr. Harrison received a Bachelor of Science in Economics from The Wharton School of The University of Pennsylvania in 1962 and his Juris Doctor from The University of Pennsylvania Law School in 1965. He is also Chairman of the Fashion Division of UJA, Treasurer and a Board member of the Southampton Hospital, Director of the Peggy Guggenheim Collection, and former Board member of the Wharton School of the University of Pennsylvania. We believe Mr. Harrison is qualified to serve as a member of our board of directors due to his tremendous depth and breadth of knowledge about the merchandising and consumer industry, and he has a long track record of facilitating value-creating transactions for companies in this sector. Mr. Harrison’s autobiography, Deal Junky, was published in January 2022.

 

Frederic Garcia-Pelayo

 

Frederic Garcia-Pelayo, age 61, has been with Interparfums SA for more than the past 20 years. He is currently the Executive Vice President and Chief Operating Officer of Interparfums SA, and was previously the Director of its Luxury and Fashion division beginning in March 2005. He was also previously the Director of Marketing and Distribution for Perfume and Cosmetics and was first named Executive Vice President in 2004.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Based solely upon a review of Forms 3, 4 and 5 and any amendments to such forms furnished to us, and written representations from various reporting persons furnished to us, we are not aware of any reporting person who has failed to file the reports required to be filed under Section 16(a) of the Securities Exchange Act of 1934 on a timely basis.

 

60

 

 

Item 11. Executive Compensation

 

Compensation Discussion and Analysis

 

General

 

The executive compensation and stock option committee of our board of directors is comprised entirely of independent directors and oversees all elements of compensation (base salary, annual bonus, long-term incentives and perquisites) of our company’s executive officers and administers our company’s stock option plans, other than the non-employee directors stock option plan, which is self-executing.

 

The objectives of our compensation program are designed to strike a balance between offering sufficient compensation to either retain existing or attract new executives on the one hand, and maintaining compensation at reasonable levels on the other hand. We do not have the resources comparable to the cosmetic giants in our industry, and, accordingly, cannot afford to pay excessive executive compensation. In furtherance of these objectives, our executive compensation packages generally include a base salary, as well as annual incentives tied to individual performance and long-term incentives tied to our operating performance.

 

During 2022 and prior years, Mr. Madar, the Chairman and Chief Executive Officer, took the initiative after discussions with Mr. Russell Greenberg, the former Executive Vice President, Chief Financial Officer and board member, and recommended executive compensation levels for executives for United States operations. Mr. Benacin, the Chief Executive Officer of Interparfums SA, took the initiative after discussions with Philippe Santi, the Chief Financial Officer of Interparfums SA, and recommended executive compensation levels for executives for European operations. The recommendations are presented to the compensation committee for its consideration, and the compensation committee makes a final determination regarding salary adjustments and annual award amounts to executives, including Jean Madar and Philippe Benacin. Messrs. Madar and Benacin are not present during deliberations or determination of their executive compensation by the compensation committee. Further, Messrs. Madar and Benacin, in addition to being executive officers and directors, are our largest beneficial shareholders, and therefore, their interests are aligned with our shareholder base in keeping executive compensation at a reasonable level.

 

The compensation committee was pleased that the most recent shareholder advisory vote on executive compensation held at our last annual meeting of shareholders in September 2022 overwhelmingly approved the compensation policies and decisions of the compensation committee. The compensation committee has determined to continue its present compensation policies in order to determine similar future decisions.

 

Our compensation committee believes that individual executive compensation is at a level comparable with executives in other companies of similar size and stage of development that operate in the fragrance industry, and takes into account our company’s performance as well as our own strategic goals. Further, the compensation committee believes that its present policies to date, with its emphasis on rewarding performance, has served to focus the efforts of our executives, which in turn has permitted our company to weather the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil in certain parts of the world, which resulted in the Company’s record results for 2022. During 2022, the members of such committee consisted of Messrs. Heilbronn and Choël, and Ms. Gabai-Pinsky.

 

Elements of Compensation

 

General

 

The compensation of our executive officers is generally comprised of base salaries, including a fee paid to the holding companies of each of Messrs. Madar and Benacin, annual cash bonuses and long-term equity incentive awards. In determining specific components of compensation, the compensation committee considers individual performance, level of responsibility, skills and experience, other compensation awards or arrangements and overall company performance. The compensation committee reviews and approves all elements of compensation for all of our executive officers taking into consideration recommendations from the Chief Executive Officer of our company and the Chief Executive Officer of Interparfums SA, as well as information regarding compensation levels at competitors in our industry.

 

61

 

 

Our named executive officers have all been with the Company for more than the past ten (10) years, other than Mr. Atwood who joined our Company in September 2022, with Messrs. Madar and Benacin being founders of the Company. As Messrs. Madar and Greenberg, the former Chief Financial Officer and Executive Vice President for United States operations, and Benacin and Santi for European operations, were most familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their respective operating segments, the compensation committee relies upon the information provided by such executive officers in determining individual performance, level of responsibility, skills and experience of each executive officer.

 

The compensation committee views the competitive marketplace very broadly, which would include executive officers from both public and privately held companies in general, including fashion and beauty companies, but not limited to the peer companies contained in the corporate performance graph contained in our annual report. Generally, rather than tie the compensation committee’s determination of compensation proposals to any specific peer companies, the members of our committee have used their business experience, judgment and knowledge to review the executive compensation proposals recommended to them by Mr. Madar for United States operations and Mr. Benacin for European operations. As such, as a general rule the compensation committee did not determine the need to benchmark of any material item of compensation or overall compensation. However, in connection with the salary increase to Mr. Madar that occurred in February 2020, surveys of both peer companies and companies with comparable market capitalizations were used by the compensation committee as one of the factors in reaching such determination.

 

The members of the compensation committee have extensive experience and business acumen and are well qualified in determining the appropriateness of executive compensation levels. Mr. Heilbronn is a managing partner of a business consulting firm in the area of mergers and acquisitions of large international companies in retail, consumer goods and consumer services throughout the world. Mr. Choël previously worked as President and Chief Executive Officer of two divisions of LVMH Moet Hennessy Louis Vuitton S.A., which included such well-known brands as Parfums Christian Dior, Guerlain, and Parfums Givenchy. Mr. Choël has also been President and CEO of both Elida Fabergé France and Chesebrough Ponds USA. Ms. Gabai-Pinsky, the final committee member, has executive experience as the former President of Vera Wang Group, as well as the Global President for Aramis and Designers Fragrances in addition to Beauty Bank and Idea Bank at The Estée Lauder Companies.

 

Base Salary

 

Base salaries for executive officers are initially determined by evaluating the responsibilities of the position held and the experience of the individual, and by reference to the competitive marketplace for executive talent. Base salaries for executive officers are reviewed on an annual basis, and adjustments are determined by evaluating our operating performance, the performance of each executive officer, as well as whether the nature of the responsibilities of the executive has changed.

 

As stated above, as Messrs. Madar and Greenberg for United States operations, and Messrs. Benacin and Santi for European operations, were most familiar with the individual performance, level of responsibility, skills and experience of each executive officer in their respective segments, the committee relied upon the information provided by such executive officers in determining individual performance, level of responsibility, skills and experience of each executive officer. 

 

For executive officers of United States operations, the bulk of their annual compensation is in base salary including a fee paid to the holding company for Mr. Madar for services rendered outside the United States. However, for executive officers of European operations base salary comprises a smaller percentage of overall compensation. We have paid a lower percentage of overall compensation in the form of base salary to executive officers of European operations for several years, principally because European operations historically have had higher profitability than United States operations, and European operations are run differently from United States operations by the Chief Executive Officer of European operations, Mr. Benacin. As the result of this historically higher profitability, European operations have had the ability to pay higher bonus compensation in addition to base salary. As bonus compensation is and has historically been discretionary, no targets were set in order to maintain flexibility. Further, if results of operations for European operations were not satisfactory (again, no target amounts were set to maintain flexibility), then bonus compensation, as well as overall compensation could be lowered without otherwise affecting base salary. Finally, by keeping annual bonus compensation at a higher percentage of overall compensation and base salary at a lower percentage, our company benefits because the base amount for annual salary adjustments would be smaller.

 

62

 

 

For the impact of COVID-19 on executive compensation in 2020 and 2021, please see our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, under Item 11, Item 11. Executive Compensation, Compensation Discussion and Analysis, Covid-19 Impact, which is incorporated by reference herein.

 

For 2022, Mr. Benacin received a base salary of $756,000, (included an increase of €12,000 but due to the foreign currency conversion this is showing as a decrease when compared to 2021), and Mr. Benacin’s holding company received $250,000 paid by the Company’s United States operations, which is included the calculation of his base salary. This same consulting fee has been paid for more than each of the past three years, in accordance with the consulting agreement with Mr. Benacin’s holding company, which provides for review on an annual basis of the amount of compensation payable to such company.

 

For 2021, although Mr. Benacin received the same base salary as he did in 2020, his salary was affected by foreign currency conversion rates and was $804,000 for 2021. For 2020, Mr. Benacin received a modest increase in base salary of $14,000 to $789,000.

 

The compensation committee considered the following salient factors in authorizing payment to Mr. Benacin’s holding company— services rendered to United States operations for several years by Mr. Benacin in connection with licensing and distribution of international brands, as well as future services to be performed by Mr. Benacin internationally relating to licensing and distribution of international brands for United States operations.

 

As Mr. Benacin values the services of two named executive officers of Interparfums SA, Mr. Philippe Santi, Executive Vice President and the Chief Financial Officer, and Mr. Frederic Garcia-Pelayo, Executive Vice President and Chief Operating Officer, equally, their base salaries, as well as their bonus compensation discussed below, have been in lockstep.

 

For 2022, the base salary of each of Messrs. Santi and Garcia-Pelayo was €432,000, and increase of €24,000. For 2021, the base salary of each of Messrs. Santi and Garcia-Pelayo was €408,000, as no executive officer received any increase in base salary due the continuing impact of the COVID-19 pandemic. However, the base salaries of Messrs. Santi and Garcia-Pelayo in 2021 were affected by foreign currency conversion rates and were both $483,000 for 2021. For 2020, each of Messrs. Santi and Garcia-Pelayo received an increase in base salary of $14,000 to $470,000. Increases in prior years were awarded primarily to reward these two executive officers for their contributions in European Operations achieving increases in both the sales and earnings. The compensation committee considered the recommendations of Mr. Benacin, results of operations for the year, as well as the services performed for European operations by Messrs. Santi and Garcia-Pelayo in authorizing these salary levels.

 

A different approach is taken for United States operations as that segment is smaller and less profitable. A more significant base salary is paid in order to attract and retain employees with the skills and talents needed to run the operation with a lesser emphasis placed on bonuses. Neither of the executive officers for United States operations have employment agreements (although Mr. Madar’s personal holding company has a consulting agreement that provides for review on an annual basis of the amount of compensation payable to such company), as we believe that having flexibility in structuring annual base salary is a benefit, which permits us to act quickly to meet a changing economic environment.

 

As previously reported, from 2013 until 2019 the annual aggregate base salary paid to Mr. Madar individually and fees paid to his holding company remained unchanged at $630,000, which was substantially below the amounts indicated by two surveys of chief executive officer salaries for 2019 (collectively the “CEO Salary Surveys”). The CEO Salary Surveys indicated that the annual and median average CEO salaries for peer companies (excluding the Madar salary) were $2,854,656 and $1,540,000, respectively, and $2,604,346 and $1,750,000 for comparable market capitalization companies, respectively. In recognition of the efforts of Mr. Madar and his holding company as one of the prime causes for our substantial increase in net sales and net income, as well as market capitalization from 2014 through 2019, thus substantially increasing shareholder value, on February 4, 2020 the Committee jointly authorized the aggregate annual increase in Mr. Madar’s base salary by $600,000 to $1.23 million effective as of January 1, 2020. For 2022 and 2021, Mr. Madar did not receive any increase in base salary.

 

63

 

 

Russell Greenberg, the former Executive Vice President and Chief Financial Officer, received a $30,000 increase in base salary for 2022 to $750,000 on an annualized basis, also did not have any salary increase for 2021, when his base salary remained at $720,000. Previously, he had received the same $30,000 increase in base salary for 2020 and 2019. In connection with the previous increases in salary, the Compensation Committee considered the following material factors in granting Mr. Greenberg his salary increases: his individual performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive Officer.

 

Mr. Atwood, who became the Chief Financial Officer in September 2022 after the retirement of Mr. Greenberg, was granted a $500,000 annual base salary, as well as a signing bonus of $100,000 that was paid in September 2022. An additional bonus of $50,000 was also paid in December 2022 for the September-December period. The Compensation Committee considered the following material factors in approving the base salary and guaranteed annual bonus of Mr. Atwood for 2022: his individual performances, level of responsibilities, skill and experience with other companies in the fragrance and cosmetic industry, as well as the recommendation of the Chief Executive Officer.

 

Bonus Compensation/Annual Incentives

 

In recognition of the Company’s turnaround from the effects of the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil in 2022 and record results in 2022, and after the recommendations of Messrs. Madar and Benacin, the compensation committee determined that Mr. Benacin receive a bonus of $211,000. Also, in recognition of record results in 2021 while dealing with the effects of the COVID-19 pandemic, supply chain disruptions and geopolitical turmoil, and after the recommendations of Messrs. Madar and Benacin, the compensation committee determined that Mr. Benacin receive a bonus of $166,000. For 2020 Mr. Benacin, the chief decision maker for European operations, proposed and the compensation committee concurred in the payment of discretionary bonus compensation of $131,000. Discretionary bonus compensation for Mr. Benacin has been approximately 28%, 30% and 17% of his base salary in 2022, 2021 and 2020, respectively.

 

In addition, the Compensation Committee agreed with the recommendation of Mr. Benacin and the contributions made by Messrs. Santi and Garcia-Pelayo to the Company’s success and growth. Bonus compensation for Messrs. Santi and Garcia-Pelayo have remained in lockstep, and each was awarded a discretionary bonus of $437,000, $378,000 and $296,000 in 2022, 2021 and 2020, respectively, or 96%, 78% and 63%of their base salary for those years.

 

A different approach is taken for United States operations as that segment is smaller and less profitable. As discussed above, a more significant base salary is paid in order to attract and retain employees with the skills and talents needed to run United States operations with a lesser emphasis placed on bonuses.

 

In 2022, as Mr. Greenberg retired, he did not receive a discretionary bonus. In 2021, although Mr. Greenberg did not receive any increase in base salary due to the continuing impact of the COVID-19 pandemic, he did receive a discretionary bonus of $70,000 based upon the recommendation of the Chief Executive Officer. Mr. Greenberg was paid a discretionary bonus of $35,000 in 2020 and $50,000 for each of the several years prior thereto. The Compensation Committee considered the following material factors in granting Mr. Greenberg his bonuses: his individual performance, level of responsibility, skill and experience, as well as the recommendation of the Chief Executive Officer.

 

Mr. Atwood, who became the Chief Financial Officer in September 2022 after the retirement of Mr. Greenberg, received a sign on bonus of $100,000. His compensation arrangement also entitles him to a guaranteed annual bonus of $100,000, as well as a $100,000 bonus based upon achieving certain milestones. For 2022, Mr. Atwood received his $100,000 sign on bonus and $50,000 pro-rated performance bonus related to the September-December period. The Compensation Committee considered the same factor in granting these two bonuses as in approving his initial annualized salary.

 

Mr. Madar, the Chief Executive Officer has not received any cash bonus in the past three years.

 

64

 

 

As required by French law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and allocated to employees based upon salary. The maximum amount payable per year per employee is approximately $32,485.

 

Calculation of the total annual benefits contribution is made according to the following formula:

 

67% of (Interparfums SA net income, less 2.5% of shareholders’ equity without net income for the year) times a fraction, the numerator of which is wages, and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization expenses + interest expenses.

 

Contribution to individual employees is then made pro rata based upon their individual salaries for the year.

 

Long-Term Incentives

 

Stock Options. In prior years, we had linked long-term incentives with corporate performance through the grant of stock options. However, no options were granted in 2021 or 2020 to either employees of United States operations or European operations, as other compensation arrangements were being considered as part of a review of the executive compensation strategy. In December 2022, at the recommendation of the Chief Executive Officer, the Compensation Committee authorized the grant of a stock option to purchase 5,000 shares to Mr. Atwood at the fair market value on the date of grant as part of his long-term incentives. Unless the market price of our common stock increases, Mr. Atwood will have no tangible benefit from this option. Thus, the option holder is provided with the additional incentive to increase individual performance with the ultimate goal of increasing our overall performance. We believe that enhanced executive incentives that result in increased corporate performance tend to build company loyalty. No other stock option grants were made to other executive officers in 2022, including Messrs. Jean Madar and Philippe Benacin.

 

Interparfums SA Stock Compensation Plans

 

2022 Free Share Plan – On March 16, 2022, the Board of Interparfums SA (“IPSA”) decided to grant 88,400 free shares of its capital stock to all of the IPSA’s employees and corporate officers having more than 6 months seniority at the grant date. The free shares are to be issued in June 2025. Issuance of those shares are based on satisfaction of performance conditions, relating to the 2024 IPSA sales for 50% of the shares and 2024 operating income for the balance.

 

IPSA used the services of third party to assist them in the valuation of the plan, with the calculations and assumptions as follows:

-Management expects the rate of staff turnover to be 12%,

-Using the Monte Carlo method, management expects the performance rate to be 80% on the consolidated sales and 80.8% on the consolidated operating income.

Based on the above assumptions, the total expenses related to this plan is valued at $3.3 million.

 

As of December 31, 2022:

-63,281 shares of IPSA Capital Stock, representing $3.0 million were purchased in the open market and allocated to this plan.

$1.0 million of expense was recorded (or $1.2 million including social contributions).

 

2019 Plan – In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, were distributed in June 2022. Under this plan in June 2022, Messrs. Benacin, Madar, Garcia Pelayo and Santi received 4,000 shares each (5,857 shares as adjusted for stock splits).

 

In June 2020, the performance conditions were modified effecting 96 employees. As of December 31, 2021, the number of shares to be distributed, after forfeited shares and adjusted for stock splits, increased to 172,343. The increase in shares anticipated to be distributed were transferred from treasury shares at the Interparfums SA level. The modification resulted in a revised cost of the grant to approximately $4.6 million.

 

65

 

 

In connection with the 2019 Plan referred to above, an incentive plan was established by Interparfums SA for certain employees of Interparfums Luxury Brands, Inc. (“IPLB”), Interparfums Singapore (“IP Singapore”) and Inter Parfums, Inc. The proposed incentive plan would not provide shares but rather, would give a cash payment or bonus (“incentive” or “award”) that mirrors the shares that Interparfums SA employees will receive. An aggregate of 42,140 “phantom” shares have been awarded in 2022, with Mr. Greenberg being awarded 1,000 of such “phantom” shares, all subject to adjustment for stock splits, with a value of approximately $69,839.

 

Stock Appreciation Rights

 

Our stock option plans authorize us to grant stock appreciation rights, or SARs. A SAR represents a right to receive the appreciation in value, if any, of our common stock over the base value of the SAR. To date, we have not granted any SARs under our plans. While the compensation committee currently does not plan to grant any SARs under our plans, it may choose to do so in the future as part of a review of the executive compensation strategy.

 

Restricted Stock

 

We have not in the past, and we do not have any future plans to grant restricted stock to our executive officers. However, while the compensation committee currently does not plan to authorize any restricted stock plans, the compensation committee may choose to do so in the future as part of a review of the executive compensation strategy. Our French operating subsidiary, Interparfums, SA, however, has instituted its 2022 and 2019 Stock Compensation Plans as discussed above.

 

Other Compensation

 

For 2022, each of Messrs. Benacin and Garcia-Pelayo received an automobile allowance of $11,372.

 

No Stock Ownership Guidelines

 

We do not require any minimum level of stock ownership by any of our executive officers. As stated above, Messrs. Madar and Benacin, are our largest beneficial shareholders, which aligns their interests with our shareholder base in keeping executive compensation at a reasonable level.

 

Retirement and Pension Plans

 

We maintain a 401(k) plan for United States operations. Commencing in October 2021 we started matching the first $6,000 of contribution for each employee, as we have determined that base compensation together with annual bonuses, are sufficient incentives to retain talented employees. Our European operations maintain a pension plan for its employees as required by French law. For each of 2022, 2021and 2020, each of Messrs. Benacin, Santi and Garcia-Pelayo received an increase of $16,006, $17,773 and $17,500, respectively, in their value of deferred compensation earnings.

 

Compensation Committee Report

 

We have reviewed and discussed with management the Compensation Discussion and Analysis provisions to be included in this Annual Report on Form 10-K for fiscal year ended December 31, 2022 and the proxy statement for the upcoming annual meeting of shareholders. Based on this review and discussion, we recommend to the board of directors that the Compensation Discussion and Analysis referred to above be included in this Annual Report on Form 10-K as well as the proxy statement for the upcoming annual meeting of shareholders.

 

Francois Heilbronn

Patrick Choël and

Veronique Gabai-Pinsky

 

66

 

 

The following table sets forth a summary of all compensation awarded to, earned by or paid to our “named executive officers,” who are our principal executive officer, our principal financial officer, and each of the three most highly compensated executive officers of our company. This table covers all such compensation during fiscal years ended December 31, 2022, December 31, 2021 and December 31, 2020. For all compensation related matters disclosed in the summary compensation table, and elsewhere where applicable, all amounts paid in euro have been converted to U.S. dollars at the average rate of exchange in each year.

 

SUMMARY COMPENSATION TABLE  
Name and Principal Position   Year   Salary
($)		   Bonus
($)		   Stock
Awards
($)		   Option
Awards
($)(1)		   Non-Equity
Incentive Plan Compensation
($)(2)		   Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings
($)		   All Other
Compensation
($)(3)		   Total
($)		  
Jean Madar,   2022   1,230,000   -0-   -0-   -0-   -0-   -0-   -0-   1,230,000  
Chairman and   2021   1,230,000   -0-   -0-   -0-   -0-   -0-   -0-   1,230,000  
Chief Executive Officer   2020   1,230,000   -0-   -0-   -0-   -0-   -0-   -0-   1,230,000  
                                       
Russell Greenberg, (4)   2022   750,000   -0-   -0-   -0-   -0-   -0-   -0-   750,000  
Chief Financial Officer and   2021   720,000   70,000   -0-   -0-   -0-   -0-   -0-   790,000  
Executive Vice President   2020   720,000   35,000   -0-   -0-   -0-   -0-   -0-   755,000  
                                       
Michel Atwood (5)   2022   161,218   150,000   -0-   101,814   -0-   -0-   -0-   413,032  
Chief Financial Officer                                      
                                       
Philippe Benacin, President Inter   2022   755,440   210,600   -0-   -0-   -0-   16,006   11,372   993,418  
Parfums, Inc., Chief Executive   2021   803,504   165,578   -0-   -0-   -0-   17,733   12,774   999,589  
Officer of Interparfums SA   2020   788,808   130,673   -0-   -0-   -0-   17,500   12,434   949,415  
                                       
Philippe Santi, Executive Vice   2022   454,896   436,995   -0-   -0-   -0-   16,006   -0-   907,897  
President and Chief Financial   2021   482,542   378,464   -0-   -0-   -0-   17,733   -0-   878,739  
Officer, Interparfums SA   2020   469,730   295,596   -0-   -0-   -0-   17,500   -0-   782,826  
                                       
Frédéric Garcia-Pelayo,   2022   454,896   436,995   -0-   -0-   -0-   16,006   11,372   919,269  
Executive Vice President and   2021   482,542   378,464   -0-   -0-   -0-   17,733   12,774   891,513  
Chief Operating Officer Interparfums SA   2020   469,730   295,596   -0-   -0-   -0-   17,500   8,980   791,806  

 

67

 

 

 

 

1 Amounts reflected under Option Awards represent the grant date fair values in 2022, 2021 and 2020 based on the fair value of stock option awards using a Black-Scholes option pricing model. The assumptions used in this model are detailed in Footnote 13 to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the SEC.

 

2 As required by French law, Interparfums SA maintains its own profit sharing plan for all French employees who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Interparfums SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and are allocated to employees based upon salary. The maximum amount payable per year is approximately $32,485.

 

Calculation of total annual benefits contribution is made according to the following formula:

 

67% of (Interparfums SA net income, less 2.5% of shareholders’ equity without net income for the year) times a fraction, the numerator of which is wages, and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization expenses + interest expenses.

 

Contribution to individual employees is then made pro rata based upon their individual salaries for the year.

 

3 The following table identifies (i) perquisites and other personal benefits provided to our named executive officers in fiscal 2022, and quantifies those required by SEC rules to be quantified and (ii) all other compensation that is required by SEC rules to be separately identified and quantified.

 

4

Mr. Greenberg retired in September 2022.

   
5

Mr. Atwood replaced Mr. Greenberg on September 6, 2022. His base salary was prorated from $500,000, annually.

 

Name and Principal Position   Perquisites
and other
Personal
Benefits
($)		     Personal
Automobile
Expense
($)		     Lodging
Expense
($)		     Total
($)		  
Jean Madar, Chairman
Chief Executive Officer		     -0-       -0-       -0-       -0-  
                                 
Russell Greenberg, Chief Financial
Officer and Executive Vice
President		     -0-       -0-       -0-       -0-  
                                 
Philippe Benacin, President of Inter
Parfums, Inc. and Chief Executive
Officer of Interparfums SA		     -0-       11,372       -0-       11,372  
                                 
Philippe Santi,
Executive Vice President and Chief
Financial Officer, Interparfums SA		     -0-       -0-       -0-       -0-  
                                 
Frédéric Garcia-Pelayo,
Executive Vice President and
Chief Operating Officer,
Interparfums SA		     -0-       11,372       -0-       11,372  

 

68

 

 

Plan Based Awards

 

The following table sets certain information relating to each grant of an award made by our company to the executive officers of our company listed in the Summary Compensation Table during the past fiscal year.

 

        Grants of Plan-Based Awards                    
Name   Grant Date   Estimated Future Payouts Under
Non-Equity Incentive Plan Awards		     Estimated Future Payouts Under
Equity Incentive Plan Awards		     All Other Stock Awards:
Number of Shares of Stock or		     All Other Option Awards:
Number of Securities Underlying		     Exercise or Base Price of Option     Closing  
        Threshold ($)     Target
($)		     Maximum ($)     Threshold (#)     Target (#)     Maximum (#)     Units
(#)		     Options
(#)		     Awards
($/Sh)		     Price
($/Sh)		  
Jean Madar   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  
Russell Greenberg   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  

Michel

Atwood 

   07/22/2022     100,000       100,000       100,000       -0-       -0-       -0-       - 0-       -0-       NA       NA  

Michel

Atwood 

   12/30/202     -0-       -0-       -0-       -0-       -0-       -0-       -0-       5,000       $97.84       $96.52  
Philippe Benacin   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  
Philippe Santi   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  
Frédéric Garcia-Pelayo   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  

 

Interparfums SA Stock Compensation Plan

 

69

 

 

The following table sets certain information relating to each grant of an award made by Interparfums SA to the executive officers of our company listed in the Summary Compensation Table during the past fiscal year. Equity awards relate to the shares of Interparfums SA.

 

        Grants of Plan-Based Awards                    
Name   Grant Date   Estimated Future Payouts Under
Non-Equity Incentive Plan Awards		     Estimated Future Payouts Under
Equity Incentive Plan Awards		     All Other Stock Awards:
Number of Shares of Stock or		     All Other Option Awards:
Number of Securities Underlying		     Exercise or Base Price of Option     Closing  
        Threshold ($)     Target
($)		     Maximum ($)     Threshold (#)     Target (#)     Maximum (#)     Units
(#)		     Options
(#)		     Awards
($/Sh)		     Price
($/Sh)		  
Jean Madar   3/16/22     NA       NA       NA       -0-       -0-       -0-       3,000       -0-       -0-       49,89 €  
Russell Greenberg   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  

Michel

Atwood 

   NA     -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       NA       NA  
Philippe Benacin   3/16/22     NA       NA       NA       -0-       -0-       -0-       3,000       -0-       NA       NA  
Philippe Santi   3/16/22     NA       NA       NA       -0-       -0-       -0-       6,000       -0-       -0-       49,89 €  
Philippe Santi   12/31/22     NA       NA       32,485       -0-       -0-       -0-       -0-       -0-       NA       NA  
Frédéric Garcia-Pelayo   3/16/22     NA       NA       NA       -0-       -0-       -0-       6,000       -0-               49,89 €  
Frédéric Garcia-Pelayo   12/31/22     NA       NA       32,485       -0-       -0-       -0-       -0-       -0-       NA       NA  

 

NA means not applicable.

 

Interparfums SA Profit Sharing Plan

 

Also as discussed above and required by French law, Inter Parfums, SA maintains its own profit sharing plan for all French employees who have completed three months of service, including executive officers of our European operations other than Mr. Benacin, the Chief Executive Officer of Inter Parfums, SA. Benefits are calculated based upon a percentage of taxable income of Interparfums SA and allocated to employees based upon salary. The maximum amount payable per year per employee is approximately $32,485.

 

Calculation of total annual benefits contribution is made according to the following formula:

 

67% of (Interparfums SA net income, less 2.5% of shareholders equity without net income for the year) times a fraction, the numerator of which is wages, and the denominator of which is net income before tax + wages + taxes (other than income tax) + valuation allowances + amortization expenses + interest expenses.

 

The following table sets certain information relating to each grant of a non-equity award made by Interparfums SA to the executive officers of our company listed in the Summary Compensation Table during the past fiscal year. Equity awards relate to the shares of Interparfums SA.

 

70

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth certain information relating to outstanding equity awards of our Company held by the executive officers listed in the Summary Compensation Table as of December 31, 2022.

 

    Option Awards  
Name   Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable(1)		     Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable		     Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)		     Option
Exercise
Price ($)		     Option
Expiration
Date		  
                                       
 Jean Madar     25,000 (2)     0 (2)     0       43.80     12/29/23  
      20,000 (2)     5,000 (2)     0       65.25     12/30/24  
      15,000 (2)     10,000 (2)     0       73.09     12/30/25  
                                       
Russell Greenberg                                      
      15,000       0       0       43.80     12/29/23  
      5,000       5,000       0       65.25     12/30/24  
      5,000       10,000       0       73.09     12/30/25  
                                       
                                       
Michel Atwood     0       5,000       0       97.84     12/30/28  
                                       
                                       
 Philippe Benacin     25,000 (2)     0 (2)     0       43.80     12/29/23  
      20,000 (2)     5,000 (2)     0       65.25     12/30/24  
      15,000 (2)     10,000 (2)     0       73.09     12/30/25  
                                       
                                       
 Philippe Santi     1,200       0       0       43.80     12/29/23  
      800       800       0       46.903     1/18/24  
      2,400       2,000       0       65.25     12/30/24  
      4,000       4,000      

0

       73.09     12/30/25  
                                       
                                       
 Frédéric Garcia-Pelayo     2,400       0       0       43.80     12/29/23  
      800       800       0       46.903     1/18/24  
      4,000       2,000       0       65.25     12/30/24  
      4,000       4,000       0       73.09     12/30/25  

 

[Footnotes from table above]

 

1 All options expire 6 years from the date of grant, and vest 20% each year commencing one year after the date of grant.
2 Options are held in the name of personal holding company.

 

71

 

 

The following table sets certain information relating to outstanding equity awards granted by Interparfums SA, our majority-owned French subsidiary which has its shares traded on the NYSE Euronext, held by the executive officers of our company listed in the Summary Compensation Table as of the end of the past fiscal year.

 

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
OF INTERPARFUMS SA

 

    Option Awards   Stock Awards  
Name   Number of Securities Underlying Unexercised Options (#) Exercisable)     Number of Securities Underlying Unexercised Options (#) Unexercisable     Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned
Options (#)		     Option
Exercise
Price ($)		     Option Expiration
Date		   Number of Shares or Units of Stock that Have Not Vested (#)(1)     Market Value of Shares or Units of Stock that Have Not Vested ($)     Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#)     Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested($)  
Jean Madar     -0-       0       -0-       NA     NA     3,000       175,640       -0-     -0-  
                                                                   
Russell Greenberg     -0-       0       -0-       NA     NA     -0-       -0-       -0-     -0-  
                                                                   
Michel                                                                  
Atwood     -0-       0       -0-       NA     NA     -0-       -0-       -0-     -0-  
                                                                   
Philippe Benacin     -0-       0       -0-       NA     NA     3,000       175,640       -0-     -0-  
                                                                   
Philippe Santi     -0-       0       -0-       NA     NA     6,000       351,281       -0-     -0-  
                                                                   
Frédéric Garcia-Pelayo     -0-       0       -0-       NA     NA     6,000       175,640       -0-     -0-  

 

1 Estimated number of shares are to be issued only to the extent that the performance conditions have been met.

2 As of December 31, 2022, the closing price of Interparfums SA as reported by Euronext was 55.60 euros, and the exchange rate was 1.053 U.S. dollars to 1 euro.

 

72

 

 

Option Exercises and Stock Vested

 

The following table sets forth certain information relating to each option exercise affected during the past fiscal year, and each vesting of stock, including restricted stock, restricted stock units and similar instruments of our company during the past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.

 

OPTION EXERCISES AND STOCK VESTED

 

    Option Awards     Stock Awards  
Name   Number
of Shares
Acquired on
Exercise
(#)		     Value
Realized on
Exercise
($)1		     Number
of Shares
Acquired on
Vesting
(#)		     Value
Realized On
Vesting
($)		  
Jean Madar     19,000       1,230,315       -0-       -0-  
                                 
Russell Greenberg     60,000       2,475,744       -0-       -0-  
                                 
Michel Atwood     -0-       -0-       -0-       -0-  
                                 
Philippe Benacin     19,000       1,191,374       -0-       -0-  
                                 
Philippe Santi     4,000       199,588       -0-       -0-  
                                 
Frédéric Garcia-Pelayo     1,200       82,973       -0-       -0-  

  

[Footnotes from table above]

 

1 Total value realized on exercise of options in dollars is based upon the difference between the fair market value of the common stock on the date of exercise, and the exercise price of the option.

 

Regarding Interparfums SA, our majority-owned French subsidiary which has its shares traded on the Euronext, no options were exercised during the past fiscal year, and there was no vesting of stock, including restricted stock, restricted stock units and similar instruments during the past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.

 

Pension Benefits

 

The following table sets forth certain information relating to payment of benefits in connection with retirement plans during the past fiscal year, for the executive officers of our company listed in the Summary Compensation Table.

 

PENSION BENEFITS

 

Name   Plan Name   Number
of Years
Credited
Service
(#)		   Present
Value of
Accumulated
Benefit*
($)		     Payments
During
Last Fiscal
Year
($)		  
Jean Madar   NA   NA     -0-       -0-  
Russell Greenberg   NA   NA     -0-       -0-  
Michel Atwood   NA   NA     -0-       -0-  
Philippe Benacin   Inter Parfums SA Pension Plan   NA     331,239       16,006  
Philippe Santi   Inter Parfums SA Pension Plan   NA     321,239       16,006  
Frédéric Garcia-Pelayo   Inter Parfums SA Pension Plan   NA     321,239       16,006  

 

* Does not include any contributions made by prior employers, or individually by the recipients as such information is confidential under French law.

 

Interparfums SA maintains a pension plan for all of its employees, including all executive officers. The calculation of commitments for severance benefits involves estimating the probable present value of projected benefit obligations. This projected benefit obligations are then prorated to take into account seniority of the employees of Interparfums SA on the calculation date.

 

In calculating benefits, the following assumptions were applied:

 

  - voluntary retirement at age 65;

 

  - a rate of 45% for employer payroll contributions for all employees;

 

  - a 3% average annual salary increase;

 

  - an annual rate of turnover for all employees under 55 years of age and nil above;

 

  - the TH 00-02 mortality table for men and the TF 00-02 mortality table for women;

 

  - a discount rate of 3.8%.

 

73

 

 

The normal retirement age is 65 years, but employees, including Messrs. Benacin, Santi and Garcia-Pelayo, can collect reduced benefits if they retire at age 62.

 

Nonqualified Deferred Compensation

 

We do not maintain any nonqualified deferred compensation plans.

 

CEO Pay Ratio

 

As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the following information about the relationship of the annual total compensation of our mean employee and the annual total compensation of Mr. Jean Madar, Chief Executive Officer (the “CEO”):

 

For 2022, our last completed fiscal year:

 

  ● Our median employee’s compensation was $66,402

 

  ● Our Chief Executive Officer’s total 2022 compensation was $2,460,315

 

  ● Accordingly, our 2022 CEO to Median Employee Pay Ratio was 37.05 to 1

 

This pay ratio is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records. We identified our median employee using our total employee population as of December 31, 2022 by applying a consistently applied compensation measure across our global employee population. For our consistently applied compensation measure, we used all compensation, including actual base salary, bonuses, commissions, and any overtime paid during the 12-month period ending December 31, 2022. We did not use any material estimates, assumptions, adjustments or statistical sampling to determine the worldwide median employee.

 

The SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. As such, the pay ratio reported by other companies may not be comparable to the pay ratio reported above, as other companies may have different employment and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.

 

Employment and Consulting Agreements

 

Please see our Annual Report on Form 10-K for the year ended December 31, 2021, Item 11 under the heading “Employment and Consulting Agreements” for a material terms of the employment agreement with Philippe Benacin, individually, and the consulting agreements with, and fees and stock options previously granted to, Philippe Benacin Holding SAS and Jean Madar Holding SAS, which is incorporated by reference herein.

 

74

 

 

Compensation of Directors

 

The following table sets forth certain information relating to the compensation for each of our directors who is not an executive officer of our Company named in the Summary Compensation Table for the past fiscal year.

 

                  DIRECTOR COMPENSATION              
Name    

Fees Earned or Paid in Cash

($)

     Stock
Awards
($)		     Option
Awards
($)		     Non-Equity Incentive Plan Compensation
($)		     Change in
Pension Value
and Nonqualified Deferred Compensation Earnings		     All Other Compensation
($)1		     Total
($)		  
Francois Heilbronn2       15,000       -0-       30,544       -0-       -0-       -0-       45,544  
Robert Bensoussan3       18,000       -0-       30,544       -0-       -0-       66,480       115,024  
Patrick Choël4       15,000       -0-       30,544       -0-       -0-       13,246       58,790  
Michel Dyens5       21,000       -0-       30,544       -0-       -0-       -0-       51,544  
Veronique Gabai-Pinsky6       18,000       -0-       30,544       -0-       -0-       84,308       132,852  
Gilbert Harrison7       18,000       -0-       30,544       -0-       -0-       120,000       168,544  

 

[Footnotes from table above]

 

1. Represents gain from exercise of stock options, except for Mr. Harrison, which consists of a $120,000 payment made in 2022 to the company controlled by Mr. Harrison in connection with the acquisition of the Donna Karan license. See “Fee for Director’s Company” in Item 13, Certain Relationships and Related Transactions, and Director Independence, in this annual report on Form 10-K.
2. As of the end of the last fiscal year, Mr. Heilbronn held options to purchase an aggregate of 6,500 shares of our common stock.
3. As of the end of the last fiscal year, Mr. Bensoussan held options to purchase an aggregate of 7,500 shares of our common stock.
4. As of the end of the last fiscal year, Mr. Choël held options to purchase an aggregate of 5,750 shares of our common stock.
5. As of the end of the last fiscal year, Mr. Dyens held options to purchase an aggregate of 6,500 shares of our common stock.
6. As of the end of the last fiscal year, Ms. Gabai-Pinsky held options to purchase an aggregate of 7,500 shares of our common stock.
7. As of the end of the last fiscal year, Mr. Harrison held options to purchase an aggregate of 7,500 shares of our common stock.

 

All nonemployee directors receive $6,000 for each board meeting at which they participate in person, and $3,000 for each meeting held by conference telephone. In addition, the annual fee for each member of the audit committee is $8,000. The compensation for the nonemployee directors remained the same for 2021 and 2022, except for Mr. Harrison. During 2021, a company owned by Mr. Harrison received a fee equal to $300,000, in connection with the Donna Karan license agreement, which is effective on July 1, 2022. A payment of $120,000 was made in 2021 to Mr. Harrison’s company, $120,000 was paid one year later in 2022, and $60,000 will be paid one year thereafter in 2023.

 

We maintain a stock option plan for our nonemployee or independent directors. The purpose of this plans is to assist us in attracting and retaining key directors who are responsible for continuing the growth and success of our company. Under such plan, until 2022 options to purchase 1,500 shares are granted on each February 1st to all nonemployee directors for as long as each is a nonemployee director on such date. However, if a nonemployee director does not attend certain of the board meetings, then such option grants are reduced according to a schedule. However, our board of directors cancelled the automatic grant of options to the nonemployee directors effective with the grant that had been scheduled for February 1, 2022.

 

After discussions Mr. Atwood had with certain financial consultants relating to potential compensation plans in lieu of stock option grants to the Company’s independent directors, and consultation between Messrs. Madar and Atwood, it was determined that the most favorable way for the nonemployee directors to be compensated was to amend the 2016 Stock Option Plan to reinstate the automatic grant of stock options previously provided to nonemployee directors, commencing with a new automatic grant on the last business day of 2022, December 30, and continuing on the last business day of each year thereafter, subject to the approval of the shareholders of this Corporation at the 2023 annual meeting of shareholders. The automatic option grants to independent directors were approved by the Board of Directors with the following changes: Reinstatement of the automatic grant of nonqualified stock options to all nonemployee directors was made without any discretion on the part of the Executive Compensation and Stock Option Committee, with the right to purchase 1,500 shares of the our common stock under our 2016 Stock Option Plan, as amended (the “2016 Stock Option Plan”), at the purchase per share on the date of grant equal to the fair market value as determined in accordance with the 2016 Stock Option Plan, each exercisable for a six (6) year period; provided that, such options shall vest and become exercisable to purchase shares of Common Stock as follows: 20% one year after the date of grant, and then 20% on each of the second, third, fourth and fifth consecutive years from the date of grant on a cumulative basis, so that each option shall become fully vested and exercisable on the first day of the sixth year from the date of grant, with the automatic grant date to commence on the last business day of this year, December 30, 2022 and continuing on the last business day of each year thereafter, in lieu of the grant date on each February 1st.

 

75

 


Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth information with respect to the beneficial ownership of our common stock by (a) each person we know to be the beneficial owner of more than 5% of our outstanding common stock, (b) our executive officers and directors and (c) all of our directors and officers as a group. Messrs. Madar and Benacin own 99.99% of their respective personal holding companies. As of February 28, 2023, we had 32,109,360 shares of common stock outstanding.

 

Name and Address of Beneficial Owner   Amount of
Beneficial
Ownership1		     Approximate
Percent of
Class		  
Jean Madar
c/o Interparfums SA
10 rue de Solférino
75007 Paris, France		     7,116,741 2   22.2 %
Philippe Benacin
c/o Interparfums SA
10 rue de Solférino
75007 Paris, France		     6,906,064 3   21.5 %
Michel Atwood
c/o Inter Parfums, Inc.
551 Fifth Avenue
New York, NY 10176		     0     NA  
Philippe Santi
Interparfums SA
10 rue de Solférino
75008, Paris, France		     800 4   Less than 1 %
Francois Heilbronn
60 Avenue de Breteuil
75007 Paris, France		     28,938 5   Less than 1 %
Robert Bensoussan
c/o Sirius Equity LLP
52 Brook Street
W1K 5DS London, UK		     10,375 6   Less than 1 %
Patrick Choël
140 Rue de Grenelle
75007, Paris, France		     7,125 7   Less than 1 %
Michel Dyens
Michel Dyens & Co.
17 Avenue Montaigne
75007 Paris, France		     7,875 8   Less than 1 %
Veronique Gabai-Pinsky
200 East End Avenue
New York, NY 10128		     2,875 9   Less than 1 %
Gilbert Harrison
Harrison Group
745 Fifth Avenue, Suite 514
New York, NY 10151		     4,875 10   Less than 1 %
Frederic Garcia-Pelayo
Interparfums SA
10 rue de Solférino
75008, Paris, France		     12,000 11   Less than 1 %
Blackrock, Inc.
55 East 52nd Street
New York, NY 10055 		    2,789,318 12   8.8 %
The Vanguard Group
100 Vanguard Blvd.
Malvern, PA 19355		     1,983,427 13   6.2 %
All Directors and Officers
(As a Group 10 Persons)		     14,097,668 14   43.7 %

 

 

1 All shares of common stock are directly held with sole voting power and sole power to dispose, unless otherwise stated. Options which are exercisable within 60 days are included in beneficial ownership calculations.
2 Consists of 24,400 shares held directly, 7,032,341 shares held indirectly through Jean Madar Holding SAS, a personal holding company, and options to purchase 60,000 shares.
3 Consists of 6,846,064 shares held indirectly through Philippe Benacin Holding SAS, a personal holding company, and options to purchase 60,000 shares.
4 Consists of shares of common stock underlying options for Mr. Santi.
5 Consists of 26,063 shares held directly and options to purchase 2,875 shares for Mr. Heilbronn.
6 Consists of 7,500 shares held directly and options to purchase 2,875 shares for Mr. Bensoussan.

7 Consists of 4,250 shares held directly and options to purchase 2,825 shares for Mr. Choël.

8 Consists of 5,000 shares held directly and options to purchase 2,875 shares for Mr. Dyens.
9 Consists of shares of common stock underlying options for Ms. Gabai-Pinsky.
10 Consists of shares of common stock underlying options for Mr. Harrison.
11 Consists of shares of common stock underlying options for Mr. Garcia-Pelayo.
12 Information based upon Schedule 13G of Blackrock, Inc. dated January 25, 2023 as filed with the Securities and Exchange Commission.

13 Information based upon Schedule 13G Amendment 5 of The Vanguard Group, an investment advisor, dated February 9, 2023 as filed with the Securities and Exchange Commission.
14 Consists of 13,945,618 shares held directly or indirectly, and options to purchase 152,050 shares.

 

76

 

 

The following table sets forth certain information as of the end of our last fiscal year regarding all equity compensation plans that provide for the award of equity securities or the grant of options, warrants or rights to purchase our equity securities.

 

Equity Compensation Plan Information

 

Plan category   Number of
securities to
be issued
upon
exercise of
outstanding
options,
warrants and
rights
(a)		     Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)		     Number of
securities
remaining
available for
future issuance
under equity
compensation
plans
(excluding
securities
reflected in
column (a))
(c)		  
Equity compensation plans approved by security holders     441,580       $67.30       558,975  
Equity compensation plans not approved by security holders     -0-       N/A       -0-  
Total      441,580        $67.30        558,975  

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Transactions with European Subsidiaries

 

We also provide (or had provided on our behalf) certain financial, accounting and legal services for Interparfums SA, and during 2022, 2021 and 2020 fees for such services were $491,300, $443,625 and $450,750, respectively.

 

In September 2021, Interparfums Luxury Brands, Inc., an indirect majority-owned subsidiary of the Company, loaned the Company $24 million, which is repayable in 12 equal monthly payments with interest at 2% per annum commencing on January 31, 2022.

 

In December 2021, Inter Parfums USA, LLC, a United States subsidiary, renewed a license agreement for five years that was initially signed in 2012 on the same terms with Interparfums Suisse (SARL), a Swiss subsidiary of Interparfums SA, for the right to sell amenities under the Lanvin brand name to luxury hotels, cruise lines and airlines in return for royalty payments as are customary in our industry.

 

In September 2022, Interparfums Luxury Brands, Inc. loaned the Company $10 million, which is repayable in one lump sum on June 30, 2023 with interest at 3.5% per annum. In addition, the $2 million payment due on September 30, 2022 by the Company against the loan made in September 2021 was postponed to January 31, 2023 together with interest at 2% per annum.

 

Fee for Director’s Company

 

In connection with the acquisition of the Donna Karan license, which became effective on July 1, 2022 as discussed above, we agreed to pay to a company controlled by Mr. Gilbert Harrison, a director, the sum of $300,000, payable over time, with $120,000 paid in 2021, $120,000 paid one year later in 2022 and $60,000 due two years later in 2023.

 

Consulting Agreements

 

Please see our Annual Report on Form 10-K for the year ended December 31, 2021, Item 11 under the heading “Employment and Consulting Agreements” for a material terms of the employment agreement with Philippe Benacin, individually, and the consulting agreements with, and fees and stock options previously granted to, Philippe Benacin Holding SAS and Jean Madar Holding SAS, which is incorporated by reference herein.

 

Procedures for Approval of Related Person Transactions

 

Transactions between related persons, such as between an executive officer or director and our company, or any company or person controlled by such officer or director, are required to be approved by our Audit Committee of our board of directors. Our Audit Committee Charter contains such explicit authority, as required by the applicable rules of The Nasdaq Stock Market.

 

77

 

 

The following are our directors who are independent directors within the applicable rules of The Nasdaq Stock Market:

 

Francois Heilbronn 

Robert Bensoussan 

Patrick Choël 

Michel Dyens 

Veronique Gabai-Pinsky 

Gilbert Harrison

 

We follow and comply with the independent director definitions as provided by The Nasdaq Stock Market rules in determining the independence of our directors, which are posted on our company’s website. In addition, such rules are also available on The Nasdaq Stock Market’s website. In addition, The Nasdaq Stock Market maintains more stringent rules relating to director independence for the members of our Audit Committee, and the members of our Audit Committee, Messrs. Heilbronn and Choël, as well as Ms. Gabai-Pinsky, are independent within the meaning of those rules.

 

Board Leadership Structure and Risk Management

 

Please see our Annual Report on Form 10-K for the year ended December 31, 2021, Item 13. Certain Relationships and Related Transactions, and Director Independence, under the heading “Board Leadership Structure and Risk Management,” for prior disclosure on this topic, which is incorporated by reference herein.

 

Item 14. Principal Accountant Fees and Services

 

Fees

 

The following sets forth the fees billed to us by Mazars USA LLP, as well as discusses the services provided for the past two fiscal years, fiscal years ended December 31, 2022 and December 31, 2021.

 

Audit Fees

 

Fees billed by Mazars USA LLP and its affiliate, Mazars S.A. for audit services and review of the financial statements contained in our Quarterly Reports on Form 10-Q were $1.4 million and $1.2 and million for 2022 and 2021, respectively.

 

Audit-Related Fees

 

Mazars USA LLP did not bill us for any audit-related services during 2022 and 2021.

 

Tax Fees

 

Mazars USA did not bill us in 2022 for any tax services. Tax services billed to us during 2021 was $49,300.

 

All Other Fees

 

Mazars S.A. billed us $6,000 and $3,000 for other services during 2022 and 2021, respectively.

 

Audit Committee Pre-Approval Policies and Procedures

 

The Audit Committee has the sole authority for the appointment, compensation and oversight of the work of our independent accountants, who prepare or issue an audit report for us.

 

78

 

 

During the first quarter of 2022, the audit committee authorized the following non-audit services to be performed by Mazars USA LLP.

 

  ● We authorized the engagement of Mazars USA LLP if deemed necessary to provide tax consultation in the ordinary course of business for fiscal year ended December 31, 2022.

 

  ● We authorized the engagement of Mazars USA LLP if deemed necessary to provide tax consultation as may be required on a project by project basis that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or €10,000 in the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December 31, 2022. If we require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.

 

  ● We authorized the engagement of Mazars USA LLP if deemed necessary to provide attestation or other services as may be required on a project by project basis that would not be considered in the ordinary course of business, up to a $10,000 fee limit per project (or €10,000 in the case of Interparfums SA), subject to an aggregate fee limit of $50,000 for fiscal year ended December 31, 2022. If we require further tax services from Mazars USA LLP, then the approval of the audit committee must be obtained.

 

  ● If we require other services by Mazars USA LLP on an expedited basis such that obtaining pre-approval of the audit committee is not practicable, then the Chairman of the Committee has authority to grant the required pre-approvals for all such services.

 

  ● We imposed a cap of $100,000 on the fees that Mazars USA LLP can charge for services on an expedited basis that are approved by the Chairman without obtaining full audit committee approval.

 

  ● None of the non-audit services of either of the Company’s auditors had the pre-approval requirement waived in accordance with Rule 2-01(c)(7)(i)(C) of Regulation S-X.
     

79

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules

 

    Page
(a)(1) Financial Statements annexed hereto    
     
Report of Independent Registered Public Accounting Firm   F-2
     
Audited Financial Statements:    
     
Consolidated Balance Sheets as of December 31, 2022 and 2021   F-5
     
Consolidated Statements of Income for each of the years in the three-year period ended December 31, 2022   F-6
     
Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December 31, 2022   F-7
     
Consolidated Statements of Changes in Shareholders’ Equity for each of the years in the three-year period ended December 31, 2022   F-8
     
Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2022   F-9
     
Notes to Consolidated Financial Statements   F-10
     
(a)(2) Financial Statement Schedule:    
     
Schedule II – Valuation and Qualifying Accounts   F-34
     
(a)(3) Exhibits – The list of exhibits is contained in the Exhibit Index, which follows the signature page of this report.    

 

Item 16. Form 10-K Summary

 

None.

 

80

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Consolidated Financial Statements and Schedule

 

Index

 

  Page
     
Report of Independent Registered Public Accounting Firm F-2  
     
(Mazars USA LLP, New York, New York, PCAOB ID 339)    
     
Audited Financial Statements:    
     
Consolidated Balance Sheets as of December 31, 2022, and 2021 F-5  
     
Consolidated Statements of Income for each of the years in the three-year period ended December 31, 2022, F-6  
     
Consolidated Statements of Comprehensive Income for each of the years in the three-year period ended December 31, 2022, F-7  
     
Consolidated Statements of Changes in Shareholders’ Equity for each of the years in the three-year period ended December 31, 2022, F-8  
     
Consolidated Statements of Cash Flows for each of the years in the three-year period ended December 31, 2022, F-9  
     
Notes to Consolidated Financial Statements F-10  
     
Financial Statement Schedule:    
     
Schedule II – Valuation and Qualifying Accounts F-34  

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To Shareholders and the Board of Directors of Inter Parfums, Inc.

 

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Inter Parfums, Inc. (the “Company”) as of December 31, 2022 and 2021, and the related consolidated statements of income, comprehensive income, shareholders' equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes and the schedule listed in the Index in Item 15(a)(2) (collectively referred to as the “financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework: (2013) issued by COSO.

 

Basis for Opinion

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

 

F-2

 

 

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

 

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the consolidated financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

As described in Notes 1 and 8 to the consolidated financial statements, the Company’s consolidated indefinite and finite - life intangible assets balance was $291 million at December 31, 2022. Indefinite lived intangible assets principally consist of trademarks and finite-lived intangible assets represent fees to acquire or enter into a license.

 

Those intangible assets are tested for impairment as follows:

-Indefinite - life intangible assets are tested for impairment at least annually at the reporting unit level or more frequently when events occur, or circumstances change. The evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair value is estimated based upon discounted future cash flow projections. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

 

F-3

 

 

-Finite - life intangible assets are tested for impairment testing whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If impairment indicators exist, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If the projection of undiscounted cash flows is less than the carrying value of a finite-lived intangible asset, an impairment charge would be recorded.

 

The determination of the future cash flows of the intangible assets requires management to make significant estimates and assumptions related to forecasts of future revenues, operating margins, and discount rates. As disclosed by management, changes in these assumptions could have a significant impact on the future cash flows and therefore, on the amount of any impairment charge. The determination of an impairment indicator on the finite - life intangible assets requires management judgments and involves assumptions.

 

We identified the impairment assessment of intangible assets as a critical audit matter as auditing management’s judgments regarding the evaluation of impairment indicators, forecasts of future revenue, operating margin, and the discount rate to be applied involve a high degree of subjectivity.

 

The primary procedures we performed to address this critical audit matter included:

 

► Reviewing the analysis of the identification of impairment evidence for each indefinite and finite-life asset based on three indicators (sales analysis, new products launches, and payment of minimum guarantees), and then corroborating that analysis with external information and evidence obtained in other areas of the audit.

 

► Testing the effectiveness of controls relating to management’s impairment tests, including controls over the impairment indicators and determination of the future cash flows.

 

► In testing management’s process for determining the future cash flows we evaluated the reasonableness of management’s forecasts of future revenue and operating margin by performing a retrospective review in comparing these forecasts to historical operating results, evaluating whether the assumptions used were reasonable considering current information as well as future expectations, and using additional evidence obtained in other areas of the audit.

 

► Utilizing a valuation specialist to assist in auditing the discount rate. It includes evaluating whether the assumptions used were reasonable by comparing to third party market data.

 

Mazars USA LLP

 

/s/ Mazars USA LLP

 

We have served as the Company's auditor since 2004. 

 

New York, New York 

February 28, 2023

F-4

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

December 31, 2022, and 2021

(In thousands except share and per share data)

 

         
Assets  2022   2021 
Current assets:          
Cash and cash equivalents  $104,713   $159,613 
Short-term investments   150,833    160,014 
Accounts receivable, net   197,584    159,281 
Inventories   289,984    198,914 
Receivables, other   28,803    10,308 
Other current assets   15,650    21,375 
Income taxes receivable   157    210 
Total current assets   787,724    709,715 
Property, equipment and leasehold improvements, net   166,722    149,352 
Right-of-use assets, net   27,964    33,728 
Trademarks, licenses and other intangible assets, net   290,853    214,047 
Deferred tax assets   11,159    7,936 
Other assets   24,120    30,586 
Total assets  $1,308,542   $1,145,364 
Liabilities and Equity          
Current liabilities:          
Current portion of long-term debt  $28,547   $15,911 
Current portion of lease liabilities   5,296    6,014 
Accounts payable - trade   88,388    81,980 
Accrued expenses   213,621    136,677 
Income taxes payable   8,715    4,328 
Total current liabilities      344,567    244,910 
Long–term debt, less current portion   151,494    132,902 
Lease liabilities, less current portion   24,335    29,220 
Equity:          
Inter Parfums, Inc. shareholders’ equity:          
Preferred stock, $0.001 par value. Authorized 1,000,000 shares:
none issued		  
 		  
 		  
—		  
 		  
 		  
 		  
—		  
 
Common stock, $0.001 par value. Authorized 100,000,000 shares:
outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively		  
 		  
 		  
32		  
 		  
 		  
 		  
32		  
 
Additional paid-in capital   90,186    87,132 
Retained earnings   620,095    560,663 
Accumulated other comprehensive loss   (56,056)   (38,432)
Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021   (37,475)   (37,475)
Total Inter Parfums, Inc. shareholders’ equity   616,782    571,920 
Noncontrolling interest   171,364    166,412 
Total equity   788,146    738,332 
Total liabilities and equity  $1,308,542   $1,145,364 

 

See accompanying notes to consolidated financial statements.

 

F-5

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

Consolidated Statements of Income

Years ended December 31, 2022, 2021, and 2020

(In thousands except share and per share data)

 

             
   2022   2021   2020 
             
Net sales  $1,086,653   $879,516   $539,009 
Cost of sales   392,231    322,614    208,278 
Gross margin   694,422    556,902    330,731 
Selling, general, and administrative expenses   492,370    406,459    260,648 
Impairment loss   7,749    2,393    — 
Income from operations   194,303    148,050    70,083 
Other expenses (income):               
Interest expense   3,599    2,825    1,970 
Loss (gain) on foreign currency   1,921    (2,338)   2,178 
Interest and investment income   (5,486)   (3,403)   (2,865)
Other loss (income)   49    (53)   (549)
  Nonoperating Income (Expense)    83    (2,969)   734 
                
Income before income taxes   194,219    151,019    69,349 
Income taxes   43,182    40,992    19,381 
Net income   151,037    110,027    49,968 
Less: Net income attributable to the noncontrolling interest   30,099    22,616    11,749 
Net income attributable to Inter Parfums, Inc.  $120,938   $87,411   $38,219 
Net income attributable to Inter Parfums, Inc. common shareholders:               
Basic  $3.80   $2.76   $1.21 
Diluted  $3.78   $2.75   $1.21 
Weighted average number of shares outstanding:               
Basic   31,859,417    31,676,796    31,536,659 
Diluted   31,988,753    31,835,408    31,654,544 
                
Dividends declared per share  $2.00   $1.00   $0.33 

  

See accompanying notes to consolidated financial statements.

 

F-6

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
Years ended December 31, 2022, 2021, and 2020
(In thousands except share and per share data)

 

             
   2022   2021   2020 
             
Net income  $151,037   $110,027   $49,968 
                
Other comprehensive income:               
Net derivative instrument income (loss),  net of tax   2,356    (1,367)   (19)
Transfer of OCI into earnings   992    —    (52)

Translation adjustments, net of tax 

   (29,683)   (42,967)   47,912 
Other comprehensive income (loss), before tax   (26,335)   (44,334)   47,841 
Comprehensive income   124,702    65,693    97,809 
                
Comprehensive income attributable to noncontrolling interests:               
Net income   30,099    22,616    11,749 
Net derivative instrument income (loss),  net of tax   647    (375)   (19)
Translation adjustments, net of tax   (9,358)   (11,524)   14,004 
Comprehensive income (loss), net of tax, atributable to noncontrolling interest   21,388    10,717    25,734 
Comprehensive income attributable to Inter Parfums Inc.  $103,314   $54,976   $72,075 

 

See accompanying notes to consolidated financial statements.

 

F-7

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES
Consolidated Statements of Changes in Shareholders’ Equity
Years ended December 31, 2022, 2021, and 2020
(In thousands except share and per share data)

 

             
   2022   2021   2020 
             
Common stock, beginning of year  $32   $32   $31 
Shares issued upon exercise of stock options   —    —    1 
Common stock, end of year   32    32    32 
                
Additional paid-in capital, beginning of year   87,132    75,708    70,664 
Shares issued upon exercise of stock options   6,004    5,393    2,771 
Share-based compensation   1,355    1,566    1,711 
Purchase of subsidiary shares from noncontrolling interests   —    —    — 
Shares issued for license acquisition   —    5,000    — 
Transfer of subsidiary shares purchased   (4,305)   (535)   562 
Additional paid-in capital, end of year   90,186    87,132    75,708 
                
Retained earnings, beginning of year   560,663    503,567    474,637 
Net income   120,938    87,411    38,219 
Dividends   (63,743)   (31,690)   (10,406)
Share-based compensation   2,237    1,375    1,117 
Retained earnings, end of year   620,095    560,663    503,567 
                
Accumulated other comprehensive loss, beginning of year   (38,432)   (5,997)   (39,853)
Foreign currency translation adjustment, net of tax   (20,325)   (31,443)   33,908 
Transfer from other comprehensive income into earnings   992    —    (52)
Net derivative instrument income (loss), net of tax   1,709    (992)   — 
Accumulated other comprehensive loss, end of year   (56,056)   (38,432)   (5,997)
                
Treasury stock, beginning and end of year   )   )   )
Net income            
Treasury stock, beginning and end of year   )   )   )
                
Noncontrolling interest, beginning of year   166,412    166,615    140,994 
Net income   30,099    22,616    11,749 
Foreign currency translation adjustment, net of tax   (9,358)   (11,524)   14,004 
Net derivative instrument income (loss), net of tax   647    (375)   (19)
Dividends   (16,056)   (9,836)   (324)
Share-based compensation   (282)   (293)   350 
Transfer of subsidiary shares purchased   (98)   (791)   (139)
Noncontrolling interest, end of year   171,364    166,412    166,615 
                
             
             
Total equity  $788,146   $738,332   $702,450 

 

See accompanying notes to consolidated financial statements.

 

F-8

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Years ended December 31, 2022, 2021, and 2020
(In thousands)

 

                         
    2022     2021     2020  
Cash flows from operating activities:                        
Net income   $ 151,037     $ 110,027     $ 49,968  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Depreciation and amortization including impairment loss     22,539       12,698       9,067  
Provision for doubtful accounts     2,353       853       4,824  
Noncash stock compensation     3,143       2,853       3,029  
Share of income of equity investment     49       (53 )     (549 )
Lease expense     4,980       7,302       5,483  
Deferred tax expense (benefit)     (3,604 )     (465 )     581  
Change in fair value of derivatives     227       65       (137 )
Changes in:                        
Accounts receivable     (59,640 )     (45,395 )     13,157  
Inventories     (98,297 )     (49,815 )     19,333  
Other assets     (13,651 )     (16,725 )     1,176  
Operating lease liabilities     (4,795 )     (7,503 )     (5,421 )
Accounts payable and accrued expenses     106,857       103,046       (32,239 )
Income taxes, net     3,952       2,698       (3,279 )
Net cash provided by operating activities     115,150       119,586       64,993  
Cash flows from investing activities:                        
Purchases of short-term investments     (1,038 )     (55,691 )     (7,582 )
Proceeds from sale of short-term investments     896       10,644       11,513  
Purchase of property, equipment and leasehold improvements     (33,756 )     (141,274 )     (11,011 )
Payment for intangible assets acquired     (98,865 )     (1,545 )     (1,251 )
Purchase of equity investment     —       —       (13,998 )
Net cash used in investing activities     (132,763 )     (187,866 )     (22,329 )
Cash flows from financing activities:                        
Repayment of long-term debt     (19,861 )     (43,056 )     (13,725 )
Proceeds from issuance of long-term debt     52,492       157,382       13,438  
Proceeds from exercise of options     6,003       5,393       2,771  
Dividends paid     (63,743 )     (31,690 )     (20,805 )
Dividends paid to noncontrolling interests     (16,056 )     (9,836 )     (324 )
Purchase of subsidiary shares from noncontrolling interests     (4,403 )     —       —  
Net cash provided by (used in) financing activities     (45,568 )     78,193       (18,645 )
Effect of exchange rate changes on cash     (493 )     (11,207 )     12,245  
Net increase (decrease) in cash and cash equivalents     (63,674 )     (1,294 )     36,264  
Cash and cash equivalents – beginning of year     168,387       169,681       133,417  
Cash and cash equivalents – end of year   $ 104,713     $ 168,387     $ 169,681  
Supplemental disclosures of cash flow information:                        
Cash paid for:                        
Interest   $ 2,987     $ 2,468     $ 1,105  
Income taxes     38,492       40,497       21,772  

 

See accompanying notes to consolidated financial statements.

 

F-9

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(1)The Company and its Significant Accounting Policies

 

Business of the Company

 

Inter Parfums, Inc. and its subsidiaries (the “Company”) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance related products.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%

 

No other brand represented 10% or more of consolidated net sales.

 

Basis of Preparation

 

The consolidated financial statements include the accounts of the Company and its subsidiaries, including 72% owned Interparfums SA, a subsidiary whose stock is publicly traded in France. All material intercompany balances and transactions have been eliminated.

 

Management Estimates

 

Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.

 

Foreign Currency Translation

 

For foreign subsidiaries with operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation adjustments are accumulated in a separate component of shareholders’ equity.

 

Cash and Cash Equivalents and Short-Term Investments

 

All highly liquid investments purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions outside the United States and are readily convertible into U.S. dollars.

 

F-10

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

  

Accounts Receivable

 

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which are estimated to be uncollectible, which aggregated $4.7 million and $2.2 million as of December 31, 2022, and 2021, respectively. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns.

 

Inventories

 

Inventories, including promotional merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company’s customers.

 

Derivatives

 

All derivative instruments are recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For cash flow hedges, the effective portion of the derivative’s gain or loss is initially reported in equity (as a component of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.

 

Property, Equipment and Leasehold Improvements

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools and molds, is included in cost of sales.

 

F-11

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

  

Long-Lived Assets

 

Indefinite-lived intangible assets principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.8% and 7.47% in 2022 and 2021, respectively. The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

 

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.

 

Revenue Recognition

 

The Company sells its products to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers’ freight and handling charges. All shipping and handling costs, which aggregated $15.8 million, $10.0 million and $5.0 million in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. No one customer represented 10% or more of net sales in 2022, 2021 or 2020.

 

F-12

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Sales Returns

 

Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $8.6 million and $5.1 million at December 31, 2022 and 2021, respectively, and the amounts recognized for the rights to recover products was $3.2 million and $1.9 million at December 31, 2022 and 2021, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

 

Payments to Customers

 

The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.

 

Advertising and Promotion

 

Advertising and promotional costs are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $212.4 million, $171.1 million and $91.7 million for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase and gift with purchase promotions that are reflected in cost of sales aggregated $43.1 million, $36.9 million and $26.4 million in 2022, 2021 and 2020, respectively.

 

Package Development Costs

 

Package development costs associated with new products and redesigns of existing product packaging are expensed as incurred.

 

Operating Leases

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

F-13

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

License Agreements

 

The Company’s license agreements generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of approximately 5 to 15 years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, excluding potential renewal periods, range from approximately 1 to 12 years. Under each license, the Company is required to pay royalties in the range of 6% to 10% to the licensor, at least annually, based on net sales to third parties.

 

In certain cases, the Company may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.

 

Most license agreements require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.

 

In addition, the Company is exposed to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.

 

Income Taxes

 

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.

 

Issuance of Common Stock by Consolidated Subsidiary

 

The difference between the Company’s share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company’s investment deemed sold, is reflected as an equity adjustment in the consolidated balance sheets.

 

Treasury Stock

 

The Board of Directors may authorize share repurchases of the Company’s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any time without notice.

 

 

F-14

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(2)Impact of COVID-19 Pandemic

 

A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain classes of workers from reporting to work.

 

Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.

 

Business significantly improved in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.

 

(3)Recent Agreements

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

F-15

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Salvatore Ferragamo

 

In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.

 

With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition.

 

Emanuel Ungaro

 

In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Future Headquarters in Paris

 

In April 2021, Interparfums SA, our 73% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price includes the complete renovation of the site. As of December 31, 2022, $148.1 million of the purchase price, including approximately $4.4 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022. The purchase price has been allocated approximately $61.1 million to land and $87.0 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $3.4 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022.

 

The acquisition was financed by a 10-year €120 million (approximately $128.0 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.

 

F-16

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(4)Inventories

               
   December 31, 
   2022   2021 
Raw materials and component parts  $146,772   $111,312 
Finished goods   143,212    87,602 
Inventories  $289,984   $198,914 

 

Overhead included in inventory aggregated $3.4 million and $3.7 million as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated events may be established. Inventory reserves aggregated $11.4 million and $15.8 million as of December 31, 2022 and 2021, respectively.

 

 

(5)Fair Value of Financial Instruments

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

                               
   Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
 Total Assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
Total liabilities  $68   $—   $68   $— 

 

F-17

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

                               
   Fair Value Measurements at December 31, 2021 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $160,014   $—   $160,014   $— 
                     
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $1,982   $—   $1,982   $— 
Foreign currency forward exchange contracts not accounted for using hedge accounting   63    —    63   $— 
Interest rate swaps   (234)   —    (234)   — 
Total liabilities  $1,811   $—   $1,811   $— 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the variable interest rates on the Company’s indebtedness approximate current market rates.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.

 

 

(6)Derivative Financial Instruments

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.

 

F-18

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $6.3 million and $0.2 million in 2022 and 2021, respectively, resulting from an interest rate swap.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying balance sheets.

 

At December 31, 2022, the Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $36.5 million, which all have maturities of less than one year.

 

 

(7)Property, Equipment and Leasehold Improvements

   December 31, 
   2022   2021 
Land and Building (construction in progress)  $148,137   $136,131 
Equipment   59,689    52,036 
Leasehold improvements   2,293    2,082 
    210,119    190,249 
Less accumulated depreciation and amortization   43,397    40,897 
   $166,722   $149,352 

 

Depreciation and amortization expense was $7.5 million, $4.4 million and $3.8 million in 2022, 2021, and 2020, respectively.

 

F-19

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(8)Trademarks, Licenses and Other Intangible Assets

2022  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $105,022   $—   $105,022 
Trademarks (finite lives)   41,267    64    41,203 
Licenses (finite lives)   205,235    63,535    141,700 
Other intangible assets (finite lives)   17,849    14,921    2,928 
Subtotal   264,351    78,520    185,831 
Total  $369,373   $78,520   $290,853 

 

2021  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $119,712   $—   $119,712 
Trademarks (finite lives)   43,820    68    43,752 
Licenses (finite lives)   109,682    62,286    47,396 
Other intangible assets (finite lives)   17,775    14,588    3,187 
Subtotal   171,277    76,942    94,335 
Total  $290,989   $76,942   $214,047 

 

Amortization expense was $6.8 million, $5.9 million and $5.3 million in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate $7.0 million in 2023, $13.3 million in 2024, $12.3 million in 2025, $10.5 million in 2026 and 2027. The weighted average amortization period for trademarks, licenses and other intangible assets with finite lives are 18 years, 14 years and 2 years, respectively, and 14 years on average.

 

The Company reviews intangible assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $6.8 million and $2.4 million in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite useful lives of $0.9 million in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.80%, 7.47%, and 6.99% as of December 31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the amount of which could be material to our results of operations.

 

F-20

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

The cost of trademarks, licenses and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license or the intangible assets estimated useful life which range from three to twenty years. If the residual value of a finite life intangible asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Trademarks (finite lives) primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the brand names and trademarks on July 1, 2027 for €70 million (approximately $7 5 million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being amortized.

 

 

 

(9)Accrued Expenses

 

Accrued expenses consist of the following:

 

             
   December 31, 
   2022   2021 
Advertising liabilities  $42,338   $31,215 
Salary (including bonus and related taxes)   21,128    19,993 
Royalties   26,532    19,154 
Due vendors (not yet invoiced)   105,869    45,707 
Retirement reserves   8,001    10,234 
Refund (return) liability   8,604    5,128 
Other   1,149    5,246 
Total  $213,621   $136,677 

 

 

 

(10)Loans Payable – Banks

 

Loans payable – banks consist of the following:

 

The Company and its domestic subsidiaries have available a $20 million unsecured revolving line of credit due on demand, which bears interest at the daily Secured Overnight Financing Rate (“SOFR”) plus 2% (the SOFR was 4.3% as of December 31, 2022). The line of credit which has a maturity date of December 15, 2023, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of credit were zero as of December 31, 2022 and 2021.

 

The Company’s foreign subsidiaries have available credit lines, including several bank overdraft facilities totaling approximately $20 million. These credit lines bear interest at EURIBOR plus between 0.6% and 0.9% (EURIBOR was minus 0.576% at December 31, 2022). Borrowings outstanding pursuant to these bank overdraft facilities were zero as of December 31, 2022 and 2021.

 

As there were no borrowings outstanding as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and 2021.

 

F-21

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(11)Long-Term Debt

 

Long-term debt consists of the following:

 

   December 31, 
   2022   2021 
$53.3 million payable in 48 equal monthly installments of $1.1 million beginning in December 2022, bearing interest at one-month Euribor plus 0.825%  $52,061   $— 
$135.9 million payable in 120 equal monthly installments of $1.1 million beginning in April 2021, bearing interest at one-month Euribor plus 0.75%   104,758    124,375 
$15.0 million payable in 14 equal annual installments of $1.1 million beginning in January 2020 including interest imputed at 4.1% per annum   9,890    10,569 
$17 million payable in 10 equal annual installments of $1.7 million beginning in October 2021 including interest imputed at 2.0% per annum   13,332    13,859 
    180,041    148,803 
Less current maturities   28,547    15,911 
Total  $151,494   $132,892 

 

In December 2022, to finance Interparfums SA’s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (€50 million) four-year loan agreement. The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In April 2021, to finance the acquisition of Interparfums SA’s future corporate headquarters, the Company entered into a $128.0 million (€120 million) ten-year credit agreement. Approximately $85.3 million (€80.0 million) of the variable rate debt was swapped for variable interest rate debt with maximum rate of 2% per annum. The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Maturities of long-term debt subsequent to December 31, 2022 are approximately $30.4 million in 2023 and $28.7 million per year thereafter through 2033.

 

F-22

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(12)Commitments

 

Leases

 

The Company leases its offices, warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of December 31, 2022, the weighted average remaining lease term was 5.8 years and the weighted average discount rate used to determine the operating lease liability was 2.6%. Rental expense related to operating leases was $5.6 million, $8.2 million, and $6.2 million for the years ended December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $4.9 million and noncash additions to operating lease assets totaled $0.3 million.

 

Maturities of lease liabilities subsequent to December 31, 2022 are as follows:

 

(In thousands)

 

2023   $5,723 
2024    5,971 
2025    4,847 
2026    4,049 
2027    4,060 
Thereafter    6,913 
     31,563 
Less imputed interest (based on 2.6% weighted-average discount rate)    (1,932)
    $29,631 

 

F-23

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

License Agreements

 

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments as follows:

 

(In thousands)

 

2023   $217,852 
2024    224,201 
2025    218,047 
2026    139,348 
2027    132,502 
Thereafter    986,434 
    $1,918,384 

 

Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations. Royalty expense included in selling, general, and administrative expenses, aggregated $87.0 million, $68.9 million and $41.1 million, in 2022, 2021 and 2020, respectively, and represented 8.0%, 7.8% and 7.6% of net sales for the years ended December 31, 2022, 2021 and 2020, respectively.

 

 

(13)Equity

 

Share-Based Payments

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested aggregated $1.3 million, $1.4 million and $1.7 million in 2022, 2021 and 2020, respectively. Compensation cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally the Company’s policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for 2022:

 

   Number of Shares    Weighted Average Grant Date Fair Value 
Nonvested options – beginning of year   209,510   $13.45 
Nonvested options granted   62,000   $20.36 
Nonvested options vested or forfeited   (102,780)  $12.93 
Nonvested options – end of year   168,730   $16.31 

 

F-24

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

The effect of share-based payment expenses decreased income statement line items as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
Income before income taxes  $3,143   $2,850   $3,030 
Net income attributable to Inter Parfums, Inc.   2,036    1,880    2,040 
Diluted earnings per share attributable to Inter Parfums, Inc.   0.06    0.06    0.06 

 

The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:

 

   Year ended December 31, 
   2022   2021   2020 
   Options  

Weighted

Average

Exercise

Price

   Options  

Weighted

Average

Exercise

Price 

   Options  

Weighted

Average

Exercise

Price 

 
 Shares under option - beginning of year   524,900   $57.58    713,210   $52.74    815,800   $49.89 
 Options granted   62,000    97.84    9,000    62.18    9,000    69.11 
 Options exercised   (136,880)   43.86    (156,490)   34.46    (95,570)   28.99 
 Options forfeited   (8,440)   67.65    (40,820)   62.57    (16,020)   58.38 
 Shares under option - end of year   441,580    67.30    524,900    57.58    713,210    52.74 

 

 

At December 31, 2022, options for 558,975 shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $13.0 million as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $2.7 million, which will be recognized over the next five years.

 

The weighted average fair values of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $20.36, $11.35 and $12.16 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value.

 

The assumptions used in the Black-Scholes pricing model are set forth in the following table:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Weighted-average expected stock-price volatility   26%   25%   25%
Weighted-average expected option life   4.0 years    5.0 years    5.0 years 
Weighted-average risk-free interest rate   4.0%   0.4%   1.4%
Weighted-average dividend yield   2.4%   1.6%   2.5%

 

F-25

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout ratio as a percentage of earnings.

 

Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Proceeds from stock options exercised  $6,003   $5,393   $2,771 
Tax benefits  $800   $1,300   $400 
Intrinsic value of stock options exercised  $6,760   $7,800   $2,873 

  

The following table summarizes additional stock option information as of December 31, 2022:

 

Exercise prices   Options outstanding   Options outstanding weighted average remaining contractual life  Options exercisable 
$40.15 - $46.90   103,460   0.96 years   101,860 
$62.18 - $69.11   139,900   2.04 years   97,210 
$73.09   136,220   3.00 years   73,780 
$97.84   62,000   5.85 years   — 
Totals   441,580   2.62 years   272,850 

 

As of December 31, 2022, the weighted average exercise price of options exercisable was $59.46 and the weighted average remaining contractual life of options exercisable is 1.88 years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $10.1 million.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

F-26

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 85,062 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.1 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired 63,281 shares at an aggregate cost of $3.0 million.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

 

Dividends

 

In October 2019, our Board of Directors authorized a 20% increase in the annual dividend to $1.32 per share on an annual basis. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023, the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on March 31, 2023 to shareholders of record on March 15, 2023.

 

 

(14)Net Income Attributable to Inter Parfums, Inc. Common Shareholders

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

F-27

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Numerator for diluted earnings per share  $120,938   $87,411   $38,219 
Denominator:               
Weighted average shares   31,859,417    31,676,796    31,536,659 
Effect of dilutive securities:               
Stock options   129,336    158,612    117,885 
                
Denominator for diluted earnings per share   31,988,753    31,835,408    31,654,544 
                
Earnings per share:               
Net income attributable to Inter Parfums, Inc. common shareholders:               
Basic  $3.80   $2.76   $1.21 
Diluted   3.78    2.75    1.21 

 

Not included in the above computations is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase 38,000, 175,000, and 450,000 shares of common stock for 2022, 2021, and 2020, respectively.

 

 

(15)Segments and Geographic Areas

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.

 

Information on the Company’s operations by segments is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Net sales:               
United States  $342,644   $216,559   $117,489 
Europe   744,075    663,290    422,947 
Eliminations of intercompany sales   (66)   (333)   (1,427)
   $1,086,653   $879,516   $539,009 
Net income attributable to Inter Parfums, Inc.:               
United States  $43,745   $29,359   $7,942 
Europe   77,193    57,869    30,241 
Eliminations   —    183    36 
   $120,938   $87,411   $38,219 
               
Depreciation and amortization expense including impairment loss:               
United States  $6,355   $3,835   $3,354 
Europe   16,184    8,863    5,713 
   $22,539   $12,698   $9,067 
Interest and investment income:            
United States  $66   $3   $24 
Europe   5,769    3,526    2,971 
Eliminations   (349)   (126)   (130)
   $5,486   $3,403   $2,865 
Interest expense:               
United States  $1,100   $636   $604 
Europe   2,848    2,315    1,496 
Eliminations   (349)   (126)   (130)
   $3,599   $2,825   $1,970 
Income tax expense:               
United States  $6,920   $5,336   $1,590 
Europe   36,262    35,607    17,782 
Eliminations   —    49    9 
   $43,182   $40,992   $19,381 

 

F-28

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

   December 31, 
   2022   2021   2020 
Total assets:               
United States  $278,090   $247,703   $141,316 
Europe   1,052,004    931,735    758,812 
Eliminations   (21,552)   (34,074)   (9,983)
   $1,308,542   $1,145,364   $890,145 
Additions to long-lived assets:               
United States  $2,318   $2,711   $1,004 
Europe   31,438    138,563    11,259 
   $33,756   $141,274   $12,263 
Total long-lived assets:               
United States  $61,539   $63,094   $40,656 
Europe   423,999    334,033    217,766 
   $485,538   $397,127   $258,422 
Deferred tax assets:               
United States  $2,906   $870   $886 
Europe   8,253    7,066    7,106 
Eliminations   —    —    49 
   $11,159   $7,936   $8,041 

 

United States export sales were approximately $169.1 million, $126.2 million and $71.5 million in 2022, 2021 and 2020, respectively. Consolidated net sales to customers by region are as follows:

 

   Year ended December 31, 
   2022   2021   2020 
North America  $431,900   $354,100   $193,500 
Europe   333,400    271,600    180,200 
Asia   152,700    128,000    79,700 
Middle East   87,800    61,000    46,800 
Central and South America   69,900    56,400    32,500 
Other   11,000    8,400    6,300 
   $1,086,700   $879,500   $539,000 

 

F-29

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Consolidated net sales to customers in major countries are as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
United States  $420,900   $351,300   $187,300 
France  $44,800   $44,000   $37,600 
Russia  $33,964   $43,400   $14,100 
United Kingdom  $37,900   $38,500   $24,600 

 

 

 

(16)Income Taxes

 

The Company and its subsidiaries file income tax returns in the U.S. federal, and various states and foreign jurisdictions.

 

The Company assessed its uncertain tax positions and determined that it has no material uncertain tax position at December 31, 2022.

 

The components of income before income taxes consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
U.S. operations  $50,250   $34,742   $9,577 
Foreign operations   143,969    116,277    59,772 
                
   $194,219   $151,019   $69,349 

 

The provision for current and deferred income tax expense (benefit) consists of the following:

 

   Year ended December 31, 
   2022   2021   2020 
Current:            
Federal  $6,829   $4,825   $1,685 
State and local   658    518    90 
Foreign   39,458    36,164    17,024 
    46,945    41,507    18,799 
Deferred:               
Federal   (802)   4    (215)
State and local   (49)   11    44 
Foreign   (2,912)   (530)   753 
    (3,763)   (515)   582 
Total income tax expense  $43,182   $40,992   $19,381 

 

F-30

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:

 

             
   December 31, 
   2022   2021 
Net deferred tax assets:          
Foreign net operating loss carry-forwards  $554   $1,292 
Inventory and accounts receivable   3,880    4,508 
Profit sharing   2,871    3,787 
Stock option compensation   716    732 
Effect of inventory profit elimination   9,342    5,112 
Other   266    407 
Total gross deferred tax assets, net   17,629    15,838 
Valuation allowance   (554)   (3,582)
Net deferred tax assets   17,075    12,256 
Deferred tax liabilities (long-term):          
Building expenses   (1,356)   (1,082)
Trademarks and licenses   (2,160)   (2,551)
Unrealized gain on marketable equity securities   (1,745)   (436)
Other   (655)   (251)
Total deferred tax liabilities   (5,916)   (4,320)
Net deferred tax assets  $11,159   $7,936 

 

Valuation allowances have been provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.

 

No other valuation allowances have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future taxable income.

 

The Company estimated of the effect of global intangible low-taxed income (“GILTI”) and has determined that it has no tax liability related to GILTI as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (“FDII”) and recorded a tax benefit of approximately $1.5 million, $0.9 million and $0.3 million as of December 31, 2022, 2021 and 2020, respectively.

 

The Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.

 

F-31

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:

 

                       
   Year ended December 31, 
   2022   2021   2020 
Statutory rates   21.0%   21.0%   21.0%
State and local taxes, net of Federal benefit   0.2    0.3    0.2 
Windfall benefit from exercise of stock options   (0.4)   (0.9)   (0.6)
Benefit of Foreign Derived Intangible Income   (0.8)   (0.6)   (0.4)
Effect of foreign taxes greater than U.S. statutory rates   3.1    7.4    7.5 
Other   (0.9)   (0.1)   0.2 
Effective rates   22.2%   27.1%   27.9%

 

 

 

 

(17)Accumulated Other Comprehensive Loss

 

The components of accumulated other comprehensive loss consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
             
Net derivative instruments, beginning of year  $(992)  $—   $52 
Net derivative instrument loss, net of tax   2,701    (992)   (52)
Net derivative instruments, end of year   1,709    (992)   — 
                
Cumulative translation adjustments, beginning of year   (37,440)   (5,997)   (39,905)
Translation adjustments   (20,325)   (31,443)   33,908 
Cumulative translation adjustments, end of year   (57,765)   (37,440)   (5,997)
                
Accumulated other comprehensive loss  $(56,056)  $(38,432)  $(5,997)

 

 

F-32

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

December 31, 2022, 2021 and 2020

(In thousands except share and per share data)

 

(18)Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest

                       
   Year ended December 31, 
   2022   2021   2020 
             
Net income attributable to Inter Parfums, Inc.  $120,938   $87,411   $38,219 
Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions   —    —    — 
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest  $120,938   $87,411   $38,219 

 

 

 

(19)Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows

 

The following table summarizes cash and cash equivalents as of December 31, 2021:

 

   December 31,
2021		 
     
Cash and cash equivalents per balance sheet  $159,613 
Cash held in escrow included in other assets (see note 3)   8,774 
      
Cash and cash equivalents per statement of cash flows  $168,387 

 

 

F-33

 

Schedule II

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Valuation and Qualifying Accounts

 

(In thousands)

  

Column A  Column B   Column C   Column D   Column E 
       Additions         
        (1)  (2)          
Description  Balance at
beginning of
period		   Charged to
costs and
expenses		   Charged to
other
accounts –
describe		   Deductions
describe		   Balance at
end of period		 
Allowance for doubtful accounts:                         
Year ended December 31, 2022  $2,247    2,353    1,134(d)  1,044(a)   4,690 
Year ended December 31, 2021  $5,550    877    (843)(d)  3,336(a)   2,247 
Year ended December 31, 2020  $2,452    4,824    381(d)  2,107(a)   5,550 
                          
Allowance for sales returns, net of inventory:                         
Year ended December 31, 2022  $3,242    4,997     —    2,829(b)   5,410 
Year ended December 31, 2021  $2,242    3,042    —    2,042(b)   3,242 
Year ended December 31, 2020  $2,587    1,978    —    2,323(b)   2,242 
                          
Inventory reserve:                         
Year ended December 31, 2022  $15,777    8,742    (378)(d)  12,710(c)   11,431 
Year ended December 31, 2021  $9,371    8,217    7,041(d)(e)  8,852(c)   15,777 
Year ended December 31, 2020  $4,909    7,212    616(d)  3,366(c)   9,371 

 

(a)Write-off of bad debts.

(b)Write-off of sales returns.

(c)Disposal of inventory

(d)Foreign currency translation adjustment

(e)Inventory reserves acquired of $7,639

 

See accompanying reports of independent registered public accounting firm.

 

F-34

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Inter Parfums, Inc.
     
  By:  /s/ Jean Madar
  Jean Madar, Chief Executive Officer
  Date: February 28, 2023

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

 

Signature   Title   Date
         
 /s/ Jean Madar   Chairman of the Board of Directors    
Jean Madar   and Chief Executive Officer   February 28, 2023
         
 /s/ Michel Atwood        
Michel Atwood   Chief Financial Officer and Director   February 28, 2023
         
 /s/ Philippe Benacin        
Philippe Benacin   Director   February 24, 2023
         
 /s/ Philippe Santi        
Philippe Santi   Director   February 24, 2023
         

/s/ François Heilbronn

        
François Heilbronn   Director   February 24, 2023
         
/s/ Robert Bensoussan        
Robert Bensoussan   Director   February 24, 2023
         
/s/ Patrick Choël        
Patrick Choël   Director   February 24, 2023
         
         
Michel Dyens   Director   February __, 2023
         
/s/ Veronique Gabai-Pinsky        
Veronique Gabai-Pinsky   Director   February 24, 2023
         
/s/ Gilbert Harrison        
Gilbert Harrison   Director   February 24, 2023

 

 

 

Exhibit Index

 

The following documents previously filed with the Commission are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017:

 

Exhibit No.   Description
10.166   Form of Option Agreement for Options Granted to Executive Officers on December 29, 2017 with Schedule of Option Holders and Options Granted
     
10.167   Form of Option Agreement for Options Granted to Executive Officers on January 19, 2018 with Schedule of Option Holders and Options Granted

 

The following documents previously filed with the Commission are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018:

 

Exhibit No.   Description
10.156   Consulting Agreement with Jean Madar Holding SAS
     
10.168   Eighth Modification of Lease for portions of 551 5th Avenue, New York, NY
     
10.168.1   Exhibits to Eighth Modification of Lease for portions of 551 5th Avenue, New York, NY
     
10.169   Fourth Amendment to Lease for 60 Stults Road, South Brunswick, NJ
     
10.171   Form of Option Agreement for Options Granted to Executive Officers on December 31, 2018 with Schedule of Option Holders and Options Granted

 

The following document previously filed with the Commission is incorporated by reference to the Company’s Current Report on Form 8-K as filed on February 7, 2020:

 

Exhibit No.   Description
10.171   Form of Amendment to Consulting Agreement for Jean Madar Holding SAS

 

81

 

 

The following documents previously filed with the Commission are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019:

 

Exhibit No.   Description
10.160   Consulting Agreement with Philippe Benacin Holding SAS
     
3.1.1   Restated Certificate of Incorporation dated September 3, 1987
     
3.1.2   Amendment to Restated Certificate of Incorporation dated July 31, 1992
     
3.1.3   Amendment to Restated Certificate of Incorporation dated July 9, 1993
     
3.1.4   Amendment to Restated Certificate of Incorporation, as amended, dated July 13, 1999
     
3.1.5   Amendment to Restated Certificate of Incorporation, as amended, dated July 12, 2000
     
3.1.6   Amendment to Restated Certificate of Incorporation dated August 6, 2004
     
3.3   Articles of Incorporation of Inter Parfums Holdings, S.A.
     
3.3.1   Articles of Incorporation of Inter Parfums Holdings, S.A. (English translation)
     
3.4   Articles of Incorporation of Interparfums SA
     
3.4.1   Articles of Incorporation of Interparfums SA (English translation)
     
10.25   Employment Agreement between the Company and Philippe Benacin dated July 29, 1991
     
10.26   Lease for portion of 15th Floor, 551 Fifth Avenue, New York, New York
     
10.61   Lease for 60 Stults Road, South Brunswick, NJ between Forsgate Industrial Complex, LP, and Jean Philippe Fragrances, Inc. dated July 10, 1995
     
10.61.1   Third Amendment to Lease for 60 Stults Road, South Brunswick, NJ
     
10.172   Form of Option Agreement for Options Granted to Executive Officers on December 31, 2019 with Schedule of Option Holders and Options Granted
     
10.173   Lease for Interparfums SA Distribution Center (confidential information in this exhibit was omitted)

 

The following documents previously filed with the Commission are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020:

 

Exhibit No.   Description  
23   Consent of Mazars USA LLP
     
31.1   Certification Required by Rule 13a-14 of Chief Executive Officer
     
31.2   Certification Required by Rule 13a-14 of Chief Financial Officer
     
32.1   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer
     
32.2   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer
     
101   Interactive data files

 

82

 

The following documents previously filed with the Commission are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021:

 

Exhibit No.   Description
4.33   2016 Stock Option Plan
     
21   List of Subsidiaries
     
23   Consent of Mazars USA LLP
     
31.1   Certification Required by Rule 13a-14 of Chief Executive Officer
     
31.2   Certification Required by Rule 13a-14 of Chief Financial Officer
     
32.1   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer
     
32.2   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer

 

Exhibits Filed and Attached to this report:

 

The following documents are filed with this report, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022:

 

Exhibit No.   Description   Page Nos.
21   List of Subsidiaries    
         
23   Consent of Mazars USA LLP    
         
31.1   Certification Required by Rule 13a-14 of Chief Executive Officer    
         
31.2   Certification Required by Rule 13a-14 of Chief Financial Officer    
         
32.1   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer    
         
32.2   Certification Required by Section 906 of the Sarbanes-Oxley Act by Chief Executive Officer    

83

 

 EX-21 2 g083417_ex21.htm EXHIBIT 21

 

Exhibit 21

 

LIST OF SUBSIDIARIES

 

Name Jurisdiction
   
Inter Parfums Holdings, S.A. France
Interparfums SA France
Jean Philippe Fragrances, LLC New York
Interparfums, USA LLC New York
IP Beauty, Inc. Delaware
Parfums Rochas Spain, SL Spain
Interparfums (Suisse) Sarl Switzerland
Interparfums Luxury Brands, Inc. Delaware
Interparfums Asia Pacific Pte., Ltd. Republic of Singapore
Inter Parfums USA Hong Kong Limited Hong Kong
Interstellar Brands LLC New York
Divabox SAS France
Interparfums Italia Srl Italy

 

 

 EX-23 3 g083417_ex23.htm EXHIBIT 23

 

Exhibit 23

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of Inter Parfums, Inc. and subsidiaries and Subsidiaries for the year ended December 31, 2022 of our reports dated February 28, 2023 included in its Registration Statements on Form S-8 (No. 333-136988 and No. 333-216705) dated February 28, 2023 relating to the consolidated financial statements and consolidated financial statement schedules and internal controls for the three years ended 2022 listed in Item 15(a)(2).

 

/s/ Mazars USA LLP  

 

New York, New York

 

February 28, 2023

 

 EX-31.1 4 g083417_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Jean Madar, certify that:

 

1. I have reviewed this annual report on Form 10-K of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 28, 2023

 

/s /Jean Madar  
Jean Madar, Chief Executive Officer  

 

 EX-31.2 5 g083417_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

I, Michel Atwood, certify that:

 

1. I have reviewed this annual report on Form 10-K of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): 

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 28, 2023

 

/s /Michel Atwood  
Michel Atwood
Chief Financial Officer and
Principal Accounting Officer		  

 

 EX-32.1 6 g083417_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for the year ended December 31, 2022, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: February 28, 2023 By: /s/ Jean Madar
    Jean Madar,
    Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 EX-32.2 7 g083417_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on Form 10-K for the year ended December 31, 2022, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: February 28, 2023 By: /s/ Michel Atwood
    Michel Atwood,
    Executive Vice President,
Chief Financial Officer and
Principal Accounting Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 GRAPHIC 8 img001_v1.jpg GRAPHIC begin 644 img001_v1.jpg M_]C_X 02D9)1@ ! @ 9 !D #_[ 11'5C:WD 0 $ 9 _^X #D%D M;V)E &3 ?_; (0 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$" M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P,# P,# P,#_\ $0@ ^0)\ P$1 (1 0,1 ?_$ /$ 0 !@,! M ! @,&!P@$!0D* 0$ 00# 0 @$#! 4&!P@)$ M!@$" P()!P8)!P<'#0 ! @,$!08 $0+,/*NP>2 MD>P:+OGKQNU9MD#N7#A90"))()E. M .&'OCRJ;6/=+V#03+2M.=.%5;])O%3W"J\)' 1T'CQ#@/CRI.4 G@>" %Q(&) 4043'70P#IIK^0?#^3!-*5YBJI MR!Y'\JD%=$-0%0H" Z::^4)AU$"@7^<8P@ Z '$P>8?)TUR >USQ& MTUD=P',\?,50$%G:#T!S0%DAX H41T = 'CH/8(AV@ ^#QX#FNS93Z)H?!12 M )&8<**U;I>*IM_7)*WW*>9URM0Y43R[*==/@5&N:X M.#N'A5IV;<2E5"6J\+9;*PA96Z20PM78 M/5@26FI0J9UQ:,DC!SJK]TF(Z!X PPB201,QD(K3G0J+AW 'T,>=,AL[) MK!]E7*Z[+EX!743IGD^I.Y]4#GK.D]OIVLV3JOV W7AJ MMMI9V4FC&5&2VC48+[65^6=NF""L>M.G:.%P!Z#;O#. Y.T=#71ASND9@":CGP)66 M=O-Q]S%]Q^GN-8[P;_6RSS6T>[C_ *CJ99V%G-6*YNTC'Z?M[4.%?A=F7DCE MCB0ME:RPP^I7,M!(=2D;)7E (9RUW@':-C /21@M7H^R=7UGBK*+'>7J-HAM MO_A_;:[G56/JT<=A#2.[)9YP21"4C3UA1)_*N6)$T7$AX+" ?"'5IXU]%&U,O-3V MUNW=@LA50L,U0ZE,SA3M%F*_IB2K4<]EP&/Y$E6:POEE?[GEYB&X: (:9B7# M8Q=N8*>JC-0\O2P48PQTC72_KJG\M/>7A+MDQWNV.GNJNL=)+(O4"G,[?7J] MTC/XN.<[B+NB.G3Z%(X2(K]>8&#&IBXD\> M'NCQ*]IF6;4"\4,(M'UZ,W*OA64S6G?Z K>\S7HJLFY&\-7+LW7Y,L[?9.VV MJ1A]VW$H@A-LJE)VIHK(JRHUQ5=RNP;IF306 !3#F "9M[ILK)9&!O5%\1X, MF>CJM2OA6PG04CNJ%GM3AUN3!6[;9 M6L119RNJ7W=WR+GL6NSBX9V1% TLH,^ /PJ\!TUH20K77,L%?3,10!LW M2;+J+,W8NR&)HH($5<-54RJF%3RT].4 N68 O+H#T!-*UYTHK!MTYU(4J(ME3AK-OK/Q]XZ3-K]SY9_ M.O;=-2$?NDXMD$WG4JXZ53%2&CS#J43!F&X12V-ZR>C M9H'597B_CACXN1*P'D^K:68O3/I^+JXFGY5C':&\]2$C3ME&GF5U4G('?>W1 M?[4L;CN1;JSNLW0K2 @"T4T026\DA] S4WSY'ZK;S6H MHYVFRU:,*/#V@ \,2VIX5IX%M2+;V7=$.'_.14X>CEZQX<*\N"R%MU9-V#S= M*>U>][]63=B<3OR?4E4K8K:5:K2F*,7)'9N&3*5:^C*Z\8N2I%C"LBB+@N@] MO'-FYL3K>=I(S&U&3AZ9.-/#Y/&M>TN]>=EQASLIT9'"E>TS,:]N'.A).-<,:K'TU\U\P:A."PQZM M+#EZ82R9S),<:58T##+CA3!;^?#/M5_L73V\0W#BI!.;KMZL%=1M"UPM]VA] MP&37S)1*WU>4O2*-E;0SY1VH0&BQ1!LHB#Q="@#= H@()E 2@!(*.K3R?B M_'Q5,K)L771(.("4=1,;4HAH)?*,/DB =G9DSB:GC5I]UOHGW/\ :HM8UKLX M]+,YW$\7D%WE(&' G MCQ52QKG]H?3_ ,*<."E!NB4=2D HB (E$P:Z !KH(:CH&FO;IDR:MR'T.A M5TI2M>7XN:@5HW)KR)%)S&$YN43%YCF[3#H(:B.4Y!O(FGCXK$.]>QFWF_E)<[=;CQ;R3J[Q_&RCALRE)&)<>=P[M%\Q4(^8 M*HN2@FY;D$0*H41 ..H<,MR11RRMFD%9&<.-![G ^,A+=[K4.$!RYA0\\.C& MM/<65X^.:QS!G'MBF!LS:-VB '444,"+=$J*8"Z1Q>\U<22? M"3Q*@UH:UK&BC6@ > # +D@W1+S 5,H 8-# &H (>(0UT$/DRV&-$8AQ,8Y$ MD\37GX4H,^?\Y1%!$>T@#P,''4=0, %, ZB.H& U_)DF]1N1N#4>!(,K\0I M!:-S% ID2&*!P.!!#4H'#L-RCY.H9%K&M>)&U#Q6A!/.M?QE *-R#T5$6R(@ M8!3#0W-S<3>5S (&YAUU'4!T_)AC&QESF8.<:G\.7N<.2IE;4&F+>'@KQ400 M2 !#D#CVZB8>''0.(CH4-> =@94#*[,":^,_@5)W6;E/ >Y^)2^:H::=WVZ M(@8X"/+_ #=1 VHZ>#7*2-$N#^%:X8>6E*^ZHM:UH:T>BT8>!1%L@(ZB34? M/,;@/C#RN _*&4R-[7M_^*&TKC@.@#@/(J=FS(8Z=1QJ?&INX2T$!( @;3F M1$0-IV /'B >#Q9*@P\"F,*4Y*4&R(!IR#IKK_//P'4!#3RN&@AK@@.!!Q!I M[W!4 %&@ >##W<.?AXJ8B"29>0A *4.;0 U /+,)S^'^D8=1\>5.)J:\*>Y MPX:JX1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3" M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81, M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$ MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$ M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8 M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(H"(!X M0UT$=/#\V$5+G$ $1,&G\'#^/++&SB9[I#]#R&'^U5(!.1OI+BF?MBN"-1=M M@7.43%0,LB1<0#^D5(Q@.8 #Q!F0([DP=NR)[HZXFF ]U8IO+-DAMI9HVW/( M9A7R+5#K&ZQ]N^BW:[VG;AM)>;1>2J,%!5Z *S&7FY5<@J @V%VLB@DDBD43 MG4-P*4-=,YOW>; U[O(U_P!@Z(P=J&%Y<2T!H'$]9[1[ZX'WE]X^A=UNW6Z_ MKSR8GRAC0 XU+N'H,)\N"L[HOZ]ML.MBBSMLHC":K4W6%UD)ZDV$\@U,L J6D.%<"0.LUO1X%XQV_XY.^T+U9O=MV>U=;;;71> MXS2BN("0C94;V[0++EAWD@WDB+^9@[='U6;H]SIW8AJ)M<]$:9]VK:M[W9G= M+[ZZ&L=@Y]<[!%5LA;3+V5> X9UY9O\ [TV^;7O4&U!96GL7M6L+.S<9>M&' M5S=K7B>(;1>J'Q2.K[=3I!Z:V>X^TD2Q=VJPVJ&K",U-Q7I6(J:$BU=K^P-C1Z]MNW:[4+B,T+V%XC):"#EJ.!=6AS<#4%8?^ M$IUY[T=86W&\LEO?>&[LML=W.Z[/2=JS3]C=PEQC>]LA806CTBRHS9OSG'AA3% M:3[MO>KN[O-VG>ZOO"*%LUI,&YXXS&7!P<< '%IRTY,J*@'%:O)?',M)^K(F MT [-1'LN<7UKMZG)&EED[PV=.9$(P)M=(ZA8LZ7?& ?-03!0"_TA'.PW_=@M M?LW_ +N;?2#5FP.E+,T88__P#5]W%WEMV7)8PNTI]TR$29 M)>VJY^6II)EZ#^K"]J^H/JJV5Z7Z2E>]Y;JTK$,[-W$4@5%1Y,S;KE XMHB) M01.Z>+$(.IM"@4H=HAGFC:VR-Q;SU/V9H$!EGIB*@!OC)_%BO5^Z=Z;9V98' M4MQ7+;> < 03F^2UQ7<=/O4AM-U.4-MN+L_:F]FKCA8S540*#:2C7A \IG*Q MR@ X8.-.(%.&HAQ#,+=FUM=V1J#M.W% 89AZ/,. XD$8&G@Z5#:>]MN;VLSJ M&W)VW%N" Z@(R$\ /!2"H' 0, AXM0X_FU\.4C>UPH>*JT9R"'=50!4![.4>.G =>/B_+ERC M>E7."@)O* .;^#A]&N1<:#.#A^'NH&D MX_FJ(F U$= #M$= /S9;[<="K12\P\1 VH#IIJ)?#^30>.7 6D9BZ@/B\R MB\O ZK?P\J&/RZ#S%T\("(>'L')@8UKU5)G6%#Z2AWOY./9Q\?9DJ-Z5/(@* M:\>P/&(@ ?+XNS+9;DZSGFGN>98^=SG%K&\#13@'PZ944. M(-0IC-6C@H&4T'3A\^2 ',JX&U%5 #ZCIP#^'*T')4;\BHPU'6&*G 1U$-0'0 \6OS M8%0VA=5X\2H,V8U'55/O>(AP$0[>/'Q9-HZHS'K4Q5W)7%1[S\@?PA\W'#A7 MT74Q\"9%#O?R?/XORY4@$8'%,B<^FNI@#B/B[ X^+,?Z0Q.H[K@G'#E[BAE= MB2.J%$3@ ('*&HZ:&$/S &@B.HAD^LXU812G _A7WU1KFEN8UIX%+S'$>!B M<=--/ET'L'CX<5D!RG+7\/"I!K7#,"ZGN>93@(\ $W'^#Q?DP9"S]8**WE<< M02Q9O M#N_0=BJ!8=T-R)KT'5*XS.ZD'ITE%3Z !N5LT;IAWBSM<2Z$*':/BS=[=T+4 M]TZW#M_1HS+J,YHT<&X5))=RH 5H=S;CTK:.BS:_K4G9V$#:N/$\0,!A7$A: MI]*7Q&NF_K*F9^K;.R5H2L]<9#(NX6XU]>'=K1IS@F209\CMX@X;&'MU4 X< M-0SFN^^Z/>7=U9Q:CKT;/5)GAH+7EV-*XU&&"Z_[O.^O9W>=J#[';TI];A87 M.#@&X Y<.G%?.'U7;7?$ DOB$6)2OQ.[CV4D;['R-%G*ZM()4\M>([;F9AWZ M"OH-FS;M2B"R:W*)R@.H".>PMEZMW,#NG,=T+)MVVW(=G$7:Y\O(.^D.-5XN M[P],[[/M@9)IQOG6#[BK,CI^SR!^.8MZ@PX KZ2>J?HNKW6KL+5=MMTYV7KU MDA"P\ZWLT HT&>/\ 8_>3J7=ONNYU MG;X!B>7L J65C)PH0#3#E1>R]^]UUAWI;%LM"W*YT=U&&/)IF(D:*8U+2?'4 M*CT.= 6W/0]59R'J$M+VVQVIUYS8[7.^:H+NDD^7S9@T8LDTVK9JW$H"'D\P MCVCDN]'O3U?O0U.*ZU*,1V\+*-ZV=P)I4DT'1A0"GA4^Z/N@TCNHTJ:TL)#- M/,['JY!05P])_3_@LBRO0_TQ3>]#?J$DMH*P[W=:N&[M"V*)N 4!VS3!)J[/ M&%<^B5721 X*&1$W-QUUS2P=Y6_[?;QVM%JMR-$I01!SJ4K4CTL!7DM_+W5] MW]QN5NZ9M+MCJPIU\D?$"@-,E:TYU6?[E0JON+79*I7FNP]FK4LV.U?PLVQ; MOV;M$^H"51(^I2" #Y)B\IR=H" AG$K&_P!3T>]9J.AW4MI?#B^,N:[ES:6G MI7+-2T?2]:M7V&M6L%W8UZLHY7;553<5M+_ +1("-@D_P!G$[" \Q9HM;%0(_T@!AUY MA\GFX\N-OGK]Q$EL"KL(&0;2*0 M)KMW1&2"YTUP$/(4 ODAG+.XWO;B[K=:DO[R R0S-(-*$M)%.8.'B%5QCOU[ MF7=[>AQV,5P8;B$B@(ZIH:X]=H_&H?#ZZ*+=T"=/FX[:P3C&Z;F63S^U236! M.[5KZ3B'CG!8F-CBNTV[E3G$?[T_*!CCIH.1[WN\NV[WMUV=Q0J4QMX>GMF:-;C"RJ[11>(<(E2EF2[-), 45<&5 MX@(^'._MX]R7=M9=V0U>UG@;J44)>"',S.<,<3VE7> $$#D%YN[O^_WO2U/O M1.@:I;W!TQTV0@]H6M;TXQY?)3@OK"L>X5(I@1HW.W5JJ&E7)6$<%@FXV)+( M/C@!BM6(OG*'G2XE_HDU'3CIGB/3M%U?6&.?I-K<7+6-S.[*-\F4=+L@-!X2 MO?>I;AV_HV4:O?V5JYYHT33Q1EQZ 'N:2?%X%=B#E)P7G2,)B:Z ?3R#<"F MR9^)%""!@T,41*/C[@^ T/E6R@FCN8Q+ 0Z(\",01T@ MC CPA5N8-?#^7P?/@X*X30T(*CJ'C#Y\)4=*:AXP^?"5'2FH>,/GPE1TJ.%7 MCP3")A$PB81,(F$3")A$PB81:P=8&Z5DV;V(N-^J;R)CIR'/7TVDC.1YY2,8 M)R=@CXMV[=,4SIG<$10>:@ "(Z^#-UMK2X]6UR.SGS&!XY G@<*L4HP9":&(S-WCM X(\O#7FX9SJZV);7\_8:866\D<+I)1, MYK0QK2 79VN>.8P+AQ I7!=='>1T6%MYJ':OLWR-8TQM<\N=)'VC0UH]+J\: M5I0]!6JTX#A-F\C7Q FEIIV,;(*] MPY6:-%T4U-0YQ !$.+C9\QC8[M8!+(TN8QSP'.;Q! -#CRP->E(_3+8G$-\= :4YUX+IMT>JQC 5C9?H,N\"/:]\8ZK8%GI=1U 0U^3,/4MK36NJQ6#71#UAK MG1C-@6M\=*GQ55[0MR0:E823Q"4MB]+JG"G%3->I6 E7SPU2HVX-SK4/((Q$ MY<:U&Q"\/$2BG=@NR.R\JVNZK&^ZUBRYF8'4)9&YP!\)%:4YK'J'5-,Q>Y.XE3GMNKJ MY9Q,_3Z_2"1L=!)+RKRPLWC@Z;EU(69NFF9=1$IDS+@CRE 2\1X9N;K84,FD MVU[!<6]9(7/?5XZM'4J*5! Y\.*T4F^+BUU:XL)H9>PB(HMK;.EKD2K&GC+(\C M7P*2:@%-HJ!B B(:=O,-,[L]1UDL]FW6GRL?*Z,$3MP\72=):YU^RZCRPMDH8G EKI60C+6E3G>W U1\Y7X!E0EXB+6MT^\M23I>!]"I(RQH]=%VBQ6$QU'*9$>Z-WAB@&N:2/9 ME[?N;ZL^)]KUP9 X=FWL\I=F=4@"C@:D@4J>2WLV[M/T^$NO!(R5WHLRD/=T M4;2IQPYXJ?:_>VP7_>J^T1W6K#4(ZI4.F31X"WP;9A*I2UBD[ DZ=S0YCPX96]H,:<'5;PZ, M:XX8.E[ANK[.2-KK1TS0YI!HU\;:D$"GI>^J]Z>A65NZ>Z%U&T2 MQ1]:)PJZ5P8S+6E02<2. Q5_CU$U8T"PD'$/;6DO(VU:BA5C1R"]A8V-),%7 M";QD$J5J9JT:G!8YP5,F*?$!'-.S:MR;AQ:Z'LV1=IF+P&EO@/ G&E!4A;MN MZ8',<2V9KVR]GE+'!Q..(:<2,.-*+%VW'5BRLT0JRAX*][NST(\FS6AY4JQ MP:%=C6D_)QS5-^RE;*P16=%08&[M-L9P=8I.;0!'3-MJFR[S3"9+MT$,)#'P%8]OO*UO"6V8GFE!(+6,;6U(]T5JJ.^]!*3F"624@DRJ"J@H0&S=?>61<[NLM/F;#=&1MPYA=D+2'T''J'K8<\ M%V-3ZHMO[[;8*IT-E:+:6:JL1=C6*-9,"0$/7YYT^8Q3^04?RS*46[U^P425 M3;H+=SH G '7,.XVE^9W1 MYP,I!IF+>''BT_CX+%%7ZU]K+<^F6T/#7M*,JU33N5GL+^'9,X*$AG+N2CV# M[S5X;2TNW&V,5ZX-A D;F<2&G$<@ X M56.[>.DLU2[T_JIM%.V^&RP^VNXE*<$GJH M5F^N57AI-E,P\E/,8R09L$H"UOTF\TNW<_W*#PR!_* ^@Z#I71MG07%[ZFZZ MLNT+78"9HH0">GAAQ'BI5:N]WM<1P&[CM+WL&N J8)!6I'++X0LOL.I6FMHN MRO;I"VVB/*E&Q5?))\BZZ'=E'G$0*/'8Q=WFH7-L+V">T?;]KD<1*WJG*''"IY$4Z2> M7%8-WO:QLWL$T=TWM6![/HG8M=6AX>!=[.]4M9@9)&$6I=Y<7 E9-K%>/V",I)A(VUI&.#2#B-5%NDP6=++%()@+H&8UALBZO9']E-!V(E9$ M'DG*Y\F;* 0,!U'9B?1PK2JC=;XT^UK!TC3^^C)B@O--[Q8:ZS7DX4\. MC5:ZAN*-01G[/"]\=6UAD=D.8 M2%X!)C.:C@[\P@T(((H"K4&Z;V]TF^N[>"4.MI)6$/8YKQD+AFR%M:85KP7% MC.I3<)KLSOQ.15IA=XY7;&6A86J;ET.L!,15A>V'T45RS/6*V]TAF:+:&X9F+)I!'DH'>D\G"I'5K0FH% <%H- M&W9=WFE7-Q'(V=L3:AT!$U29&,R@,_.&;,0,0VI(IBL;RW4-U"2]'83&V=RB M[TFMZ7;,[@?9IS$(O+A#RB3:0H%LKDY.1,A2TVD.560*]5(GW@I% #!6\/3=-;CV6D'L6Y$ZSG'4[-2#^LE8P+.!4C:H*:!8 ME)^U9.'7^N/DP%R(JF*<"*E#3P9PC>=CI=EJ+K736/;$P"N;,:N-:@9JFC:4 M)'/"@HN8[7OKZZM?]:^-\F-G'.(4?V-.=%OZCMU6R2R$P MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%14/RAJ&G9X0$0[=..@@/;F M/*0QX;R*DP9A5>/?Q0/B7SW1"O0ZGM_2HJVWFXMW4RJI9"/DX!A!-G7F 51 M@8%W#]=V0WDAH!$P 1[<]"]R/- M>;>_?OSD[H[>R?$S.^[DF;C&'T[)K3SEC ]+I-? L@[662F_% [L71ZFU[&W0RG+6+'!U<'2TX>%6S MT"_"OHW1+<;#N(AN).7^X3<,I7VR[YK'1L?&0QUQ6.1-HT;@LN\6T#G4,<2B M(<"ES)[V^_+7N]/28-,='%#:L>'8,#22&Y3S?X^*UW=!]W_0^Z35[C4XGR2W M,C"T$RN>*%V;AV<7XEZP=T@!B^003 &FHD+KQ#P&*4!SHF.V: *N>2T?"-/R M+T,^W$CNV:R(D\RW'W,%RR$ -. !P[/^7+K7 ^B"!^'A*!KOSS7\/$%4RJ MFF$3")A$PB814%4^\$-1, TU%%;=7-0@&, MBA6*XC9+9ROVM]?(3:_;Z(N\@!QD+?%T^ 8V5Z)QYE#.IIO')/US*&XF$R@B M(YOKC<&O75D-.EN[A]J!0,<]Q;3HH213P+CEOM?:5G?.U*TLH6WSN+P#7PG$ M\5\^GQ>>@CJUZ@]Z:UN'M%$N]Q::6*;0[:OI6-BS/3I45$B&>)Q,H\8(HM71 M?*4W)]/W0!;:J0,3'G9( Z0FA&:AHYHI@:!> M.OO)]R_>AO37[;6=K.B?H8<2&FX$;V59%2HV>N$7T(]$6U"/ M5I?V41)[?5%M#VV=\"]&RK8=A/*71M)$0RAHJ?I'FE:$@$U/0%Z5T34/LS[N[)^\9R)88@ M'D RFI(%.HW'$K83I\ZF-F^J*F!?]DKBTMU9*X\T=JIM7K*0CW0@H8K61CGR M3=RQ5.!.8O, @Y-I:B_3=P1-BEJ0VCFO%10GK,)& (Y\PN9;9W MEMW>>G#4-#G=+!E#C5CV$ DM&#F@G%IX="SUS!_EKG'>QEZ5O\]KTGR'S)S! M_EKCL9>E,]KTGR'S)S!_EKCL9>E,]KTGR'S*LF("4=/'_(&2:US11W%7&F,C MZ/T?PZ54R2DF$3")A$PB81,(F$3")A%B#>S:R.WGHDKM]*R3N*9R;F">J/&2 M3=99,T/,MYA-,4W2*Z!DG"D>!#@8HZEXW$ TP M%"!48XK"U2RAU/2[C3920)[>6,T-.K(PLXT/2>1\2X]OVGBK8UV]2\[4B4MO M[:PM;5)BT03(_=,(B2BTVZJ/*!$D%1DQ4/RE QA+H!@#76_8;BN[>:Z&+F7M ML6.J:$#M&/%#4D8LISP-%I+S;6GWMC8VA%(K2=DC3CB60R18X&OIG"@X ^/! M,UTI3;M2T5.$W+6@ME[S-/K%:J*G76J\^M(RLKZ:E6T596J.TKNVO)9= M%G:RSN#](UV)()-0VL9(XG\Y5)?I;GV[:U5;;S=->A[;7A1R]LE<3K4=,S24 MD]!,))Q 6"06'T:UD.[_ +Q%1NN4HF'D$H9&WWI:230SZK;F:_C83&02RH-2 M,V5U"6U.%,>95RYVI>5)T*9L5O( V0.QJ0*.RYHW4K0<_<5.7Z59I5T\A*_N M+Z&VRLSB%DKS4U:I'2,S.2D05J4[F,LIG!/1*$EYF05D^X5TX\@EURY_?=C+ M''=W]J7ZI"US(' D -/P@'4)'3@2KD&T[S3(#::7.UD$Q^FS8D].6L>'-=W6 MNGNW[=/WD;M3N::F;<2TXM/R=7*4\ -4CVEJ.B7#8MKSLBL7'-() M"'$D\G=M)N(:(M;!B]W$;4F0,=#.U[7M=B"Q]:@#-4 M&AP*V-UM_P!;T>VT^ZD+GQMCKB*\118?D^DVPWFP(V[<[=Y]9Y M]NI4.[&#J<)6H)HVJ%B)9&Z+6-(I)N#*OG1 (NHHJ0=#!O]+[PH=+9 MZGH=@UD';.>YSW.S:_37]H9&.Q)SA@-#6HP:*$8@XA;36=NV^L MYKEQ(U.%M8B"6M%*D5&4@]8)A$1[8[A9,KE:5.*O?.%>;E+X0UR.K[AT[4M!AT+3[;LK."=T MECZ!J=MKC-P:G,U]UZFZ"@X!KGL?P#&X_1C'QK" M]KZ,$;M8[9;+)=R.9F2LS:SU-!"J0J%=A'[!+N&Z\[6C**1]H?JMP!)9=0"* M*E#41YA$P[JQWL=.ABBLXJ.CAR/)+BXUX936HH#A0BF % M1J.PO:]YV.R,#V."O$1=G#NGTZO4V&>'@@ M,1C%DA(EDHL5KR''G,HNJH)N(&+V9CVV^9(9'MM8W&V,$L9#R2XF04)J7NQ' M):[5N[?V_IWJ>I2-$C+B&5A8LLA.^FY M""&)&O>??_M=)\JD=!2QH0P)&)Z?49F[HS@3R RC&$=;@ MZ@QRU!X+FE]MV&ZUBWUH.RY6]9M<"33&F4_C6)*/TFV7:+TFILYN^_K*MJ?2 M#NY#.U6*LA9)9W)R4BW=Q:*QF98F08DDCI%4'O4S)E+S)F$-4MI9-TTQGU1LS7MRES3@<&DAS<#7$U.*RM;V>R^O(]4NWY MM9[)S2X4#*.IFHT,(!X4PJ%.*0!D3Z#'&@S24KV=>)KQ5JR.SN]4AOEO3;*I?CT&M6Z M'V\@VXO:_$61A,MX^ORK69D(M-4[>1C)YDLY[HJRJAD- #5$V; ZYM^UVG86 M4\;WW=O-'>MWKAB8DZ>35562 MXDT>PEU!0L<*@DG@WQKA5'HLV]J\5<809B=D8FX4NMU%X MBN9FBX;.*V^DY="PHKM$D!]*+2LF*X@( D4Q"@!.776%QOB^O(K:*!H;%:3$ ML'&@ZHH:G$4:*]/0HV>R;&QU:_U:_D=)+J419(E&LHT4EUN_E%WZA@:]R8$E$$N01$ M" ;CEB/<.GVEP+ZQL0VY+7--7.(;6H-*R'C6N)/B5V/;FJ&W-M>7F:$N!% W M@"*?\$="O;<'IUK>XSRQN9Y_(*)6& @(=-LBDT2"*?UER=[%3;980.)W";KE M,*9RB00+IV#IF+8;GO-*8V.)C3"U[W<*U[2F88NX8P[QM;!8@V\D-NH9L]VYK:]/:0[Z3C M9A5>7K:[@WII\N[C")J',L0@H<"D(;RAVD.[M/ALQIEO;/;;NN.WS"1P<'EN M4D$&M,HX5YXE:*3;&J3R":^FC=+# (XQ04RBM*_1XG$XX>)8Y8=$0UE*+?5J M[PCVXG@4:S<)B_T.$O#)_"-967F(1*LQ4@MR50U=/,K(,4RBJW(AR%,0_)QR MI-\"XMZ0Y<2L"/9%W8V[KO396C4Y[>5K MS(G*WNWRE3DH.=V=O;:A65E4X^A6%W+U&&L$78*U% M2$A,1?) ,3UV/C)>+>3#HR"R)"I[+.ZB=!K$)DM#()&AI+2" M&T)S T.45\H' #9P;4OM/["?3Y6MO UP)=0@XNY=F1P_VJ[-J=BAVHVEF-LV METF[!(RSJZRBMQG&,*-L=K:6\<3&5)^CB:QK XFA<22/D)IE':%Q(: QH ZQPH:=)Y\&'V!0VZVEB]L]E+0\V^?04@%@;V$\:REB M34T=TJ\EU[7'K))-Y5E8%ESE=I)BBIR\H)&3!,HEE<[H;JNLNUG-PA'! A<7S*"CX:&A8YE'*@VAX!)*) M:>=)\AE'2;8I3J>4;7*O-S63I8Y[6)T9@RBTYY0"""\UJXBC:5JWC48FN-!M M=MHRXC[2KKBX:;G$G-UG9LG5&6N9_"E*BG#"OL5TSEV;N5EM9;8K)HRT<>#C MXII&HP[=2/&6=32T!QJ.SZ?\ &J^>SX@GQ@MV>E?J4D-E=N=LJ7-P5-CH1[9Y>Z&F M?/YE>78-Y)=O&I1DBR1CF+=FL/=+'YC*'#F$.[*;/7'\?9QW/JVH7 M,4TKI@QL79T9V51B7AQJT-,TZUF@RPDNE,H)[85 MP#'-&%13C[X7HA>^G+I_^(QLYM3<=Z:$_4*XC&%IB"L91>#FH962:D5=1H2[ M(R3QQ&J*#Q3UY#@!1'CQSI6UW/N7NDW/J6@;9O)7"*8QO=VDD9=V;G!KB(GM MQ&/-=ZW^U=K=[&V],U/=5C;"4PB9H,,4E#,QA< 9F/-,!T>%;=[1;24+9"@0 M.VFVM?:UNH5QMYK%Q38B>B91'F4574(4#.'*YQ$RBAM3G,(B(ZYPK6MC1LCLV<&L8Q@'^ZQK6CW L MF@0H?T2A_ &:AP#Z9Q6G"N*W8:T< !7BH\I?\T.'9P#*J0P&4>CT(!2AV% / MR 96I/%1#&--6@ ^)1RBDF$3")A$PB810T >T ''.O-%#D)Q\@O'M\D./Y> M&4RMS9J#-T\U1K6M]$ >)0[I/_[,G]@O@[/!X-,J[K"CL1X5'LXZURMK6O < M5YQ?$JZ'I/K@V!<[7[GN\AO=GNANL2P,FM@,0#E>.JX=5PK08XBA72_?CW63=ZFUG M:1;W,D-U5H'!S#1[78M-*\#^<%H?TJ?#+B^B;:'=#<[J8Z@KG5N8J5AM)]FM MR;AM]4*]$P:3AFBJ[>Q(1LG9Y-QY\!"=^B @=0")AY6@]K=X'?C-WM;DMK7; M.@V$]X9SD%U&9G/<6-;S##P82<"2*4X8]1=WG<%!W2[;N+O=.OZA;638!VCK M61MN&@/PM=C>J+JPL+^K&3/-1DCOONW7IE MNU6,=-!^G'3+ANN[CEU"Z LF E 1#40UTSA^]_[TV/!$_6MN;>BM93^L]5(H M>C,7BAZIP\:Y-L4;%WP)F:!N?<=Q=QNH&>N-<3@#6@83S6WA.B*F"4!]MG5; MX>WJ.W#$>T>W_7PT'^+.!M[R[W*,NW]N.;04/J]:^&N;GQ790[J+5P#G:YN? M,<<+N@\5.Q-/*IOVY_+?^95^R>T_[YNC M^<'[!7= =&NR;)FHE94+QN:_,Y.HE/;G;CW2WSS1H*2)4XAI).IE%1"(;K$4 M630 .4JSA4^NIQS'F[Q]RO=6PCM-+AIC%:Q,;&YW.1P<''.11I-:96-P6?:] MU>U61D:KZ[J5Q7"6\GD?*UM!2-I9V0[,&K@,I.9SC7$ =Y[H/3E]V;']>VOU M]EK[1=Y_OS_D1?LUD_9;L+_M[/K)OVB>Z#TY?=FQ_7MK]?8^T7>?[\_Y$7[- M/LMV%_V]GUDW[1/=!ZZ#TY?=FQ_7MK]?8^T7>?[\_Y$7[-/LMV%_V]GUDW[1/=!ZSZR;]HGN@].7W9L?U[:_7V/M%WG^_/\ D1?LT^RW M87_;V?63?M$]T'IR^[-C^O;7Z^Q]HN\_WY_R(OV:?9;L+_M[/K)OVB>Z#TY? M=FQ_7MK]?8^T7>?[\_Y$7[-/LMV%_P!O9]9-^T3W0>G+[LV/Z]M?K['VB[S_ M 'Y_R(OV:?9;L+_M[/K)OVB>Z#TY?=FQ_7MK]?8^T7>?[\_Y$7[-/LMV%_V] MGUDW[16G/=%FU#YVFK6[-O/MDQ!L1):!VPWBO50@'CH%5C*2SR-:RJR:\NNB M=-%1<1U,BW2)IH0,SK;O,UF.,LU*QTK4YJFDMW;"21K2 .S:6E@# 07 4K5S ML:$ 8%UW6:(7TTB\UC3+4M =%9W3HXGNJ>NYKVRDO((:3FIE:T4&)/2!T04@ M"\H;U]5P% >8"AU&;B 4#?YVGI#37YW M3V0. ]=%!XAV%!Q/E4H]#U%[3;T]5G:(B(]1FX7;X1XO^W+GVI7G'V#MVM*? M\F>'1^LX>!6QW26E:MUO<^;_ *P?L%-[D%($ TWKZKM-=0_\1NX>FOC#_:'; ME!WH73<6Z#MP'_HS^T4CW3VU<=,>HSYZ_\ 6#]@I?A^C!_\:NJP!$!U MTZC-P@UU[=='_AR8[S;HM ?M_;GNV9/O]HHM[I;2.O9ZWN=H(H:7@%1T'Z#@ MHCT0TGAIO9U6ZE#0O_B-W#\D![0#_:' !RDG>;=N9E&W]N$5X>J4_P#&5='= M9%4$Z]NJH%!_K> Z/U'#P*F/1)2"F 3;W=513"8H (]1^X0&$QM0( :R&O,( M]F6_M-U&F7^W]NT_Z<_.4/LEL\V8:WNC-QKZX*__ "%,'1#2PXAO9U6 /R=1 MNX8=G9_Q#P8^TW4/_M_;O\O_ .92'=3:@%HUW=.4BA_UHQ'A^@Q3W(:7II[; M.JS3AP]XW#7'VFZA6O]O[=K_TY^+*#O-U%HH-O[= _Z<_.1 MW=1:N]/7-TGQWH_8*/N/T<0U-O5U6#J :B/49N&.H!V:_P"O]@:9>C[S[N-N M&@;<:3Q_TA]\]H*J#NZ>U=U3KFYRWH-X/V"B/1'21\D-[NJT1_G:>\?N'V"& MFNGI#PAPR)[S;H"D6W]MU)KA:9?=KG*F[NH@< )-=W26CA6]X>+Z#!2AT04H M.S>OJL#CKPZC=PPX\>/"0[>.6_M-U#_[?V[_ "Y^/&OTF->?2K9[J8:9?;NZ&G'J,W M#[ #0 XR'BR$O>;>/>)!M_;AEZ?5"#PIQSD\,%7[*H#3-KNZ<.'^MX>+Z!2A MT04H T#>OJK UT .HW<, #737_B'ATR'VG:B!0;?V[3_IS\Y0/=)8N!!UO< MY!X_ZP8^/Z#%1]R*D@ _]MG58 ".HA[Q^X0!KXQ_U_(_:5J1-?86@5/\.?GJ M [I(1Z.O;J'BO?\ Z"%Z)*.8?^^[JK$=/_[(;A&'3M\$AKIDH^\BZC/TFA[? M8.7^E)__ ) ICNEB;B[7=U$^&]X?_L)[D-*'LWLZK!#3E#_Q&[A_S1\'^\.P M0RA[S+ZA:W0-NF,G]VX^&F?SJ1[J+4O$CMPJ!B-W"#37P:^D.&HCE'=Y=^X .V]MT@<*VW_F4CW3VSAE.N;I M((/_ +WB#Q_X'E3W(J2&O_;;U5:AKK_XCMPN'9KK_M#Y0^?*CO,U!OH[?VZ/ M_P"N?G([NHMW@-=KFZ2T<*WM>GA]!X_?53W(:/IRCO7U6\?YP>\;N'H(CXP] M(<=+L**0_0_ M10Y>;>KJJ 1'E+S]1FX7$=!-REUD.(Z%UT^3#^\V]V]T=F#6@O!2O33L*>ZGN1TDH@/MNZJP$N@@/O';A )>.H" ^ MD>'$>&8Y[Q[]PH= T C_ *<_/5S[*(.6N;JQ-?\ G>8Y_J.(5_[5=-4!M=:U M+7%;D[ZVET>-=1)HO<+>*WWFO DY526%P2"G7*S%)\@*0%26('.4IA !T$&M/2L
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�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img002_v1.jpg GRAPHIC begin 644 img002_v1.jpg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end EX-101.SCH 10 ipar-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - The Company and its Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Impact of COVID-19 Pandemic link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Agreements link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Property, Equipment and Leasehold Improvements link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Loans Payable – Banks link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Segments and Geographic Areas link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Segments and Geographic Areas (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of lanvin brand name for our class (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Recent Agreements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Schedule of inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Inventories (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Derivative Financial Instruments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Accrued expenses consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Long-term debt consists of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Loans Payable – Banks (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Long-Term Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - Information on the Company’s operations by segments is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - Segments and Geographic Areas (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - The components of income before income taxes consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 ipar-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 ipar-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 13 ipar-20221231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Treasury Stock [Member] Noncontrolling Interest [Member] Concentration Risk Type [Axis] Product Sales Concentration Risk [Member] Concentration Risk Benchmark [Axis] Montblanc [Member] Concentration of Credit or Market Risk [Axis] Janvin [Member] Jimmy Choo [Member] Coach [Member] G U E S S [Member] Ownership [Axis] Interparfums SA Subsidiary [Member] Measurement Input Type [Axis] Measurement Input, Discount Rate [Member] Product and Service [Axis] Shipping and Handling [Member] Revenue Benchmark [Member] Customer Concentration Risk [Member] Servicing Assets and Servicing Liabilities Risk [Axis] Credit Risk [Member] Statistical Measurement [Axis] Minimum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Licensing Agreements [Member] Maximum [Member] Business Acquisition [Axis] Emanuel Ungar [Member] Legal Entity [Axis] Donna Karan and DKNY [Member] Rochas Fashion [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building [Member] Currency [Axis] Euro Member Countries, Euro Product [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Derivative Instrument [Axis] Foreign Exchange Contract [Member] Equipment [Member] Leasehold Improvements [Member] Asset Class [Axis] Indefinite-Lived Intangible Assets [Member] Finite-Lived Intangible Assets [Member] Other Intangible Assets [Member] Subtotal [Member] Trademarks [Member] Rochas Fashion Business [Member] Domestic Subsidiaries [Member] Variable Rate [Axis] London Interbank Offered Rate [Member] Foreign Subsidiaries [Member] Euro Interbank Offered Rate [Member] Long-Term Debt, Type [Axis] Loans Payable [Member] Loans Payable One [Member] Loans Payable Two [Member] Loans Payable Three [Member] Operating Lease [Member] Equity Option [Member] Debt Instrument [Axis] Stock Option One [Member] Consolidated Entities [Axis] Title of Individual [Axis] Employees [Member] interparfums S A [Member] Board of Directors Chairman [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Income Statement Location [Axis] Operating Income (Loss) [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Geographical [Axis] UNITED STATES Europe [Member] Eliminations [Member] North America [Member] Asia [Member] Middle East [Member] Central and South America [Member] Other Segment Country [Member] Segments [Axis] United States [Member] France [Member] Russia [Member] United Kingdom [Member] Related Party [Axis] Foreign Derived Intangible Income [Member] Accumulated Defined Benefit Plans Net Derivative Instruments [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Allowance, Credit Loss [Member] Sales Returns and Allowances [Member] SEC Schedule, 12-09, Reserve, Inventory [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Inventories Receivables, other Other current assets Income taxes receivable Total current assets Property, equipment and leasehold improvements, net Right-of-use assets, net Trademarks, licenses and other intangible assets, net Deferred tax assets Other assets Total assets Liabilities and Equity Current liabilities: Current portion of long-term debt Current portion of lease liabilities Accounts payable - trade Accrued expenses Income taxes payable Total current liabilities Long–term debt, less current portion Lease liabilities, less current portion Equity: Inter Parfums, Inc. shareholders’ equity: Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively Additional paid-in capital Retained earnings Accumulated other comprehensive loss Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021 Total Inter Parfums, Inc. shareholders’ equity Noncontrolling interest Total equity Total liabilities and equity Preferred Stock, Par or Stated Value Per Share Preferred stock, authorized Preferred stock, issued Common Stock, Par or Stated Value Per Share Common stock, authorized Common stock, outstanding Treasury Stock, Shares Income Statement [Abstract] Net sales Cost of sales Gross margin Selling, general, and administrative expenses Impairment loss Income from operations Other expenses (income): Interest expense Loss (gain) on foreign currency Interest and investment income Other loss (income)   Nonoperating Income (Expense) Income before income taxes Income taxes Net income Less: Net income attributable to the noncontrolling interest Net income attributable to Inter Parfums, Inc. Net income attributable to Inter Parfums, Inc. common shareholders: Basic Diluted Weighted average number of shares outstanding: Basic Diluted Dividends declared per share Net income Other comprehensive income: Net derivative instrument income (loss),  net of tax Transfer of OCI into earnings Translation adjustments, net of tax  Other comprehensive income (loss), before tax Comprehensive income Comprehensive income attributable to noncontrolling interests: Net income Net derivative instrument income (loss),  net of tax Translation adjustments, net of tax Comprehensive income (loss), net of tax, atributable to noncontrolling interest Comprehensive income attributable to Inter Parfums Inc. Statement [Table] Statement [Line Items] Beginning Balance Shares issued upon exercise of stock options Share-based compensation Purchase of subsidiary shares from noncontrolling interests Shares issued for license acquisition Transfer of subsidiary shares purchased Dividends Foreign currency translation adjustment, net of tax Transfer from other comprehensive income into earnings Transfer from other comprehensive income into earnings Net derivative instrument loss, net of tax Ending Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization including impairment loss Provision for doubtful accounts Noncash stock compensation Share of income of equity investment Lease expense Deferred tax expense (benefit) Change in fair value of derivatives Changes in: Accounts receivable Inventories Other assets Operating lease liabilities Accounts payable and accrued expenses Income taxes, net Net cash provided by operating activities Cash flows from investing activities: Purchases of short-term investments Proceeds from sale of short-term investments Purchase of property, equipment and leasehold improvements Payment for intangible assets acquired Purchase of equity investment Net cash used in investing activities Cash flows from financing activities: Repayment of long-term debt Proceeds from issuance of long-term debt Proceeds from exercise of options Dividends paid Dividends paid to noncontrolling interests Purchase of subsidiary shares from noncontrolling interests Net cash provided by (used in) financing activities Effect of exchange rate changes on cash Net increase (decrease) in cash and cash equivalents Cash and cash equivalents – beginning of year Cash and cash equivalents – end of year Supplemental disclosures of cash flow information: Cash paid for: Interest Income taxes Accounting Policies [Abstract] The Company and its Significant Accounting Policies Impact Of Covid-19 Pandemic Impact of COVID-19 Pandemic Business Combination and Asset Acquisition [Abstract] Recent Agreements Inventory Disclosure [Abstract] Inventories Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Financial Instruments Property, Plant and Equipment [Abstract] Property, Equipment and Leasehold Improvements Goodwill and Intangible Assets Disclosure [Abstract] Trademarks, Licenses and Other Intangible Assets Payables and Accruals [Abstract] Accrued Expenses Debt Disclosure [Abstract] Loans Payable – Banks Long-Term Debt Commitments and Contingencies Disclosure [Abstract] Commitments Equity [Abstract] Equity Earnings Per Share [Abstract] Net Income Attributable to Inter Parfums, Inc. Common Shareholders Segment Reporting [Abstract] Segments and Geographic Areas Income Tax Disclosure [Abstract] Income Taxes Accumulated Other Comprehensive Loss Noncontrolling Interest [Abstract] Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Schedule II - Valuation and Qualifying Accounts Business of the Company Basis of Preparation Management Estimates Foreign Currency Translation Cash and Cash Equivalents and Short-Term Investments Accounts Receivable Inventories Derivatives Property, Equipment and Leasehold Improvements Long-Lived Assets Revenue Recognition Sales Returns Payments to Customers Advertising and Promotion Package Development Costs Operating Leases License Agreements Income Taxes Issuance of Common Stock by Consolidated Subsidiary Treasury Stock Schedule of lanvin brand name for our class Schedule of inventories Schedule of fair value, assets measured on recurring basis Schedule of equipment and leasehold improvements Schedule of trademarks, licenses and other intangible assets Accrued expenses consist of the following: Long-term debt consists of the following: Maturities of lease liabilities subsequent to December 31, 2022 are as follows: minimum annual royalties and other commitments as follows: The following table sets forth information with respect to nonvested options for 2022: The effect of share-based payment expenses decreased income statement line items as follows: The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: The assumptions used in the Black-Scholes pricing model are set forth in the following table: Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: The following table summarizes additional stock option information as of December 31, 2022: The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: Information on the Company’s operations by segments is as follows: Consolidated net sales to customers by region are as follows: Consolidated net sales to customers in major countries are as follows: The components of income before income taxes consist of the following: The provision for current and deferred income tax expense (benefit) consists of the following: The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: The components of accumulated other comprehensive loss consist of the following: Schedule of net income attributable to transfers from the noncontrolling interest The following table summarizes cash and cash equivalents as of December 31, 2021: Schedule of Valuation and Qualifying Accounts Schedule of Product Information [Table] Product Information [Line Items] Concentration risk percentage Ownership percentage in Interparfums SA Allowances for sales returns and doubtful accounts Weighted average cost of capital Shipping and handling costs Contract with customer, refund liability Contract with customer, right to recover products Advertising costs Customer incentives cost License agreement term License agreement renewal term Royalty expense, percentage of net sales Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Description of recent agreement Shares issue Shares value Impairment Charge on Reclassified Assets Ownership percentage Purchase price, period cost Acquisition costs, period cost Depreciated over a range Cash held in escrow is included in other assets Long-term debt, term Long-term line of credit Description of debt instrument interest rate terms Debt instrument, face amount Raw materials and component parts Finished goods Cost of Goods Sold, Overhead Inventory Valuation Reserves Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Short-term investments Interest rate swaps Foreign currency forward exchange contracts accounted for using hedge accounting  Total Assets Liabilities: Foreign currency forward exchange contracts not accounted for using hedge accounting Total liabilities Foreign currency forward exchange contracts not accounted for using hedge accounting Interest rate swaps Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Loan amount Foreign currency contracts, liability, fair value disclosure Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Equipment and leasehold improvements Less accumulated depreciation and amortization Property, Plant and Equipment, Net, Total Depreciation and amortization expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross Amount Accumulated Amortization Net Book Value Amortization of Intangible Assets 2023 2024 2025 2026 2027 Amortization period Impairment charge Indefinite-Lived License Agreements Advertising liabilities Salary (including bonus and related taxes) Royalties Due vendors (not yet invoiced) Retirement reserves Refund (return) liability Other Total Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Debt Instrument, Face Amount Number of installments Installment amount (in Dollars) Interest per annum Loan payable Less current maturities Total Line of credit, maximum borrowing amount Basis spread over variable interest rate Variable rate Line of Credit Facility, Expiration Date Long term debt maturity, description Long-term Debt, Maturities, 2021 2023 2024 2025 2026 2027 Thereafter Gross Total Less imputed interest (based on 2.6% weighted-average discount rate) Net Total License agreement, expiration description 2023 2024 2025 2026 2027 Thereafter Total Weighted average remaining lease term Operating lease, weighted average discount rate Operating lease of related to rental expenses Operating lease payments Noncash additions to operating lease assets Royalty expense Nonvested options - beginning of year Weighted Average Grant Date Fair Value, beginning of year Nonvested options granted Weighted Average Grant Date Fair Value, granted Nonvested options vested or forfeited Weighted Average Grant Date Fair Value, vested or forfeited Nonvested options - end of year Weighted Average Grant Date Fair Value, end of year Net income attributable to Inter Parfums, Inc. Diluted earnings per share attributable to Inter Parfums, Inc Options shares under option - beginning of year Weighted average exercise price shares under option - beginning of year Options granted Weighted average exercise price options granted Options exercised Weighted average exercise price options exercised Options forfeited Weighted average exercise price options forfeited Options shares under option - end of year Weighted average exercise price shares under option - end of year Weighted-average expected stock-price volatility Weighted-average expected option life Weighted-average risk-free interest rate Weighted-average dividend yield Proceeds from stock options exercised Tax benefits Intrinsic value of stock options exercised Exercise price range (in dollars per share) Options outstanding Options outstanding weighted average remaining contractual life Options exercisable Schedule of Subsidiary or Equity Method Investee [Table] Subsidiary or Equity Method Investee [Line Items] Share-based compensation arrangement by share-based payment award, award vesting period Fair value of shares vested Number of shares available for grant (in shares) Aggregate intrinsic value of options outstanding Term Weighted average grant date fair value (in dollars per share) Weighted average exercise price of options exercisable Weighted average remaining contractual life of options exercisable Aggregate intrinsic value of options exercisable Adjusted for stock splits (in shares) Shares adjusted for stock splits Recognized as compensation cost Straight line basis over the requisite Number of share distributed Aggregate cost Percentage of increase in annual dividend Dividends payable, amount per share (in Dollars per share) Numerator for diluted earnings per share (in dollars) Weighted average shares Stock options Denominator for diluted earnings per share Basic (in dollars per share) Diluted (in dollars per share) Antidilutive securities excluded from computation of earnings per share, amount Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Revenue from Contract with Customer, Including Assessed Tax Net Income (Loss) Attributable to Parent Depreciation, Depletion and Amortization, Nonproduction Investment Income, Interest and Dividend Investment Income, Interest and Dividend Interest expense Income Tax Expense (Benefit) Assets Assets Additions to Other Assets, Amount Long-Lived Assets Deferred Income Tax Assets, Net Net sales Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Revenue from export sales U.S. operations Foreign operations Federal State and local Foreign Current income tax expense Federal State and local Foreign Deferred income tax expense Total income tax expense Net deferred tax assets: Foreign net operating loss carry-forwards Inventory and accounts receivable Profit sharing Stock option compensation Effect of inventory profit elimination Other Total gross deferred tax assets, net Valuation allowance Net deferred tax assets Deferred tax liabilities (long-term): Building expenses Trademarks and licenses Unrealized gain on marketable equity securities Other Total deferred tax liabilities Net deferred tax assets Statutory rates State and local taxes, net of Federal benefit Windfall benefit from exercise of stock options Benefit of Foreign Derived Intangible Income Effect of foreign taxes greater than U.S. statutory rates Other Effective rates Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Deferred Foreign Income Tax Expense (Benefit) Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Net derivative instruments, beginning of year Net derivative instrument gain (loss), net of tax Net derivative instruments, end of year Cumulative translation adjustments, beginning of year Translation adjustments Cumulative translation adjustments, end of year Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021 Cash and cash equivalents per balance sheet Cash held in escrow included in other assets (see note 3) Cash and cash equivalents per statement of cash flows SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Balance at beginning of period Charged to costs and expenses Charged to other accounts describe Deductions describe Balance at end of period The element represents salvatore ferragamo member. The element represents inventory member. The element represents other asset member. The element represents emanuel ungar member. The element represents donna karan and dkny member. The element represents interparfums sa subsidiary member. The element represents employees member. The element represents officers and managers member. The element represents transfer of subsidiary shares purchased to treasury shares. The element represents interparfums s a member. The element represents salvatore ferragamo s a member. The element represents net income loss attributable to noncontrolling interest1. The element represents other comprehensive income derivatives qualifying as hedges tax portion attributable to noncontrolling interest1. The element represents other comprehensive income derivatives qualifying as hedges net of tax portion attributable to noncontrolling interest1. The element represents operating leases rent expense net1. The element represents investment income interest and dividend1. The element represents other comprehensive income loss reclassification adjustment from a o c i on derivatives net of tax1. The element represents reconciliation of cash and cash equivalents to the statement of cash flows text block. The element represents montblanc member. The element represents jimmy choo member. The element represents coach member. The element represents g u e s s member. Cash held in escrow included in other assets. Cash and cash equivalents per statement of cash flows. The element represents royalty expense net sales percentage. The element represents impact of c o v i d19 pandemic text block. The element represents accumulated defined benefit plans net derivative instruments member. The element represents discription of recent agreement. This member stans for anna SuiCorp. This member stans for rochas fashion. Cash held in escrow. The element represents s t dupont member. This member stans for global settlement agreement. The element represents deferred tax assets inventory and accounts receivable. The element represents due vendors not yet invoiced. The element represents foreign derived intangible income member. The element represents domestic subsidiaries member. The element represents london interbank offered rate member. The element represents foreign subsidiaries member. The element represents euro interbank offered rate member. This member stans for eliminations. The element represents loans payable one member. The element represents loans payable two member. The element represents loans payable three member. The element represents number of installment. The element represents central and south america member. The element represents other segment country member. The element represents united states member. The element represents france member. The element represents russia member. The element represents united kingdom member. The element represents exercise price range one member. The element represents exercise price range five member. The element represents exercise price range four member. The element represents exercise price range three member. The element represents operating leases future minimum payments due in six years. The element represents covid19 description. The element represents revaluation resulted in reduction of cost description. The element represents percentage of increase in annual dividend. The element represents stock option one member. The element represents unrealized gain on marketable equity securities. The element represents building expenses. The element represents subtotal member. The element represents e u r member. The element represents u s d member. The element represents schedule of inventory current table text block1. The element represents effective income tax rate reconciliation at federal statutory income tax rate1. The element represents finite lived intangible assets amortization expense after two years. The element represents deferred tax liabilities building expenses. The element represents deferred tax liabilities unrealized gain on marketable equity securities. The element represents less imputed interest based on2.6 weightedaverage discount rate. The element represents lessee operating lease liability payments due net total. The element represents product sales concentration risk member. The element represents janvin member. The element represents operating lease of related to rental expenses. The element represents net derivative instrument loss net of tax. The element represents schedule of maturities of lease liabilities subsequent table text block. The element represents other comprehensive income foreign currency transaction and translation adjustment net of taxs portion attributable to noncontrolling interest. The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and taxs. The element represents exercise price range two member. The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and tax abstract one. The element represents other comprehensive income loss derivative excluded component increase decrease after adjustments and tax. The element represents reclassification from aoci current period net of tax attributable to parent1. The element represents other comprehensive income loss foreign currency transaction and translation adjustment net of tax1. The element represents other comprehensive income loss before tax1. The element represents other comprehensive income loss net of tax portion attributable to noncontrolling interest1. The element represents comprehensive income net of tax attributable to noncontrolling interest1. The element represents comprehensive income net of tax1. The element represents other comprehensive income loss net of tax period increase decrease1 abstract. The element represents deferred income tax expense benefit1. The element represents income loss from equity method investments1. The element represents increase decrease in accounts payable and accrued liabilities1. The element represents increase decrease in accounts receivable1. The element represents increase decrease in accrued taxes payable1. The element represents increase decrease in inventories1. The element represents increase decrease in operating lease liability1. The element represents schedule of valuation and qualifying accounts table text block. The element represents provision for doubtful accounts1. The element represents change in fair value of derivatives. The element represents operating lease member. The element represents rochas fashion business member. The element represents us export member. The element represents accumulated other comprehensive income loss net of tax. The element represents accumulated other comprehensive income loss net of tax. Assets, Current Assets [Default Label] Liabilities, Current Treasury Stock, Value Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity [Default Label] Gross Profit Operating Income (Loss) Foreign Currency Transaction Gain (Loss), before Tax Other Income Nonoperating Income (Expense) Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Other Comprehensive Income (Loss), before Tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Noncontrolling Interest, Increase from Subsidiary Equity Issuance Dividends, Cash Income (Loss) from Equity Method Investments Change in Fair Value of Derivatives Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Payments to Acquire Equity Method Investments Net Cash Provided by (Used in) Investing Activities Repayments of Long-Term Debt Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Noncontrolling Interest Payments to Noncontrolling Interests Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Income Taxes Paid Inventory Disclosure [Text Block] Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Investments, Fair Value Disclosure Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value Interest Rate Derivative Liabilities, at Fair Value Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Less Imputed Interest Based on2.6 Weighted Average Discount Rate Other Commitment, to be Paid, Year One Other Commitment, to be Paid, Year Two Other Commitment, to be Paid, Year Three Other Commitment, to be Paid, Year Four Other Commitment, to be Paid, Year Five Other Commitment, to be Paid, after Year Five Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Long-Lived Assets [Default Label] Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Tax Assets, Other Deferred Tax Assets, Valuation Allowance Deferred Tax Liabilities, Other Finite-Lived Assets Deferred Tax Liabilities, Other Deferred Tax Liabilities, Gross Deferred Tax Assets, Net Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated Other Comprehensive Income Loss Net Of Tax [Default Label] SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount EX-101.PRE 14 ipar-20221231_pre.xml XBRL PRESENTATION FILE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Feb. 28, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 0-16469    
Entity Registrant Name Inter Parfums, Inc.    
Entity Central Index Key 0000822663    
Entity Tax Identification Number 13-3275609    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 551 Fifth Avenue    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10176    
City Area Code 212    
Local Phone Number 983.2640    
Title of 12(b) Security Common Stock, $.001 par value per share    
Trading symbol IPAR    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 1,274,342,976
Entity Common Stock, Shares Outstanding   32,109,360  
ICFR Auditor Attestation Flag true    
Auditor Firm ID 339    
Auditor Name Mazars USA LLP    
Auditor Location New York, New York    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 104,713 $ 159,613
Short-term investments 150,833 160,014
Accounts receivable, net 197,584 159,281
Inventories 289,984 198,914
Receivables, other 28,803 10,308
Other current assets 15,650 21,375
Income taxes receivable 157 210
Total current assets 787,724 709,715
Property, equipment and leasehold improvements, net 166,722 149,352
Right-of-use assets, net 27,964 33,728
Trademarks, licenses and other intangible assets, net 290,853 214,047
Deferred tax assets 11,159 7,936
Other assets 24,120 30,586
Total assets 1,308,542 1,145,364
Current liabilities:    
Current portion of long-term debt 28,547 15,911
Current portion of lease liabilities 5,296 6,014
Accounts payable - trade 88,388 81,980
Accrued expenses 213,621 136,677
Income taxes payable 8,715 4,328
Total current liabilities 344,567 244,910
Long–term debt, less current portion 151,494 132,902
Lease liabilities, less current portion 24,335 29,220
Inter Parfums, Inc. shareholders’ equity:    
Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued
Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively 32 32
Additional paid-in capital 90,186 87,132
Retained earnings 620,095 560,663
Accumulated other comprehensive loss (56,056) (38,432)
Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021 (37,475) (37,475)
Total Inter Parfums, Inc. shareholders’ equity 616,782 571,920
Noncontrolling interest 171,364 166,412
Total equity 788,146 738,332
Total liabilities and equity $ 1,308,542 $ 1,145,364
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred stock, authorized 1,000,000 1,000,000
Preferred stock, issued 0 0
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common stock, authorized 100,000,000 100,000,000
Common stock, outstanding 31,967,300 31,830,420
Treasury Stock, Shares 9,864,805 9,864,805
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 1,086,653 $ 879,516 $ 539,009
Cost of sales 392,231 322,614 208,278
Gross margin 694,422 556,902 330,731
Selling, general, and administrative expenses 492,370 406,459 260,648
Impairment loss 7,749 2,393
Income from operations 194,303 148,050 70,083
Other expenses (income):      
Interest expense 3,599 2,825 1,970
Loss (gain) on foreign currency 1,921 (2,338) 2,178
Interest and investment income (5,486) (3,403) (2,865)
Other loss (income) 49 (53) (549)
  Nonoperating Income (Expense) 83 (2,969) 734
Income before income taxes 194,219 151,019 69,349
Income taxes 43,182 40,992 19,381
Net income 151,037 110,027 49,968
Less: Net income attributable to the noncontrolling interest 30,099 22,616 11,749
Net income attributable to Inter Parfums, Inc. $ 120,938 $ 87,411 $ 38,219
Net income attributable to Inter Parfums, Inc. common shareholders:      
Basic $ 3.80 $ 2.76 $ 1.21
Diluted $ 3.78 $ 2.75 $ 1.21
Weighted average number of shares outstanding:      
Basic 31,859,417 31,676,796 31,536,659
Diluted 31,988,753 31,835,408 31,654,544
Dividends declared per share $ 2.00 $ 1.00 $ 0.33
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net income $ 151,037 $ 110,027 $ 49,968
Other comprehensive income:      
Net derivative instrument income (loss),  net of tax 2,356 (1,367) (19)
Transfer of OCI into earnings 992 (52)
Translation adjustments, net of tax  (29,683) (42,967) 47,912
Other comprehensive income (loss), before tax (26,335) (44,334) 47,841
Comprehensive income 124,702 65,693 97,809
Comprehensive income attributable to noncontrolling interests:      
Net income 30,099 22,616 11,749
Net derivative instrument income (loss),  net of tax 647 (375) (19)
Translation adjustments, net of tax (9,358) (11,524) 14,004
Comprehensive income (loss), net of tax, atributable to noncontrolling interest 21,388 10,717 25,734
Comprehensive income attributable to Inter Parfums Inc. $ 103,314 $ 54,976 $ 72,075
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholder's Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Total
Beginning Balance at Dec. 31, 2019 $ 31 $ 70,664 $ 474,637 $ (39,853) $ (37,475) $ 140,994 $ 608,998
Shares issued upon exercise of stock options 1 2,771          
Share-based compensation   1,711 1,117     350  
Purchase of subsidiary shares from noncontrolling interests   0          
Shares issued for license acquisition            
Transfer of subsidiary shares purchased   562       (139)  
Net income     38,219   11,749 49,968
Dividends     (10,406)     (324)  
Foreign currency translation adjustment, net of tax       33,908   14,004  
Transfer from other comprehensive income into earnings       52      
Transfer from other comprehensive income into earnings       (52)      
Net derivative instrument loss, net of tax         (19)  
Ending Balance at Dec. 31, 2020 32 75,708 503,567 (5,997) (37,475) 166,615 702,450
Shares issued upon exercise of stock options 0 5,393          
Share-based compensation   1,566 1,375     (293)  
Purchase of subsidiary shares from noncontrolling interests   0          
Shares issued for license acquisition   5,000          
Transfer of subsidiary shares purchased   (535)       (791)  
Net income     87,411   22,616 110,027
Dividends     (31,690)     (9,836)  
Foreign currency translation adjustment, net of tax       (31,443)   (11,524)  
Transfer from other comprehensive income into earnings            
Transfer from other comprehensive income into earnings            
Net derivative instrument loss, net of tax       (992)   (375)  
Ending Balance at Dec. 31, 2021 32 87,132 560,663 (38,432) (37,475) 166,412 738,332
Shares issued upon exercise of stock options 6,004          
Share-based compensation   1,355 2,237     (282)  
Purchase of subsidiary shares from noncontrolling interests   0          
Shares issued for license acquisition            
Transfer of subsidiary shares purchased   (4,305)       (98)  
Net income     120,938   30,099 151,037
Dividends     (63,743)     (16,056)  
Foreign currency translation adjustment, net of tax       (20,325)   (9,358)  
Transfer from other comprehensive income into earnings       992      
Transfer from other comprehensive income into earnings       (992)      
Net derivative instrument loss, net of tax       1,709   647  
Ending Balance at Dec. 31, 2022 $ 32 $ 90,186 $ 620,095 $ (56,056) $ (37,475) $ 171,364 $ 788,146
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 151,037 $ 110,027 $ 49,968
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization including impairment loss 22,539 12,698 9,067
Provision for doubtful accounts 2,353 853 4,824
Noncash stock compensation 3,143 2,853 3,029
Share of income of equity investment 49 (53) (549)
Lease expense 4,980 7,302 5,483
Deferred tax expense (benefit) (3,604) (465) 581
Change in fair value of derivatives 227 65 (137)
Changes in:      
Accounts receivable (59,640) (45,395) 13,157
Inventories (98,297) (49,815) 19,333
Other assets (13,651) (16,725) 1,176
Operating lease liabilities (4,795) (7,503) (5,421)
Accounts payable and accrued expenses 106,857 103,046 (32,239)
Income taxes, net 3,952 2,698 (3,279)
Net cash provided by operating activities 115,150 119,586 64,993
Cash flows from investing activities:      
Purchases of short-term investments (1,038) (55,691) (7,582)
Proceeds from sale of short-term investments 896 10,644 11,513
Purchase of property, equipment and leasehold improvements (33,756) (141,274) (11,011)
Payment for intangible assets acquired (98,865) (1,545) (1,251)
Purchase of equity investment (13,998)
Net cash used in investing activities (132,763) (187,866) (22,329)
Cash flows from financing activities:      
Repayment of long-term debt (19,861) (43,056) (13,725)
Proceeds from issuance of long-term debt 52,492 157,382 13,438
Proceeds from exercise of options 6,003 5,393 2,771
Dividends paid (63,743) (31,690) (20,805)
Dividends paid to noncontrolling interests (16,056) (9,836) (324)
Purchase of subsidiary shares from noncontrolling interests (4,403)
Net cash provided by (used in) financing activities (45,568) 78,193 (18,645)
Effect of exchange rate changes on cash (493) (11,207) 12,245
Net increase (decrease) in cash and cash equivalents (63,674) (1,294) 36,264
Cash and cash equivalents – beginning of year 168,387 169,681 133,417
Cash and cash equivalents – end of year 104,713 168,387 169,681
Cash paid for:      
Interest 2,987 2,468 1,105
Income taxes $ 38,492 $ 40,497 $ 21,772
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
The Company and its Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
The Company and its Significant Accounting Policies

 

(1)The Company and its Significant Accounting Policies

 

Business of the Company

 

Inter Parfums, Inc. and its subsidiaries (the “Company”) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance related products.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%

 

No other brand represented 10% or more of consolidated net sales.

 

Basis of Preparation

 

The consolidated financial statements include the accounts of the Company and its subsidiaries, including 72% owned Interparfums SA, a subsidiary whose stock is publicly traded in France. All material intercompany balances and transactions have been eliminated.

 

Management Estimates

 

Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.

 

Foreign Currency Translation

 

For foreign subsidiaries with operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation adjustments are accumulated in a separate component of shareholders’ equity.

 

Cash and Cash Equivalents and Short-Term Investments

 

All highly liquid investments purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions outside the United States and are readily convertible into U.S. dollars.

 

Accounts Receivable

 

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which are estimated to be uncollectible, which aggregated $4.7 million and $2.2 million as of December 31, 2022, and 2021, respectively. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns.

 

Inventories

 

Inventories, including promotional merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company’s customers.

 

Derivatives

 

All derivative instruments are recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For cash flow hedges, the effective portion of the derivative’s gain or loss is initially reported in equity (as a component of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.

 

Property, Equipment and Leasehold Improvements

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools and molds, is included in cost of sales.

 

Long-Lived Assets

 

Indefinite-lived intangible assets principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.8% and 7.47% in 2022 and 2021, respectively. The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

 

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.

 

Revenue Recognition

 

The Company sells its products to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers’ freight and handling charges. All shipping and handling costs, which aggregated $15.8 million, $10.0 million and $5.0 million in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. No one customer represented 10% or more of net sales in 2022, 2021 or 2020.

 

Sales Returns

 

Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $8.6 million and $5.1 million at December 31, 2022 and 2021, respectively, and the amounts recognized for the rights to recover products was $3.2 million and $1.9 million at December 31, 2022 and 2021, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

 

Payments to Customers

 

The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.

 

Advertising and Promotion

 

Advertising and promotional costs are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $212.4 million, $171.1 million and $91.7 million for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase and gift with purchase promotions that are reflected in cost of sales aggregated $43.1 million, $36.9 million and $26.4 million in 2022, 2021 and 2020, respectively.

 

Package Development Costs

 

Package development costs associated with new products and redesigns of existing product packaging are expensed as incurred.

 

Operating Leases

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

License Agreements

 

The Company’s license agreements generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of approximately 5 to 15 years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, excluding potential renewal periods, range from approximately 1 to 12 years. Under each license, the Company is required to pay royalties in the range of 6% to 10% to the licensor, at least annually, based on net sales to third parties.

 

In certain cases, the Company may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.

 

Most license agreements require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.

 

In addition, the Company is exposed to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.

 

Income Taxes

 

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.

 

Issuance of Common Stock by Consolidated Subsidiary

 

The difference between the Company’s share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company’s investment deemed sold, is reflected as an equity adjustment in the consolidated balance sheets.

 

Treasury Stock

 

The Board of Directors may authorize share repurchases of the Company’s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any time without notice.

 
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Impact of COVID-19 Pandemic
 12 Months Ended
Dec. 31, 2022
Impact Of Covid-19 Pandemic  
Impact of COVID-19 Pandemic

 

(2)Impact of COVID-19 Pandemic

 

A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain classes of workers from reporting to work.

 

Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.

 

Business significantly improved in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Recent Agreements
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Recent Agreements

 

(3)Recent Agreements

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

Salvatore Ferragamo

 

In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.

 

With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition.

 

Emanuel Ungaro

 

In October 2021, we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Future Headquarters in Paris

 

In April 2021, Interparfums SA, our 73% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price includes the complete renovation of the site. As of December 31, 2022, $148.1 million of the purchase price, including approximately $4.4 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022. The purchase price has been allocated approximately $61.1 million to land and $87.0 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $3.4 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022.

 

The acquisition was financed by a 10-year €120 million (approximately $128.0 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories

 

(4)Inventories

               
   December 31, 
   2022   2021 
Raw materials and component parts  $146,772   $111,312 
Finished goods   143,212    87,602 
Inventories  $289,984   $198,914 

 

Overhead included in inventory aggregated $3.4 million and $3.7 million as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated events may be established. Inventory reserves aggregated $11.4 million and $15.8 million as of December 31, 2022 and 2021, respectively.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

 

(5)Fair Value of Financial Instruments

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

                               
   Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
 Total Assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
Total liabilities  $68   $—   $68   $— 

 

                               
   Fair Value Measurements at December 31, 2021 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $160,014   $—   $160,014   $— 
                     
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $1,982   $—   $1,982   $— 
Foreign currency forward exchange contracts not accounted for using hedge accounting   63    —    63   $— 
Interest rate swaps   (234)   —    (234)   — 
Total liabilities  $1,811   $—   $1,811   $— 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the variable interest rates on the Company’s indebtedness approximate current market rates.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Financial Instruments
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

 

(6)Derivative Financial Instruments

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.

 

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $6.3 million and $0.2 million in 2022 and 2021, respectively, resulting from an interest rate swap.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying balance sheets.

 

At December 31, 2022, the Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $36.5 million, which all have maturities of less than one year.
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Equipment and Leasehold Improvements
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property, Equipment and Leasehold Improvements

 

(7)Property, Equipment and Leasehold Improvements

   December 31, 
   2022   2021 
Land and Building (construction in progress)  $148,137   $136,131 
Equipment   59,689    52,036 
Leasehold improvements   2,293    2,082 
    210,119    190,249 
Less accumulated depreciation and amortization   43,397    40,897 
   $166,722   $149,352 

 

Depreciation and amortization expense was $7.5 million, $4.4 million and $3.8 million in 2022, 2021, and 2020, respectively.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Trademarks, Licenses and Other Intangible Assets
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Trademarks, Licenses and Other Intangible Assets

 

(8)Trademarks, Licenses and Other Intangible Assets

2022  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $105,022   $—   $105,022 
Trademarks (finite lives)   41,267    64    41,203 
Licenses (finite lives)   205,235    63,535    141,700 
Other intangible assets (finite lives)   17,849    14,921    2,928 
Subtotal   264,351    78,520    185,831 
Total  $369,373   $78,520   $290,853 

 

2021  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $119,712   $—   $119,712 
Trademarks (finite lives)   43,820    68    43,752 
Licenses (finite lives)   109,682    62,286    47,396 
Other intangible assets (finite lives)   17,775    14,588    3,187 
Subtotal   171,277    76,942    94,335 
Total  $290,989   $76,942   $214,047 

 

Amortization expense was $6.8 million, $5.9 million and $5.3 million in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate $7.0 million in 2023, $13.3 million in 2024, $12.3 million in 2025, $10.5 million in 2026 and 2027. The weighted average amortization period for trademarks, licenses and other intangible assets with finite lives are 18 years, 14 years and 2 years, respectively, and 14 years on average.

 

The Company reviews intangible assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $6.8 million and $2.4 million in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite useful lives of $0.9 million in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.80%, 7.47%, and 6.99% as of December 31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the amount of which could be material to our results of operations.

 

The cost of trademarks, licenses and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license or the intangible assets estimated useful life which range from three to twenty years. If the residual value of a finite life intangible asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Trademarks (finite lives) primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the brand names and trademarks on July 1, 2027 for €70 million (approximately $7 5 million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being amortized.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accrued Expenses

 

(9)Accrued Expenses

 

Accrued expenses consist of the following:

 

             
   December 31, 
   2022   2021 
Advertising liabilities  $42,338   $31,215 
Salary (including bonus and related taxes)   21,128    19,993 
Royalties   26,532    19,154 
Due vendors (not yet invoiced)   105,869    45,707 
Retirement reserves   8,001    10,234 
Refund (return) liability   8,604    5,128 
Other   1,149    5,246 
Total  $213,621   $136,677 

 
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Loans Payable – Banks
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Loans Payable – Banks

 

(10)Loans Payable – Banks

 

Loans payable – banks consist of the following:

 

The Company and its domestic subsidiaries have available a $20 million unsecured revolving line of credit due on demand, which bears interest at the daily Secured Overnight Financing Rate (“SOFR”) plus 2% (the SOFR was 4.3% as of December 31, 2022). The line of credit which has a maturity date of December 15, 2023, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of credit were zero as of December 31, 2022 and 2021.

 

The Company’s foreign subsidiaries have available credit lines, including several bank overdraft facilities totaling approximately $20 million. These credit lines bear interest at EURIBOR plus between 0.6% and 0.9% (EURIBOR was minus 0.576% at December 31, 2022). Borrowings outstanding pursuant to these bank overdraft facilities were zero as of December 31, 2022 and 2021.

 

As there were no borrowings outstanding as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and 2021.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Long-Term Debt
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Long-Term Debt

 

(11)Long-Term Debt

 

Long-term debt consists of the following:

 

   December 31, 
   2022   2021 
$53.3 million payable in 48 equal monthly installments of $1.1 million beginning in December 2022, bearing interest at one-month Euribor plus 0.825%  $52,061   $— 
$135.9 million payable in 120 equal monthly installments of $1.1 million beginning in April 2021, bearing interest at one-month Euribor plus 0.75%   104,758    124,375 
$15.0 million payable in 14 equal annual installments of $1.1 million beginning in January 2020 including interest imputed at 4.1% per annum   9,890    10,569 
$17 million payable in 10 equal annual installments of $1.7 million beginning in October 2021 including interest imputed at 2.0% per annum   13,332    13,859 
    180,041    148,803 
Less current maturities   28,547    15,911 
Total  $151,494   $132,892 

 

In December 2022, to finance Interparfums SA’s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (€50 million) four-year loan agreement. The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In April 2021, to finance the acquisition of Interparfums SA’s future corporate headquarters, the Company entered into a $128.0 million (€120 million) ten-year credit agreement. Approximately $85.3 million (€80.0 million) of the variable rate debt was swapped for variable interest rate debt with maximum rate of 2% per annum. The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Maturities of long-term debt subsequent to December 31, 2022 are approximately $30.4 million in 2023 and $28.7 million per year thereafter through 2033.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments

 

(12)Commitments

 

Leases

 

The Company leases its offices, warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of December 31, 2022, the weighted average remaining lease term was 5.8 years and the weighted average discount rate used to determine the operating lease liability was 2.6%. Rental expense related to operating leases was $5.6 million, $8.2 million, and $6.2 million for the years ended December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $4.9 million and noncash additions to operating lease assets totaled $0.3 million.

 

Maturities of lease liabilities subsequent to December 31, 2022 are as follows:

 

(In thousands)

 

2023   $5,723 
2024    5,971 
2025    4,847 
2026    4,049 
2027    4,060 
Thereafter    6,913 
     31,563 
Less imputed interest (based on 2.6% weighted-average discount rate)    (1,932)
    $29,631 

 

 

 

 

License Agreements

 

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments as follows:

 

(In thousands)

 

2023   $217,852 
2024    224,201 
2025    218,047 
2026    139,348 
2027    132,502 
Thereafter    986,434 
    $1,918,384 

 

Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations. Royalty expense included in selling, general, and administrative expenses, aggregated $87.0 million, $68.9 million and $41.1 million, in 2022, 2021 and 2020, respectively, and represented 8.0%, 7.8% and 7.6% of net sales for the years ended December 31, 2022, 2021 and 2020, respectively.

 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Equity
 12 Months Ended
Dec. 31, 2022
Equity:  
Equity

 

(13)Equity

 

Share-Based Payments

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested aggregated $1.3 million, $1.4 million and $1.7 million in 2022, 2021 and 2020, respectively. Compensation cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally the Company’s policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for 2022:

 

   Number of Shares    Weighted Average Grant Date Fair Value 
Nonvested options – beginning of year   209,510   $13.45 
Nonvested options granted   62,000   $20.36 
Nonvested options vested or forfeited   (102,780)  $12.93 
Nonvested options – end of year   168,730   $16.31 

 

The effect of share-based payment expenses decreased income statement line items as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
Income before income taxes  $3,143   $2,850   $3,030 
Net income attributable to Inter Parfums, Inc.   2,036    1,880    2,040 
Diluted earnings per share attributable to Inter Parfums, Inc.   0.06    0.06    0.06 

 

The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:

 

   Year ended December 31, 
   2022   2021   2020 
   Options  

Weighted

Average

Exercise

Price

   Options  

Weighted

Average

Exercise

Price 

   Options  

Weighted

Average

Exercise

Price 

 
 Shares under option - beginning of year   524,900   $57.58    713,210   $52.74    815,800   $49.89 
 Options granted   62,000    97.84    9,000    62.18    9,000    69.11 
 Options exercised   (136,880)   43.86    (156,490)   34.46    (95,570)   28.99 
 Options forfeited   (8,440)   67.65    (40,820)   62.57    (16,020)   58.38 
 Shares under option - end of year   441,580    67.30    524,900    57.58    713,210    52.74 

 

 

At December 31, 2022, options for 558,975 shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $13.0 million as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $2.7 million, which will be recognized over the next five years.

 

The weighted average fair values of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $20.36, $11.35 and $12.16 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value.

 

The assumptions used in the Black-Scholes pricing model are set forth in the following table:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Weighted-average expected stock-price volatility   26%   25%   25%
Weighted-average expected option life   4.0 years    5.0 years    5.0 years 
Weighted-average risk-free interest rate   4.0%   0.4%   1.4%
Weighted-average dividend yield   2.4%   1.6%   2.5%

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout ratio as a percentage of earnings.

 

Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Proceeds from stock options exercised  $6,003   $5,393   $2,771 
Tax benefits  $800   $1,300   $400 
Intrinsic value of stock options exercised  $6,760   $7,800   $2,873 

  

The following table summarizes additional stock option information as of December 31, 2022:

 

Exercise prices   Options outstanding   Options outstanding weighted average remaining contractual life  Options exercisable 
$40.15 - $46.90   103,460   0.96 years   101,860 
$62.18 - $69.11   139,900   2.04 years   97,210 
$73.09   136,220   3.00 years   73,780 
$97.84   62,000   5.85 years   — 
Totals   441,580   2.62 years   272,850 

 

As of December 31, 2022, the weighted average exercise price of options exercisable was $59.46 and the weighted average remaining contractual life of options exercisable is 1.88 years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $10.1 million.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 85,062 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.1 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired 63,281 shares at an aggregate cost of $3.0 million.

 

 

Dividends

 

In October 2019, our Board of Directors authorized a 20% increase in the annual dividend to $1.32 per share on an annual basis. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023, the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on March 31, 2023 to shareholders of record on March 15, 2023.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Net Income Attributable to Inter Parfums, Inc. Common Shareholders
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders

 

(14)Net Income Attributable to Inter Parfums, Inc. Common Shareholders

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Numerator for diluted earnings per share  $120,938   $87,411   $38,219 
Denominator:               
Weighted average shares   31,859,417    31,676,796    31,536,659 
Effect of dilutive securities:               
Stock options   129,336    158,612    117,885 
                
Denominator for diluted earnings per share   31,988,753    31,835,408    31,654,544 
                
Earnings per share:               
Net income attributable to Inter Parfums, Inc. common shareholders:               
Basic  $3.80   $2.76   $1.21 
Diluted   3.78    2.75    1.21 

 

Not included in the above computations is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase 38,000, 175,000, and 450,000 shares of common stock for 2022, 2021, and 2020, respectively.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Segments and Geographic Areas
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segments and Geographic Areas

 

(15)Segments and Geographic Areas

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.

 

Information on the Company’s operations by segments is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Net sales:               
United States  $342,644   $216,559   $117,489 
Europe   744,075    663,290    422,947 
Eliminations of intercompany sales   (66)   (333)   (1,427)
   $1,086,653   $879,516   $539,009 
Net income attributable to Inter Parfums, Inc.:               
United States  $43,745   $29,359   $7,942 
Europe   77,193    57,869    30,241 
Eliminations   —    183    36 
   $120,938   $87,411   $38,219 
               
Depreciation and amortization expense including impairment loss:               
United States  $6,355   $3,835   $3,354 
Europe   16,184    8,863    5,713 
   $22,539   $12,698   $9,067 
Interest and investment income:            
United States  $66   $3   $24 
Europe   5,769    3,526    2,971 
Eliminations   (349)   (126)   (130)
   $5,486   $3,403   $2,865 
Interest expense:               
United States  $1,100   $636   $604 
Europe   2,848    2,315    1,496 
Eliminations   (349)   (126)   (130)
   $3,599   $2,825   $1,970 
Income tax expense:               
United States  $6,920   $5,336   $1,590 
Europe   36,262    35,607    17,782 
Eliminations   —    49    9 
   $43,182   $40,992   $19,381 

 

   December 31, 
   2022   2021   2020 
Total assets:               
United States  $278,090   $247,703   $141,316 
Europe   1,052,004    931,735    758,812 
Eliminations   (21,552)   (34,074)   (9,983)
   $1,308,542   $1,145,364   $890,145 
Additions to long-lived assets:               
United States  $2,318   $2,711   $1,004 
Europe   31,438    138,563    11,259 
   $33,756   $141,274   $12,263 
Total long-lived assets:               
United States  $61,539   $63,094   $40,656 
Europe   423,999    334,033    217,766 
   $485,538   $397,127   $258,422 
Deferred tax assets:               
United States  $2,906   $870   $886 
Europe   8,253    7,066    7,106 
Eliminations   —    —    49 
   $11,159   $7,936   $8,041 

 

United States export sales were approximately $169.1 million, $126.2 million and $71.5 million in 2022, 2021 and 2020, respectively. Consolidated net sales to customers by region are as follows:

 

   Year ended December 31, 
   2022   2021   2020 
North America  $431,900   $354,100   $193,500 
Europe   333,400    271,600    180,200 
Asia   152,700    128,000    79,700 
Middle East   87,800    61,000    46,800 
Central and South America   69,900    56,400    32,500 
Other   11,000    8,400    6,300 
   $1,086,700   $879,500   $539,000 

 

 

Consolidated net sales to customers in major countries are as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
United States  $420,900   $351,300   $187,300 
France  $44,800   $44,000   $37,600 
Russia  $33,964   $43,400   $14,100 
United Kingdom  $37,900   $38,500   $24,600 

 
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

 

(16)Income Taxes

 

The Company and its subsidiaries file income tax returns in the U.S. federal, and various states and foreign jurisdictions.

 

The Company assessed its uncertain tax positions and determined that it has no material uncertain tax position at December 31, 2022.

 

The components of income before income taxes consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
U.S. operations  $50,250   $34,742   $9,577 
Foreign operations   143,969    116,277    59,772 
                
   $194,219   $151,019   $69,349 

 

The provision for current and deferred income tax expense (benefit) consists of the following:

 

   Year ended December 31, 
   2022   2021   2020 
Current:            
Federal  $6,829   $4,825   $1,685 
State and local   658    518    90 
Foreign   39,458    36,164    17,024 
    46,945    41,507    18,799 
Deferred:               
Federal   (802)   4    (215)
State and local   (49)   11    44 
Foreign   (2,912)   (530)   753 
    (3,763)   (515)   582 
Total income tax expense  $43,182   $40,992   $19,381 

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:

 

             
   December 31, 
   2022   2021 
Net deferred tax assets:          
Foreign net operating loss carry-forwards  $554   $1,292 
Inventory and accounts receivable   3,880    4,508 
Profit sharing   2,871    3,787 
Stock option compensation   716    732 
Effect of inventory profit elimination   9,342    5,112 
Other   266    407 
Total gross deferred tax assets, net   17,629    15,838 
Valuation allowance   (554)   (3,582)
Net deferred tax assets   17,075    12,256 
Deferred tax liabilities (long-term):          
Building expenses   (1,356)   (1,082)
Trademarks and licenses   (2,160)   (2,551)
Unrealized gain on marketable equity securities   (1,745)   (436)
Other   (655)   (251)
Total deferred tax liabilities   (5,916)   (4,320)
Net deferred tax assets  $11,159   $7,936 

 

Valuation allowances have been provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.

 

No other valuation allowances have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future taxable income.

 

The Company estimated of the effect of global intangible low-taxed income (“GILTI”) and has determined that it has no tax liability related to GILTI as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (“FDII”) and recorded a tax benefit of approximately $1.5 million, $0.9 million and $0.3 million as of December 31, 2022, 2021 and 2020, respectively.

 

The Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.

 

Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:

 

                       
   Year ended December 31, 
   2022   2021   2020 
Statutory rates   21.0%   21.0%   21.0%
State and local taxes, net of Federal benefit   0.2    0.3    0.2 
Windfall benefit from exercise of stock options   (0.4)   (0.9)   (0.6)
Benefit of Foreign Derived Intangible Income   (0.8)   (0.6)   (0.4)
Effect of foreign taxes greater than U.S. statutory rates   3.1    7.4    7.5 
Other   (0.9)   (0.1)   0.2 
Effective rates   22.2%   27.1%   27.9%

 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Accumulated Other Comprehensive Loss
 12 Months Ended
Dec. 31, 2022
Equity:  
Accumulated Other Comprehensive Loss

 

(17)Accumulated Other Comprehensive Loss

 

The components of accumulated other comprehensive loss consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
             
Net derivative instruments, beginning of year  $(992)  $—   $52 
Net derivative instrument loss, net of tax   2,701    (992)   (52)
Net derivative instruments, end of year   1,709    (992)   — 
                
Cumulative translation adjustments, beginning of year   (37,440)   (5,997)   (39,905)
Translation adjustments   (20,325)   (31,443)   33,908 
Cumulative translation adjustments, end of year   (57,765)   (37,440)   (5,997)
                
Accumulated other comprehensive loss  $(56,056)  $(38,432)  $(5,997)

 
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest
 12 Months Ended
Dec. 31, 2022
Noncontrolling Interest [Abstract]  
Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest

 

(18)Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest

                       
   Year ended December 31, 
   2022   2021   2020 
             
Net income attributable to Inter Parfums, Inc.  $120,938   $87,411   $38,219 
Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions   —    —    — 
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest  $120,938   $87,411   $38,219 

 
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows
 12 Months Ended
Dec. 31, 2022
Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows  
Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows

 

(19)Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows

 

The following table summarizes cash and cash equivalents as of December 31, 2021:

 

   December 31,
2021		 
     
Cash and cash equivalents per balance sheet  $159,613 
Cash held in escrow included in other assets (see note 3)   8,774 
      
Cash and cash equivalents per statement of cash flows  $168,387 

 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts

Schedule II

 

 

Valuation and Qualifying Accounts

 

(In thousands)

  

Column A  Column B   Column C   Column D   Column E 
       Additions         
        (1)  (2)          
Description  Balance at
beginning of
period		   Charged to
costs and
expenses		   Charged to
other
accounts –
describe		   Deductions
describe		   Balance at
end of period		 
Allowance for doubtful accounts:                         
Year ended December 31, 2022  $2,247    2,353    1,134(d)  1,044(a)   4,690 
Year ended December 31, 2021  $5,550    877    (843)(d)  3,336(a)   2,247 
Year ended December 31, 2020  $2,452    4,824    381(d)  2,107(a)   5,550 
                          
Allowance for sales returns, net of inventory:                         
Year ended December 31, 2022  $3,242    4,997     —    2,829(b)   5,410 
Year ended December 31, 2021  $2,242    3,042    —    2,042(b)   3,242 
Year ended December 31, 2020  $2,587    1,978    —    2,323(b)   2,242 
                          
Inventory reserve:                         
Year ended December 31, 2022  $15,777    8,742    (378)(d)  12,710(c)   11,431 
Year ended December 31, 2021  $9,371    8,217    7,041(d)(e)  8,852(c)   15,777 
Year ended December 31, 2020  $4,909    7,212    616(d)  3,366(c)   9,371 

 

(a)Write-off of bad debts.

(b)Write-off of sales returns.

(c)Disposal of inventory

(d)Foreign currency translation adjustment

(e)Inventory reserves acquired of $7,639

 

See accompanying reports of independent registered public accounting firm.
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.4
The Company and its Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Business of the Company

Business of the Company

 

Inter Parfums, Inc. and its subsidiaries (the “Company”) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance related products.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%

 

No other brand represented 10% or more of consolidated net sales.
Basis of Preparation

Basis of Preparation

 

The consolidated financial statements include the accounts of the Company and its subsidiaries, including 72% owned Interparfums SA, a subsidiary whose stock is publicly traded in France. All material intercompany balances and transactions have been eliminated.
Management Estimates

Management Estimates

 

Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.
Foreign Currency Translation

Foreign Currency Translation

 

For foreign subsidiaries with operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation adjustments are accumulated in a separate component of shareholders’ equity.
Cash and Cash Equivalents and Short-Term Investments

Cash and Cash Equivalents and Short-Term Investments

 

All highly liquid investments purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions outside the United States and are readily convertible into U.S. dollars.
Accounts Receivable

Accounts Receivable

 

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which are estimated to be uncollectible, which aggregated $4.7 million and $2.2 million as of December 31, 2022, and 2021, respectively. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns.
Inventories

Inventories

 

Inventories, including promotional merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company’s customers.
Derivatives

Derivatives

 

All derivative instruments are recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For cash flow hedges, the effective portion of the derivative’s gain or loss is initially reported in equity (as a component of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.
Property, Equipment and Leasehold Improvements

Property, Equipment and Leasehold Improvements

 

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools and molds, is included in cost of sales.
Long-Lived Assets

Long-Lived Assets

 

Indefinite-lived intangible assets principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.8% and 7.47% in 2022 and 2021, respectively. The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

 

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.
Revenue Recognition

Revenue Recognition

 

The Company sells its products to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers’ freight and handling charges. All shipping and handling costs, which aggregated $15.8 million, $10.0 million and $5.0 million in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. No one customer represented 10% or more of net sales in 2022, 2021 or 2020.

 
Sales Returns

Sales Returns

 

Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $8.6 million and $5.1 million at December 31, 2022 and 2021, respectively, and the amounts recognized for the rights to recover products was $3.2 million and $1.9 million at December 31, 2022 and 2021, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.
Payments to Customers

Payments to Customers

 

The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.
Advertising and Promotion

Advertising and Promotion

 

Advertising and promotional costs are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $212.4 million, $171.1 million and $91.7 million for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase and gift with purchase promotions that are reflected in cost of sales aggregated $43.1 million, $36.9 million and $26.4 million in 2022, 2021 and 2020, respectively.
Package Development Costs

Package Development Costs

 

Package development costs associated with new products and redesigns of existing product packaging are expensed as incurred.
Operating Leases

Operating Leases

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.
License Agreements

License Agreements

 

The Company’s license agreements generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of approximately 5 to 15 years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, excluding potential renewal periods, range from approximately 1 to 12 years. Under each license, the Company is required to pay royalties in the range of 6% to 10% to the licensor, at least annually, based on net sales to third parties.

 

In certain cases, the Company may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.

 

Most license agreements require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.

 

In addition, the Company is exposed to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.
Income Taxes

Income Taxes

 

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.
Issuance of Common Stock by Consolidated Subsidiary

Issuance of Common Stock by Consolidated Subsidiary

 

The difference between the Company’s share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company’s investment deemed sold, is reflected as an equity adjustment in the consolidated balance sheets.
Treasury Stock

Treasury Stock

 

The Board of Directors may authorize share repurchases of the Company’s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any time without notice.
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.4
The Company and its Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of lanvin brand name for our class

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:

   Year Ended December 31, 
   2022   2021   2020 
Montblanc   18%   19%   21%
Jimmy Choo   18%   18%   16%
Coach   15%   16%   17%
GUESS   12%   12%   11%
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of inventories

               
   December 31, 
   2022   2021 
Raw materials and component parts  $146,772   $111,312 
Finished goods   143,212    87,602 
Inventories  $289,984   $198,914 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value, assets measured on recurring basis

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

                               
   Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758    —    6,758    — 
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189    —    1,189    — 
                     
 Total Assets  $158,780   $19,861   $138,122   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68    —    68    — 
Total liabilities  $68   $—   $68   $— 

 

                               
   Fair Value Measurements at December 31, 2021 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)		   Significant Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets:                
Short-term investments  $160,014   $—   $160,014   $— 
                     
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $1,982   $—   $1,982   $— 
Foreign currency forward exchange contracts not accounted for using hedge accounting   63    —    63   $— 
Interest rate swaps   (234)   —    (234)   — 
Total liabilities  $1,811   $—   $1,811   $— 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Equipment and Leasehold Improvements (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of equipment and leasehold improvements

   December 31, 
   2022   2021 
Land and Building (construction in progress)  $148,137   $136,131 
Equipment   59,689    52,036 
Leasehold improvements   2,293    2,082 
    210,119    190,249 
Less accumulated depreciation and amortization   43,397    40,897 
   $166,722   $149,352 
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Trademarks, Licenses and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of trademarks, licenses and other intangible assets

2022  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $105,022   $—   $105,022 
Trademarks (finite lives)   41,267    64    41,203 
Licenses (finite lives)   205,235    63,535    141,700 
Other intangible assets (finite lives)   17,849    14,921    2,928 
Subtotal   264,351    78,520    185,831 
Total  $369,373   $78,520   $290,853 

 

2021  Gross
Amount		   Accumulated
Amortization		   Net Book
Value		 
Trademarks (indefinite lives)  $119,712   $—   $119,712 
Trademarks (finite lives)   43,820    68    43,752 
Licenses (finite lives)   109,682    62,286    47,396 
Other intangible assets (finite lives)   17,775    14,588    3,187 
Subtotal   171,277    76,942    94,335 
Total  $290,989   $76,942   $214,047 
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accrued expenses consist of the following:

Accrued expenses consist of the following:

 

             
   December 31, 
   2022   2021 
Advertising liabilities  $42,338   $31,215 
Salary (including bonus and related taxes)   21,128    19,993 
Royalties   26,532    19,154 
Due vendors (not yet invoiced)   105,869    45,707 
Retirement reserves   8,001    10,234 
Refund (return) liability   8,604    5,128 
Other   1,149    5,246 
Total  $213,621   $136,677 
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Long-Term Debt (Tables)
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Long-term debt consists of the following:

Long-term debt consists of the following:

 

   December 31, 
   2022   2021 
$53.3 million payable in 48 equal monthly installments of $1.1 million beginning in December 2022, bearing interest at one-month Euribor plus 0.825%  $52,061   $— 
$135.9 million payable in 120 equal monthly installments of $1.1 million beginning in April 2021, bearing interest at one-month Euribor plus 0.75%   104,758    124,375 
$15.0 million payable in 14 equal annual installments of $1.1 million beginning in January 2020 including interest imputed at 4.1% per annum   9,890    10,569 
$17 million payable in 10 equal annual installments of $1.7 million beginning in October 2021 including interest imputed at 2.0% per annum   13,332    13,859 
    180,041    148,803 
Less current maturities   28,547    15,911 
Total  $151,494   $132,892 
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Maturities of lease liabilities subsequent to December 31, 2022 are as follows:

Maturities of lease liabilities subsequent to December 31, 2022 are as follows:

 

(In thousands)

 

2023   $5,723 
2024    5,971 
2025    4,847 
2026    4,049 
2027    4,060 
Thereafter    6,913 
     31,563 
Less imputed interest (based on 2.6% weighted-average discount rate)    (1,932)
    $29,631 
minimum annual royalties and other commitments as follows:

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments as follows:

 

(In thousands)

 

2023   $217,852 
2024    224,201 
2025    218,047 
2026    139,348 
2027    132,502 
Thereafter    986,434 
    $1,918,384 
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Equity:  
The following table sets forth information with respect to nonvested options for 2022:

The following table sets forth information with respect to nonvested options for 2022:

 

   Number of Shares    Weighted Average Grant Date Fair Value 
Nonvested options – beginning of year   209,510   $13.45 
Nonvested options granted   62,000   $20.36 
Nonvested options vested or forfeited   (102,780)  $12.93 
Nonvested options – end of year   168,730   $16.31 
The effect of share-based payment expenses decreased income statement line items as follows:

The effect of share-based payment expenses decreased income statement line items as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
Income before income taxes  $3,143   $2,850   $3,030 
Net income attributable to Inter Parfums, Inc.   2,036    1,880    2,040 
Diluted earnings per share attributable to Inter Parfums, Inc.   0.06    0.06    0.06 
The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:

The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:

 

   Year ended December 31, 
   2022   2021   2020 
   Options  

Weighted

Average

Exercise

Price

   Options  

Weighted

Average

Exercise

Price 

   Options  

Weighted

Average

Exercise

Price 

 
 Shares under option - beginning of year   524,900   $57.58    713,210   $52.74    815,800   $49.89 
 Options granted   62,000    97.84    9,000    62.18    9,000    69.11 
 Options exercised   (136,880)   43.86    (156,490)   34.46    (95,570)   28.99 
 Options forfeited   (8,440)   67.65    (40,820)   62.57    (16,020)   58.38 
 Shares under option - end of year   441,580    67.30    524,900    57.58    713,210    52.74 

 
The assumptions used in the Black-Scholes pricing model are set forth in the following table:

The assumptions used in the Black-Scholes pricing model are set forth in the following table:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Weighted-average expected stock-price volatility   26%   25%   25%
Weighted-average expected option life   4.0 years    5.0 years    5.0 years 
Weighted-average risk-free interest rate   4.0%   0.4%   1.4%
Weighted-average dividend yield   2.4%   1.6%   2.5%
Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:

Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:

 

                       
   Year Ended December 31, 
   2022   2021   2020 
Proceeds from stock options exercised  $6,003   $5,393   $2,771 
Tax benefits  $800   $1,300   $400 
Intrinsic value of stock options exercised  $6,760   $7,800   $2,873 
The following table summarizes additional stock option information as of December 31, 2022:

The following table summarizes additional stock option information as of December 31, 2022:

 

Exercise prices   Options outstanding   Options outstanding weighted average remaining contractual life  Options exercisable 
$40.15 - $46.90   103,460   0.96 years   101,860 
$62.18 - $69.11   139,900   2.04 years   97,210 
$73.09   136,220   3.00 years   73,780 
$97.84   62,000   5.85 years   — 
Totals   441,580   2.62 years   272,850 
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Numerator for diluted earnings per share  $120,938   $87,411   $38,219 
Denominator:               
Weighted average shares   31,859,417    31,676,796    31,536,659 
Effect of dilutive securities:               
Stock options   129,336    158,612    117,885 
                
Denominator for diluted earnings per share   31,988,753    31,835,408    31,654,544 
                
Earnings per share:               
Net income attributable to Inter Parfums, Inc. common shareholders:               
Basic  $3.80   $2.76   $1.21 
Diluted   3.78    2.75    1.21 
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Segments and Geographic Areas (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Information on the Company’s operations by segments is as follows:

Information on the Company’s operations by segments is as follows:

 

   Year ended December 31, 
   2022   2021   2020 
Net sales:               
United States  $342,644   $216,559   $117,489 
Europe   744,075    663,290    422,947 
Eliminations of intercompany sales   (66)   (333)   (1,427)
   $1,086,653   $879,516   $539,009 
Net income attributable to Inter Parfums, Inc.:               
United States  $43,745   $29,359   $7,942 
Europe   77,193    57,869    30,241 
Eliminations   —    183    36 
   $120,938   $87,411   $38,219 
               
Depreciation and amortization expense including impairment loss:               
United States  $6,355   $3,835   $3,354 
Europe   16,184    8,863    5,713 
   $22,539   $12,698   $9,067 
Interest and investment income:            
United States  $66   $3   $24 
Europe   5,769    3,526    2,971 
Eliminations   (349)   (126)   (130)
   $5,486   $3,403   $2,865 
Interest expense:               
United States  $1,100   $636   $604 
Europe   2,848    2,315    1,496 
Eliminations   (349)   (126)   (130)
   $3,599   $2,825   $1,970 
Income tax expense:               
United States  $6,920   $5,336   $1,590 
Europe   36,262    35,607    17,782 
Eliminations   —    49    9 
   $43,182   $40,992   $19,381 

 

   December 31, 
   2022   2021   2020 
Total assets:               
United States  $278,090   $247,703   $141,316 
Europe   1,052,004    931,735    758,812 
Eliminations   (21,552)   (34,074)   (9,983)
   $1,308,542   $1,145,364   $890,145 
Additions to long-lived assets:               
United States  $2,318   $2,711   $1,004 
Europe   31,438    138,563    11,259 
   $33,756   $141,274   $12,263 
Total long-lived assets:               
United States  $61,539   $63,094   $40,656 
Europe   423,999    334,033    217,766 
   $485,538   $397,127   $258,422 
Deferred tax assets:               
United States  $2,906   $870   $886 
Europe   8,253    7,066    7,106 
Eliminations   —    —    49 
   $11,159   $7,936   $8,041 
Consolidated net sales to customers by region are as follows:

 

   Year ended December 31, 
   2022   2021   2020 
North America  $431,900   $354,100   $193,500 
Europe   333,400    271,600    180,200 
Asia   152,700    128,000    79,700 
Middle East   87,800    61,000    46,800 
Central and South America   69,900    56,400    32,500 
Other   11,000    8,400    6,300 
   $1,086,700   $879,500   $539,000 
Consolidated net sales to customers in major countries are as follows:

Consolidated net sales to customers in major countries are as follows:

 

   Year Ended December 31, 
   2022   2021   2020 
United States  $420,900   $351,300   $187,300 
France  $44,800   $44,000   $37,600 
Russia  $33,964   $43,400   $14,100 
United Kingdom  $37,900   $38,500   $24,600 
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
The components of income before income taxes consist of the following:

The components of income before income taxes consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
U.S. operations  $50,250   $34,742   $9,577 
Foreign operations   143,969    116,277    59,772 
                
   $194,219   $151,019   $69,349 
The provision for current and deferred income tax expense (benefit) consists of the following:

The provision for current and deferred income tax expense (benefit) consists of the following:

 

   Year ended December 31, 
   2022   2021   2020 
Current:            
Federal  $6,829   $4,825   $1,685 
State and local   658    518    90 
Foreign   39,458    36,164    17,024 
    46,945    41,507    18,799 
Deferred:               
Federal   (802)   4    (215)
State and local   (49)   11    44 
Foreign   (2,912)   (530)   753 
    (3,763)   (515)   582 
Total income tax expense  $43,182   $40,992   $19,381 
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:

 

             
   December 31, 
   2022   2021 
Net deferred tax assets:          
Foreign net operating loss carry-forwards  $554   $1,292 
Inventory and accounts receivable   3,880    4,508 
Profit sharing   2,871    3,787 
Stock option compensation   716    732 
Effect of inventory profit elimination   9,342    5,112 
Other   266    407 
Total gross deferred tax assets, net   17,629    15,838 
Valuation allowance   (554)   (3,582)
Net deferred tax assets   17,075    12,256 
Deferred tax liabilities (long-term):          
Building expenses   (1,356)   (1,082)
Trademarks and licenses   (2,160)   (2,551)
Unrealized gain on marketable equity securities   (1,745)   (436)
Other   (655)   (251)
Total deferred tax liabilities   (5,916)   (4,320)
Net deferred tax assets  $11,159   $7,936 
Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:

Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:

 

                       
   Year ended December 31, 
   2022   2021   2020 
Statutory rates   21.0%   21.0%   21.0%
State and local taxes, net of Federal benefit   0.2    0.3    0.2 
Windfall benefit from exercise of stock options   (0.4)   (0.9)   (0.6)
Benefit of Foreign Derived Intangible Income   (0.8)   (0.6)   (0.4)
Effect of foreign taxes greater than U.S. statutory rates   3.1    7.4    7.5 
Other   (0.9)   (0.1)   0.2 
Effective rates   22.2%   27.1%   27.9%
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Accumulated Other Comprehensive Loss (Tables)
 12 Months Ended
Dec. 31, 2022
Equity:  
The components of accumulated other comprehensive loss consist of the following:

The components of accumulated other comprehensive loss consist of the following:

 

   Year ended December 31, 
   2022   2021   2020 
             
Net derivative instruments, beginning of year  $(992)  $—   $52 
Net derivative instrument loss, net of tax   2,701    (992)   (52)
Net derivative instruments, end of year   1,709    (992)   — 
                
Cumulative translation adjustments, beginning of year   (37,440)   (5,997)   (39,905)
Translation adjustments   (20,325)   (31,443)   33,908 
Cumulative translation adjustments, end of year   (57,765)   (37,440)   (5,997)
                
Accumulated other comprehensive loss  $(56,056)  $(38,432)  $(5,997)
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)
 12 Months Ended
Dec. 31, 2022
Noncontrolling Interest [Abstract]  
Schedule of net income attributable to transfers from the noncontrolling interest

                       
   Year ended December 31, 
   2022   2021   2020 
             
Net income attributable to Inter Parfums, Inc.  $120,938   $87,411   $38,219 
Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions   —    —    — 
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest  $120,938   $87,411   $38,219 
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)
 12 Months Ended
Dec. 31, 2022
Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows  
The following table summarizes cash and cash equivalents as of December 31, 2021:

The following table summarizes cash and cash equivalents as of December 31, 2021:

 

   December 31,
2021		 
     
Cash and cash equivalents per balance sheet  $159,613 
Cash held in escrow included in other assets (see note 3)   8,774 
      
Cash and cash equivalents per statement of cash flows  $168,387 
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts (Tables)
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule of Valuation and Qualifying Accounts

 

Valuation and Qualifying Accounts

 

(In thousands)

  

Column A  Column B   Column C   Column D   Column E 
       Additions         
        (1)  (2)          
Description  Balance at
beginning of
period		   Charged to
costs and
expenses		   Charged to
other
accounts –
describe		   Deductions
describe		   Balance at
end of period		 
Allowance for doubtful accounts:                         
Year ended December 31, 2022  $2,247    2,353    1,134(d)  1,044(a)   4,690 
Year ended December 31, 2021  $5,550    877    (843)(d)  3,336(a)   2,247 
Year ended December 31, 2020  $2,452    4,824    381(d)  2,107(a)   5,550 
                          
Allowance for sales returns, net of inventory:                         
Year ended December 31, 2022  $3,242    4,997     —    2,829(b)   5,410 
Year ended December 31, 2021  $2,242    3,042    —    2,042(b)   3,242 
Year ended December 31, 2020  $2,587    1,978    —    2,323(b)   2,242 
                          
Inventory reserve:                         
Year ended December 31, 2022  $15,777    8,742    (378)(d)  12,710(c)   11,431 
Year ended December 31, 2021  $9,371    8,217    7,041(d)(e)  8,852(c)   15,777 
Year ended December 31, 2020  $4,909    7,212    616(d)  3,366(c)   9,371 

 

(a)Write-off of bad debts.

(b)Write-off of sales returns.

(c)Disposal of inventory

(d)Foreign currency translation adjustment

(e)Inventory reserves acquired of $7,639

XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of lanvin brand name for our class (Details) - Product Sales Concentration Risk [Member] - Janvin [Member]
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Montblanc [Member]      
Product Information [Line Items]      
Concentration risk percentage 18.00% 19.00% 21.00%
Jimmy Choo [Member]      
Product Information [Line Items]      
Concentration risk percentage 18.00% 18.00% 16.00%
Coach [Member]      
Product Information [Line Items]      
Concentration risk percentage 15.00% 16.00% 17.00%
G U E S S [Member]      
Product Information [Line Items]      
Concentration risk percentage 12.00% 12.00% 11.00%
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.22.4
The Company and its Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Apr. 30, 2021
Product Information [Line Items]        
Allowances for sales returns and doubtful accounts $ 4,700,000 $ 2,200,000    
Shipping and handling costs 392,231,000 322,614,000 $ 208,278,000  
Contract with customer, refund liability 8,600,000 5,100,000    
Contract with customer, right to recover products 3,200,000 1,900,000    
Advertising costs 212,400,000 171,100,000 91,700,000  
Customer incentives cost $ 43,100,000 $ 36,900,000 $ 26,400,000  
Royalty expense, percentage of net sales 8.00% 7.80% 7.60%  
Minimum [Member] | Licensing Agreements [Member]        
Product Information [Line Items]        
License agreement term 5 years      
License agreement renewal term 1 year      
Royalty expense, percentage of net sales 6.00%      
Maximum [Member] | Licensing Agreements [Member]        
Product Information [Line Items]        
License agreement term 15 years      
License agreement renewal term 12 years      
Royalty expense, percentage of net sales 10.00%      
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Credit Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 10.00% 10.00% 10.00%  
Shipping and Handling [Member]        
Product Information [Line Items]        
Shipping and handling costs $ 15,800,000 $ 0.00 $ 5,000,000.0  
Measurement Input, Discount Rate [Member]        
Product Information [Line Items]        
Weighted average cost of capital 9.80% 7.47% 6.99%  
Interparfums SA Subsidiary [Member]        
Product Information [Line Items]        
Ownership percentage in Interparfums SA 72.00%     73.00%
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Recent Agreements (Details Narrative)
€ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2021
USD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
EUR (€)
Apr. 30, 2021
Business Acquisition [Line Items]        
Purchase price, period cost   $ 148,100,000    
Acquisition costs, period cost   4,400,000    
Cash held in escrow is included in other assets   $ 3,400,000    
Long-term debt, term   10 years 10 years  
Long-term line of credit   $ 128,000,000.0 € 120  
Description of debt instrument interest rate terms   one-month Euribor plus 0.75%    
Euro Member Countries, Euro        
Business Acquisition [Line Items]        
Debt instrument, face amount | €     € 80  
Minimum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range   7 years    
Maximum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range   50 years    
Land [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost   $ 61,100,000    
Building [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost   $ 87,000,000.0    
Interparfums SA Subsidiary [Member]        
Business Acquisition [Line Items]        
Ownership percentage   72.00% 72.00% 73.00%
Donna Karan and DKNY [Member]        
Business Acquisition [Line Items]        
Shares issue | shares   65,342    
Shares value   $ 5,000,000    
Rochas Fashion [Member]        
Business Acquisition [Line Items]        
Impairment Charge on Reclassified Assets $ 2,400,000      
Emanuel Ungar [Member]        
Business Acquisition [Line Items]        
Description of recent agreement   we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand.    
Rochas Fashion [Member]        
Business Acquisition [Line Items]        
Description of recent agreement   we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.    
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials and component parts $ 146,772 $ 111,312
Finished goods 143,212 87,602
Inventories $ 289,984 $ 198,914
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Inventory Valuation Reserves $ 11,400,000 $ 15,800,000
Product [Member]    
Cost of Goods Sold, Overhead $ 3,400,000 $ 3,700,000
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of fair value, assets measured on recurring basis (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets:    
Short-term investments $ 150,833 $ 160,014
Interest rate swaps 6,758  
Foreign currency forward exchange contracts accounted for using hedge accounting 1,189 1,982
 Total Assets 158,780  
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting 68  
Total liabilities 68 1,811
Foreign currency forward exchange contracts not accounted for using hedge accounting   63
Interest rate swaps   (234)
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Short-term investments 19,861
Interest rate swaps  
Foreign currency forward exchange contracts accounted for using hedge accounting
 Total Assets 19,861  
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting  
Total liabilities
Foreign currency forward exchange contracts not accounted for using hedge accounting  
Interest rate swaps  
Fair Value, Inputs, Level 2 [Member]    
Assets:    
Short-term investments 130,174 160,014
Interest rate swaps 6,758  
Foreign currency forward exchange contracts accounted for using hedge accounting 1,189 1,982
 Total Assets 138,122  
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting 68  
Total liabilities 68 1,811
Foreign currency forward exchange contracts not accounted for using hedge accounting   63
Interest rate swaps   (234)
Fair Value, Inputs, Level 3 [Member]    
Assets:    
Short-term investments 798
Interest rate swaps  
Foreign currency forward exchange contracts accounted for using hedge accounting
 Total Assets 798  
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting  
Total liabilities
Foreign currency forward exchange contracts not accounted for using hedge accounting  
Interest rate swaps  
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Financial Instruments (Details Narrative) - Foreign Exchange Contract [Member] - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]    
Loan amount $ 6,300,000 $ 200,000
Foreign currency contracts, liability, fair value disclosure $ 36,500,000  
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of equipment and leasehold improvements (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Equipment and leasehold improvements $ 210,119 $ 190,249
Less accumulated depreciation and amortization 43,397 40,897
Property, Plant and Equipment, Net, Total 166,722 149,352
Building [Member]    
Property, Plant and Equipment [Line Items]    
Equipment and leasehold improvements 148,137 136,131
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Equipment and leasehold improvements 59,689 52,036
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Equipment and leasehold improvements $ 2,293 $ 2,082
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Equipment and Leasehold Improvements (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract]      
Depreciation and amortization expense $ 7,500,000 $ 4,400,000 $ 3,800,000
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of trademarks, licenses and other intangible assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Amount $ 369,373 $ 290,989
Accumulated Amortization 78,520 76,942
Net Book Value 290,853 214,047
Licensing Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 205,235 109,682
Accumulated Amortization 63,535 62,286
Net Book Value 141,700 47,396
Other Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 17,849 17,775
Accumulated Amortization 14,921 14,588
Net Book Value 2,928 3,187
Indefinite-Lived Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 105,022 119,712
Accumulated Amortization
Net Book Value 105,022 119,712
Finite-Lived Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 41,267 43,820
Accumulated Amortization 64 68
Net Book Value 41,203 43,752
Subtotal [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 264,351 171,277
Accumulated Amortization 78,520 76,942
Net Book Value $ 185,831 $ 94,335
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Trademarks, Licenses and Other Intangible Assets (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]      
Amortization of Intangible Assets $ 6,800,000 $ 5,900,000 $ 5,300,000
2023 7,000,000    
2024 13,300,000    
2025 12,300,000    
2026 10,500,000    
2027 $ 10,500,000    
Amortization period 14 years    
Indefinite-Lived License Agreements $ 7,000,000    
Minimum [Member]      
Finite-Lived Intangible Assets [Line Items]      
Amortization period 3 years    
Maximum [Member]      
Finite-Lived Intangible Assets [Line Items]      
Amortization period 20 years    
Measurement Input, Discount Rate [Member]      
Finite-Lived Intangible Assets [Line Items]      
Weighted average cost of capital 9.80% 7.47% 6.99%
Indefinite-Lived Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment charge $ 6,800,000 $ 2,400,000  
Indefinite-Lived Intangible Assets [Member] | Rochas Fashion Business [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment charge $ 900,000    
Trademarks [Member]      
Finite-Lived Intangible Assets [Line Items]      
Amortization period 8 years    
Licensing Agreements [Member]      
Finite-Lived Intangible Assets [Line Items]      
Amortization period 14 years    
Other Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Amortization period 2 years    
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued expenses consist of the following: (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Advertising liabilities $ 42,338 $ 31,215
Salary (including bonus and related taxes) 21,128 19,993
Royalties 26,532 19,154
Due vendors (not yet invoiced) 105,869 45,707
Retirement reserves 8,001 10,234
Refund (return) liability 8,604 5,128
Other 1,149 5,246
Total $ 213,621 $ 136,677
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Long-term debt consists of the following: (Details)
€ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Number
Dec. 31, 2022
EUR (€)
Number
Dec. 31, 2021
USD ($)
Apr. 30, 2021
USD ($)
Apr. 30, 2021
EUR (€)
Debt Instrument [Line Items]          
Loan payable $ 180,041,000   $ 148,803,000    
Less current maturities 28,547,000   15,911,000    
Total 151,494,000   132,902,000    
Loans Payable [Member]          
Debt Instrument [Line Items]          
Debt Instrument, Face Amount $ 53,300,000 € 50      
Number of installments | Number 48 48      
Installment amount (in Dollars) $ 1,100,000,000        
Interest per annum 0.825% 0.825%      
Loan payable $ 52,061,000      
Loans Payable One [Member]          
Debt Instrument [Line Items]          
Debt Instrument, Face Amount $ 135,900,000     $ 128,000,000.0 € 120
Number of installments | Number 120 120      
Installment amount (in Dollars) $ 1,100,000,000        
Interest per annum 0.75% 0.75%      
Loan payable $ 104,758,000   124,375,000    
Loans Payable Two [Member]          
Debt Instrument [Line Items]          
Debt Instrument, Face Amount $ 15,000,000.0        
Number of installments | Number 14 14      
Installment amount (in Dollars) $ 1,100,000,000        
Interest per annum 4.10% 4.10%      
Loan payable $ 9,890,000   10,569,000    
Loans Payable Three [Member]          
Debt Instrument [Line Items]          
Debt Instrument, Face Amount $ 17,000,000        
Number of installments | Number 10 10      
Installment amount (in Dollars) $ 1,700,000,000        
Interest per annum 2.00% 2.00%      
Loan payable $ 13,332,000   $ 13,859,000    
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Loans Payable – Banks (Details Narrative)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Domestic Subsidiaries [Member]  
Debt Instrument [Line Items]  
Line of credit, maximum borrowing amount $ 20
Domestic Subsidiaries [Member] | London Interbank Offered Rate [Member]  
Debt Instrument [Line Items]  
Basis spread over variable interest rate 2.00%
Variable rate 4.30%
Line of Credit Facility, Expiration Date Dec. 15, 2023
Foreign Subsidiaries [Member]  
Debt Instrument [Line Items]  
Line of credit, maximum borrowing amount $ 20
Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member]  
Debt Instrument [Line Items]  
Variable rate 0.576%
Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member] | Minimum [Member]  
Debt Instrument [Line Items]  
Basis spread over variable interest rate 0.60%
Foreign Subsidiaries [Member] | Euro Interbank Offered Rate [Member] | Maximum [Member]  
Debt Instrument [Line Items]  
Basis spread over variable interest rate 0.90%
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Long-Term Debt (Details Narrative)
€ in Millions
 1 Months Ended 12 Months Ended
Apr. 30, 2021
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Apr. 30, 2021
EUR (€)
Debt Instrument [Line Items]        
Long term debt maturity, description   28.7 million per year thereafter through 2033.    
Long-term Debt, Maturities, 2021   $ 30,400,000    
Loans Payable [Member]        
Debt Instrument [Line Items]        
Debt Instrument, Face Amount   $ 53,300,000 € 50  
Long term debt maturity, description   The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.    
Loans Payable One [Member]        
Debt Instrument [Line Items]        
Debt Instrument, Face Amount $ 128,000,000.0 $ 135,900,000   € 120
Long term debt maturity, description Approximately $85.3 million (€80.0 million) of the variable rate debt was swapped for variable interest rate debt with maximum rate of 2% per annum.      
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2023 $ 5,723
2024 5,971
2025 4,847
2026 4,049
2027 4,060
Thereafter 6,913
Gross Total 31,563
Less imputed interest (based on 2.6% weighted-average discount rate) (1,932)
Net Total $ 29,631
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.22.4
minimum annual royalties and other commitments as follows: (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
License agreement, expiration description The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033.
2023 $ 217,852
2024 224,201
2025 218,047
2026 139,348
2027 132,502
Thereafter 986,434
Total $ 1,918,384
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]      
Weighted average remaining lease term 5 years 9 months 18 days    
Operating lease of related to rental expenses $ 5,600,000 $ 8,200,000 $ 6,200,000
Operating lease payments 4,900,000    
Noncash additions to operating lease assets 300,000    
Royalty expense $ 87,000,000.0 $ 68,900,000 $ 41,100,000
Royalty expense, percentage of net sales 8.00% 7.80% 7.60%
Operating Lease [Member]      
Finite-Lived Intangible Assets [Line Items]      
Operating lease, weighted average discount rate 2.60%    
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.22.4
The following table sets forth information with respect to nonvested options for 2022: (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity:      
Nonvested options - beginning of year 209,510    
Weighted Average Grant Date Fair Value, beginning of year $ 13.45    
Nonvested options granted 62,000 9,000 9,000
Weighted Average Grant Date Fair Value, granted $ 20.36    
Nonvested options vested or forfeited (102,780)    
Weighted Average Grant Date Fair Value, vested or forfeited $ 12.93    
Nonvested options - end of year 168,730 209,510  
Weighted Average Grant Date Fair Value, end of year $ 16.31 $ 13.45  
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.22.4
The effect of share-based payment expenses decreased income statement line items as follows: (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income before income taxes $ 194,219 $ 151,019 $ 69,349
Net income attributable to Inter Parfums, Inc. $ 120,938 $ 87,411 $ 38,219
Diluted earnings per share attributable to Inter Parfums, Inc $ 3.78 $ 2.75 $ 1.21
Operating Income (Loss) [Member]      
Income before income taxes $ 3,143 $ 2,850 $ 3,030
Net income attributable to Inter Parfums, Inc. $ 2,036 $ 1,880 $ 2,040
Diluted earnings per share attributable to Inter Parfums, Inc $ 0.06 $ 0.06 $ 0.06
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.22.4
The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity:      
Options shares under option - beginning of year 524,900 713,210 815,800
Weighted average exercise price shares under option - beginning of year $ 57.58 $ 52.74 $ 49.89
Options granted 62,000 9,000 9,000
Weighted average exercise price options granted $ 97.84 $ 62.18 $ 69.11
Options exercised (136,880) (156,490) (95,570)
Weighted average exercise price options exercised $ 43.86 $ 34.46 $ 28.99
Options forfeited (8,440) (40,820) (16,020)
Weighted average exercise price options forfeited $ 67.65 $ 62.57 $ 58.38
Options shares under option - end of year 441,580 524,900 713,210
Weighted average exercise price shares under option - end of year $ 67.30 $ 57.58 $ 52.74
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.22.4
The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity:      
Weighted-average expected stock-price volatility 26.00% 25.00% 25.00%
Weighted-average expected option life 4 years 5 years 5 years
Weighted-average risk-free interest rate 4.00% 0.40% 1.40%
Weighted-average dividend yield 2.40% 1.60% 2.50%
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity:      
Proceeds from stock options exercised $ 6,003 $ 5,393 $ 2,771
Tax benefits 800 1,300 400
Intrinsic value of stock options exercised $ 6,760 $ 7,800 $ 2,873
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.22.4
The following table summarizes additional stock option information as of December 31, 2022: (Details)
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Options outstanding 441,580
Options outstanding weighted average remaining contractual life 2 years 7 months 13 days
Options exercisable 272,850
Exercise Price Range One [Member]  
Options outstanding 103,460
Options exercisable 101,860
Exercise Price Range Two [Member]  
Options outstanding 139,900
Options exercisable 97,210
Exercise Price Range Three [Member]  
Exercise price range (in dollars per share) | $ / shares $ 73.09
Options outstanding 136,220
Options outstanding weighted average remaining contractual life 3 years
Options exercisable 73,780
Exercise Price Range Four [Member]  
Exercise price range (in dollars per share) | $ / shares $ 97.84
Options outstanding 62,000
Options outstanding weighted average remaining contractual life 5 years 10 months 6 days
Options exercisable
Minimum [Member] | Exercise Price Range One [Member]  
Exercise price range (in dollars per share) | $ / shares $ 40.15
Minimum [Member] | Exercise Price Range Two [Member]  
Exercise price range (in dollars per share) | $ / shares 62.18
Maximum [Member] | Exercise Price Range One [Member]  
Exercise price range (in dollars per share) | $ / shares $ 46.90
Options outstanding weighted average remaining contractual life 11 months 15 days
Maximum [Member] | Exercise Price Range Two [Member]  
Exercise price range (in dollars per share) | $ / shares $ 69.11
Options outstanding weighted average remaining contractual life 2 years 15 days
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2022
Oct. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Feb. 28, 2021
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]                  
Weighted average grant date fair value (in dollars per share)     $ 20.36            
Weighted average exercise price of options exercisable     $ 59.46            
Weighted average remaining contractual life of options exercisable     1 year 10 months 17 days            
Aggregate intrinsic value of options exercisable     $ 10,100,000            
Straight line basis over the requisite     3 years            
Aggregate cost     $ 3,000,000.0            
Percentage of increase in annual dividend   20.00%              
Dividends payable, amount per share (in Dollars per share)   $ 1.32              
Subsequent Event [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)           $ 0.625      
interparfums S A [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate cost     4,100,000            
Board of Directors Chairman [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)               $ 2.50  
Interparfums SA Subsidiary [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Shares adjusted for stock splits 211,955                
Recognized as compensation cost     $ 4,800,000            
Interparfums SA Subsidiary [Member] | Employees [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding                 $ 133,000
Adjusted for stock splits (in shares)     63,281       88,400   26,600
Number of share distributed     85,062            
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Number of shares available for grant (in shares)     558,975            
Aggregate intrinsic value of options outstanding     $ 13,000,000.0            
Term     5 years            
Stock Option One [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding     $ 2,700,000            
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Fair value of shares vested     $ 1,300,000 $ 1,400,000 $ 1,700,000        
Weighted average grant date fair value (in dollars per share)     $ 20.36 $ 11.35 $ 12.16        
Minimum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period     4 years            
Maximum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period     5 years            
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.22.4
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]      
Numerator for diluted earnings per share (in dollars) $ 120,938 $ 87,411 $ 38,219
Weighted average shares 31,859,417 31,676,796 31,536,659
Stock options 129,336 158,612 117,885
Denominator for diluted earnings per share 31,988,753 31,835,408 31,654,544
Basic (in dollars per share) $ 3.80 $ 2.76 $ 1.21
Diluted (in dollars per share) $ 3.78 $ 2.75 $ 1.21
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share, amount 38,000 175,000 450,000
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Information on the Company’s operations by segments is as follows: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax $ 1,086,653 $ 879,516 $ 539,009
Net Income (Loss) Attributable to Parent 120,938 87,411 38,219
Depreciation, Depletion and Amortization, Nonproduction 22,539 12,698 9,067
Investment Income, Interest and Dividend 5,486 3,403 2,865
Investment Income, Interest and Dividend (5,486) (3,403) (2,865)
Interest expense 3,599 2,825 1,970
Interest expense (3,599) (2,825) (1,970)
Income Tax Expense (Benefit) 43,182 40,992 19,381
Assets 1,308,542 1,145,364 890,145
Assets (1,308,542) (1,145,364) (890,145)
Additions to Other Assets, Amount 33,756 141,274 12,263
Long-Lived Assets 485,538 397,127 258,422
Deferred Income Tax Assets, Net 11,159 7,936 8,041
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 342,644 216,559 117,489
Net Income (Loss) Attributable to Parent 43,745 29,359 7,942
Depreciation, Depletion and Amortization, Nonproduction 6,355 3,835 3,354
Investment Income, Interest and Dividend 66 3 24
Investment Income, Interest and Dividend (66) (3) (24)
Interest expense 1,100 636 604
Interest expense (1,100) (636) (604)
Income Tax Expense (Benefit) 6,920 5,336 1,590
Assets 278,090 247,703 141,316
Assets (278,090) (247,703) (141,316)
Additions to Other Assets, Amount 2,318 2,711 1,004
Long-Lived Assets 61,539 63,094 40,656
Deferred Income Tax Assets, Net 2,906 870 886
Europe [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 744,075 663,290 422,947
Net Income (Loss) Attributable to Parent 77,193 57,869 30,241
Depreciation, Depletion and Amortization, Nonproduction 16,184 8,863 5,713
Investment Income, Interest and Dividend 5,769 3,526 2,971
Investment Income, Interest and Dividend (5,769) (3,526) (2,971)
Interest expense 2,848 2,315 1,496
Interest expense (2,848) (2,315) (1,496)
Income Tax Expense (Benefit) 36,262 35,607 17,782
Assets 1,052,004 931,735 758,812
Assets (1,052,004) (931,735) (758,812)
Additions to Other Assets, Amount 31,438 138,563 11,259
Long-Lived Assets 423,999 334,033 217,766
Deferred Income Tax Assets, Net 8,253 7,066 7,106
Eliminations [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax (66) (333) (1,427)
Net Income (Loss) Attributable to Parent 183 36
Investment Income, Interest and Dividend 349 126 130
Investment Income, Interest and Dividend (349) (126) (130)
Interest expense 349 126 130
Interest expense (349) (126) (130)
Income Tax Expense (Benefit) 49 9
Assets 21,552 34,074 9,983
Assets (21,552) (34,074) (9,983)
Deferred Income Tax Assets, Net $ 49
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated net sales to customers by region are as follows: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 1,086,700 $ 879,500 $ 539,000
North America [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 431,900 354,100 193,500
Europe [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 333,400 271,600 180,200
Asia [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 152,700 128,000 79,700
Middle East [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 87,800 61,000 46,800
Central and South America [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 69,900 56,400 32,500
Other Segment Country [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 11,000 $ 8,400 $ 6,300
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated net sales to customers in major countries are as follows: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax $ 1,086,653 $ 879,516 $ 539,009
United States [Member]      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 420,900 351,300 187,300
France [Member]      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 44,800 44,000 37,600
Russia [Member]      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 33,964 43,400 14,100
United Kingdom [Member]      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax $ 37,900 $ 38,500 $ 24,600
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Segments and Geographic Areas (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from export sales $ 1,086,700,000 $ 879,500,000 $ 539,000,000
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from export sales $ 169,100,000 $ 126,200,000 $ 71,500,000
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.22.4
The components of income before income taxes consist of the following: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
U.S. operations $ 50,250 $ 34,742 $ 9,577
Foreign operations 143,969 116,277 59,772
Income before income taxes $ 194,219 $ 151,019 $ 69,349
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.22.4
The provision for current and deferred income tax expense (benefit) consists of the following: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Federal $ 6,829 $ 4,825 $ 1,685
State and local 658 518 90
Foreign 39,458 36,164 17,024
Current income tax expense 46,945 41,507 18,799
Federal (802) 4 (215)
State and local (49) 11 44
Foreign (2,912) (530) 753
Deferred income tax expense (3,763) (515) 582
Total income tax expense $ 43,182 $ 40,992 $ 19,381
XML 92 R78.htm IDEA: XBRL DOCUMENT v3.22.4
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Net deferred tax assets:    
Foreign net operating loss carry-forwards $ 554 $ 1,292
Inventory and accounts receivable 3,880 4,508
Profit sharing 2,871 3,787
Stock option compensation 716 732
Effect of inventory profit elimination 9,342 5,112
Other 266 407
Total gross deferred tax assets, net 17,629 15,838
Valuation allowance (554) (3,582)
Net deferred tax assets 17,075 12,256
Deferred tax liabilities (long-term):    
Building expenses (1,356) (1,082)
Trademarks and licenses (2,160) (2,551)
Unrealized gain on marketable equity securities (1,745) (436)
Other (655) (251)
Total deferred tax liabilities (5,916) (4,320)
Net deferred tax assets $ 11,159 $ 7,936
XML 93 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Statutory rates 21.00% 21.00% 21.00%
State and local taxes, net of Federal benefit 0.20% 0.30% 0.20%
Windfall benefit from exercise of stock options (0.40%) (0.90%) (0.60%)
Benefit of Foreign Derived Intangible Income (0.80%) (0.60%) (0.40%)
Effect of foreign taxes greater than U.S. statutory rates 3.10% 7.40% 7.50%
Other (0.90%) (0.10%) 0.20%
Effective rates 22.20% 27.10% 27.90%
XML 94 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]      
Deferred Foreign Income Tax Expense (Benefit) $ (2,912,000) $ (530,000) $ 753,000
Foreign Derived Intangible Income [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Deferred Foreign Income Tax Expense (Benefit) $ 1,500,000 $ 900,000 $ 300,000
XML 95 R81.htm IDEA: XBRL DOCUMENT v3.22.4
The components of accumulated other comprehensive loss consist of the following: (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Accumulated other comprehensive loss $ (56,056) $ (38,432) $ (5,997)
Accumulated Defined Benefit Plans Net Derivative Instruments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Net derivative instruments, beginning of year (992) 52
Net derivative instrument gain (loss), net of tax 2,701 (992) (52)
Net derivative instruments, end of year 1,709 (992)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Cumulative translation adjustments, beginning of year (37,440) (5,997) (39,905)
Translation adjustments (20,325) (31,443) 33,908
Cumulative translation adjustments, end of year $ (57,765) $ (37,440) $ (5,997)
XML 96 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of net income attributable to transfers from the noncontrolling interest (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Noncontrolling Interest [Abstract]      
Net income attributable to Inter Parfums, Inc. $ 120,938 $ 87,411 $ 38,219
Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest $ 120,938 $ 87,411 $ 38,219
XML 97 R83.htm IDEA: XBRL DOCUMENT v3.22.4
The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)
$ in Thousands
Dec. 31, 2021
USD ($)
Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows  
Cash and cash equivalents per balance sheet $ 159,613
Cash held in escrow included in other assets (see note 3) 8,774
Cash and cash equivalents per statement of cash flows $ 168,387
XML 98 R84.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
SEC Schedule, 12-09, Allowance, Credit Loss [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of period $ 2,247 $ 5,550 $ 2,452
Charged to costs and expenses 2,353 877 4,824
Charged to other accounts describe [1] 1,134 (843) 381
Deductions describe [2] 1,044 3,336 2,107
Balance at end of period 4,690 2,247 5,550
Sales Returns and Allowances [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of period 3,242 2,242 2,587
Charged to costs and expenses 4,997 3,042 1,978
Charged to other accounts describe
Deductions describe [3] 2,829 2,042 2,323
Balance at end of period 5,410 3,242 2,242
SEC Schedule, 12-09, Reserve, Inventory [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of period 15,777 9,371 4,909
Charged to costs and expenses 8,742 8,217 7,212
Charged to other accounts describe [1] (378) 7,041 [4] 616
Deductions describe [5] 12,710 8,852 3,366
Balance at end of period $ 11,431 $ 15,777 $ 9,371
[1] Foreign currency translation adjustment
[2] Write-off of bad debts.
[3] Write-off of sales returns.
[4] Inventory reserves acquired of $7,639
[5] Disposal of inventory
XML 99 g083417_10k_htm.xml IDEA: XBRL DOCUMENT 0000822663 2022-01-01 2022-12-31 0000822663 2022-06-30 0000822663 2023-02-28 0000822663 2022-12-31 0000822663 2021-12-31 0000822663 2021-01-01 2021-12-31 0000822663 2020-01-01 2020-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:CommonStockMember 2020-12-31 0000822663 us-gaap:CommonStockMember 2019-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2020-12-31 0000822663 us-gaap:RetainedEarningsMember 2019-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000822663 us-gaap:TreasuryStockMember 2021-12-31 0000822663 us-gaap:TreasuryStockMember 2020-12-31 0000822663 us-gaap:TreasuryStockMember 2019-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2020-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2019-12-31 0000822663 2020-12-31 0000822663 2019-12-31 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000822663 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000822663 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0000822663 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0000822663 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:TreasuryStockMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 ipar:MontblancMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:MontblancMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:MontblancMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:JimmyChooMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:JimmyChooMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:JimmyChooMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:CoachMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:CoachMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:CoachMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:GUESSMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2022-01-01 2022-12-31 0000822663 ipar:GUESSMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2021-01-01 2021-12-31 0000822663 ipar:GUESSMember ipar:ProductSalesConcentrationRiskMember ipar:JanvinMember 2020-01-01 2020-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2021-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0000822663 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2021-01-01 2021-12-31 0000822663 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:CreditRiskMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 ipar:EmanuelUngarMember 2022-01-01 2022-12-31 0000822663 ipar:DonnaKaranAndDKNYMember 2022-01-01 2022-12-31 0000822663 ipar:RochasFashionMember 2022-01-01 2022-12-31 0000822663 ipar:RochasFashionMember 2021-01-01 2021-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2021-04-30 0000822663 us-gaap:LandMember 2022-01-01 2022-12-31 0000822663 us-gaap:BuildingMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember 2022-01-01 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 us-gaap:ProductMember 2022-01-01 2022-12-31 0000822663 us-gaap:ProductMember 2021-01-01 2021-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2022-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2021-12-31 0000822663 us-gaap:BuildingMember 2022-12-31 0000822663 us-gaap:BuildingMember 2021-12-31 0000822663 us-gaap:EquipmentMember 2022-12-31 0000822663 us-gaap:EquipmentMember 2021-12-31 0000822663 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000822663 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0000822663 us-gaap:FiniteLivedIntangibleAssetsMember 2022-12-31 0000822663 us-gaap:LicensingAgreementsMember 2022-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000822663 ipar:SubtotalMember 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-12-31 0000822663 us-gaap:FiniteLivedIntangibleAssetsMember 2021-12-31 0000822663 us-gaap:LicensingAgreementsMember 2021-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000822663 ipar:SubtotalMember 2021-12-31 0000822663 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0000822663 us-gaap:LicensingAgreementsMember 2022-01-01 2022-12-31 0000822663 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000822663 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-01-01 2021-12-31 0000822663 ipar:RochasFashionBusinessMember us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000822663 us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0000822663 ipar:DomesticSubsidiariesMember 2022-12-31 0000822663 ipar:LondonInterbankOfferedRateMember ipar:DomesticSubsidiariesMember 2022-01-01 2022-12-31 0000822663 ipar:LondonInterbankOfferedRateMember ipar:DomesticSubsidiariesMember 2022-12-31 0000822663 ipar:ForeignSubsidiariesMember 2022-12-31 0000822663 srt:MinimumMember ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember 2022-01-01 2022-12-31 0000822663 ipar:EuroInterbankOfferedRateMember ipar:ForeignSubsidiariesMember 2022-12-31 0000822663 us-gaap:LoansPayableMember 2022-12-31 0000822663 us-gaap:LoansPayableMember 2022-01-01 2022-12-31 0000822663 us-gaap:LoansPayableMember 2021-12-31 0000822663 ipar:LoansPayableOneMember 2022-12-31 0000822663 ipar:LoansPayableOneMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableOneMember 2021-12-31 0000822663 ipar:LoansPayableTwoMember 2022-12-31 0000822663 ipar:LoansPayableTwoMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableTwoMember 2021-12-31 0000822663 ipar:LoansPayableThreeMember 2022-12-31 0000822663 ipar:LoansPayableThreeMember 2022-01-01 2022-12-31 0000822663 ipar:LoansPayableThreeMember 2021-12-31 0000822663 ipar:LoansPayableOneMember 2021-04-30 0000822663 ipar:LoansPayableOneMember 2021-04-01 2021-04-30 0000822663 ipar:OperatingLeaseMember 2022-12-31 0000822663 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000822663 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0000822663 us-gaap:StockOptionMember 2022-12-31 0000822663 ipar:StockOptionOneMember 2022-12-31 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-06-27 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSAMember 2022-01-01 2022-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-12-31 0000822663 2019-10-01 2019-10-31 0000822663 2019-10-31 0000822663 srt:BoardOfDirectorsChairmanMember 2021-02-28 0000822663 us-gaap:SubsequentEventMember 2023-03-31 0000822663 us-gaap:OperatingIncomeLossMember 2022-01-01 2022-12-31 0000822663 us-gaap:OperatingIncomeLossMember 2021-01-01 2021-12-31 0000822663 us-gaap:OperatingIncomeLossMember 2020-01-01 2020-12-31 0000822663 srt:MinimumMember ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 ipar:ExercisePriceRangeOneMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeOneMember 2022-01-01 2022-12-31 0000822663 srt:MinimumMember ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 ipar:ExercisePriceRangeTwoMember 2022-12-31 0000822663 srt:MaximumMember ipar:ExercisePriceRangeTwoMember 2022-01-01 2022-12-31 0000822663 ipar:ExercisePriceRangeThreeMember 2022-12-31 0000822663 ipar:ExercisePriceRangeThreeMember 2022-01-01 2022-12-31 0000822663 ipar:ExercisePriceRangeFourMember 2022-12-31 0000822663 ipar:ExercisePriceRangeFourMember 2022-01-01 2022-12-31 0000822663 country:US 2022-01-01 2022-12-31 0000822663 country:US 2021-01-01 2021-12-31 0000822663 country:US 2020-01-01 2020-12-31 0000822663 srt:EuropeMember 2022-01-01 2022-12-31 0000822663 srt:EuropeMember 2021-01-01 2021-12-31 0000822663 srt:EuropeMember 2020-01-01 2020-12-31 0000822663 ipar:EliminationsMember 2022-01-01 2022-12-31 0000822663 ipar:EliminationsMember 2021-01-01 2021-12-31 0000822663 ipar:EliminationsMember 2020-01-01 2020-12-31 0000822663 country:US 2022-12-31 0000822663 country:US 2021-12-31 0000822663 country:US 2020-12-31 0000822663 srt:EuropeMember 2022-12-31 0000822663 srt:EuropeMember 2021-12-31 0000822663 srt:EuropeMember 2020-12-31 0000822663 ipar:EliminationsMember 2022-12-31 0000822663 ipar:EliminationsMember 2021-12-31 0000822663 ipar:EliminationsMember 2020-12-31 0000822663 srt:NorthAmericaMember 2022-01-01 2022-12-31 0000822663 srt:NorthAmericaMember 2021-01-01 2021-12-31 0000822663 srt:NorthAmericaMember 2020-01-01 2020-12-31 0000822663 srt:AsiaMember 2022-01-01 2022-12-31 0000822663 srt:AsiaMember 2021-01-01 2021-12-31 0000822663 srt:AsiaMember 2020-01-01 2020-12-31 0000822663 us-gaap:MiddleEastMember 2022-01-01 2022-12-31 0000822663 us-gaap:MiddleEastMember 2021-01-01 2021-12-31 0000822663 us-gaap:MiddleEastMember 2020-01-01 2020-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2022-01-01 2022-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2021-01-01 2021-12-31 0000822663 ipar:CentralAndSouthAmericaMember 2020-01-01 2020-12-31 0000822663 ipar:OtherSegmentCountryMember 2022-01-01 2022-12-31 0000822663 ipar:OtherSegmentCountryMember 2021-01-01 2021-12-31 0000822663 ipar:OtherSegmentCountryMember 2020-01-01 2020-12-31 0000822663 ipar:UnitedStatesMember 2022-01-01 2022-12-31 0000822663 ipar:UnitedStatesMember 2021-01-01 2021-12-31 0000822663 ipar:UnitedStatesMember 2020-01-01 2020-12-31 0000822663 ipar:FranceMember 2022-01-01 2022-12-31 0000822663 ipar:FranceMember 2021-01-01 2021-12-31 0000822663 ipar:FranceMember 2020-01-01 2020-12-31 0000822663 ipar:RussiaMember 2022-01-01 2022-12-31 0000822663 ipar:RussiaMember 2021-01-01 2021-12-31 0000822663 ipar:RussiaMember 2020-01-01 2020-12-31 0000822663 ipar:UnitedKingdomMember 2022-01-01 2022-12-31 0000822663 ipar:UnitedKingdomMember 2021-01-01 2021-12-31 0000822663 ipar:UnitedKingdomMember 2020-01-01 2020-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2022-01-01 2022-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2021-01-01 2021-12-31 0000822663 ipar:ForeignDerivedIntangibleIncomeMember 2020-01-01 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2021-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2019-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2022-01-01 2022-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2021-01-01 2021-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2020-01-01 2020-12-31 0000822663 ipar:AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember 2022-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000822663 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2021-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2022-01-01 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2022-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2020-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2019-12-31 0000822663 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2021-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2022-01-01 2022-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2022-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2020-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2021-01-01 2021-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2019-12-31 0000822663 us-gaap:SalesReturnsAndAllowancesMember 2020-01-01 2020-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2021-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2022-01-01 2022-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2022-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2020-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2021-01-01 2021-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2019-12-31 0000822663 us-gaap:InventoryValuationReserveMember 2020-01-01 2020-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:EUR ipar:Number 0000822663 false --12-31 2022 FY NASDAQ P5Y P15Y P1Y P12Y P7Y P50Y P10Y 7000000 P8Y P14Y P2Y P14Y P3Y P20Y 2023-12-15 132902000 P5Y9M18D P4Y P5Y P5Y P4Y P5Y P5Y P0Y11M15D P2Y0M15D P3Y0M0D P5Y10M6D P2Y7M13D P1Y10M17D P3Y 31859417 31835408 194219000 151019000 69349000 10-K true 2022-12-31 false 0-16469 Inter Parfums, Inc. DE 13-3275609 551 Fifth Avenue New York NY 10176 212 983.2640 Common Stock, $.001 par value per share IPAR Yes No Yes Yes Large Accelerated Filer false false true false 1274342976 32109360 339 Mazars USA LLP New York, New York 104713000 159613000 150833000 160014000 197584000 159281000 289984000 198914000 28803000 10308000 15650000 21375000 157000 210000 787724000 709715000 166722000 149352000 27964000 33728000 290853000 214047000 11159000 7936000 24120000 30586000 1308542000 1145364000 28547000 15911000 5296000 6014000 88388000 81980000 213621000 136677000 8715000 4328000 344567000 244910000 151494000 132902000 24335000 29220000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 100000000 100000000 31967300 31830420 32000 32000 90186000 87132000 620095000 560663000 -56056000 -38432000 9864805 9864805 37475000 37475000 616782000 571920000 171364000 166412000 788146000 738332000 1308542000 1145364000 1086653000 879516000 539009000 392231000 322614000 208278000 694422000 556902000 330731000 492370000 406459000 260648000 7749000 2393000 194303000 148050000 70083000 3599000 2825000 1970000 -1921000 2338000 -2178000 5486000 3403000 2865000 -49000 53000 549000 -83000 2969000 -734000 194219000 151019000 69349000 43182000 40992000 19381000 151037000 110027000 49968000 30099000 22616000 11749000 120938000 87411000 38219000 3.80 2.76 1.21 3.78 2.75 1.21 31859417 31676796 31536659 31988753 31835408 31654544 2.00 1.00 0.33 151037000 110027000 49968000 2356000 -1367000 -19000 -992000 52000 -29683000 -42967000 47912000 -26335000 -44334000 47841000 124702000 65693000 97809000 30099000 22616000 11749000 647000 -375000 -19000 9358000 11524000 -14004000 21388000 10717000 25734000 103314000 54976000 72075000 32000 32000 31000 0 1000 32000 32000 32000 87132000 75708000 70664000 6004000 5393000 2771000 1355000 1566000 1711000 -0 -0 -0 5000000 -4305000 -535000 562000 90186000 87132000 75708000 560663000 503567000 474637000 120938000 87411000 38219000 63743000 31690000 10406000 2237000 1375000 1117000 620095000 560663000 503567000 -38432000 -5997000 -39853000 -20325000 -31443000 33908000 992000 52000 1709000 -992000 -56056000 -38432000 -5997000 -37475000 -37475000 -37475000 -37475000 -37475000 -37475000 166412000 166615000 140994000 30099000 22616000 11749000 -9358000 -11524000 14004000 647000 -375000 -19000 16056000 9836000 324000 -282000 -293000 350000 -98000 -791000 -139000 171364000 166412000 166615000 738332000 702450000 608998000 151037000 110027000 49968000 788146000 738332000 702450000 151037000 110027000 49968000 22539000 12698000 9067000 2353000 853000 4824000 3143000 2853000 3029000 -49000 53000 549000 4980000 7302000 5483000 -3604000 -465000 581000 -227000 -65000 137000 59640000 45395000 -13157000 98297000 49815000 -19333000 13651000 16725000 -1176000 -4795000 -7503000 -5421000 106857000 103046000 -32239000 3952000 2698000 -3279000 115150000 119586000 64993000 1038000 55691000 7582000 896000 10644000 11513000 33756000 141274000 11011000 98865000 1545000 1251000 13998000 -132763000 -187866000 -22329000 19861000 43056000 13725000 52492000 157382000 13438000 6003000 5393000 2771000 63743000 31690000 20805000 16056000 9836000 324000 4403000 -45568000 78193000 -18645000 -493000 -11207000 12245000 -63674000 -1294000 36264000 168387000 169681000 133417000 104713000 168387000 169681000 2987000 2468000 1105000 38492000 40497000 21772000 <p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zd1EKIHGXhJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.5in; text-align: left"><b>(1)</b></td><td id="xdx_828_znbAHDBviiWh" style="text-align: justify"><b>The Company and its Significant Accounting Policies</b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zNT0b1hpSc">Business of the Company</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries (the “Company”) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance related products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%">Montblanc</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jimmy Choo</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Coach</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>GUESS</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10% or more of consolidated net sales.</p> <p id="xdx_852_zkLqrsGkJApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zAi7NibSjYo">Basis of Preparation</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA">72</span>% owned Interparfums SA, a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances and transactions have been eliminated</span>.</p> <p id="xdx_858_zhK8rh8t0VFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_zxhhk0ZXFq5">Management Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.</p> <p id="xdx_850_zBwbKroun2Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_z6rIV82Xvpje">Foreign Currency Translation</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation adjustments are accumulated in a separate component of shareholders’ equity.</p> <p id="xdx_85D_z8zurES5J9S2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zQ2usvaXHXs5">Cash and Cash Equivalents and Short-Term Investments</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions outside the United States and are readily convertible into U.S. dollars.</p> <p id="xdx_85D_zZPquTcOQRla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zbpNXfQ5UYnk">Accounts Receivable</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which are estimated to be uncollectible, which aggregated $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts">4.7 million</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts">2.2 million</span> as of December 31, 2022, and 2021, respectively. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_850_zeVmfblcJqaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zB6czE4UKP8b">Inventories</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company’s customers.</p> <p id="xdx_859_z8E6H25uy7b6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_z8KfMRukTmb">Derivatives</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For cash flow hedges, the effective portion of the derivative’s gain or loss is initially reported in equity (as a component of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p> <p id="xdx_85A_zBXJO3IV73i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zjzUiz8tMvX9">Property, Equipment and Leasehold Improvements</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools and molds, is included in cost of sales.</p> <p id="xdx_859_zEts96VpM581" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zftBm8SvL7Bd">Long-Lived Assets</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital">9.8</span>% and <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital">7.47</span>% in 2022 and 2021, respectively. The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p> <p id="xdx_850_zz1nwOS3naq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_866_zn7swQC93rge">Revenue Recognition</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers’ freight and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs">15.8 million</span>, $1<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs">0.0 million</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs">5.0 million</span> in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. No one customer represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2022, 2021 or 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_znG0d2ejty9j">Sales Returns</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $<span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability">8.6 million</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability">5.1 million</span> at December 31, 2022 and 2021, respectively, and the amounts recognized for the rights to recover products was $<span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products">3.2 million</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products">1.9 million</span> at December 31, 2022 and 2021, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p> <p id="xdx_850_zIceJJmoSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpZS8YHNN1fl">Payments to Customers</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</p> <p id="xdx_857_zXoMw6n70mia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zIZybcTPiYQ3">Advertising and Promotion</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs">212.4 million</span>, $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs">171.1 million</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs">91.7 million</span> for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost">43.1 million</span>, $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost">36.9 million</span> and $<span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost">26.4 million</span> in 2022, 2021 and 2020, respectively.</p> <p id="xdx_854_zH3jODrKQ9K8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zqec8gj621I2">Package Development Costs</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated with new products and redesigns of existing product packaging are expensed as incurred.</p> <p id="xdx_853_zOZeg8z2S3Xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zxkrSXeufu6">Operating Leases</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p> <p id="xdx_85F_zrc4W7gVcqB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zSbdHovAxh91">License Agreements</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s license agreements generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of approximately <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0811">5</span></span> to <span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0813">15</span></span> years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, excluding potential renewal periods, range from approximately <span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">1</span></span> to <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">12</span></span> years. Under each license, the Company is required to pay royalties in the range of <span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.</p> <p id="xdx_85B_zh64ekd6mbY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zWZrltbKXMm6">Income Taxes</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p> <p id="xdx_85D_zixJEyMNLdl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86D_ziVu2DnrRlH1">Issuance of Common Stock by Consolidated Subsidiary</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company’s share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company’s investment deemed sold, is reflected as an equity adjustment in the consolidated balance sheets.</p> <p id="xdx_854_zakTrhiCpMz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_861_zOSRLpHtTRY4">Treasury Stock</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize share repurchases of the Company’s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any time without notice.</p> <p id="xdx_859_zckO1rZ36bOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zGmovrrEdML5" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zNT0b1hpSc">Business of the Company</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inter Parfums, Inc. and its subsidiaries (the “Company”) are in the fragrance business and manufacture and distribute a wide array of fragrances and fragrance related products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%">Montblanc</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jimmy Choo</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Coach</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>GUESS</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A9_zWLvTaK9xAv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other brand represented 10% or more of consolidated net sales.</p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zeUKZgkpFlab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zxSvNwyH1ozk" style="display: none; visibility: hidden">Schedule of lanvin brand name for our class</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%">Montblanc</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zdl0ABZB0Lw1" style="width: 10%; text-align: right" title="Concentration risk percentage">18</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zs1JPz9urfRj" style="width: 10%; text-align: right" title="Concentration risk percentage">19</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--MontblancMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zcVhRVw6oFlj" style="width: 10%; text-align: right" title="Concentration risk percentage">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jimmy Choo</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zv9UurlHH9k1" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zO7c9WAkOcp2" style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--JimmyChooMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zptIIqIiUMf6" style="text-align: right">16</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Coach</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zkbzpWCxEdSk" style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zDZyJdJLwMC6" style="text-align: right">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CoachMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zuqN2P0SFEvf" style="text-align: right">17</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>GUESS</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_zXMdQ1tDw489" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_z77EFHlFzLMf" style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ProductSalesConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--GUESSMember__us-gaap--FairValueConcentrationOfRiskDisclosureItemsAxis__custom--JanvinMember_ztT3JKTuDCmd" style="text-align: right">11</td><td style="text-align: left">%</td></tr> </table> 0.18 0.19 0.21 0.18 0.18 0.16 0.15 0.16 0.17 0.12 0.12 0.11 <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zA0h2d59pkmk" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zAi7NibSjYo">Basis of Preparation</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt; color: windowtext">The consolidated financial statements include the accounts of the Company and its subsidiaries, including <span id="xdx_90F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221231__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z3T6JW9Bz4wk" title="Ownership percentage in Interparfums SA">72</span>% owned Interparfums SA, a subsidiary whose stock is publicly traded in France.</span> <span style="font-size: 10pt">All material intercompany balances and transactions have been eliminated</span>.</p> 0.72 <p id="xdx_844_eus-gaap--UseOfEstimates_zdE7oD5XMjQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_zxhhk0ZXFq5">Management Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the consolidated financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the consolidated financial statements.</p> <p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zrHlcrzDDRh4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_z6rIV82Xvpje">Foreign Currency Translation</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For foreign subsidiaries with operations denominated in a foreign currency, assets and liabilities are translated to U.S. dollars at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Gains and losses from translation adjustments are accumulated in a separate component of shareholders’ equity.</p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCCttOwAn507" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_868_zQ2usvaXHXs5">Cash and Cash Equivalents and Short-Term Investments</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All highly liquid investments purchased with a maturity of three months or less are considered to be cash equivalents. The Company also has short-term investments which consist of certificates of deposit and other contracts with maturities greater than three months and available for sale marketable equity securities. The Company monitors concentrations of credit risk associated with financial institutions with which the Company conducts significant business. The Company believes its credit risk is minimal, as the Company primarily conducts business with large, well-established financial institutions. Substantially all cash and cash equivalents are primarily held at financial institutions outside the United States and are readily convertible into U.S. dollars.</p> <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zF4LvYsTRFef" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zbpNXfQ5UYnk">Accounts Receivable</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for doubtful accounts or balances which are estimated to be uncollectible, which aggregated $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20221231_zNUIYtlmDaEc" title="Allowances for sales returns and doubtful accounts">4.7 million</span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_dm_c20211231_zWt0SO6veioj" title="Allowances for sales returns and doubtful accounts">2.2 million</span> as of December 31, 2022, and 2021, respectively. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 4700000 2200000 <p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zMTka31MOqD8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86B_zB6czE4UKP8b">Inventories</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories, including promotional merchandise, only include inventory considered saleable or usable in future periods, and are stated at the lower of cost and net realizable value, with cost being determined on the first-in, first-out method. Cost components include raw materials, direct labor and overhead (e.g., indirect labor, utilities, depreciation, purchasing, receiving, inspection and warehousing) as well as inbound freight. Promotional merchandise is charged to cost of sales at the time the merchandise is shipped to the Company’s customers.</p> <p id="xdx_842_eus-gaap--DerivativesPolicyTextBlock_zFXi5AYHeHs" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_z8KfMRukTmb">Derivatives</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are recorded as either assets or liabilities and measured at fair value. The Company uses derivative instruments to principally manage a variety of market risks. For derivatives designated as hedges of the exposure to changes in fair value of the recognized asset or liability or a firm commitment (referred to as fair value hedges), the gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to include in earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For cash flow hedges, the effective portion of the derivative’s gain or loss is initially reported in equity (as a component of accumulated other comprehensive income) and is subsequently reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The ineffective portion of the gain or loss of a cash flow hedge is reported in earnings immediately. The Company also holds certain instruments for economic purposes that are not designated for hedge accounting treatment. For these derivative instruments, changes in their fair value are recorded in earnings immediately.</p> <p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgKZ5odhmqsg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zjzUiz8tMvX9">Property, Equipment and Leasehold Improvements</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives for equipt, which range between three and ten years and the shorter of the lease term or estimated useful asset lives for leasehold improvements. Depreciation has not yet begun on property recently purchased, as it has not yet been put into service. Depreciation provided on equipment used to produce inventory, such as tools and molds, is included in cost of sales.</p> <p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zysBYzOCfBYg" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86E_zftBm8SvL7Bd">Long-Lived Assets</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Indefinite-lived intangible assets principally consist of trademarks which are not amortized. The Company evaluates indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more-likely-than-not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z8e1liLwoqJc" title="Weighted average cost of capital">9.8</span>% and <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zEB7lS6Hzop2" title="Weighted average cost of capital">7.47</span>% in 2022 and 2021, respectively. The cash flow projections are based upon a number of assumptions, including future sales levels, future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value.</p> 0.098 0.0747 <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z77pMWQ8bQ02" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_866_zn7swQC93rge">Revenue Recognition</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company sells its products to department stores, perfumeries, specialty stores and domestic and international wholesalers and distributors. Our revenue contracts represent single performance obligations to sell our products to customers. Sales of such products by our domestic subsidiaries are denominated primarily in U.S. dollars, and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. The Company recognizes revenues when contract terms are met, the price is fixed and determinable, collectability is reasonably assured, and control of the assets has passed to the customer based on the agreed upon shipping terms. Net sales are comprised of gross revenues less returns, trade discounts and allowances. The Company does not bill its customers’ freight and handling charges. All shipping and handling costs, which aggregated $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zUN9neAC3YTg" title="Shipping and handling costs">15.8 million</span>, $1<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zjweNgTFj4J4" title="Shipping and handling costs">0.0 million</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_dm_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zY0JwfAeM1h1" title="Shipping and handling costs">5.0 million</span> in 2022, 2021 and 2020, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. No one customer represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zx1mQONHCdHh" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zl4tEhw1aiDc" title="Concentration risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis__us-gaap--CreditRiskMember_zp1FFx6kRI5k" title="Concentration risk percentage">10</span></span></span>% or more of net sales in 2022, 2021 or 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> 15800000 0.00 5000000.0 0.10 0.10 0.10 <p id="xdx_844_eus-gaap--RevenueRecognitionSalesReturns_z7p0BdYoMiM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i><span id="xdx_860_znG0d2ejty9j">Sales Returns</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, the Company does not permit customers to return their unsold products. However, for U.S. based customers, we allow returns if properly requested, authorized and approved. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we consider include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records its estimate of potential sales returns as a reduction of sales and cost of sales with corresponding entries to accrued expenses, to record the refund liability, and inventory, for the right to recover goods from the customer. The refund liability associated with estimated returns was $<span id="xdx_905_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20221231_zCFt4jdf8MCa" title="Contract with customer, refund liability">8.6 million</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerRefundLiability_iI_dm_c20211231_zLcs09aPj7Gf" title="Contract with customer, refund liability">5.1 million</span> at December 31, 2022 and 2021, respectively, and the amounts recognized for the rights to recover products was $<span id="xdx_905_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20221231_zQ07imnqckr2" title="Contract with customer, right to recover products">3.2 million</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerRightToRecoverProduct_iI_dm_c20211231_zg7hST02UUib" title="Contract with customer, right to recover products">1.9 million</span> at December 31, 2022 and 2021, respectively. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.</p> 8600000 5100000 3200000 1900000 <p id="xdx_843_eus-gaap--RevenueRecognitionAllowances_z2AmnUnlhIpj" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zpZS8YHNN1fl">Payments to Customers</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company records revenues generated from purchase with purchase and gift with purchase promotions as sales and the costs of its purchase with purchase and gift with purchase promotions as cost of sales. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.</p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zeMtiqt9J2Se" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zIZybcTPiYQ3">Advertising and Promotion</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Advertising and promotional costs are expensed as incurred and recorded as a component of cost of goods sold (in the case of free goods given to customers) or selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $<span id="xdx_906_eus-gaap--AdvertisingExpense_dm_c20220101__20221231_zeSk5ejmEYTi" title="Advertising costs">212.4 million</span>, $<span id="xdx_90F_eus-gaap--AdvertisingExpense_dm_c20210101__20211231_zpHQx1SYHnx4" title="Advertising costs">171.1 million</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_dm_c20200101__20201231_zXYaz2S5P4y5" title="Advertising costs">91.7 million</span> for 2022, 2021 and 2020, respectively. Costs relating to purchase with purchase and gift with purchase promotions that are reflected in cost of sales aggregated $<span id="xdx_904_eus-gaap--MarketingExpense_dm_c20220101__20221231_zrgqRx4x4uSa" title="Customer incentives cost">43.1 million</span>, $<span id="xdx_90B_eus-gaap--MarketingExpense_dm_c20210101__20211231_z7zvnbf9HtXe" title="Customer incentives cost">36.9 million</span> and $<span id="xdx_903_eus-gaap--MarketingExpense_dm_c20200101__20201231_zay7hYHTG7H" title="Customer incentives cost">26.4 million</span> in 2022, 2021 and 2020, respectively.</p> 212400000 171100000 91700000 43100000 36900000 26400000 <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu3t5L63Puy1" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_864_zqec8gj621I2">Package Development Costs</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Package development costs associated with new products and redesigns of existing product packaging are expensed as incurred.</p> <p id="xdx_84F_eus-gaap--LessorLeasesPolicyTextBlock_z4lsvWV8hpZb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_862_zxkrSXeufu6">Operating Leases</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p> <p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zTPknOSUYTU3" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86A_zSbdHovAxh91">License Agreements</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s license agreements generally provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of approximately <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zo9amukjIzPk" title="License agreement term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0811">5</span></span> to <span id="xdx_90E_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zy2ifG3cCUF" title="License agreement term::XDX::P15Y"><span style="-sec-ix-hidden: xdx2ixbrl0813">15</span></span> years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, excluding potential renewal periods, range from approximately <span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zIYj9f8haO93" title="License agreement renewal term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0815">1</span></span> to <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zVWHIMy1FV46" title="License agreement renewal term::XDX::P12Y"><span style="-sec-ix-hidden: xdx2ixbrl0817">12</span></span> years. Under each license, the Company is required to pay royalties in the range of <span id="xdx_900_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z0wv4Auf7Rmh" title="Royalty expense, percentage of net sales">6</span>% to <span id="xdx_903_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z9rzqGvsAwB4" title="Royalty expense, percentage of net sales">10</span>% to the licensor, at least annually, based on net sales to third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In certain cases, the Company may pay an entry fee to acquire, or enter into, a license where the licensor or another licensee was operating a pre-existing fragrance business. In those cases, the entry fee is capitalized as an intangible asset and amortized over its useful life.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Most license agreements require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Company is exposed to certain concentration risk. Most of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses.</p> 0.06 0.10 <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zC92YBjg8SO2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_860_zWZrltbKXMm6">Income Taxes</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying financial statements.</p> <p id="xdx_849_eus-gaap--ConsolidationSubsidiaryStockIssuancesPolicy_zqHnXSRhwNe9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_86D_ziVu2DnrRlH1">Issuance of Common Stock by Consolidated Subsidiary</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The difference between the Company’s share of the proceeds received by the subsidiary and the carrying amount of the portion of the Company’s investment deemed sold, is reflected as an equity adjustment in the consolidated balance sheets.</p> <p id="xdx_843_eus-gaap--RepurchaseAgreementsCollateralPolicy_z4pTFMDyRIp9" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_861_zOSRLpHtTRY4">Treasury Stock</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Board of Directors may authorize share repurchases of the Company’s common stock (Share Repurchase Authorizations). Share repurchases under Share Repurchase Authorizations may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts within the parameters authorized by the Board. Shares repurchased under Share Repurchase Authorizations are held in treasury for general corporate purposes, including issuances under various employee stock option plans. Treasury shares are accounted for under the cost method and reported as a reduction of equity. Share Repurchase Authorizations may be suspended, limited or terminated at any time without notice.</p> <p id="xdx_80B_ecustom--ImpactOfCOVID19PandemicTextBlock_zmuAy07zyRm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(2)</td><td id="xdx_823_zTZ7NfolXM2g">Impact of COVID-19 Pandemic</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and in March 2020, the World Health Organization declared COVID-19 a pandemic. In response, various national, state, and local governments issued decrees prohibiting certain businesses from operating and certain classes of workers from reporting to work.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill and caused a significant unfavorable impact on our results of operations in 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Business significantly improved in the second half of 2020 and continued to improve throughout 2021 and 2022, as retail stores reopened, and consumers increased online purchasing. While we expect this trend to continue, the introduction of variants of COVID-19 in various parts of the world has caused the temporary re-implementation of governmental restrictions to prevent further spread of the virus. In addition, international air travel remains curtailed in many jurisdictions due to both governmental restrictions and consumer health concerns. While COVID-19 has significantly restricted international travel, the travel retail business is beginning to pick up. Lastly, the improved economy has put significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions have come at a time when demand for our product lines has never been stronger or more sustained. We have been addressing this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. We do not expect the supply chain bottlenecks to begin lifting until the second half of 2023. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic might continue to have adverse effects on our results of our operations, financial position and cash flows through at least the first half of 2023.</p> <p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_z4GAOYWVwyJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(3)</td><td id="xdx_820_zvvCe9AfJeN1">Recent Agreements</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Salvatore Ferragamo </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, we closed on a transaction agreement with Salvatore Ferragamo S.p.A., whereby an exclusive and worldwide license was granted for the production and distribution of Ferragamo brand perfumes. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in October 2021 and will last for 10 years with a 5-year optional term, subject to certain conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With respect to the management and coordination of activities related to the license agreement, the Company operates through a wholly-owned Italian subsidiary based in Florence, that was acquired from Salvatore Ferragamo on October 1, 2021. The acquisition together with the license agreement was accounted for as an asset acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Emanuel Ungaro</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2021, <span id="xdx_901_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--EmanuelUngarMember_z7orWVKIZK91" title="Description of recent agreement">we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand.</span> Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zGE1fIms7cI" title="Shares issue">65,342</span> shares of Inter Parfums, Inc. common stock valued at $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20220101__20221231__dei--LegalEntityAxis__custom--DonnaKaranAndDKNYMember_zP05Z3DKOrIh" title="Shares value">5</span>.0 million to the licensor. The exclusive license is effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021, <span id="xdx_90D_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_z1l2yFbEEYbc" title="Description of recent agreement">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $<span id="xdx_903_eus-gaap--ImpairmentChargeOnReclassifiedAssets_dm_c20210101__20210331__dei--LegalEntityAxis__custom--RochasFashionMember_zYTSjFo1J7o5" title="Impairment Charge on Reclassified Assets">2.4 million</span> impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span title="Description of recent agreement"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land and Building Acquisition - Future Headquarters in Paris</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In April 2021, Interparfums SA, our <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSASubsidiaryMember_z4n07UjPSSTf" title="Ownership percentage">73</span>% owned French subsidiary, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The purchase price includes the complete renovation of the site. As of December 31, 2022, $<span id="xdx_904_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231_z5jptVveA3dg" title="Purchase price, period cost">148.1 million</span> of the purchase price, including approximately $<span id="xdx_90F_eus-gaap--AcquisitionCosts_dm_c20220101__20221231_zKT9pTNyaDc6" title="Acquisition costs, period cost">4.4 million</span> of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022. The purchase price has been allocated approximately $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zDCgyiyNbLfc" title="Purchase price, period cost">61.1 million</span> to land and $<span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_dm_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zLQLzk0FdM0j" title="Purchase price, period cost">87.0 million</span> to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zGe7YQOs4dY3" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0862">7</span></span> to <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zZmef4g63Fse" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0864">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $<span id="xdx_905_eus-gaap--EscrowDeposit_iI_dm_c20221231_zKMnXiE3mdkl" title="Cash held in escrow is included in other assets">3.4 million</span> of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The acquisition was financed by a <span id="xdx_903_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z4VGt2LRdjB2" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0868">10</span></span>-year €<span id="xdx_906_eus-gaap--LineOfCredit_iI_pn6n6_uUSDEUR_c20221231_zKVvzG0WcZaf" title="Long-term line of credit">120</span> million (approximately $<span id="xdx_900_eus-gaap--LineOfCredit_iI_dm_c20221231_zfoF6FEzvm3c" title="Long-term line of credit">128.0 million</span>) bank loan which bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateTerms_c20220101__20221231_zCDYNEZyZR4h" title="Description of debt instrument interest rate terms">one-month Euribor plus 0.75%</span>. Approximately €<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zsMdkVzocId9" title="Debt instrument, face amount">80</span> million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> we also entered into a 10-year exclusive global licensing agreement a with a 5-year optional term subject to certain conditions, with Emanuel Ungaro Italia S.r.l, for the creation, development and distribution of fragrances and fragrance-related products, under the Emanuel Ungaro brand. 65342 5000000 we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value. 2400000 0.73 148100000 4400000 61100000 87000000.0 3400000 120000000 128000000.0 one-month Euribor plus 0.75% 80000000 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_z2H4TVyUgGs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(4)</td><td id="xdx_82C_zONtxktEjTW7">Inventories</td></tr></table> <p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden">Schedule of inventories</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">111,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">198,914</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_8A6_zJnpHd5uesY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Overhead included in inventory aggregated $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zcpC9lIdwDT5" title="Cost of Goods Sold, Overhead">3.4 million</span> and $<span id="xdx_903_eus-gaap--CostOfGoodsAndServicesSoldOverhead_dm_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zawROXE2RwDh">3.7 million</span> as of December 31, 2022 and 2021, respectively. Included in inventories is an inventory reserve, which represents the difference between the cost of the inventory and its estimated realizable value, based upon sales forecasts and the physical condition of the inventories. In addition, and as necessary, specific reserves for future known or anticipated events may be established. Inventory reserves aggregated $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_dm_c20221231_zRYbMeXh3tEl" title="Inventory Valuation Reserves">11.4 million</span> and $<span id="xdx_908_eus-gaap--InventoryValuationReserves_iI_dm_c20211231_zTjfvkqnMGke" title="Inventory Valuation Reserves">15.8 million</span> as of December 31, 2022 and 2021, respectively.</p> <p id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z7oYwKWZuzk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B0_zpCyl9Vyf21e" style="display: none; visibility: hidden">Schedule of inventories</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49B_20221231_zuLB1DUmGkle" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20211231_zIu7atxbfsV5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINz9tx_z4RvDJQBS63e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">111,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_maINz9tx_zkpzCrIlYzSk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">87,602</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryNet_iI_mtINz9tx_zlLrzFtQIBTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">198,914</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> 146772000 111312000 143212000 87602000 289984000 198914000 3400000 3700000 11400000 15800000 <p id="xdx_803_eus-gaap--FairValueDisclosuresTextBlock_z5WnGP2HTJMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(5)</td><td id="xdx_82B_zewNog1Z67i7">Fair Value of Financial Instruments</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">150,833</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">798</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0913">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> <b style="display: none; visibility: hidden">Total Assets</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Short-term investments</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0977">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0982">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <p id="xdx_8A0_zd20yXHgXpb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and cash equivalents including money market funds, short-term investments including marketable equity securities, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the variable interest rates on the Company’s indebtedness approximate current market rates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.</p> <p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zr4MtDoaT4r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z3sxCAafZhUk" style="display: none; visibility: hidden">Schedule of fair value, assets measured on recurring basis</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaVbI899jHLd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfCpLzfWHD5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDhn1dHHeSp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zS7GabQ3W1B6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zZNQIICgP5Ha" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zKIZuY46B7Ie" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">150,833</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">19,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">130,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">798</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InterestRateFairValueHedgeDerivativeAtFairValueNet_i01I_z58zZwbOrj1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0913">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">6,758</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zeNp2bM0n0Qk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,189</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AssetsFairValueDisclosure_i01I_zbwOnVZ3o3Rc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> <b style="display: none; visibility: hidden">Total Assets</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">158,780</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,861</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,122</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zpCI1rQ9uoN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zKtTaolKcQqh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zwN6OsO55WN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0938">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziz6gpFEeulj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zj5X0XUc3HHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKHwf2PRB3Zj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_490_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp5FUnJRPzg4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Measurements at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Quoted Prices in<br/> Active Markets for<br/> Identical Assets<br/> (Level 1)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zrOldU61kbd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCfuEvbH5Bad" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Short-term investments</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 14%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">160,014</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zEhgqY9w3Oof" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zheLXiI1NzP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,982</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_i01I_zvQWx6rdQmvi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InterestRateDerivativeLiabilitiesAtFairValue_iNI_di_zjjO0bgjYohe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Interest rate swaps</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0977">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(234</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_zOokjo3FxD19" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total liabilities</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0982">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,811</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> 150833000 19861000 130174000 798000 6758000 6758000 1189000 1189000 158780000 19861000 138122000 798000 68000 68000 68000 68000 160014000 160014000 1982000 1982000 63000 63000 234000 234000 1811000 1811000 <p id="xdx_801_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zpsKbcjSP5Fc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(6)</td><td id="xdx_823_z5OyFdJ7Zwd3">Derivative Financial Instruments</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial in each of the years in the three-year period ended December 31, 2022. Interest expense includes a gain of $<span id="xdx_902_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_z0Th4GfsSfD2" title="Loan amount">6.3 million</span> and $<span id="xdx_908_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_uUSD_c20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zLFSfFgqCEA8" title="Loan amount">0.2 million</span> in 2022 and 2021, respectively, resulting from an interest rate swap.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swap is included in other assets on the accompanying balance sheet for the period ended December 31, 2022 and was included in long-term debt on the accompanying balance sheet for the period ended December 31, 2021. The valuation of foreign currency forward exchange contracts at December 31, 2022 and December 31, 2021, resulted in an asset and is included in other current assets on the accompanying balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, the Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $<span id="xdx_907_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_dm_uUSD_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zzciTf9stfI8" title="Foreign currency contracts, liability, fair value disclosure">36.5 million</span>, which all have maturities of less than one year.</p> 6300000 200000 36500000 <p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zzPgk7acn2Uk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(7)</td><td id="xdx_829_z4yVTpn8yy73">Property, Equipment and Leasehold Improvements</td></tr></table> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">148,137</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements">59,689</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,293</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right">210,119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right">190,249</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">43,397</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">166,722</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_8A3_zznwfvvUieqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Depreciation and amortization expense was $<span id="xdx_908_eus-gaap--Depreciation_dm_c20220101__20221231_zCM1bM8qcIdf" title="Depreciation and amortization expense">7.5 million</span>, $<span id="xdx_90B_eus-gaap--Depreciation_dm_c20210101__20211231_zwixaZb6pDr7" title="Depreciation and amortization expense">4.4 million</span> and $<span id="xdx_903_eus-gaap--Depreciation_dm_c20200101__20201231_z5iqMiT4q11j" title="Depreciation and amortization expense">3.8 million</span> in 2022, 2021, and 2020, respectively.</p> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zfx9C1oJlR4h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BA_zOrbWgElSCf7" style="display: none; visibility: hidden">Schedule of equipment and leasehold improvements</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Land and Building (construction in progress)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqeksNzDdhmc" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">148,137</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_ze2ZFzDojYZ8" style="width: 10%; text-align: right" title="Equipment and leasehold improvements">136,131</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zfEit3eM4cYl" style="text-align: right" title="Equipment and leasehold improvements">59,689</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zEFKYW65VP01" style="text-align: right" title="Equipment and leasehold improvements">52,036</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zneIjngOwmj2" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,293</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zL1Ydd66LLfi" style="border-bottom: Black 1pt solid; text-align: right" title="Equipment and leasehold improvements">2,082</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zWw3Lyp6Meff" style="text-align: right">210,119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20211231_zQVBkPGjj7b1" style="text-align: right">190,249</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20221231_zbznPsrc2j6f" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">43,397</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_c20211231_zf5uZXXwvtZf" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">40,897</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20221231_zmfIxYkk4Vrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">166,722</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211231_z4eAjzKVrd4a" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net, Total">149,352</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> 148137000 136131000 59689000 52036000 2293000 2082000 210119000 190249000 43397000 40897000 166722000 149352000 7500000 4400000 3800000 <p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z7h8bft4ZVJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(8)</td><td id="xdx_822_zz9hd6R2SV27">Trademarks, Licenses and Other Intangible Assets</td></tr></table> <p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1040">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademarks (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right">41,267</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right">64</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right">41,203</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Licenses (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right">205,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right">63,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right">141,700</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right">17,849</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right">14,921</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right">2,928</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right">264,351</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right">185,831</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right">369,373</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right">290,853</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross <br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book <br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1061">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademarks (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right">43,820</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right">68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right">43,752</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Licenses (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right">109,682</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right">62,286</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right">47,396</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right">290,989</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right">214,047</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <p id="xdx_8A1_zeQ09ycLVty5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_dm_c20220101__20221231_ziBicTVGvRNe">6.8 million</span>, $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_dm_c20210101__20211231_zRSgahoBzRde">5.9 million</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_dm_c20200101__20201231_zrrZnnOOg6Eh">5.3 million</span> in 2022, 2021 and 2020, respectively. Amortization expense is expected to approximate $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_dxL_c20221231_zXscZXrnUoki" title="2023::XDX::7000000"><span style="-sec-ix-hidden: xdx2ixbrl1083">7.0</span></span> million in 2023, $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_dm_c20221231_zMd0BL1SBgxe" title="2024">13.3 million</span> in 2024, $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_dm_c20221231_z9ERUTqKJJYe" title="2025">12.3 million</span> in 2025, $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_dm_c20221231_zabK9mHOHGNh" title="2026"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_dm_c20221231_z8WZ84eTOJFa" title="2027">10.5 million</span></span> in 2026 and 2027. The weighted average amortization period for trademarks, licenses and other intangible assets with finite lives are <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_znS4kMqpChN3" title="Amortization period::XDX::P8Y"><span style="-sec-ix-hidden: xdx2ixbrl1093">18 </span></span>years, <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_ztClFyOdnMkg" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1094">14</span></span> years and <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVDNwAWPVYoh" title="::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1095">2</span></span> years, respectively, and <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231_zsIvae8lf0k8" title="::XDX::P14Y"><span style="-sec-ix-hidden: xdx2ixbrl1096">14</span></span> years on average.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company reviews intangible assets with indefinite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. There was an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_903_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zhTMH5ORxlr2" title="Impairment charge">6.8 million</span> and $<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_dm_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zWWEb43iMPY5">2.4 million</span> in 2022 and 2021, respectively, relating to our Rochas fashion business and an impairment charge for trademarks with indefinite useful lives of $<span id="xdx_907_eus-gaap--AssetImpairmentCharges_dm_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionBusinessMember_zlHEFoRLvQY4">0.9 million</span> in 2022 relating to our Intimate trademark. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of <span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zeFmOx2jwC1f" title="Weighted average cost of capital">9.80</span>%, <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z1vX5T2FQCJi">7.47</span>%, and <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20201231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z4MGmXYlzuB6">6.99</span>% as of December 31, 2022, 2021 and 2020, respectively. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. The Company believes that the assumptions it has made in projecting future cash flows for the evaluations described above are reasonable and currently no other impairment indicators exist for our indefinite-lived assets. However, if future actual results do not meet our expectations, the Company may be required to record an impairment charge, the amount of which could be material to our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of trademarks, licenses and other intangible assets with finite lives is being amortized by the straight-line method over the term of the respective license or the intangible assets estimated useful life which range from <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zWGvEvWj4cxb" title="Amortization period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1114">three</span></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z0j651Fi1xv6" title="Amortization period::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl1116">twenty years</span></span>. If the residual value of a finite life intangible asset exceeds its carrying value, then the asset is not amortized. The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Trademarks (finite lives) primarily represent Lanvin brand names and trademarks and in connection with their purchase, Lanvin was granted the right to repurchase the brand names and trademarks on July 1, 2027 for €70 million (approximately $<span id="xdx_904_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20221231_z72Xc9HoRtKl">7 5</span> million) (residual value) in accordance with an amendment signed in 2021. Because the residual value of the intangible asset exceeds its carrying value, the asset is not being amortized.</p> <p id="xdx_890_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zjtb9I7LEYm3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_ztzSmpZMM3Of" style="display: none; visibility: hidden">Schedule of trademarks, licenses and other intangible assets</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zus8isjvTpE5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z7GW27DUekF4" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1040">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zjF2ZF9a6UJ" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">105,022</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademarks (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBmEeFyCsuP2" style="text-align: right">41,267</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvjcHCUeSxf" style="text-align: right">64</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zwKPG3qXKOt9" style="text-align: right">41,203</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Licenses (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zLfrSccbRBE4" style="text-align: right">205,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zEAdw09DGff9" style="text-align: right">63,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zjglfJAc8g7i" style="text-align: right">141,700</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zaK2MtsMHHk8" style="border-bottom: Black 1pt solid; text-align: right">17,849</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zheljbwAra66" style="border-bottom: Black 1pt solid; text-align: right">14,921</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z5s3ajK9OaI4" style="border-bottom: Black 1pt solid; text-align: right">2,928</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_z5LhyUxAhfX6" style="border-bottom: Black 1pt solid; text-align: right">264,351</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zBQKR7vee4ai" style="border-bottom: Black 1pt solid; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zFoSEqaPRS28" style="border-bottom: Black 1pt solid; text-align: right">185,831</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zHvuiiCStnX3" style="border-bottom: Black 2.5pt double; text-align: right">369,373</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9aoDj8l0jOk" style="border-bottom: Black 2.5pt double; text-align: right">78,520</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zceYFUFSbSli" style="border-bottom: Black 2.5pt double; text-align: right">290,853</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross <br/> Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book <br/> Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-bottom: 1pt">Trademarks (indefinite lives)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zXJXDywob8H1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Gross Amount">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPvV8lW9PGu1" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1061">—</span></td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zMfjHtEbbGs2" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Net Book Value">119,712</td><td style="width: 1%; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademarks (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zmIHkoktPd7a" style="text-align: right">43,820</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zm28o85jLmth" style="text-align: right">68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_z1AlnW2Xyvw3" style="text-align: right">43,752</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Licenses (finite lives)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7rq3dlvXTCi" style="text-align: right">109,682</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zhvVyoGXouv5" style="text-align: right">62,286</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z8MXQHPGLele" style="text-align: right">47,396</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other intangible assets (finite lives)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zFSZzK9PvdP9" style="border-bottom: Black 1pt solid; text-align: right">17,775</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zXyWWv4eUEbg" style="border-bottom: Black 1pt solid; text-align: right">14,588</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zffaISsiEOX1" style="border-bottom: Black 1pt solid; text-align: right">3,187</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 0.125in">Subtotal</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zCBD7uOYdIb6" style="border-bottom: Black 1pt solid; text-align: right">171,277</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zkQsOrS8ov2a" style="border-bottom: Black 1pt solid; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231__us-gaap--FairValueByAssetClassAxis__custom--SubtotalMember_zPBU1eWTmx4j" style="border-bottom: Black 1pt solid; text-align: right">94,335</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.625in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20211231_zOsd7UZNVpqb" style="border-bottom: Black 2.5pt double; text-align: right">290,989</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20211231_ztXmV0ojtwWf" style="border-bottom: Black 2.5pt double; text-align: right">76,942</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20211231_zlTMk2ApZRbj" style="border-bottom: Black 2.5pt double; text-align: right">214,047</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> 105022000 105022000 41267000 64000 41203000 205235000 63535000 141700000 17849000 14921000 2928000 264351000 78520000 185831000 369373000 78520000 290853000 119712000 119712000 43820000 68000 43752000 109682000 62286000 47396000 17775000 14588000 3187000 171277000 76942000 94335000 290989000 76942000 214047000 6800000 5900000 5300000 13300000 12300000 10500000 10500000 6800000 2400000 900000 0.0980 0.0747 0.0699 7000000 <p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zfFpH5PpqeDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(9)</td><td><span id="xdx_824_zBsQzl8NGjl">Accrued Expenses</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zk4nlSz7Fm3e">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Advertising liabilities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42,338</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">31,215</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Salary (including bonus and related taxes)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,993</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Royalties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,154</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Due vendors (not yet invoiced)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105,869</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Retirement reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,234</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Refund (return) liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,604</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,128</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,149</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><b style="display: none; visibility: hidden">Total</b></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">213,621</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">136,677</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8A7_z3YQAjvVt3Rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in"> </p> <p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z4LC22hlNlV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zk4nlSz7Fm3e">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20221231_zlYimrUPDYEa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td colspan="2" id="xdx_49B_20211231_zqLUMzSRM33d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedAdvertisingCurrent_iI_maALCzkev_zH7O6VjEiMu5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Advertising liabilities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42,338</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">31,215</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_maALCzkev_zupVDSPuleM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Salary (including bonus and related taxes)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,993</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedRoyaltiesCurrent_iI_maALCzkev_ztiBC4UeFMW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Royalties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,154</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--DueVendorsNotYetInvoiced_iI_maALCzkev_zSFSAMrJIkBg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Due vendors (not yet invoiced)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105,869</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent_iI_maALCzkev_zS1Y1fHXjS4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Retirement reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,234</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CustomerRefundLiabilityCurrent_iI_maALCzkev_zGZE8YyTyn26" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Refund (return) liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,604</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,128</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzkev_zp35iBsWCb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,149</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,246</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_mtALCzkev_zEBtn1N6ft05" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><b style="display: none; visibility: hidden">Total</b></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">213,621</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">136,677</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 42338000 31215000 21128000 19993000 26532000 19154000 105869000 45707000 8001000 10234000 8604000 5128000 1149000 5246000 213621000 136677000 <p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zWWvHPes4W7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(10)</td><td><span id="xdx_823_zVsRs3VmVzEf">Loans Payable – Banks</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Loans payable – banks consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its domestic subsidiaries have available a $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zSvSlrua0U5b" title="Line of credit, maximum borrowing amount">20 million</span> unsecured revolving line of credit due on demand, which bears interest at the daily Secured Overnight Financing Rate (“SOFR”) plus <span id="xdx_90B_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zYLPXJapi36a" title="Basis spread over variable interest rate">2</span>% (the SOFR was <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zf2wEZRDgLT3" title="Variable rate">4.3</span>% as of December 31, 2022). The line of credit which has a maturity date of <span id="xdx_90D_eus-gaap--LineOfCreditFacilityExpirationDate1_ddpxL_c20220101__20221231__us-gaap--VariableRateAxis__custom--LondonInterbankOfferedRateMember__dei--LegalEntityAxis__custom--DomesticSubsidiariesMember_zOIGxK6Ah7y7" title="::XDX::2023-12-15"><span style="-sec-ix-hidden: xdx2ixbrl1154">December 15, 2023</span></span>, is expected to be renewed on an annual basis. Borrowings outstanding pursuant to lines of credit were zero as of December 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s foreign subsidiaries have available credit lines, including several bank overdraft facilities totaling approximately $<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zOTqYWKWmLyl">20</span> million. These credit lines bear interest at EURIBOR plus between <span id="xdx_90F_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MinimumMember_zoZlAWLpGPic" title="Basis spread over variable interest rate">0.6</span>% and <span id="xdx_90E_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20220101__20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember__srt--RangeAxis__srt--MaximumMember_z5O2OZQtFDba" title="Basis spread over variable interest rate">0.9</span>% (EURIBOR was minus <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--VariableRateAxis__custom--EuroInterbankOfferedRateMember__dei--LegalEntityAxis__custom--ForeignSubsidiariesMember_zqXxBh8x2uIi" title="Variable rate">0.576</span>% at December 31, 2022). Borrowings outstanding pursuant to these bank overdraft facilities were zero as of December 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As there were no borrowings outstanding as of December 31, 2022 and 2021, there is no weighted average interest rate on short-term borrowings as of December 31, 2022 and 2021.</p> 20000000 0.02 0.043 20000000 0.006 0.009 0.00576 <p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zXDC79Sujj8c" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(11)</td><td><span id="xdx_826_zpKuRONIxAV8">Long-Term Debt</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B6_zftsybzXQda9">Long-term debt consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj">53.3</span> million payable in <span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments">48</span> equal monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)">1.1 million</span> beginning in December 2022, bearing interest at one-month Euribor plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum">0.825</span>%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable">52,061</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1183">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i">135.9</span> million payable in <span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf">0.75</span>%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right">104,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right">124,375</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf">15.0</span> million payable in <span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments">14</span> equal annual installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum">4.1</span>% per annum</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right">9,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right">10,569</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6">17</span> million payable in <span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments">10</span> equal annual installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum">2.0</span>% per annum</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable">13,332</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right">13,859</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right">180,041</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right">148,803</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">28,547</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">151,494</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"><span style="-sec-ix-hidden: xdx2ixbrl1216">132,892</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <p id="xdx_8A8_z5HmvadJDHEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, to finance Interparfums SA’s acquisition of the Lacoste trademark, the Company entered into a $53.3 million (€<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zQT8YHh7sZk7">50</span> million) four-year loan agreement. <span id="xdx_908_eus-gaap--LongTermDebtDescription_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zo0dolFaZI1g" title="Debt description">The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum.</span> The swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, to finance the acquisition of Interparfums SA’s future corporate headquarters, the Company entered into a $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_dm_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z8Fs8D40OnTe">128.0 million</span> (€<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_uUSDEUR_c20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zAjWWQRyuBv2">120</span> million) ten-year credit agreement.<span id="xdx_90E_eus-gaap--LongTermDebtDescription_c20210401__20210430__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zaZaVlRPeZS" title="Debt description"> Approximately $85.3 million (€80.0 million) of the variable rate debt was swapped for variable interest rate debt with maximum rate of 2% per annum. </span>The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Maturities of long-term debt subsequent to December 31, 2022 are approximately $<span id="xdx_907_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_dm_c20221231_zXSKH0X9ZWa5" title="Long-term Debt, Maturities, 2021">30.4 million</span> in 2023 and $<span id="xdx_909_eus-gaap--LongTermDebtDescription_c20220101__20221231_zZdNR4ZToCMj" title="Long term debt maturity, description">28.7 million per year thereafter through 2033.</span></p> <p id="xdx_897_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zNW8mmxRL0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B6_zftsybzXQda9">Long-term debt consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zAkXz7nmCCpj">53.3</span> million payable in <span id="xdx_904_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zebilTCgzuyd" title="Number of installments">48</span> equal monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDw4TKuRbmrh" title="Installment amount (in Dollars)">1.1 million</span> beginning in December 2022, bearing interest at one-month Euribor plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zr7fx0OZPrkd" title="Interest per annum">0.825</span>%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zwtN9JCg2hc6" style="width: 10%; text-align: right" title="Loan payable">52,061</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--LoansPayableMember_zDTeK6YU8aza" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1183">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zBj6ukyWO90i">135.9</span> million payable in <span id="xdx_905_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zxBzaCAJeub3" title="Number of installments">120</span> equal monthly installments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_z9LDYPQS0D26">1.1 million</span> beginning in April 2021, bearing interest at one-month Euribor plus <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zheEMY577OQf">0.75</span>%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zWgXjtVSnDK" style="text-align: right">104,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableOneMember_zgKROT1v3bY1" style="text-align: right">124,375</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">$<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zljF3MzsMtrf">15.0</span> million payable in <span id="xdx_908_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zYWnENyuIXO6" title="Number of installments">14</span> equal annual installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zp4xWhZ5GOKh">1.1 million</span> beginning in January 2020 including interest imputed at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zZy5MxSisiRe" title="Interest per annum">4.1</span>% per annum</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zEy388ZYZwKd" style="text-align: right">9,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableTwoMember_zz7DZZhPS7q3" style="text-align: right">10,569</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt">$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn6n6_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zf4nKV9omaf6">17</span> million payable in <span id="xdx_90C_ecustom--NumberOfInstallment_iI_pid_uN_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z7wrAhjhy6J4" title="Number of installments">10</span> equal annual installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_dm_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zgOI1XtEQNP8">1.7 million</span> beginning in October 2021 including interest imputed at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_zrMNvOhBgXoj" title="Interest per annum">2.0</span>% per annum</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_znVO1Sky6Dbi" style="border-bottom: Black 1pt solid; text-align: right" title="Loan payable">13,332</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--LoansPayableThreeMember_z2UvAaU130T6" style="border-bottom: Black 1pt solid; text-align: right">13,859</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20221231_zylJI0om3L17" style="text-align: right">180,041</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231_zMoO37yIT6Hf" style="text-align: right">148,803</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_c20221231_zAgaWtyzjBY4" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">28,547</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_iI_c20211231_zZ7pop3KQOg3" style="border-bottom: Black 1pt solid; text-align: right" title="Less current maturities">15,911</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1.25in; text-indent: -0.125in; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zsiKcJSz6wR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">151,494</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_dxL_c20211231_z8hBpbFeAyp4" style="border-bottom: Black 2.5pt double; text-align: right" title="::XDX::132902"><span style="-sec-ix-hidden: xdx2ixbrl1216">132,892</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> 53300000 48 1100000000 0.00825 52061000 135900000 120 1100000000 0.0075 104758000 124375000 15000000.0 14 1100000000 0.041 9890000 10569000 17000000 10 1700000000 0.020 13332000 13859000 180041000 148803000 28547000 15911000 151494000 50000000 The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. 128000000.0 120000000 Approximately $85.3 million (€80.0 million) of the variable rate debt was swapped for variable interest rate debt with maximum rate of 2% per annum. 30400000 28.7 million per year thereafter through 2033. <p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTwr7Ra7eKO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(12)</td><td><span id="xdx_822_zv6FdTOer5w7">Commitments</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Leases</p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices, warehouses and vehicles, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the weighted average remaining lease term was <span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtxL_c20221231_zYWOvqd8k7Z" title="Weighted average remaining lease term::XDX::P5Y9M18D"><span style="-sec-ix-hidden: xdx2ixbrl1234">5.8</span></span> years and the weighted average discount rate used to determine the operating lease liability was <span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--OperatingLeaseMember_zmmFrMrS3QQ3" title="Operating lease, weighted average discount rate">2.6</span>%. Rental expense related to operating leases was $<span id="xdx_906_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20220101__20221231_zDmGhOiSjPBb" title="Operating lease of related to rental expenses">5.6 million</span>, $<span id="xdx_90C_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20210101__20211231_zOpXgtuxey95" title="Operating lease of related to rental expenses">8.2 million</span>, and $<span id="xdx_90D_ecustom--OperatingLeaseOfRelatedToRentalExpenses_dm_c20200101__20201231_z6e3ua44YPd5" title="Operating lease of related to rental expenses">6.2 million</span> for the years ended December 31, 2022, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $<span id="xdx_90C_eus-gaap--OperatingLeasePayments_dm_c20220101__20221231_zOycA2qmyVT8" title="Operating lease payments">4.9 million</span> and noncash additions to operating lease assets totaled $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_dm_c20220101__20221231_zCokZCjQiWch" title="Noncash additions to operating lease assets">0.3 million</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B6_zJZSArOFca1k">Maturities of lease liabilities subsequent to December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023">5,723</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024">5,971</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025">4,847</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026">4,049</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">2027</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027">4,060</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Thereafter</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">6,913</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"> </td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total">31,563</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><span style="font-size: 10pt">Less imputed interest (based on 2.6%</span> weighted-average discount rate)</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)">(1,932</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total">29,631</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <p id="xdx_8AD_zy90NeZibwc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; color: Red"> </p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">License Agreements</p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description">The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, <span id="xdx_8B6_zLKFQSlOwCib">minimum annual royalties and other commitments as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands) </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023">217,852</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024">224,201</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025">218,047</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026">139,348</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027">132,502</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Thereafter</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">986,434</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,918,384</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/> <p id="xdx_8AB_zqW0gUZLUbSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 40.5pt; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods. The above figures do not reflect the fact that our distributors share our advertising obligations. Royalty expense included in selling, general, and administrative expenses, aggregated $<span id="xdx_906_eus-gaap--RoyaltyExpense_dm_c20220101__20221231_zJ4Vw88JOFd" title="Royalty expense">87.0 million</span>, $<span id="xdx_900_eus-gaap--RoyaltyExpense_dm_c20210101__20211231_zEFGKRKYN0Kl" title="Royalty expense">68.9 million</span> and $<span id="xdx_90B_eus-gaap--RoyaltyExpense_dm_c20200101__20201231_zKT2XSaeLDt6" title="Royalty expense">41.1 million</span>, in 2022, 2021 and 2020, respectively, and represented <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20220101__20221231_zja2h94g7ujk" title="Royalty expense, percentage of net sales">8.0</span>%, <span id="xdx_90A_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20210101__20211231_zfGTtDuPHMu" title="Royalty expense, percentage of net sales">7.8</span>% and <span id="xdx_907_ecustom--RoyaltyExpenseNetSalesPercentage_pid_dp_uPure_c20200101__20201231_zAIxykTL3msl" title="Royalty expense, percentage of net sales">7.6</span>% of net sales for the years ended December 31, 2022, 2021 and 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.026 5600000 8200000 6200000 4900000 300000 <p id="xdx_898_ecustom--ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock_zvYH3oyJXIA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B6_zJZSArOFca1k">Maturities of lease liabilities subsequent to December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(In thousands)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20221231_zqLk3QiYf3Rj" style="width: 10%; text-align: right" title="2023">5,723</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20221231_zzZ6LX4BvbD4" style="text-align: right" title="2024">5,971</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20221231_zpKrpeHoIr1" style="text-align: right" title="2025">4,847</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20221231_zkBsH1Uaf9ab" style="text-align: right" title="2026">4,049</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">2027</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20221231_zwYCESEDmb73" style="text-align: right" title="2027">4,060</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Thereafter</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20221231_zyZCLruLmldf" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">6,913</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"> </td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20221231_zftHDJbBHSZk" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Total">31,563</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><span style="font-size: 10pt">Less imputed interest (based on 2.6%</span> weighted-average discount rate)</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--LessImputedInterestBasedOn2.6WeightedaverageDiscountRate_iNI_di_c20221231_z1GWyajjbQ7j" style="border-bottom: Black 1pt solid; text-align: right" title="Less imputed interest (based on 2.6% weighted-average discount rate)">(1,932</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueNetTotal_iI_c20221231_z6HYWZOlqmYl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Total">29,631</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> 5723000 5971000 4847000 4049000 4060000 6913000 31563000 1932000 29631000 <p id="xdx_891_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_zNRcjHKMdYAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement_c20220101__20221231_zr15oPvrYtr5" title="License agreement, expiration description">The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033.</span> In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, <span id="xdx_8B6_zLKFQSlOwCib">minimum annual royalties and other commitments as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">(In thousands) </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_c20221231_zJgsEHrVoAGc" style="width: 10%; text-align: right" title="2023">217,852</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherCommitmentDueInSecondYear_iI_c20221231_zNL4OeVPZKYi" style="text-align: right" title="2024">224,201</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OtherCommitmentDueInThirdYear_iI_c20221231_zkDDJzFKesbk" style="text-align: right" title="2025">218,047</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherCommitmentDueInFourthYear_iI_c20221231_zVJRcC028D5g" style="text-align: right" title="2026">139,348</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OtherCommitmentDueInFifthYear_iI_c20221231_zM0WMjbHkbSk" style="text-align: right" title="2027">132,502</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Thereafter</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--OtherCommitmentDueAfterFifthYear_iI_c20221231_zma3kShz1MEc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">986,434</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OtherCommitment_iI_c20221231_zJKytjr4JKE1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,918,384</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"/> The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2033. 217852000 224201000 218047000 139348000 132502000 986434000 1918384000 87000000.0 68900000 41100000 0.080 0.078 0.076 <p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0xEZThRjPSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(13)</td><td><span id="xdx_824_z4QG4D9JjvZj">Equity</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Share-Based Payments</p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbUkuxEy131l" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1304">four</span></span> to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUm5qZQr8np4" title="Share-based compensation arrangement by share-based payment award, award vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1306">five</span></span>-year period. The fair value of shares vested aggregated $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQiTTmRm9Ryg">1.3 million</span>, $<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zNTy7pkKCtLa" title="Fair value of shares vested">1.4 million</span> and $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqrJtdNf4GM">1.7 million</span> in 2022, 2021 and 2020, respectively. <span style="font-family: Times New Roman, Times, Serif">Compensation cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. </span>It is generally the Company’s policy to issue new shares upon exercise of stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zFjpmdCfOPe7">The following table sets forth information with respect to nonvested options for 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Nonvested options – beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year">209,510</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">13.45</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">20.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(102,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.93</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options – end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year">168,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">16.31</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z2lp4EWwj9ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zaFiKtjKr3b5">The effect of share-based payment expenses decreased income statement line items as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Income before income taxes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes">3,143</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes">3,030</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,040</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zmgo6RZltrt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z10lqP2NV1bl">The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b> </p></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b> </p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Shares under option - beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">524,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">57.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right">815,800</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right">49.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted">97.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right">69.11</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised">(136,880</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised">43.86</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right">28.99</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> Options forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(8,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited">67.65</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"> Shares under option - end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">441,580</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year">67.30</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right">713,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right">52.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_8A7_zMusYQdqpD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December 31, 2022, options for <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zRbzGPHLcDW9" title="Number of shares available for grant (in shares)">558,975</span> shares were available for future grant under the plans. The aggregate intrinsic value of options outstanding is $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zPczbZ4CHEe9" title="Aggregate intrinsic value of options outstanding">13.0 million</span> as of December 31, 2022 and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20221231__us-gaap--DebtInstrumentAxis__custom--StockOptionOneMember_zrJOO8xEv2Zk" title="Aggregate intrinsic value of options outstanding">2.7 million</span>, which will be recognized over the next <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dxL_c20220101__20221231__us-gaap--DebtInstrumentAxis__us-gaap--StockOptionMember_zNds05itzyhh" title="Term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1418">five</span></span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted average fair values of options granted by Inter Parfums, Inc. during 2022, 2021 and 2020 were $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3ts39aUaVf" title="Weighted average grant date fair value (in dollars per share)">20.36</span>, $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqCA6fheI8Gb" title="Weighted average grant date fair value (in dollars per share)">11.35</span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGXHMgADgBg2" title="Weighted average grant date fair value (in dollars per share)">12.16</span> per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zZGs8M9wlPE9">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average expected option life</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">4.0 years</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1434">5.0 years</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">5.0 years</span></span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.5</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AB_zjBkLAW2FMue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would maintain its current payout ratio as a percentage of earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zZTZ2TudDlj9">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,003</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,393</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,771</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax benefits</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,760</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zXo8dwKlRsok" style="margin-top: 0; margin-bottom: 0">  </p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B1_zT9VrNCHVHH3">The following table summarizes additional stock option information as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding weighted average remaining contractual life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options exercisable</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 27%; text-align: center"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1">40.15</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)">46.90</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding">103,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"><span style="-sec-ix-hidden: xdx2ixbrl1475">0.96</span></span> years</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable">101,860</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">$<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8">62.18</span> - $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm">69.11</span></span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding">139,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"><span style="-sec-ix-hidden: xdx2ixbrl1483">2.04</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable">97,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb">73.09</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right">136,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1488">3.00</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right">73,780</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi">97.84</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"><span style="-sec-ix-hidden: xdx2ixbrl1492">5.85</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1493">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-size: 10pt">Totals</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right">441,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"><span style="-sec-ix-hidden: xdx2ixbrl1495">2.62</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right">272,850</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/> <p id="xdx_8A2_zbPfi6PqJBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the weighted average exercise price of options exercisable was $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uUSDPShares_c20221231_ztPpZ95AvzX" title="Weighted average exercise price of options exercisable">59.46</span> and the weighted average remaining contractual life of options exercisable is <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20220101__20221231_zEGDcIwT5I72" title="Weighted average remaining contractual life of options exercisable::XDX::P1Y10M17D"><span style="-sec-ix-hidden: xdx2ixbrl1500">1.88</span></span> years. The aggregate intrinsic value of options exercisable at December 31, 2022 is $<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_dm_c20221231_zWPFWaH7sF3f" title="Aggregate intrinsic value of options exercisable">10.1 million</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums SA approved a plan to grant an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zolqUtSNVf35" title="Adjusted for stock splits (in shares)">26,600</span> shares of its stock to employees with no performance condition requirement, and an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zKV5xx7gtrzh" title="Aggregate intrinsic value of options outstanding">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220627__20220630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zmz0K9mMiMia" title="Shares adjusted for stock splits">211,955</span> shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $<span id="xdx_908_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_dm_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zpMHa71JZO72" title="Recognized as compensation cost">4.8 million</span> was recognized as compensation cost on a straight-line basis over the requisite <span id="xdx_909_eus-gaap--DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_dxL_c20220101__20221231_zn6Zy3HzEP4i" title="Straight line basis over the requisite::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1512">three</span></span>-year service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2022, Interparfums SA approved an additional plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z6WQrzRaEvP4">88,400</span> shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of <span id="xdx_904_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4xDvfHemfK7" title="Number of share distributed">85,062</span> has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20220101__20221231__srt--OwnershipAxis__custom--InterparfumsSAMember_z7xoxRrTw8na">4.1 million</span> will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. During the year ended December 31, 2022, the Company acquired <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zvzvYImHjQzh">63,281</span> shares at an aggregate cost of $<span id="xdx_902_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231_z1yhgjJBhuJ3" title="Aggregate cost">3.0</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Dividends</p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2019, our Board of Directors authorized a <span id="xdx_90B_ecustom--PercentageOfIncreaseInAnnualDividend_pid_dp_c20191001__20191031_zq1BtKsWXw1j" title="Percentage of increase in annual dividend">20</span>% increase in the annual dividend to $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20191031_zT4bsZb7yhz">1.32</span> per share on an annual basis. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend. In February 2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. In February 2022, the Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share and in February 2023, the Board of Directors further increased the annual dividend to $<span id="xdx_90C_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210228__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zn5dEgZpNPql" title="Dividends payable, amount per share (in dollars per share)">2.50</span> per share. The next quarterly cash dividend of $<span id="xdx_908_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3H9aLSa9j2g" title="Dividends payable, amount per share (in Dollars per share)">0.625</span> per share is payable on March 31, 2023 to shareholders of record on March 15, 2023.</p> 1300000 1400000 1700000 <p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTb42Y8Srq7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zFjpmdCfOPe7">The following table sets forth information with respect to nonvested options for 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Nonvested options – beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20220101__20221231_zzgYhZnb1jF1" style="width: 10%; text-align: right" title="Nonvested options - beginning of year">209,510</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_uUSDPShares_c20220101__20221231_zuCbJdqjut1c" style="width: 10%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning of year">13.45</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zLiQtgkpeyob" style="text-align: right" title="Nonvested options granted">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_z7xOmyJCkvq1" style="text-align: right" title="Weighted Average Grant Date Fair Value, granted">20.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20220101__20221231_zAy05Do3ElPf" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(102,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220101__20221231_zrFA7lEoE1Q7" style="text-align: right" title="Weighted Average Grant Date Fair Value, vested or forfeited">12.93</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options – end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20220101__20221231_zpTZuICFdaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options - end of year">168,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_uUSDPShares_c20220101__20221231_zJdycW9sf2ud" style="text-align: right" title="Weighted Average Grant Date Fair Value, end of year">16.31</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 209510 13.45 62000 20.36 102780 12.93 168730 16.31 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_ziYc9dPwzTE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zaFiKtjKr3b5">The effect of share-based payment expenses decreased income statement line items as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Income before income taxes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z4JvFUraIA72" style="width: 10%; text-align: right" title="Income before income taxes">3,143</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zLqw9FGpFaN2" style="width: 10%; text-align: right" title="Income before income taxes">2,850</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zAqTWWAFJ7g8" style="width: 10%; text-align: right" title="Income before income taxes">3,030</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_z33mqbSBi9n9" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zVZV4NdykLOd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">1,880</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zGeabsAdM377" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">2,040</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted earnings per share attributable to Inter Parfums, Inc.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zJN0uOvAkeY5" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zrNnwsix92o9" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--OperatingIncomeLossMember_zYuSPMQdcIk7" style="text-align: right" title="Diluted earnings per share attributable to Inter Parfums, Inc">0.06</td><td style="text-align: left"> </td></tr> </table> 3143000 2850000 3030000 2036000 1880000 2040000 0.06 0.06 0.06 <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zrHXehwY2W0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z10lqP2NV1bl">The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b> </p></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b> </p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Shares under option - beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220101__20221231_zY4XLsiv5slh" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">524,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20220101__20221231_zE8mTW31nEJh" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">57.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210101__20211231_z1emwTadQle5" style="width: 10%; text-align: right" title="Options shares under option - beginning of year">713,210</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20210101__20211231_z5MeCWQV8wK3" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">52.74</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200101__20201231_zcxu8vezyKX7" style="width: 10%; text-align: right">815,800</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20200101__20201231_zLBfSjwmteB1" style="width: 10%; text-align: right">49.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220101__20221231_zgJjwq1En5pc" style="text-align: right" title="Options granted">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zOMMYa48bIj2" style="text-align: right" title="Weighted average exercise price options granted">97.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210101__20211231_zjt85imfQWoh" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zpcamiKif4rg" style="text-align: right" title="Weighted average exercise price options granted">62.18</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200101__20201231_zHfAk8PaOY3l" style="text-align: right" title="Options granted">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_z8WmjCG1yL1g" style="text-align: right">69.11</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220101__20221231_zYDvrEohnwUh" style="text-align: right" title="Options exercised">(136,880</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zqLbS6PSoD5" style="text-align: right" title="Weighted average exercise price options exercised">43.86</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20210101__20211231_zww8QpHJLjvc" style="text-align: right" title="Options exercised">(156,490</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zOaNY4cb5gS3" style="text-align: right" title="Weighted average exercise price options exercised">34.46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200101__20201231_zRAT35E48rp6" style="text-align: right" title="Options exercised">(95,570</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zKsUflL3QCll" style="text-align: right">28.99</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> Options forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220101__20221231_zEdLIoQPv33d" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(8,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20220101__20221231_zDjudhORdhdj" style="text-align: right" title="Weighted average exercise price options forfeited">67.65</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210101__20211231_zSOJg0kFER0k" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(40,820</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20210101__20211231_zAmBsFfGnqed" style="text-align: right" title="Weighted average exercise price options forfeited">62.57</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200101__20201231_zRq9QkHRGCw2" style="border-bottom: Black 1pt solid; text-align: right" title="Options forfeited">(16,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20200101__20201231_zc4O3jtqsoM6" style="text-align: right">58.38</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"> Shares under option - end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220101__20221231_z5lft4byEKZ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">441,580</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20220101__20221231_zdKa79sBVUz9" style="text-align: right" title="Weighted average exercise price shares under option - end of year">67.30</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20210101__20211231_zQT3Txypfihh" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">524,900</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20210101__20211231_zBebrJ6ZpNSc" style="text-align: right" title="Weighted average exercise price shares under option - end of year">57.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20200101__20201231_zv9OEwZ7nGkf" style="border-bottom: Black 2.5pt double; text-align: right">713,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20200101__20201231_znniKLTUdBU7" style="text-align: right">52.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 524900 57.58 713210 52.74 815800 49.89 62000 97.84 9000 62.18 9000 69.11 136880 43.86 156490 34.46 95570 28.99 8440 67.65 40820 62.57 16020 58.38 441580 67.30 524900 57.58 713210 52.74 558975 13000000.0 2700000 20.36 11.35 12.16 <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWUEE7AtQwF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zZGs8M9wlPE9">The assumptions used in the Black-Scholes pricing model are set forth in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zvqGz0A99Xo1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20210101__20211231_zPtMYzHRmHjd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20200101__20201231_zrBSm5nyZENj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pii_dp_uPure_z4ycrG1QcEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Weighted-average expected stock-price volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average expected option life</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220101__20221231_zjNoJmidEBVb" style="text-align: right" title="Weighted-average expected option life::XDX::P4Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">4.0 years</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210101__20211231_zsYfBf8QcdY" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1434">5.0 years</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20200101__20201231_zt8bDjRsKLIc" style="text-align: right" title="Weighted-average expected option life::XDX::P5Y"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">5.0 years</span></span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pii_dp_uPure_zHJwLWyydEF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pii_dp_uPure_zlgi0aZR2cZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.5</td><td style="text-align: left">%</td></tr> </table> 0.26 0.25 0.25 0.040 0.004 0.014 0.024 0.016 0.025 <p id="xdx_897_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z4ePvp53YnLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BA_zZTZ2TudDlj9">Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49F_20220101__20221231_zlHF582uBKjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49C_20210101__20211231_znzirrOSbhZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_499_20200101__20201231_zApitgCAiwke" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--ProceedsFromStockOptionsExercised_ziyhKmcZqGo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">6,003</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,393</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,771</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_zKAscnXB1GWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax benefits</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_zen1DsmwZXbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,760</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,873</td><td style="text-align: left"> </td></tr> </table> 6003000 5393000 2771000 800000 1300000 400000 6760000 7800000 2873000 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqiPs7fzhrO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B1_zT9VrNCHVHH3">The following table summarizes additional stock option information as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise prices</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options outstanding weighted average remaining contractual life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options exercisable</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 27%; text-align: center"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmiIjmogqDx1">40.15</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z4N7WzoJBoT2" title="Exercise price range (in dollars per share)">46.90</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0fom8s52sOa" style="width: 22%; text-align: right" title="Options outstanding">103,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXdbYmteBI3e" title="Options outstanding weighted average remaining contractual life::XDX::P0Y11M15D"><span style="-sec-ix-hidden: xdx2ixbrl1475">0.96</span></span> years</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z2iBWc6YDRn" style="width: 22%; text-align: right" title="Options exercisable">101,860</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">$<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zF29Ycx7PGg8">62.18</span> - $<span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zTR4p5QusXm">69.11</span></span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zwFiXSWGihpe" style="text-align: right" title="Options outstanding">139,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ze9B4J03BnXk" title="Options outstanding weighted average remaining contractual life::XDX::P2Y0M15D"><span style="-sec-ix-hidden: xdx2ixbrl1483">2.04</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOYATfKF2b2i" style="text-align: right" title="Options exercisable">97,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zQGeXPx396zb">73.09</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzcc5E5Wsl0b" style="text-align: right">136,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zdIgktEVqGb5" title="::XDX::P3Y0M0D"><span style="-sec-ix-hidden: xdx2ixbrl1488">3.00</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_za9UT1KlUgDi" style="text-align: right">73,780</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBjinIZJAwfi">97.84</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3OX2oxbR7yk" style="border-bottom: Black 1pt solid; text-align: right">62,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zxQ61zomiuTi" title="::XDX::P5Y10M6D"><span style="-sec-ix-hidden: xdx2ixbrl1492">5.85</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSTP3WxcN5aa" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1493">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-size: 10pt">Totals</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20221231_zT6AF5cSItO9" style="border-bottom: Black 1pt solid; text-align: right">441,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtxL_c20220101__20221231_zutmqdsST1C4" title="::XDX::P2Y7M13D"><span style="-sec-ix-hidden: xdx2ixbrl1495">2.62</span></span> years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20221231_ztVHaa4mKFVd" style="border-bottom: Black 1pt solid; text-align: right">272,850</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; color: Red"/> 40.15 46.90 103460 101860 62.18 69.11 139900 97210 73.09 136220 73780 97.84 62000 441580 272850 59.46 10100000 26600 133000 211955 4800000 88400 85062 4100000 63281 3000000.0 0.20 1.32 2.50 0.625 <p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zx5E95p2u826" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><b>(14)</b></td><td id="xdx_82C_zg2XEdxMVec8" style="text-align: justify"><b>Net Income Attributable to Inter Parfums, Inc. Common Shareholders</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_z0oWgrF1Exze">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">120,938</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">87,411</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">38,219</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"><span style="-sec-ix-hidden: xdx2ixbrl1557">31,859,417</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares">31,536,659</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">129,336</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">158,612</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">117,885</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"><span style="-sec-ix-hidden: xdx2ixbrl1569">31,988,753</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,654,544</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)">3.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)">2.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)">1.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)">3.78</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)">2.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)">1.21</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8A9_zbK4fmd08pt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Not included in the above computations is the effect of anti-dilutive potential common shares, which consist of outstanding options to purchase <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zg2q9bpdlHmj" title="Antidilutive securities excluded from computation of earnings per share, amount">38,000</span>, <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zZ3Omt4U4Yj3" title="Antidilutive securities excluded from computation of earnings per share, amount">175,000</span>, and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zIqUqAS4cqsk" title="Antidilutive securities excluded from computation of earnings per share, amount">450,000</span> shares of common stock for 2022, 2021, and 2020, respectively.</p> <p id="xdx_897_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zv7hwf7dCyXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_z0oWgrF1Exze">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Numerator for diluted earnings per share</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20220101__20221231_zCiyiWHZzD9e" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">120,938</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8dyOm5OSjd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">87,411</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_zxltG1mdA8a8" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Numerator for diluted earnings per share (in dollars)">38,219</td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Weighted average shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_dxL_c20220101__20221231_z0iF4HmZySVa" style="text-align: right" title="Weighted average shares::XDX::31859417"><span style="-sec-ix-hidden: xdx2ixbrl1557">31,859,417</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210101__20211231_znl3O3DVPL5f" style="text-align: right" title="Weighted average shares">31,676,796</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20200101__20201231_zxtlnG0jJ4X6" style="text-align: right" title="Weighted average shares">31,536,659</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in; padding-bottom: 1pt">Stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20220101__20221231_zsvjkLQl0CNc" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">129,336</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20210101__20211231_zuCHuRYe4iHj" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">158,612</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_c20200101__20201231_zOVwBi2G4dLd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock options">117,885</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_dxL_c20210101__20211231_zIFqJPdTDUW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share::XDX::31835408"><span style="-sec-ix-hidden: xdx2ixbrl1569">31,988,753</span></td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zxzYe13HVNH" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,835,408</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20201231_zKMEjk4kAt26" style="border-bottom: Black 2.5pt double; text-align: right" title="Denominator for diluted earnings per share">31,654,544</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in">Earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc. common shareholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in; text-indent: -0.125in">Basic</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20220101__20221231_zK87ctIZFJe8" style="text-align: right" title="Basic (in dollars per share)">3.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20210101__20211231_zRqGrAkD7y67" style="text-align: right" title="Basic (in dollars per share)">2.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20200101__20201231_z5D4wtGpTIs2" style="text-align: right" title="Basic (in dollars per share)">1.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5in; text-indent: -0.125in">Diluted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20220101__20221231_zHt3qnRgHWOh" style="text-align: right" title="Diluted (in dollars per share)">3.78</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20210101__20211231_z15EC85a0oR7" style="text-align: right" title="Diluted (in dollars per share)">2.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20200101__20201231_zCLMlsd7marj" style="text-align: right" title="Diluted (in dollars per share)">1.21</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 120938000 87411000 38219000 31676796 31536659 129336 158612 117885 31835408 31654544 3.80 2.76 1.21 3.78 2.75 1.21 38000 175000 450000 <p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zGZBHf28LoC8" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><b>(15)</b></td><td id="xdx_82C_zH7uC5DUdNy3" style="text-align: justify"><b>Segments and Geographic Areas</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company <span style="font-family: Times New Roman, Times, Serif">manufactures and distributes one product line, fragrances and fragrance related products. The Company</span> manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European and United States operations primarily represent the sale of prestige brand name fragrances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B9_zpH2kTnlYawl">Information on the Company’s operations by segments is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right">342,644</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right">216,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right">117,489</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right">744,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right">663,290</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right">422,947</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations of intercompany sales</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right">(66</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right">(333</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right">(1,427</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right">1,086,653</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right">879,516</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right">539,009</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right">43,745</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right">29,359</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right">7,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right">77,193</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right">57,869</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right">30,241</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right">183</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Depreciation and amortization expense including impairment loss:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right">6,355</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right">3,835</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right">3,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right">16,184</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right">8,863</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right">5,713</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right">22,539</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right">12,698</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right">9,067</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Interest and investment income:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right">66</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right">3</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right">24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right">5,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right">3,526</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right">2,971</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right">5,486</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right">3,403</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right">2,865</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest expense:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right">1,100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right">636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right">604</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense">2,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense">2,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense">1,496</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">3,599</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">2,825</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">1,970</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income tax expense:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right">6,920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right">5,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right">1,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right">36,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right">35,607</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right">17,782</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right">43,182</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right">40,992</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right">19,381</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right">278,090</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right">247,703</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right">141,316</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right">1,052,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right">931,735</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right">758,812</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right">(21,552</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right">1,308,542</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right">1,145,364</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right">890,145</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additions to long-lived assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right">2,318</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right">2,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right">1,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right">31,438</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right">33,756</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right">141,274</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right">12,263</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total long-lived assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right">61,539</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right">63,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right">40,656</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right">423,999</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right">485,538</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right">397,127</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right">258,422</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right">2,906</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right">886</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right">8,253</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right">7,066</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right">7,106</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right">8,041</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8A3_z3AfBJKqYq4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">United States export sales were approximately $<span id="xdx_906_eus-gaap--Revenues_dm_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z9mKYeG4Bxvg" title="Revenue from export sales">169.1 million</span>, $<span id="xdx_90C_eus-gaap--Revenues_dm_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zRk6SmlGxoJf" title="Revenue from export sales">126.2 million</span> and $<span id="xdx_908_eus-gaap--Revenues_dm_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z12uafZ15sJ3" title="Revenue from export sales">71.5 million</span> in 2022, 2021 and 2020, respectively. <span>Consolidated net sales to customers by region are as follows:</span></p> <p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden">Consolidated net sales to customers by region are as follows:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">North America</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales">431,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales">193,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right">333,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right">271,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right">180,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Asia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right">152,700</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right">128,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right">79,700</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Middle East</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right">87,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right">61,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right">46,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Central and South America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right">69,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right">56,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right">32,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right">1,086,700</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right">879,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right">539,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_ztRhsXR8V6Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B7_z7FpI55o74vh">Consolidated net sales to customers in major countries are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">420,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">187,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>France</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right">44,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right">44,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right">37,600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Russia</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right">33,964</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right">43,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right">14,100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">United Kingdom</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right">37,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right">38,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right">24,600</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A9_zpCmLcFFUQ57" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z5t7gndtoTnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B9_zpH2kTnlYawl">Information on the Company’s operations by segments is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zN1JQHAanSa1" style="width: 10%; text-align: right">342,644</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zXfROlyoafN8" style="width: 10%; text-align: right">216,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z6H47XcLm8c2" style="width: 10%; text-align: right">117,489</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zFaoY3D3paJ9" style="text-align: right">744,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zMioSAOF5qK4" style="text-align: right">663,290</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zdsrK7CzOPwg" style="text-align: right">422,947</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations of intercompany sales</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zUorSmNAGGjb" style="border-bottom: Black 1pt solid; text-align: right">(66</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zJWPkjfafPP5" style="border-bottom: Black 1pt solid; text-align: right">(333</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z9306gQ0Ju5c" style="border-bottom: Black 1pt solid; text-align: right">(1,427</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zKj8Tc1r4Rsa" style="border-bottom: Black 2.5pt double; text-align: right">1,086,653</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231_z0Bg3aoESQj8" style="border-bottom: Black 2.5pt double; text-align: right">879,516</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231_zotUOgNFoWDe" style="border-bottom: Black 2.5pt double; text-align: right">539,009</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zOMntQyw1un3" style="text-align: right">43,745</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zLXnt0PFDWWb" style="text-align: right">29,359</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zZlkWXpCPoK2" style="text-align: right">7,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zlIjcRQW0w2b" style="text-align: right">77,193</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z8fyVCv7v7bi" style="text-align: right">57,869</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_ztitXKrX5WGb" style="text-align: right">30,241</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNDfjNiofmI3" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zmUmLDz8KfC5" style="border-bottom: Black 1pt solid; text-align: right">183</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_z2W4y0erklU1" style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20221231_zc6kjf8Ghzeb" style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210101__20211231_zC8SO5Qw23F9" style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20200101__20201231_z1i5GjIgi0aa" style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Depreciation and amortization expense including impairment loss:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zVjxv1iroHDd" style="text-align: right">6,355</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zJ4lDFCv8644" style="text-align: right">3,835</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zmZNSf9Ek7Ib" style="text-align: right">3,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--DepreciationAndAmortization_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zsYCV2HAc5U5" style="border-bottom: Black 1pt solid; text-align: right">16,184</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zDANNjkSFM6b" style="border-bottom: Black 1pt solid; text-align: right">8,863</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z18l4eXNbCy5" style="border-bottom: Black 1pt solid; text-align: right">5,713</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zxDkbnTstgy" style="border-bottom: Black 2.5pt double; text-align: right">22,539</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationAndAmortization_c20210101__20211231_ztTiIMuNAvUc" style="border-bottom: Black 2.5pt double; text-align: right">12,698</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DepreciationAndAmortization_c20200101__20201231_zkjhYX4Cv7w5" style="border-bottom: Black 2.5pt double; text-align: right">9,067</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Interest and investment income:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zXxHF0AeZqY8" style="width: 10%; text-align: right">66</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zVTleM6KdyK8" style="width: 10%; text-align: right">3</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zSrSUilNTWW9" style="width: 10%; text-align: right">24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb0LMngtbxWh" style="text-align: right">5,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_z7vVGvaCsqGh" style="text-align: right">3,526</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zPdE8y4vwT81" style="text-align: right">2,971</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zHv8NF9VOHMc" style="border-bottom: Black 1pt solid; text-align: right">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zikptBn7iXa2" style="border-bottom: Black 1pt solid; text-align: right">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentIncomeInterestAndDividend_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zVX6r3q5wh14" style="border-bottom: Black 1pt solid; text-align: right">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentIncomeInterestAndDividend_c20220101__20221231_z2OjKZxJv1Fi" style="border-bottom: Black 2.5pt double; text-align: right">5,486</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentIncomeInterestAndDividend_c20210101__20211231_zZpix50Tpfw8" style="border-bottom: Black 2.5pt double; text-align: right">3,403</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentIncomeInterestAndDividend_c20200101__20201231_zu4Udp83eRLk" style="border-bottom: Black 2.5pt double; text-align: right">2,865</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest expense:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zTZ8lvHEt6W6" style="text-align: right">1,100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__country--US_z7Ev1UvZJdlg" style="text-align: right">636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z13ohoSQzARb" style="text-align: right">604</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InterestExpense_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zbWWrKDyaYu5" style="text-align: right" title="Interest expense">2,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InterestExpense_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zNYIaqJaV6vf" style="text-align: right" title="Interest expense">2,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InterestExpense_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zG7aH5rfZPj3" style="text-align: right" title="Interest expense">1,496</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--InterestExpense_iN_di_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_z7IYQNHtiEw2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(349</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--InterestExpense_iN_di_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zIMrgYiwHVq5" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(126</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InterestExpense_iN_di_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zNrf82PPj2pc" style="border-bottom: Black 1pt solid; text-align: right" title="Interest expense">(130</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestExpense_c20220101__20221231_zTrCLKfNyVyh" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">3,599</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestExpense_c20210101__20211231_ze2ObTVpTywj" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">2,825</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--InterestExpense_c20200101__20201231_zMMCNxeBBWZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Interest expense">1,970</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income tax expense:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__country--US_z18EDGbKRHed" style="text-align: right">6,920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zBIWfIOJjLog" style="text-align: right">5,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zrIDv9IBHjSk" style="text-align: right">1,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zraO42AMjP33" style="text-align: right">36,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zYG7viPK0JU1" style="text-align: right">35,607</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zMY7NLFYdDz9" style="text-align: right">17,782</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_ziDOSrGeHe15" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zP23j3YK7tC" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zrbjLxb2TCzj" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zRw5JwAS1Hy5" style="border-bottom: Black 2.5pt double; text-align: right">43,182</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zJdL4UVy25E8" style="border-bottom: Black 2.5pt double; text-align: right">40,992</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zwiocxhIWLI6" style="border-bottom: Black 2.5pt double; text-align: right">19,381</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zKlDWvQvpf75" style="width: 10%; text-align: right">278,090</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zFIfQsFaMxH1" style="width: 10%; text-align: right">247,703</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zV6OB2VBkwAj" style="width: 10%; text-align: right">141,316</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zLYsTjG3tS38" style="text-align: right">1,052,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zP9YqOWheBUd" style="text-align: right">931,735</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Assets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zeXk0ME2vt95" style="text-align: right">758,812</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zLQGZKJPd113" style="border-bottom: Black 1pt solid; text-align: right">(21,552</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_iNI_di_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zAuNoI9ziX06" style="border-bottom: Black 1pt solid; text-align: right">(34,074</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iNI_di_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYiu84VhdQp6" style="border-bottom: Black 1pt solid; text-align: right">(9,983</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20221231_zEuCjEKiI7Ta" style="border-bottom: Black 2.5pt double; text-align: right">1,308,542</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20211231_zd5qR7xUyJtd" style="border-bottom: Black 2.5pt double; text-align: right">1,145,364</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_c20201231_zKQUNAI513K9" style="border-bottom: Black 2.5pt double; text-align: right">890,145</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Additions to long-lived assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zek5zpVwMZc7" style="text-align: right">2,318</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zY6aBxmjkZ2g" style="text-align: right">2,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__country--US_z044WgPELgeh" style="text-align: right">1,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zb1tH5PLqAR3" style="border-bottom: Black 1pt solid; text-align: right">31,438</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zOjgFMN7n6D3" style="border-bottom: Black 1pt solid; text-align: right">138,563</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zq7wJwOLiUve" style="border-bottom: Black 1pt solid; text-align: right">11,259</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AdditionsToOtherAssetsAmount_c20220101__20221231_z7Stt2YeEOEf" style="border-bottom: Black 2.5pt double; text-align: right">33,756</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AdditionsToOtherAssetsAmount_c20210101__20211231_zua6Y8Q6Rtkg" style="border-bottom: Black 2.5pt double; text-align: right">141,274</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AdditionsToOtherAssetsAmount_c20200101__20201231_z8hrTn69lBZ7" style="border-bottom: Black 2.5pt double; text-align: right">12,263</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total long-lived assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__country--US_zS7RgbTudsHg" style="text-align: right">61,539</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__country--US_zIcRp6pjZWOf" style="text-align: right">63,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__country--US_zF6003GCMDBf" style="text-align: right">40,656</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zJ5Jt0k4yWvg" style="border-bottom: Black 1pt solid; text-align: right">423,999</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NoncurrentAssets_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zHyC72DxJq9i" style="border-bottom: Black 1pt solid; text-align: right">334,033</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NoncurrentAssets_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zK2gfC1BG6Jl" style="border-bottom: Black 1pt solid; text-align: right">217,766</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_c20221231_zVTGg7EpzUq3" style="border-bottom: Black 2.5pt double; text-align: right">485,538</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_c20211231_zf6MTAGi1SY8" style="border-bottom: Black 2.5pt double; text-align: right">397,127</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_c20201231_z5j8o90TDusd" style="border-bottom: Black 2.5pt double; text-align: right">258,422</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__country--US_zRuWDL2Mm6Rc" style="text-align: right">2,906</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__country--US_z9J0xHlCQ4i8" style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__country--US_zxYvJlJxyBA7" style="text-align: right">886</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zWK4THQDXda1" style="text-align: right">8,253</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zEeCYDdYVVX2" style="text-align: right">7,066</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__srt--EuropeMember_z1AnXAlUQ8mk" style="text-align: right">7,106</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zYomYzOcp7t9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231__srt--StatementGeographicalAxis__custom--EliminationsMember_zfORPVP2ukm5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231__srt--StatementGeographicalAxis__custom--EliminationsMember_zs5KA5VNF7bd" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20221231_zyYD2oGQ3u95" style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20211231_zwPYgE7gRNfl" style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxAssetsNet_iI_c20201231_zmpahORPzxE5" style="border-bottom: Black 2.5pt double; text-align: right">8,041</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 342644000 216559000 117489000 744075000 663290000 422947000 -66000 -333000 -1427000 1086653000 879516000 539009000 43745000 29359000 7942000 77193000 57869000 30241000 183000 36000 120938000 87411000 38219000 6355000 3835000 3354000 16184000 8863000 5713000 22539000 12698000 9067000 66000 3000 24000 5769000 3526000 2971000 349000 126000 130000 5486000 3403000 2865000 1100000 636000 604000 2848000 2315000 1496000 349000 126000 130000 3599000 2825000 1970000 6920000 5336000 1590000 36262000 35607000 17782000 49000 9000 43182000 40992000 19381000 278090000 247703000 141316000 1052004000 931735000 758812000 21552000 34074000 9983000 1308542000 1145364000 890145000 2318000 2711000 1004000 31438000 138563000 11259000 33756000 141274000 12263000 61539000 63094000 40656000 423999000 334033000 217766000 485538000 397127000 258422000 2906000 870000 886000 8253000 7066000 7106000 49000 11159000 7936000 8041000 169100000 126200000 71500000 <p id="xdx_894_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_zYiEJZjDP7Jf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <span id="xdx_8B3_zjICCQhU3Pqg" style="display: none; visibility: hidden">Consolidated net sales to customers by region are as follows:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">North America</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zqcas1VLgiZj" style="width: 10%; text-align: right" title="Net sales">431,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zoaNeuvGZOSf" style="width: 10%; text-align: right" title="Net sales">354,100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zOxg6tt1swCd" style="width: 10%; text-align: right" title="Net sales">193,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zEhmilmeaoH" style="text-align: right">333,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zmYNzCTUZY1j" style="text-align: right">271,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--EuropeMember_zLNVjkDedtEj" style="text-align: right">180,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Asia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zBX2VQpdUPxk" style="text-align: right">152,700</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zWuTa2AgfTil" style="text-align: right">128,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__srt--AsiaMember_zifHguhWeNz9" style="text-align: right">79,700</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Middle East</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zOmeAe8c3wBg" style="text-align: right">87,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_z47lyRQbsUxl" style="text-align: right">61,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_zlNFHHY1HxJl" style="text-align: right">46,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Central and South America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_ztq0xL8oxiq2" style="text-align: right">69,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zKfWzppoERt9" style="text-align: right">56,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--CentralAndSouthAmericaMember_zyDZFGchDOF9" style="text-align: right">32,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_z04nco0KR4ob" style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zR4JjP4cALak" style="border-bottom: Black 1pt solid; text-align: right">8,400</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherSegmentCountryMember_zhK4EUGSURI9" style="border-bottom: Black 1pt solid; text-align: right">6,300</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20221231_znKQk9HAzRr6" style="border-bottom: Black 2.5pt double; text-align: right">1,086,700</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231_zeKucAMMA6la" style="border-bottom: Black 2.5pt double; text-align: right">879,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231_zHVtKI4Zp6K6" style="border-bottom: Black 2.5pt double; text-align: right">539,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 431900000 354100000 193500000 333400000 271600000 180200000 152700000 128000000 79700000 87800000 61000000 46800000 69900000 56400000 32500000 11000000 8400000 6300000 1086700000 879500000 539000000 <p id="xdx_890_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_zNMmjYjoZQla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span id="xdx_8B7_z7FpI55o74vh">Consolidated net sales to customers in major countries are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zzvJIjqy5vZe" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">420,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zwGcu4dsaDH" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">351,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedStatesMember_zkAOG3eA40Ci" style="width: 10%; text-align: right" title="Revenue from Contract with Customer, Including Assessed Tax">187,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>France</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zBBy9Pzi0qS8" style="text-align: right">44,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zFb1oFRJgPf8" style="text-align: right">44,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--FranceMember_zS7uXTSlAwtb" style="text-align: right">37,600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Russia</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zPMIyjik1y0l" style="text-align: right">33,964</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zvNeOvEsY7rb" style="text-align: right">43,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--RussiaMember_zI8qinlo983l" style="text-align: right">14,100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">United Kingdom</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_z9oa7jP039g7" style="text-align: right">37,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zz1fGDV2YKo5" style="text-align: right">38,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20200101__20201231__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zIOzImonFwre" style="text-align: right">24,600</td><td style="text-align: left"> </td></tr> </table> 420900000 351300000 187300000 44800000 44000000 37600000 33964000 43400000 14100000 37900000 38500000 24600000 <p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zEzULplDcgK7" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(16)</td><td id="xdx_821_zrAktrtcrZrl">Income Taxes</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and its subsidiaries file income tax returns in the U.S. federal, and various states and foreign jurisdictions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed its uncertain tax positions and determined that it has no material uncertain tax position at December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z7VnI34zzwX8">The components of income before income taxes consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">U.S. operations</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations">50,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">143,969</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"><span style="-sec-ix-hidden: xdx2ixbrl1797">194,219</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"><span style="-sec-ix-hidden: xdx2ixbrl1799">151,019</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"><span style="-sec-ix-hidden: xdx2ixbrl1801">69,349</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zMdKdsLj6jH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zcy74h7kGdd5">The provision for current and deferred income tax expense (benefit) consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; padding-left: 0.125in">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal">6,829</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal">4,825</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal">1,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in">State and local</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local">658</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local">518</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local">90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">39,458</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">36,164</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">17,024</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">46,945</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">41,507</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">18,799</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Federal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal">(802</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal">(215</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in">State and local</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local">(49</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local">11</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local">44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(2,912</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(530</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">753</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(3,763</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(515</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">582</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">43,182</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">40,992</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">19,381</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8AA_zu1mvlECuEsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_zp6bQ94sbp35">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">554</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,292</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inventory and accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,880</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Profit sharing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,871</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,787</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Stock option compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">732</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of inventory profit elimination</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,342</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,112</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">407</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Total gross deferred tax assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,629</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,838</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(554</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,582</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,075</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,256</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities (long-term):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Building expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,356</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,082</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Trademarks and licenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,551</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Unrealized gain on marketable equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,745</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(436</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(655</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(251</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,916</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,320</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8A9_zi5Iazzkwjqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Valuation allowances have been provided for deferred tax assets relating to foreign net operating loss carry-forwards as future profitable operations from certain foreign subsidiaries might not be sufficient to realize the full amount of the deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No other valuation allowances have been provided as management believes that it is more likely than not that the asset will be realized in the reduction of future taxable income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company estimated of the effect of global intangible low-taxed income (“GILTI”) and has determined that it has no tax liability related to GILTI as of December 31, 2022, 2021 and 2020. The Company also estimated the effect of foreign derived intangible income (“FDII”) and recorded a tax benefit of approximately $<span id="xdx_909_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_z2RduZVyNBx2">1.5 million</span>, $<span id="xdx_90B_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zEdLfbzCw8lk">0.9 million</span> and $<span id="xdx_90A_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_dm_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ForeignDerivedIntangibleIncomeMember_zsIXtt16Baih">0.3 million</span> as of December 31, 2022, 2021 and 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z8w289QLD5Z9">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Statutory rates</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State and local taxes, net of Federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Windfall benefit from exercise of stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Benefit of Foreign Derived Intangible Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.8</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of foreign taxes greater than U.S. statutory rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.5</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.625in">Effective rates</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">22.2</td><td style="text-align: left; padding-bottom: 2pt">%</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.1</td><td style="text-align: left; padding-bottom: 2pt">%</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.9</td><td style="text-align: left; padding-bottom: 2pt">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p id="xdx_8A7_z0csr17AQpCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p id="xdx_89D_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOEM9bV8kGMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_z7VnI34zzwX8">The components of income before income taxes consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">U.S. operations</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20220101__20221231_z2Nivpfvpfi2" style="width: 10%; text-align: right" title="U.S. operations">50,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20210101__20211231_zrnu5QBCnPu9" style="width: 10%; text-align: right" title="U.S. operations">34,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20201231_zXqtA4RyDFSe" style="width: 10%; text-align: right" title="U.S. operations">9,577</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20220101__20221231_z1mAmpkLVYf4" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">143,969</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20210101__20211231_zqx46KuIPtYg" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">116,277</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20201231_zZzxuis02MM7" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign operations">59,772</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20220101__20221231_znP0vZwzBCZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::194219"><span style="-sec-ix-hidden: xdx2ixbrl1797">194,219</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20210101__20211231_zEKtuxY9Ahma" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::151019"><span style="-sec-ix-hidden: xdx2ixbrl1799">151,019</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dxL_c20200101__20201231_znhqSMTCEHNc" style="border-bottom: Black 1pt solid; text-align: right" title="Income before income taxes::XDX::69349"><span style="-sec-ix-hidden: xdx2ixbrl1801">69,349</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 50250000 34742000 9577000 143969000 116277000 59772000 <p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zVdFDu7gp8Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BF_zcy74h7kGdd5">The provision for current and deferred income tax expense (benefit) consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; padding-left: 0.125in">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220101__20221231_z1otUHPaLqr4" style="width: 10%; text-align: right" title="Federal">6,829</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CurrentFederalTaxExpenseBenefit_c20210101__20211231_zULWeE3HgcSg" style="width: 10%; text-align: right" title="Federal">4,825</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_zw1Eus7l8J14" style="width: 10%; text-align: right" title="Federal">1,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in">State and local</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20220101__20221231_zWVPZN8j7pll" style="text-align: right" title="State and local">658</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20210101__20211231_z1iw88rrK0Kd" style="text-align: right" title="State and local">518</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_zIj250073we6" style="text-align: right" title="State and local">90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--CurrentForeignTaxExpenseBenefit_c20220101__20221231_zvQWW5kwL0b9" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">39,458</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--CurrentForeignTaxExpenseBenefit_c20210101__20211231_zQbHbwbdm4Pd" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">36,164</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--CurrentForeignTaxExpenseBenefit_c20200101__20201231_zErlN4gNb6X8" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">17,024</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20220101__20221231_zSDygTP06Ls3" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">46,945</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20210101__20211231_z9OljPG9eiZ8" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">41,507</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_zTNN2end360d" style="border-bottom: Black 1pt solid; text-align: right" title="Current income tax expense">18,799</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Federal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220101__20221231_zbkamzsZzFV4" style="text-align: right" title="Federal">(802</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20210101__20211231_z1XeBFs62n27" style="text-align: right" title="Federal">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_z0dMMuTNv0fh" style="text-align: right" title="Federal">(215</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in">State and local</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20220101__20221231_zlGazpEbqXK5" style="text-align: right" title="State and local">(49</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20210101__20211231_zLtwg8Si8Mq9" style="text-align: right" title="State and local">11</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_zJtlVnwmlu2d" style="text-align: right" title="State and local">44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20220101__20221231_zvqbzQ3pnMp6" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(2,912</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20210101__20211231_zoKDDARaGSle" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">(530</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_c20200101__20201231_z4axfVIybuej" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign">753</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20220101__20221231_z2QKZshV5iBl" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(3,763</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20210101__20211231_zwn3gpFFxNr6" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">(515</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredIncomeTaxesAndTaxCredits_c20200101__20201231_zo8F8O5fOJnd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred income tax expense">582</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 1in">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zU3TqCCNVtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">43,182</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231_zo1HpdewVIcc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">40,992</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_zYcyG9pBBowj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total income tax expense">19,381</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 6829000 4825000 1685000 658000 518000 90000 39458000 36164000 17024000 46945000 41507000 18799000 -802000 4000 -215000 -49000 11000 44000 -2912000 -530000 753000 -3763000 -515000 582000 43182000 40992000 19381000 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zpZrkkDGpM9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_zp6bQ94sbp35">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_49C_20221231_zGqr5dkQVKP2" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td colspan="2" id="xdx_499_20211231_z5GT0Yoacf0j" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zKHePLO5Fmbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zxp5zHZoV8df" style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign net operating loss carry-forwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">554</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,292</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsInventoryAndAccountsReceivable_zvctRYn1yls" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Inventory and accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,880</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,508</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_zfWYpMvxHKN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Profit sharing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,871</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,787</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_z3pgURA6KKtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Stock option compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">732</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInventory_iI_zYSgXwjXg1V9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Effect of inventory profit elimination</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,342</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,112</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zpiMqn03c2N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">266</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">407</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iI_zgYX95vUcX92" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in">Total gross deferred tax assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,629</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,838</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z0LO6Vohev8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(554</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,582</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iI_zqAVwoJJ8Kfd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,075</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,256</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zYm1K3yz1Pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities (long-term):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DeferredTaxLiabilitiesBuildingExpenses_iI_zDeueYVn4Ah7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Building expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,356</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,082</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesOtherFiniteLivedAssets_i01NI_di_zJCsKykYzng1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Trademarks and licenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,160</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,551</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities_i01I_zAu3YFJQhZ72" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Unrealized gain on marketable equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,745</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(436</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesOther_i01I_zSBVREFXUmic" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(655</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(251</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_di_zJxgaWEyvY99" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,916</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,320</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zxK321ZvjdGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.75in; text-indent: -0.125in; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,159</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,936</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 554000 1292000 3880000 4508000 2871000 3787000 716000 732000 9342000 5112000 266000 407000 17629000 15838000 554000 3582000 17075000 12256000 -1356000 -1082000 2160000 2551000 -1745000 -436000 -655000 -251000 5916000 4320000 11159000 7936000 1500000 900000 300000 <p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zhsr4zRIV8y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BE_z8w289QLD5Z9">Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_490_20220101__20221231_zEsCHMGHUqH5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_49B_20210101__20211231_z7LfDGlzwXgb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20200101__20201231_zeVSdnkDmTz6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zunsqnvCRdlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Statutory rates</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_z5la0mQu9Hdh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State and local taxes, net of Federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends_iN_pid_dpi_uPure_zHT5jDMph3P8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Windfall benefit from exercise of stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zlt9IZKFxSy9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Benefit of Foreign Derived Intangible Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.8</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.6</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.4</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1_pid_dp_uPure_zpLtAT6bNoua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Effect of foreign taxes greater than U.S. statutory rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.5</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_zpJ3npeQbNSf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_zGoTTxj4M0ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.625in">Effective rates</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">22.2</td><td style="text-align: left; padding-bottom: 2pt">%</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.1</td><td style="text-align: left; padding-bottom: 2pt">%</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.9</td><td style="text-align: left; padding-bottom: 2pt">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> 0.210 0.210 0.210 0.002 0.003 0.002 0.004 0.009 0.006 -0.008 -0.006 -0.004 0.031 0.074 0.075 -0.009 -0.001 0.002 0.222 0.271 0.279 <p id="xdx_801_eus-gaap--ComprehensiveIncomeNoteTextBlock_zggFcT5jBCP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(17)</td><td><span id="xdx_820_z08Cgu9j1Gii">Accumulated Other Comprehensive Loss</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8B6_zdI2PfJTcWk4">The components of accumulated other comprehensive loss consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">(992</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1968">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">2,701</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">1,709</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1982">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cumulative translation adjustments, beginning of year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(37,440</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(20,325</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(31,443</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">33,908</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(57,765</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated other comprehensive loss</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(56,056</td><td style="text-align: left; padding-bottom: 2pt">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="text-align: left; padding-bottom: 2pt">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right">(5,997</td><td style="text-align: left; padding-bottom: 2pt">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/> <p id="xdx_8A5_z6Qdw7p9XLe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z2kGNuCLjxF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span id="xdx_8B6_zdI2PfJTcWk4">The components of accumulated other comprehensive loss consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left">Net derivative instruments, beginning of year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zu4KuLpfmpv2" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">(992</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zBfe4q0DbTnl" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1968">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zSntSU3OSine" style="width: 10%; text-align: right" title="Net derivative instruments, beginning of year">52</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net derivative instrument loss, net of tax</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zMZYBDmEYwI5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">2,701</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z279Cn4yOqNf" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_z3nDjvxnl65" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instrument gain (loss), net of tax">(52</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Net derivative instruments, end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zpy8B3QSO1S2" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">1,709</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zp8AcFS6z0z5" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year">(992</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax1_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember_zjGXhQzLg4F1" style="border-bottom: Black 1pt solid; text-align: right" title="Net derivative instruments, end of year"><span style="-sec-ix-hidden: xdx2ixbrl1982">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cumulative translation adjustments, beginning of year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zKeg2R8UCQxd" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(37,440</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9VXGg8GvH4h" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(5,997</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z9KQ7hTLCbV4" style="text-align: right" title="Cumulative translation adjustments, beginning of year">(39,905</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Translation adjustments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zsKD6BDAYCSa" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(20,325</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zrvBjUJ57oAi" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">(31,443</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zBjljDmR5Zy7" style="border-bottom: Black 1pt solid; text-align: right" title="Translation adjustments">33,908</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Cumulative translation adjustments, end of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zGlh9Zvt3vOl" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(57,765</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_z1jDXEuHsV22" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(37,440</td><td style="text-align: left; padding-bottom: 1pt">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--AccumulatedOtherComprehensiveIncomeLossNetOfTax2_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--AccumulatedTranslationAdjustmentMember_zIQfBhGe3Gr1" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative translation adjustments, end of year">(5,997</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated other comprehensive loss</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20221231_zGweYhgm2Ulc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(56,056</td><td style="text-align: left; padding-bottom: 2pt">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20211231_z5VvMY5o9Wil" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated other comprehensive loss">(38,432</td><td style="text-align: left; padding-bottom: 2pt">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_c20201231_zIUq6io1lIyl" style="border-bottom: Black 2.5pt double; text-align: right">(5,997</td><td style="text-align: left; padding-bottom: 2pt">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"/> -992000 52000 2701000 -992000 -52000 1709000 -992000 -37440000 -5997000 -39905000 -20325000 -31443000 33908000 -57765000 -37440000 -5997000 -56056000 -38432000 -5997000 <p id="xdx_806_eus-gaap--MinorityInterestDisclosureTextBlock_z0NbJg2VBBYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; color: Red"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(18)</td><td><span id="xdx_820_zOpk2joaSrZ8">Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest</span></td></tr></table> <p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">120,938</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">87,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">38,219</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_8A6_zlQaVNVUJMd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red"> </p> <p id="xdx_892_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zBjq4EoRnkM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zzzGaflmxvlb" style="display: none; visibility: hidden">Schedule of net income attributable to transfers from the noncontrolling interest</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zxWLW9IpH0P9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_494_20210101__20211231_zMR6HNbbFp6b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td> <td id="xdx_492_20200101__20201231_zRw2gnDm9Wla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLoss_z6mZpBT3Z0Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net income attributable to Inter Parfums, Inc.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">120,938</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">87,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">38,219</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet_zuYjYxL0vsyc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Decrease in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">—</span></td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet_zKdVhwlah8p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">120,938</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,411</td><td style="text-align: left; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,219</td><td style="text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> 120938000 87411000 38219000 120938000 87411000 38219000 <p id="xdx_80D_ecustom--ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock_zwaHVFtCoXM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 9pt; color: Red"> </p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(19)</td><td><span id="xdx_82D_zPzQ3HIOQUij">Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zWO24NCWEtHj">The following table summarizes cash and cash equivalents as of December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-family: Courier New, Courier, Monospace; text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet">159,613</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387">8,774</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387">168,387</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z5GK5tdRTIOa" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_893_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zU7o7TPA21Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BB_zWO24NCWEtHj">The following table summarizes cash and cash equivalents as of December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-family: Courier New, Courier, Monospace; text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; text-align: left">Cash and cash equivalents per balance sheet</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211231_z5mzEl0PtqSj" style="width: 12%; text-align: right" title="Cash and cash equivalents per balance sheet">159,613</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Cash held in escrow included in other assets (see note 3)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CashHeldInEscrowIncludedInOtherAssets_iI_c20211231_zaetYEyxCFse" style="border-bottom: Black 1pt solid; text-align: right" title="Cash held in escrow included in other assets (see note 3)::XDX::168387">8,774</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cash and cash equivalents per balance sheet::XDX::168387"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents per statement of cash flows</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20211231_zL7Jo4CVj9lk" style="border-bottom: Black 2.5pt double; text-align: right" title="Cash and cash equivalents per statement of cash flows::XDX::168387">168,387</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 159613000 8774000 168387000 <p id="xdx_80D_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zfjmJJOx1YB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_829_zQO6hwDTuQBc" style="display: none; visibility: hidden"> Schedule II - Valuation and Qualifying Accounts</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Schedule II</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> </p> <p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden">Schedule of Valuation and Qualifying Accounts</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Valuation and Qualifying Accounts</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Column A</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(1)</td><td style="font-weight: bold; text-align: left"/><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="font-weight: bold; text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance at</b></span><br/> <span style="font-size: 10pt"><b>beginning of</b></span><br/> <span style="font-size: 10pt"><b>period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged to</b></span><br/> <span style="font-size: 10pt"><b>costs and</b></span><br/> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged to</b></span><br/> <span style="font-size: 10pt"><b>other</b></span><br/> <span style="font-size: 10pt"><b>accounts –</b></span><br/> <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Deductions</b></span><br/> <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance at</b></span><br/> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 3%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period">2,247</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right">2,353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe">1,134</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right">1,044</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period">4,690</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period">5,550</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right">877</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right">(843</td><td colspan="2" style="text-align: left">)(d)</td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right">3,336</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period">2,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period">2,452</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses">4,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right">381</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe">2,107</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period">5,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period">3,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right">4,997 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right">2,829</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period">5,410</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period">2,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right">3,042</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right">2,042</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period">3,242</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period">2,587</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right">1,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right">2,323</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period">2,242</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period">15,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right">8,742</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right">(378</td><td colspan="2" style="text-align: left">)(d)</td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right">12,710</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period">11,431</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period">9,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right">8,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right">7,041</td><td colspan="2" style="text-align: left">(d)(e)</td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right">8,852</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period">15,777</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period">4,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right">7,212</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right">616</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right">3,366</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period">9,371</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left">(a)</td><td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify">Write-off of bad debts.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left">(b)</td><td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify">Write-off of sales returns.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left">(c)</td><td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify">Disposal of inventory</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left">(d)</td><td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify">Foreign currency translation adjustment</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left">(e)</td><td id="xdx_F19_z623xCp9iOT7" style="text-align: justify">Inventory reserves acquired of $7,639</td> </tr></table> <p id="xdx_8A7_zbYGZKrqekt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See accompanying reports of independent registered public accounting firm.</p> <p id="xdx_890_eus-gaap--SummaryOfValuationAllowanceTextBlock_zb2tomN5uyXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zGKK3sVOG6k2" style="display: none; visibility: hidden">Schedule of Valuation and Qualifying Accounts</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Valuation and Qualifying Accounts</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In thousands)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Column A</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column B</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column C</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column D</td><td style="font-weight: bold; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Column E</td><td style="font-weight: bold; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(1)</td><td style="font-weight: bold; text-align: left"/><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="font-weight: bold; text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-left: 0.125in; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance at</b></span><br/> <span style="font-size: 10pt"><b>beginning of</b></span><br/> <span style="font-size: 10pt"><b>period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged to</b></span><br/> <span style="font-size: 10pt"><b>costs and</b></span><br/> <span style="font-size: 10pt"><b>expenses</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Charged to</b></span><br/> <span style="font-size: 10pt"><b>other</b></span><br/> <span style="font-size: 10pt"><b>accounts –</b></span><br/> <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Deductions</b></span><br/> <span style="font-size: 10pt"><b>describe</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Balance at</b></span><br/> <span style="font-size: 10pt"><b>end of period</b></span></td><td style="font-weight: bold; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 33%; padding-left: 0.125in; text-indent: -0.125in">Allowance for doubtful accounts:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 3%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z4KrWUEPciDj" style="text-align: right" title="Balance at beginning of period">2,247</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zJ4TeMihP4fj" style="text-align: right">2,353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zAdTySpLNQwj" style="text-align: right" title="Charged to other accounts describe">1,134</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zUadVVo121G4" style="text-align: right">1,044</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zIAYKz9whLge" style="text-align: right" title="Balance at end of period">4,690</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zLxLcrpCLpkf" style="text-align: right" title="Balance at beginning of period">5,550</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_z7N5ezaXJQG1" style="text-align: right">877</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zCJphbZwz9f5" style="text-align: right">(843</td><td colspan="2" style="text-align: left">)(d)</td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zXph4fLWF9Ai" style="text-align: right">3,336</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zE8fMBs6N0Ff" style="text-align: right" title="Balance at end of period">2,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zpLWsDbzrMu" style="text-align: right" title="Balance at beginning of period">2,452</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zYh5aSDSxKDj" style="text-align: right" title="Charged to costs and expenses">4,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGQp_zVnDKtT3VWNa" style="text-align: right">381</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_fKGEp_zBHmGGeefBCj" style="text-align: right" title="Deductions describe">2,107</td><td style="text-align: left">(a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--AllowanceForCreditLossMember_zzaJrV8UnqLk" style="text-align: right" title="Balance at end of period">5,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Allowance for sales returns, net of inventory:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zl7Dh1YssXok" style="text-align: right" title="Balance at beginning of period">3,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z2S0qv7cKALj" style="text-align: right">4,997 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zYmmVjAgKMrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zhBMLUBagMNb" style="text-align: right">2,829</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zI82d0wxUkA1" style="text-align: right" title="Balance at end of period">5,410</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z6cwwMmzAFX5" style="text-align: right" title="Balance at beginning of period">2,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_z20GYfbr2H0j" style="text-align: right">3,042</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zVae1IdzCf22" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2075">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zzA8bMouuE8j" style="text-align: right">2,042</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zyWfLuV1ea19" style="text-align: right" title="Balance at end of period">3,242</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zxIoxbrhPEzd" style="text-align: right" title="Balance at beginning of period">2,587</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_ze7sbUf0GRR9" style="text-align: right">1,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zM7kdOZo2oIj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_fKGIp_zjQabfRwy76k" style="text-align: right">2,323</td><td style="text-align: left">(b)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--SalesReturnsAndAllowancesMember_zXJT40BJMzfa" style="text-align: right" title="Balance at end of period">2,242</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Inventory reserve:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zqnhh47Vt4ma" style="text-align: right" title="Balance at beginning of period">15,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z9oOIqpzUmxk" style="text-align: right">8,742</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zu2KjbR5KFJ9" style="text-align: right">(378</td><td colspan="2" style="text-align: left">)(d)</td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zubcc3LAz1K8" style="text-align: right">12,710</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20220101__20221231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zNiRGD68WWPb" style="text-align: right" title="Balance at end of period">11,431</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zx6ZvFcrae0a" style="text-align: right" title="Balance at beginning of period">9,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zFNPHNQPO5q6" style="text-align: right">8,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQpKGUp_zB2PnZovpixj" style="text-align: right">7,041</td><td colspan="2" style="text-align: left">(d)(e)</td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zLJyyqnFnqG6" style="text-align: right">8,852</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20210101__20211231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_z0H0aoD7ihdf" style="text-align: right" title="Balance at end of period">15,777</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in; text-indent: -0.125in">Year ended December 31, 2020</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ValuationAllowancesAndReservesBalance_iS_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zAKR6Rvlbs8i" style="text-align: right" title="Balance at beginning of period">4,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowancesAndReservesChargedToCostAndExpense_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zO5aitIjofuk" style="text-align: right">7,212</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ValuationAllowancesAndReservesChargedToOtherAccounts_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGQp_zR9WqsOaKwXi" style="text-align: right">616</td><td colspan="2" style="text-align: left">(d)</td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesDeductions_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_fKGMp_zCmy7XgBJXE2" style="text-align: right">3,366</td><td style="text-align: left">(c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ValuationAllowancesAndReservesBalance_iE_pn3n3_c20200101__20201231__us-gaap--ValuationAllowancesAndReservesTypeAxis__us-gaap--InventoryValuationReserveMember_zRRJbQpjTwb6" style="text-align: right" title="Balance at end of period">9,371</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F04_z2cTW3g1BBT8" style="width: 0.25in; text-align: left">(a)</td><td id="xdx_F19_zzwXqT1INxx2" style="text-align: justify">Write-off of bad debts.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F09_zuihMh2Bj061" style="width: 0.25in; text-align: left">(b)</td><td id="xdx_F1D_zRRYEdMz6T94" style="text-align: justify">Write-off of sales returns.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F00_zrHDA6iDePJf" style="width: 0.25in; text-align: left">(c)</td><td id="xdx_F17_zbX0jhKMFzEj" style="text-align: justify">Disposal of inventory</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 287pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F08_zErIwCpIa0T7" style="width: 0.25in; text-align: left">(d)</td><td id="xdx_F1A_zrbruHm8wVP4" style="text-align: justify">Foreign currency translation adjustment</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 224.9pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td id="xdx_F04_zAcSOUcEXGFj" style="width: 0.25in; text-align: left">(e)</td><td id="xdx_F19_z623xCp9iOT7" style="text-align: justify">Inventory reserves acquired of $7,639</td> </tr></table> 2247000 2353000 1134000 1044000 4690000 5550000 877000 -843000 3336000 2247000 2452000 4824000 381000 2107000 5550000 3242000 4997000 2829000 5410000 2242000 3042000 2042000 3242000 2587000 1978000 2323000 2242000 15777000 8742000 -378000 12710000 11431000 9371000 8217000 7041000 8852000 15777000 4909000 7212000 616000 3366000 9371000 Write-off of bad debts. Write-off of sales returns. Disposal of inventory Foreign currency translation adjustment Inventory reserves acquired of $7,639 EXCEL 100 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end

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end XML 101 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 102 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 103 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 258 393 1 true 82 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://interparfumsinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://interparfumsinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://interparfumsinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Income Sheet http://interparfumsinc.com/role/StatementsOfIncome Consolidated Statements of Income Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Comprehensive Income Sheet http://interparfumsinc.com/role/StatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity Sheet http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholder's Equity Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statements of Cash Flows Sheet http://interparfumsinc.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00000008 - Disclosure - The Company and its Significant Accounting Policies Sheet http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies The Company and its Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Impact of COVID-19 Pandemic Sheet http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic Impact of COVID-19 Pandemic Notes 9 false false R10.htm 00000010 - Disclosure - Recent Agreements Sheet http://interparfumsinc.com/role/RecentAgreements Recent Agreements Notes 10 false false R11.htm 00000011 - Disclosure - Inventories Sheet http://interparfumsinc.com/role/Inventories Inventories Notes 11 false false R12.htm 00000012 - Disclosure - Fair Value of Financial Instruments Sheet http://interparfumsinc.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 00000013 - Disclosure - Derivative Financial Instruments Sheet http://interparfumsinc.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 13 false false R14.htm 00000014 - Disclosure - Property, Equipment and Leasehold Improvements Sheet http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements Property, Equipment and Leasehold Improvements Notes 14 false false R15.htm 00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets Sheet http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets Trademarks, Licenses and Other Intangible Assets Notes 15 false false R16.htm 00000016 - Disclosure - Accrued Expenses Sheet http://interparfumsinc.com/role/AccruedExpenses Accrued Expenses Notes 16 false false R17.htm 00000017 - Disclosure - Loans Payable ??? Banks Sheet http://interparfumsinc.com/role/LoansPayableBanks Loans Payable ??? Banks Notes 17 false false R18.htm 00000018 - Disclosure - Long-Term Debt Sheet http://interparfumsinc.com/role/Long-termDebt Long-Term Debt Notes 18 false false R19.htm 00000019 - Disclosure - Commitments Sheet http://interparfumsinc.com/role/Commitments Commitments Notes 19 false false R20.htm 00000020 - Disclosure - Equity Sheet http://interparfumsinc.com/role/Equity Equity Notes 20 false false R21.htm 00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders Net Income Attributable to Inter Parfums, Inc. Common Shareholders Notes 21 false false R22.htm 00000022 - Disclosure - Segments and Geographic Areas Sheet http://interparfumsinc.com/role/SegmentsAndGeographicAreas Segments and Geographic Areas Notes 22 false false R23.htm 00000023 - Disclosure - Income Taxes Sheet http://interparfumsinc.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 00000024 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 24 false false R25.htm 00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest Notes 25 false false R26.htm 00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows Sheet http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows Notes 26 false false R27.htm 00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 27 false false R28.htm 00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies) Sheet http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies The Company and its Significant Accounting Policies (Policies) Policies http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables) Sheet http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables The Company and its Significant Accounting Policies (Tables) Tables http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - Inventories (Tables) Sheet http://interparfumsinc.com/role/InventoriesTables Inventories (Tables) Tables http://interparfumsinc.com/role/Inventories 30 false false R31.htm 00000031 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://interparfumsinc.com/role/FairValueOfFinancialInstruments 31 false false R32.htm 00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables) Sheet http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables Property, Equipment and Leasehold Improvements (Tables) Tables http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements 32 false false R33.htm 00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables) Sheet http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables Trademarks, Licenses and Other Intangible Assets (Tables) Tables http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets 33 false false R34.htm 00000034 - Disclosure - Accrued Expenses (Tables) Sheet http://interparfumsinc.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://interparfumsinc.com/role/AccruedExpenses 34 false false R35.htm 00000035 - Disclosure - Long-Term Debt (Tables) Sheet http://interparfumsinc.com/role/Long-termDebtTables Long-Term Debt (Tables) Tables http://interparfumsinc.com/role/Long-termDebt 35 false false R36.htm 00000036 - Disclosure - Commitments (Tables) Sheet http://interparfumsinc.com/role/CommitmentsTables Commitments (Tables) Tables http://interparfumsinc.com/role/Commitments 36 false false R37.htm 00000037 - Disclosure - Equity (Tables) Sheet http://interparfumsinc.com/role/EquityTables Equity (Tables) Tables http://interparfumsinc.com/role/Equity 37 false false R38.htm 00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables) Tables http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders 38 false false R39.htm 00000039 - Disclosure - Segments and Geographic Areas (Tables) Sheet http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables Segments and Geographic Areas (Tables) Tables http://interparfumsinc.com/role/SegmentsAndGeographicAreas 39 false false R40.htm 00000040 - Disclosure - Income Taxes (Tables) Sheet http://interparfumsinc.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://interparfumsinc.com/role/IncomeTaxes 40 false false R41.htm 00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss 41 false false R42.htm 00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables) Tables http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest 42 false false R43.htm 00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables) Sheet http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables) Tables http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows 43 false false R44.htm 00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables) Sheet http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables Schedule II - Valuation and Qualifying Accounts (Tables) Tables http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts 44 false false R45.htm 00000045 - Disclosure - Schedule of lanvin brand name for our class (Details) Sheet http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails Schedule of lanvin brand name for our class (Details) Details 45 false false R46.htm 00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative) Sheet http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative The Company and its Significant Accounting Policies (Details Narrative) Details http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables 46 false false R47.htm 00000047 - Disclosure - Recent Agreements (Details Narrative) Sheet http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative Recent Agreements (Details Narrative) Details http://interparfumsinc.com/role/RecentAgreements 47 false false R48.htm 00000048 - Disclosure - Schedule of inventories (Details) Sheet http://interparfumsinc.com/role/ScheduleOfInventoriesDetails Schedule of inventories (Details) Details 48 false false R49.htm 00000049 - Disclosure - Inventories (Details Narrative) Sheet http://interparfumsinc.com/role/InventoriesDetailsNarrative Inventories (Details Narrative) Details http://interparfumsinc.com/role/InventoriesTables 49 false false R50.htm 00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details) Sheet http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails Schedule of fair value, assets measured on recurring basis (Details) Details 50 false false R51.htm 00000051 - Disclosure - Derivative Financial Instruments (Details Narrative) Sheet http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative Derivative Financial Instruments (Details Narrative) Details http://interparfumsinc.com/role/DerivativeFinancialInstruments 51 false false R52.htm 00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details) Sheet http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails Schedule of equipment and leasehold improvements (Details) Details 52 false false R53.htm 00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative) Sheet http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative Property, Equipment and Leasehold Improvements (Details Narrative) Details http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables 53 false false R54.htm 00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details) Sheet http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails Schedule of trademarks, licenses and other intangible assets (Details) Details 54 false false R55.htm 00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative) Sheet http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative Trademarks, Licenses and Other Intangible Assets (Details Narrative) Details http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables 55 false false R56.htm 00000056 - Disclosure - Accrued expenses consist of the following: (Details) Sheet http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails Accrued expenses consist of the following: (Details) Details 56 false false R57.htm 00000057 - Disclosure - Long-term debt consists of the following: (Details) Sheet http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails Long-term debt consists of the following: (Details) Details 57 false false R58.htm 00000058 - Disclosure - Loans Payable ??? Banks (Details Narrative) Sheet http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative Loans Payable ??? Banks (Details Narrative) Details http://interparfumsinc.com/role/LoansPayableBanks 58 false false R59.htm 00000059 - Disclosure - Long-Term Debt (Details Narrative) Sheet http://interparfumsinc.com/role/Long-termDebtDetailsNarrative Long-Term Debt (Details Narrative) Details http://interparfumsinc.com/role/Long-termDebtTables 59 false false R60.htm 00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details) Sheet http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details) Details 60 false false R61.htm 00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details) Sheet http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails minimum annual royalties and other commitments as follows: (Details) Details 61 false false R62.htm 00000062 - Disclosure - Commitments (Details Narrative) Sheet http://interparfumsinc.com/role/CommitmentsDetailsNarrative Commitments (Details Narrative) Details http://interparfumsinc.com/role/CommitmentsTables 62 false false R63.htm 00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details The following table sets forth information with respect to nonvested options for 2022: (Details) Details 63 false false R64.htm 00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details) Sheet http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails The effect of share-based payment expenses decreased income statement line items as follows: (Details) Details 64 false false R65.htm 00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details) Details 65 false false R66.htm 00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details) Sheet http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details) Details 66 false false R67.htm 00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details) Sheet http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details) Details 67 false false R68.htm 00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details The following table summarizes additional stock option information as of December 31, 2022: (Details) Details 68 false false R69.htm 00000069 - Disclosure - Equity (Details Narrative) Sheet http://interparfumsinc.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://interparfumsinc.com/role/EquityTables 69 false false R70.htm 00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Sheet http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Details 70 false false R71.htm 00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative) Details http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables 71 false false R72.htm 00000072 - Disclosure - Information on the Company???s operations by segments is as follows: (Details) Sheet http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails Information on the Company???s operations by segments is as follows: (Details) Details 72 false false R73.htm 00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details) Sheet http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails Consolidated net sales to customers by region are as follows: (Details) Details 73 false false R74.htm 00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details) Sheet http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails Consolidated net sales to customers in major countries are as follows: (Details) Details 74 false false R75.htm 00000075 - Disclosure - Segments and Geographic Areas (Details Narrative) Sheet http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative Segments and Geographic Areas (Details Narrative) Details http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables 75 false false R76.htm 00000076 - Disclosure - The components of income before income taxes consist of the following: (Details) Sheet http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails The components of income before income taxes consist of the following: (Details) Details 76 false false R77.htm 00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details) Sheet http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails The provision for current and deferred income tax expense (benefit) consists of the following: (Details) Details 77 false false R78.htm 00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) Sheet http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details) Details 78 false false R79.htm 00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details) Sheet http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details) Details 79 false false R80.htm 00000080 - Disclosure - Income Taxes (Details Narrative) Sheet http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://interparfumsinc.com/role/IncomeTaxesTables 80 false false R81.htm 00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details) Sheet http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails The components of accumulated other comprehensive loss consist of the following: (Details) Details 81 false false R82.htm 00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details) Sheet http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails Schedule of net income attributable to transfers from the noncontrolling interest (Details) Details 82 false false R83.htm 00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details The following table summarizes cash and cash equivalents as of December 31, 2021: (Details) Details 83 false false R84.htm 00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details) Sheet http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails Schedule of Valuation and Qualifying Accounts (Details) Details 84 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 37 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:SecurityExchangeName, us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension, us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife, us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths, us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments, us-gaap:LineOfCreditFacilityExpirationDate1, us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebtTerm, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - g083417_10k.htm 29, 32, 49, 50, 51, 52, 53, 54, 55, 76, 77, 78, 79, 80, 81, 82, 83, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 98, 99, 100, 101, 102, 107, 108, 109 g083417_10k.htm g083417_ex21.htm g083417_ex23.htm g083417_ex31-1.htm g083417_ex31-2.htm g083417_ex32-1.htm g083417_ex32-2.htm ipar-20221231.xsd ipar-20221231_cal.xml ipar-20221231_def.xml ipar-20221231_lab.xml ipar-20221231_pre.xml img001_v1.jpg img002_v1.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 106 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g083417_10k.htm": { "axisCustom": 0, "axisStandard": 30, "baseTaxonomies": { "http://fasb.org/srt/2022": 2, "http://fasb.org/us-gaap/2022": 1114, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 258, "dts": { "calculationLink": { "local": [ "ipar-20221231_cal.xml" ] }, "definitionLink": { "local": [ "ipar-20221231_def.xml" ] }, "inline": { "local": [ "g083417_10k.htm" ] }, "labelLink": { "local": [ "ipar-20221231_lab.xml" ] }, "presentationLink": { "local": [ "ipar-20221231_pre.xml" ] }, "schema": { "local": [ "ipar-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 630, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 82, "http://interparfumsinc.com/20221231": 3, "http://xbrl.sec.gov/dei/2022": 6, "total": 91 }, "keyCustom": 21, "keyStandard": 372, "memberCustom": 36, "memberStandard": 43, "nsprefix": "ipar", "nsuri": "http://interparfumsinc.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://interparfumsinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Recent Agreements", "menuCat": "Notes", "order": "10", "role": "http://interparfumsinc.com/role/RecentAgreements", "shortName": "Recent Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Inventories", "menuCat": "Notes", "order": "11", "role": "http://interparfumsinc.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Fair Value of Financial Instruments", "menuCat": "Notes", "order": "12", "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Derivative Financial Instruments", "menuCat": "Notes", "order": "13", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Property, Equipment and Leasehold Improvements", "menuCat": "Notes", "order": "14", "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements", "shortName": "Property, Equipment and Leasehold Improvements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Trademarks, Licenses and Other Intangible Assets", "menuCat": "Notes", "order": "15", "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets", "shortName": "Trademarks, Licenses and Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Accrued Expenses", "menuCat": "Notes", "order": "16", "role": "http://interparfumsinc.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Loans Payable \u2013 Banks", "menuCat": "Notes", "order": "17", "role": "http://interparfumsinc.com/role/LoansPayableBanks", "shortName": "Loans Payable \u2013 Banks", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Long-Term Debt", "menuCat": "Notes", "order": "18", "role": "http://interparfumsinc.com/role/Long-termDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Commitments", "menuCat": "Notes", "order": "19", "role": "http://interparfumsinc.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://interparfumsinc.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Equity", "menuCat": "Notes", "order": "20", "role": "http://interparfumsinc.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders", "menuCat": "Notes", "order": "21", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Segments and Geographic Areas", "menuCat": "Notes", "order": "22", "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreas", "shortName": "Segments and Geographic Areas", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "23", "role": "http://interparfumsinc.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Accumulated Other Comprehensive Loss", "menuCat": "Notes", "order": "24", "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest", "menuCat": "Notes", "order": "25", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest", "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows", "menuCat": "Notes", "order": "26", "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows", "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "menuCat": "Notes", "order": "27", "role": "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - The Company and its Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "28", "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies", "shortName": "The Company and its Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - The Company and its Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "29", "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables", "shortName": "The Company and its Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://interparfumsinc.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "30", "role": "http://interparfumsinc.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Fair Value of Financial Instruments (Tables)", "menuCat": "Tables", "order": "31", "role": "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)", "menuCat": "Tables", "order": "32", "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables", "shortName": "Property, Equipment and Leasehold Improvements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Tables)", "menuCat": "Tables", "order": "33", "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables", "shortName": "Trademarks, Licenses and Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Accrued Expenses (Tables)", "menuCat": "Tables", "order": "34", "role": "http://interparfumsinc.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Long-Term Debt (Tables)", "menuCat": "Tables", "order": "35", "role": "http://interparfumsinc.com/role/Long-termDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Commitments (Tables)", "menuCat": "Tables", "order": "36", "role": "http://interparfumsinc.com/role/CommitmentsTables", "shortName": "Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "37", "role": "http://interparfumsinc.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)", "menuCat": "Tables", "order": "38", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Segments and Geographic Areas (Tables)", "menuCat": "Tables", "order": "39", "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables", "shortName": "Segments and Geographic Areas (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Income", "menuCat": "Statements", "order": "4", "role": "http://interparfumsinc.com/role/StatementsOfIncome", "shortName": "Consolidated Statements of Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "40", "role": "http://interparfumsinc.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "menuCat": "Tables", "order": "41", "role": "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)", "menuCat": "Tables", "order": "42", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables", "shortName": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)", "menuCat": "Tables", "order": "43", "role": "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables", "shortName": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfValuationAllowanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)", "menuCat": "Tables", "order": "44", "role": "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables", "shortName": "Schedule II - Valuation and Qualifying Accounts (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfValuationAllowanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of lanvin brand name for our class (Details)", "menuCat": "Details", "order": "45", "role": "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails", "shortName": "Schedule of lanvin brand name for our class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_custom_ProductSalesConcentrationRiskMember_custom_MontblancMember_custom_JanvinMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - The Company and its Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "shortName": "The Company and its Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireProductiveAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Recent Agreements (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "shortName": "Recent Agreements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireProductiveAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Schedule of inventories (Details)", "menuCat": "Details", "order": "48", "role": "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails", "shortName": "Schedule of inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Inventories (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://interparfumsinc.com/role/InventoriesDetailsNarrative", "shortName": "Inventories (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "5", "role": "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Schedule of fair value, assets measured on recurring basis (Details)", "menuCat": "Details", "order": "50", "role": "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "shortName": "Schedule of fair value, assets measured on recurring basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_us-gaap_ForeignExchangeContractMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Derivative Financial Instruments (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "shortName": "Derivative Financial Instruments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_us-gaap_ForeignExchangeContractMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Schedule of equipment and leasehold improvements (Details)", "menuCat": "Details", "order": "52", "role": "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails", "shortName": "Schedule of equipment and leasehold improvements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Property, Equipment and Leasehold Improvements (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative", "shortName": "Property, Equipment and Leasehold Improvements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Schedule of trademarks, licenses and other intangible assets (Details)", "menuCat": "Details", "order": "54", "role": "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "shortName": "Schedule of trademarks, licenses and other intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Trademarks, Licenses and Other Intangible Assets (Details Narrative)", "menuCat": "Details", "order": "55", "role": "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative", "shortName": "Trademarks, Licenses and Other Intangible Assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedAdvertisingCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Accrued expenses consist of the following: (Details)", "menuCat": "Details", "order": "56", "role": "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails", "shortName": "Accrued expenses consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedAdvertisingCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Long-term debt consists of the following: (Details)", "menuCat": "Details", "order": "57", "role": "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "shortName": "Long-term debt consists of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_custom_DomesticSubsidiariesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - Loans Payable \u2013 Banks (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "shortName": "Loans Payable \u2013 Banks (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31_custom_DomesticSubsidiariesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Long-Term Debt (Details Narrative)", "menuCat": "Details", "order": "59", "role": "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative", "shortName": "Long-Term Debt (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Changes in Shareholder's Equity", "menuCat": "Statements", "order": "6", "role": "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)", "menuCat": "Details", "order": "60", "role": "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails", "shortName": "Maturities of lease liabilities subsequent to December 31, 2022 are as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ipar:ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "p", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - minimum annual royalties and other commitments as follows: (Details)", "menuCat": "Details", "order": "61", "role": "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails", "shortName": "minimum annual royalties and other commitments as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ipar:OperatingLeaseOfRelatedToRentalExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - Commitments (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "shortName": "Commitments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ipar:OperatingLeaseOfRelatedToRentalExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - The following table sets forth information with respect to nonvested options for 2022: (Details)", "menuCat": "Details", "order": "63", "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details", "shortName": "The following table sets forth information with respect to nonvested options for 2022: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - The effect of share-based payment expenses decreased income statement line items as follows: (Details)", "menuCat": "Details", "order": "64", "role": "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "shortName": "The effect of share-based payment expenses decreased income statement line items as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_OperatingIncomeLossMember", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)", "menuCat": "Details", "order": "65", "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details", "shortName": "The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)", "menuCat": "Details", "order": "66", "role": "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails", "shortName": "The assumptions used in the Black-Scholes pricing model are set forth in the following table: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromStockOptionsExercised", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)", "menuCat": "Details", "order": "67", "role": "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails", "shortName": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredTaxExpenseFromStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - The following table summarizes additional stock option information as of December 31, 2022: (Details)", "menuCat": "Details", "order": "68", "role": "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "shortName": "The following table summarizes additional stock option information as of December 31, 2022: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - Equity (Details Narrative)", "menuCat": "Details", "order": "69", "role": "http://interparfumsinc.com/role/EquityDetailsNarrative", "shortName": "Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://interparfumsinc.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "menuCat": "Details", "order": "70", "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)", "menuCat": "Details", "order": "71", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - Information on the Company\u2019s operations by segments is as follows: (Details)", "menuCat": "Details", "order": "72", "role": "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "shortName": "Information on the Company\u2019s operations by segments is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - Consolidated net sales to customers by region are as follows: (Details)", "menuCat": "Details", "order": "73", "role": "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "shortName": "Consolidated net sales to customers by region are as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_srt_NorthAmericaMember", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - Consolidated net sales to customers in major countries are as follows: (Details)", "menuCat": "Details", "order": "74", "role": "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails", "shortName": "Consolidated net sales to customers in major countries are as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_custom_UnitedStatesMember", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - Segments and Geographic Areas (Details Narrative)", "menuCat": "Details", "order": "75", "role": "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative", "shortName": "Segments and Geographic Areas (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_country_US", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - The components of income before income taxes consist of the following: (Details)", "menuCat": "Details", "order": "76", "role": "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails", "shortName": "The components of income before income taxes consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - The provision for current and deferred income tax expense (benefit) consists of the following: (Details)", "menuCat": "Details", "order": "77", "role": "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails", "shortName": "The provision for current and deferred income tax expense (benefit) consists of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)", "menuCat": "Details", "order": "78", "role": "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails", "shortName": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)", "menuCat": "Details", "order": "79", "role": "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails", "shortName": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - The Company and its Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies", "shortName": "The Company and its Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "80", "role": "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-012022-12-31_custom_ForeignDerivedIntangibleIncomeMember", "decimals": "0", "lang": null, "name": "us-gaap:DeferredForeignIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - The components of accumulated other comprehensive loss consist of the following: (Details)", "menuCat": "Details", "order": "81", "role": "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails", "shortName": "The components of accumulated other comprehensive loss consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - Schedule of net income attributable to transfers from the noncontrolling interest (Details)", "menuCat": "Details", "order": "82", "role": "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails", "shortName": "Schedule of net income attributable to transfers from the noncontrolling interest (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)", "menuCat": "Details", "order": "83", "role": "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details", "shortName": "The following table summarizes cash and cash equivalents as of December 31, 2021: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ipar:ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_AllowanceForCreditLossMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000084 - Disclosure - Schedule of Valuation and Qualifying Accounts (Details)", "menuCat": "Details", "order": "84", "role": "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails", "shortName": "Schedule of Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_AllowanceForCreditLossMember", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ImpactOfCOVID19PandemicTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic", "menuCat": "Notes", "order": "9", "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic", "shortName": "Impact of COVID-19 Pandemic", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083417_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ipar:ImpactOfCOVID19PandemicTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 82, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r709", "r711", "r712" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r709", "r711", "r712" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r709", "r711", "r712" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r709", "r711", "r712" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r709", "r711", "r712" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ipar_AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents accumulated defined benefit plans net derivative instruments member.", "label": "Accumulated Defined Benefit Plans Net Derivative Instruments [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansNetDerivativeInstrumentsMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "domainItemType" }, "ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents accumulated other comprehensive income loss net of tax.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "periodEndLabel": "Net derivative instruments, end of year", "periodStartLabel": "Net derivative instruments, beginning of year" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax1", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "ipar_AccumulatedOtherComprehensiveIncomeLossNetOfTax2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents accumulated other comprehensive income loss net of tax.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax [Default Label]", "periodEndLabel": "Cumulative translation adjustments, end of year", "periodStartLabel": "Cumulative translation adjustments, beginning of year" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax2", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "ipar_CashHeldInEscrowIncludedInOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash held in escrow included in other assets.", "label": "Cash held in escrow included in other assets (see note 3)" } } }, "localname": "CashHeldInEscrowIncludedInOtherAssets", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" ], "xbrltype": "monetaryItemType" }, "ipar_CentralAndSouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents central and south america member.", "label": "Central and South America [Member]" } } }, "localname": "CentralAndSouthAmericaMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_ChangeInFairValueOfDerivatives": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents change in fair value of derivatives.", "label": "Change in Fair Value of Derivatives", "negatedLabel": "Change in fair value of derivatives" } } }, "localname": "ChangeInFairValueOfDerivatives", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ipar_CoachMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents coach member.", "label": "Coach [Member]" } } }, "localname": "CoachMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_DeferredTaxAssetsInventoryAndAccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax assets inventory and accounts receivable.", "label": "Inventory and accounts receivable" } } }, "localname": "DeferredTaxAssetsInventoryAndAccountsReceivable", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "ipar_DeferredTaxLiabilitiesBuildingExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax liabilities building expenses.", "label": "Building expenses" } } }, "localname": "DeferredTaxLiabilitiesBuildingExpenses", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "ipar_DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax liabilities unrealized gain on marketable equity securities.", "label": "Unrealized gain on marketable equity securities" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedGainOnMarketableEquitySecurities", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "ipar_DisclosureImpactOfCovid19PandemicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact Of Covid-19 Pandemic" } } }, "localname": "DisclosureImpactOfCovid19PandemicAbstract", "nsuri": "http://interparfumsinc.com/20221231", "xbrltype": "stringItemType" }, "ipar_DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation Of Cash And Cash Equivalents To Statement Of Cash Flows", "verboseLabel": "Following Table Summarizes Cash And Cash Equivalents As Of December 31 2021" } } }, "localname": "DisclosureReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsAbstract", "nsuri": "http://interparfumsinc.com/20221231", "xbrltype": "stringItemType" }, "ipar_DomesticSubsidiariesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents domestic subsidiaries member.", "label": "Domestic Subsidiaries [Member]" } } }, "localname": "DomesticSubsidiariesMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_DonnaKaranAndDKNYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents donna karan and dkny member.", "label": "Donna Karan and DKNY [Member]" } } }, "localname": "DonnaKaranAndDKNYMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_DueVendorsNotYetInvoiced": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents due vendors not yet invoiced.", "label": "Due vendors (not yet invoiced)" } } }, "localname": "DueVendorsNotYetInvoiced", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "ipar_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents effective income tax rate reconciliation at federal statutory income tax rate1.", "label": "Effect of foreign taxes greater than U.S. statutory rates" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "ipar_EliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stans for eliminations.", "label": "Eliminations [Member]" } } }, "localname": "EliminationsMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_EmanuelUngarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents emanuel ungar member.", "label": "Emanuel Ungar [Member]" } } }, "localname": "EmanuelUngarMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents employees member.", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_EuroInterbankOfferedRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents euro interbank offered rate member.", "label": "Euro Interbank Offered Rate [Member]" } } }, "localname": "EuroInterbankOfferedRateMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exercise price range four member.", "label": "Exercise Price Range Four [Member]" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "domainItemType" }, "ipar_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exercise price range one member.", "label": "Exercise Price Range One [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "domainItemType" }, "ipar_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exercise price range three member.", "label": "Exercise Price Range Three [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "domainItemType" }, "ipar_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents exercise price range two member.", "label": "Exercise Price Range Two [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "domainItemType" }, "ipar_ForeignDerivedIntangibleIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents foreign derived intangible income member.", "label": "Foreign Derived Intangible Income [Member]" } } }, "localname": "ForeignDerivedIntangibleIncomeMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_ForeignSubsidiariesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents foreign subsidiaries member.", "label": "Foreign Subsidiaries [Member]" } } }, "localname": "ForeignSubsidiariesMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_FranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents france member.", "label": "France [Member]" } } }, "localname": "FranceMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_GUESSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents g u e s s member.", "label": "G U E S S [Member]" } } }, "localname": "GUESSMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_ImpactOfCOVID19PandemicTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents impact of c o v i d19 pandemic text block.", "label": "Impact of COVID-19 Pandemic" } } }, "localname": "ImpactOfCOVID19PandemicTextBlock", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" ], "xbrltype": "textBlockItemType" }, "ipar_InterparfumsSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interparfums s a member.", "label": "interparfums S A [Member]" } } }, "localname": "InterparfumsSAMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_InterparfumsSASubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interparfums sa subsidiary member.", "label": "Interparfums SA Subsidiary [Member]" } } }, "localname": "InterparfumsSASubsidiaryMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_JanvinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents janvin member.", "label": "Janvin [Member]" } } }, "localname": "JanvinMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_JimmyChooMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents jimmy choo member.", "label": "Jimmy Choo [Member]" } } }, "localname": "JimmyChooMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_LessImputedInterestBasedOn2.6WeightedaverageDiscountRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents less imputed interest based on2.6 weightedaverage discount rate.", "label": "Less Imputed Interest Based on2.6 Weighted Average Discount Rate", "negatedLabel": "Less imputed interest (based on 2.6% weighted-average discount rate)" } } }, "localname": "LessImputedInterestBasedOn2.6WeightedaverageDiscountRate", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "ipar_LesseeOperatingLeaseLiabilityPaymentsDueNetTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents lessee operating lease liability payments due net total.", "label": "Net Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNetTotal", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "ipar_LoansPayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loans payable one member.", "label": "Loans Payable One [Member]" } } }, "localname": "LoansPayableOneMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_LoansPayableThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loans payable three member.", "label": "Loans Payable Three [Member]" } } }, "localname": "LoansPayableThreeMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "domainItemType" }, "ipar_LoansPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents loans payable two member.", "label": "Loans Payable Two [Member]" } } }, "localname": "LoansPayableTwoMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "domainItemType" }, "ipar_LondonInterbankOfferedRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents london interbank offered rate member.", "label": "London Interbank Offered Rate [Member]" } } }, "localname": "LondonInterbankOfferedRateMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_MontblancMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents montblanc member.", "label": "Montblanc [Member]" } } }, "localname": "MontblancMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_NetDerivativeInstrumentLossNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents net derivative instrument loss net of tax.", "label": "Net derivative instrument loss, net of tax" } } }, "localname": "NetDerivativeInstrumentLossNetOfTax", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ipar_NumberOfInstallment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents number of installment.", "label": "Number of installments" } } }, "localname": "NumberOfInstallment", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "integerItemType" }, "ipar_OperatingLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents operating lease member.", "label": "Operating Lease [Member]" } } }, "localname": "OperatingLeaseMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_OperatingLeaseOfRelatedToRentalExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents operating lease of related to rental expenses.", "label": "Operating lease of related to rental expenses" } } }, "localname": "OperatingLeaseOfRelatedToRentalExpenses", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ipar_OtherSegmentCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents other segment country member.", "label": "Other Segment Country [Member]" } } }, "localname": "OtherSegmentCountryMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_PercentageOfIncreaseInAnnualDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents percentage of increase in annual dividend.", "label": "Percentage of increase in annual dividend" } } }, "localname": "PercentageOfIncreaseInAnnualDividend", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "ipar_ProductSalesConcentrationRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents product sales concentration risk member.", "label": "Product Sales Concentration Risk [Member]" } } }, "localname": "ProductSalesConcentrationRiskMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "ipar_ProvisionForDoubtfulAccounts1": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents provision for doubtful accounts1.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts1", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ipar_ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents reconciliation of cash and cash equivalents to the statement of cash flows text block.", "label": "Reconciliation of Cash and Cash Equivalents to the Statement of Cash Flows" } } }, "localname": "ReconciliationOfCashAndCashEquivalentsToTheStatementOfCashFlowsTextBlock", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlows" ], "xbrltype": "textBlockItemType" }, "ipar_RochasFashionBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents rochas fashion business member.", "label": "Rochas Fashion Business [Member]" } } }, "localname": "RochasFashionBusinessMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_RochasFashionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stans for rochas fashion.", "label": "Rochas Fashion [Member]" } } }, "localname": "RochasFashionMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_RoyaltyExpenseNetSalesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents royalty expense net sales percentage.", "label": "Royalty expense, percentage of net sales" } } }, "localname": "RoyaltyExpenseNetSalesPercentage", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "ipar_RussiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents russia member.", "label": "Russia [Member]" } } }, "localname": "RussiaMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents schedule of maturities of lease liabilities subsequent table text block.", "label": "Maturities of lease liabilities subsequent to December 31, 2022 are as follows:" } } }, "localname": "ScheduleOfMaturitiesOfLeaseLiabilitiesSubsequentTableTextBlock", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/CommitmentsTables" ], "xbrltype": "textBlockItemType" }, "ipar_StockOptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents stock option one member.", "label": "Stock Option One [Member]" } } }, "localname": "StockOptionOneMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_SubtotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents subtotal member.", "label": "Subtotal [Member]" } } }, "localname": "SubtotalMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ipar_SupplementalDisclosureOfCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalDisclosureOfCashFlowInformationAbstract", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents transfer of subsidiary shares purchased to treasury shares.", "label": "Transfer of subsidiary shares purchased" } } }, "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ipar_UnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents united kingdom member.", "label": "United Kingdom [Member]" } } }, "localname": "UnitedKingdomMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_UnitedStatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents united states member.", "label": "United States [Member]" } } }, "localname": "UnitedStatesMember", "nsuri": "http://interparfumsinc.com/20221231", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Asia.", "label": "Asia [Member]" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "Leader of board of directors.", "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r294", "r527", "r528", "r531", "r532", "r585", "r649", "r653", "r750", "r753", "r754", "r791", "r792", "r793" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r294", "r527", "r528", "r531", "r532", "r585", "r649", "r653", "r750", "r753", "r754", "r791", "r792", "r793" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "minimum annual royalties and other commitments as follows:" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsTables" ], "xbrltype": "textBlockItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by currency.", "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r402", "r403", "r404", "r405", "r476", "r593", "r624", "r650", "r651", "r678", "r686", "r697", "r755", "r782", "r783", "r784", "r785", "r786", "r787" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r402", "r403", "r404", "r405", "r476", "r593", "r624", "r650", "r651", "r678", "r686", "r697", "r755", "r782", "r783", "r784", "r785", "r786", "r787" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r362", "r595", "r679", "r695", "r747", "r748", "r756", "r788" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/InventoriesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r362", "r595", "r679", "r695", "r747", "r748", "r756", "r788" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services." } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/InventoriesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r402", "r403", "r404", "r405", "r468", "r476", "r486", "r487", "r488", "r590", "r593", "r624", "r650", "r651", "r678", "r686", "r697", "r746", "r755", "r783", "r784", "r785", "r786", "r787" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r402", "r403", "r404", "r405", "r468", "r476", "r486", "r487", "r488", "r590", "r593", "r624", "r650", "r651", "r678", "r686", "r697", "r746", "r755", "r783", "r784", "r785", "r786", "r787" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r302", "r663" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "Schedule II - Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r363", "r364", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r652", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r680", "r696", "r756" ], "lang": { "en-us": { "role": { "documentation": "Geographical area." } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r363", "r364", "r632", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r652", "r654", "r680", "r696", "r756" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r744", "r778" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r295", "r296", "r297", "r300", "r301", "r663" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r16", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable - trade" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r368", "r369" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedAdvertisingCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Advertising liabilities" } } }, "localname": "AccruedAdvertisingCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://interparfumsinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses", "verboseLabel": "Total" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails", "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRoyaltiesCurrent": { "auth_ref": [ "r20", "r666" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Royalties" } } }, "localname": "AccruedRoyaltiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r20", "r666" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Salary (including bonus and related taxes)" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r106", "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r31", "r33", "r34", "r257", "r617", "r629", "r630" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r270", "r271", "r558", "r559", "r560", "r561", "r562", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r30", "r34", "r174", "r582", "r625", "r626", "r725", "r726", "r727", "r739", "r740", "r741" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r28", "r34", "r174", "r271", "r272", "r559", "r560", "r561", "r562", "r565", "r725" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "License agreement renewal term" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "License agreement term" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_AcquisitionCosts": { "auth_ref": [ "r209", "r210" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.", "label": "Acquisition costs, period cost" } } }, "localname": "AcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r489", "r490", "r491", "r739", "r740", "r741", "r771" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionsToOtherAssetsAmount": { "auth_ref": [ "r719" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of significant additions in the period in other assets (current, noncurrent, or unclassified).", "label": "Additions to Other Assets, Amount" } } }, "localname": "AdditionsToOtherAssetsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising and Promotion" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r493" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r734", "r735", "r736", "r737", "r738" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r258", "r372", "r377" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowances for sales returns and doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r61", "r89", "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r61", "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Impairment charge" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r211", "r230", "r255", "r289", "r346", "r352", "r358", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r527", "r531", "r548", "r694", "r751", "r752", "r780" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "negatedLabel": "Assets", "totalLabel": "Total assets", "verboseLabel": "Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r247", "r262", "r289", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r527", "r531", "r548", "r694", "r751", "r752", "r780" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r195" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total Assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Preparation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r524", "r684", "r685" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r159", "r160", "r524", "r684", "r685" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Description of recent agreement" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r163", "r525" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Recent Agreements" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r68", "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Business of the Company" } } }, "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r63", "r250", "r664" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents per balance sheet" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents and Short-Term Investments" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r57", "r63", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and cash equivalents per statement of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesCashAndCashEquivalentsAsOfDecember312021Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r57", "r63", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents \u2013 end of year", "periodStartLabel": "Cash and cash equivalents \u2013 beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r57", "r203" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r718" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.", "label": "Proceeds, tax benefits and intrinsic value related to stock options exercised were as follows:" } } }, "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r109", "r400", "r401", "r634", "r749" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r110", "r636" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "License Agreements" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r739", "r740", "r771" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value. Authorized 100,000,000 shares: outstanding, 31,967,300 and 31,830,420 shares on December 31, 2022, and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r35", "r266", "r268", "r278", "r613", "r621" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to Inter Parfums Inc." } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r167", "r168", "r178", "r266", "r268", "r277", "r612", "r620" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss), net of tax, atributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income attributable to noncontrolling interests:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r166", "r178", "r266", "r268", "r276", "r611", "r619" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r47", "r275", "r610", "r618" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r71", "r72", "r198", "r199", "r366", "r633" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r71", "r72", "r198", "r199", "r366", "r631", "r633" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r71", "r72", "r198", "r199", "r366", "r633", "r789" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r71", "r72", "r198", "r199", "r366" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r71", "r72", "r198", "r199", "r366", "r633" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet": { "auth_ref": [ "r120", "r175", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.", "label": "Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet": { "auth_ref": [ "r120", "r175", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.", "label": "Decrease in Inter Parfums, Inc.\u2019s additional paid-in capital for subsidiary share transactions" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": { "auth_ref": [ "r175", "r179" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Schedule of net income attributable to transfers from the noncontrolling interest" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterestTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationSubsidiaryStockIssuancesPolicy": { "auth_ref": [ "r169", "r170" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Issuance of Common Stock by Consolidated Subsidiary" } } }, "localname": "ConsolidationSubsidiaryStockIssuancesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerRefundLiability": { "auth_ref": [ "r757" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.", "label": "Contract with customer, refund liability" } } }, "localname": "ContractWithCustomerRefundLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerRightToRecoverProduct": { "auth_ref": [ "r757" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to recover product from customer on settling refund liability.", "label": "Contract with customer, right to recover products" } } }, "localname": "ContractWithCustomerRightToRecoverProduct", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r42", "r595" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of sales", "verboseLabel": "Shipping and handling costs" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "auth_ref": [ "r728" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect cost incurred related to good produced and service rendered.", "label": "Cost of Goods Sold, Overhead" } } }, "localname": "CostOfGoodsAndServicesSoldOverhead", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InventoriesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The risk that a borrower will fail to pay interest or principal on a loan or debt security when due.", "label": "Credit Risk [Member]" } } }, "localname": "CreditRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r732", "r762", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r732", "r762" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r157", "r508", "r516", "r732" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current income tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r732", "r762", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r70", "r366" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRefundLiabilityCurrent": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.", "label": "Refund (return) liability" } } }, "localname": "CustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r113", "r287", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r431", "r438", "r439", "r441" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Loans Payable \u2013 Banks" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanks" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r1", "r2", "r3", "r212", "r214", "r228", "r294", "r415", "r416", "r417", "r418", "r419", "r421", "r427", "r428", "r429", "r430", "r432", "r433", "r434", "r435", "r436", "r437", "r569", "r673", "r674", "r675", "r676", "r677", "r730" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Basis spread over variable interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r205", "r207", "r415", "r569", "r674", "r675" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount", "verboseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r22", "r416" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest per annum", "verboseLabel": "Variable rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Description of debt instrument interest rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r23", "r294", "r415", "r416", "r417", "r418", "r419", "r421", "r427", "r428", "r429", "r430", "r432", "r433", "r434", "r435", "r436", "r437", "r569", "r673", "r674", "r675", "r676", "r677", "r730" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r23", "r225" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Installment amount (in Dollars)" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r23", "r115", "r116", "r117", "r118", "r204", "r205", "r207", "r226", "r294", "r415", "r416", "r417", "r418", "r419", "r421", "r427", "r428", "r429", "r430", "r432", "r433", "r434", "r435", "r436", "r437", "r440", "r569", "r673", "r674", "r675", "r676", "r677", "r730" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative", "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTransferToTradingLoss": { "auth_ref": [ "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss recognized in earnings from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) to investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Transfer from other comprehensive income into earnings", "negatedLabel": "Transfer from other comprehensive income into earnings" } } }, "localname": "DebtSecuritiesAvailableForSaleTransferToTradingLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": { "auth_ref": [ "r124", "r134" ], "lang": { "en-us": { "role": { "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Straight line basis over the requisite" } } }, "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r732", "r763", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r157", "r732", "r763" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative", "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r496", "r497" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax assets", "verboseLabel": "Deferred Income Tax Assets, Net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r61", "r157", "r509", "r515", "r516", "r732" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax expense (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r4", "r5", "r213", "r227", "r503" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred income tax expense" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r732", "r763", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r155", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Profit sharing" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r504" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total gross deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r155", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Effect of inventory profit elimination" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r760" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "verboseLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r760" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r155", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Foreign net operating loss carry-forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r155", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r155", "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Stock option compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.", "label": "Tax benefits" } } }, "localname": "DeferredTaxExpenseFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities (long-term):" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r155", "r761" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "verboseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": { "auth_ref": [ "r155", "r761" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.", "label": "Deferred Tax Liabilities, Other Finite-Lived Assets", "negatedLabel": "Trademarks and licenses" } } }, "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TaxEffectsOfTemporaryDifferencesThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesAreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r61", "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation and amortization expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r61", "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r61", "r341" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization including impairment loss" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r186", "r187", "r189", "r190", "r667" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r194", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r184", "r186", "r189", "r190", "r192", "r193", "r534" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r769", "r770" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Loan amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r182", "r183", "r184", "r185", "r191", "r293" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DistributionMadeToLimitedPartnerUnitDistribution": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP).", "label": "Number of share distributed" } } }, "localname": "DistributionMadeToLimitedPartnerUnitDistribution", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r119", "r224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "negatedLabel": "Dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends payable, amount per share (in Dollars per share)" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r279", "r308", "r309", "r310", "r311", "r312", "r316", "r318", "r320", "r321", "r322", "r326", "r538", "r539", "r614", "r622", "r670" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r279", "r308", "r309", "r310", "r311", "r312", "r318", "r320", "r321", "r322", "r326", "r538", "r539", "r614", "r622", "r670" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share attributable to Inter Parfums, Inc" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r323", "r324", "r325", "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r556" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective rates" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r291", "r499", "r518" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory rates" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends": { "auth_ref": [ "r759", "r765" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend paid to employee stock ownership plan.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Percent", "negatedLabel": "Windfall benefit from exercise of stock options" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r759", "r765" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Benefit of Foreign Derived Intangible Income" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r759", "r765" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "verboseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r759", "r765" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State and local taxes, net of Federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DifferencesBetweenUnitedStatesFederalStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateWereAsFollowsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "auth_ref": [ "r150" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of plan compensation cost recognized during the period.", "label": "Aggregate cost" } } }, "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity:", "verboseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r114", "r243", "r270", "r271", "r272", "r303", "r304", "r305", "r307", "r313", "r315", "r329", "r376", "r456", "r489", "r490", "r491", "r511", "r512", "r537", "r558", "r559", "r560", "r561", "r562", "r565", "r582", "r625", "r626", "r627" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r219", "r635" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Cash held in escrow is included in other assets" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r540", "r541", "r546" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r195", "r197" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r429", "r469", "r470", "r471", "r472", "r473", "r474", "r541", "r587", "r588", "r589", "r674", "r675", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r540", "r541", "r543", "r544", "r547" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis": { "auth_ref": [ "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Information by type of credit or market risk.", "label": "Concentration of Credit or Market Risk [Axis]" } } }, "localname": "FairValueConcentrationOfRiskDisclosureItemsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain": { "auth_ref": [ "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Provides the general information items required or determined to be disclosed with respect to all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties." } } }, "localname": "FairValueConcentrationOfRiskDisclosureItemsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r429", "r469", "r474", "r541", "r587", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r429", "r469", "r474", "r541", "r588", "r674", "r675", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r429", "r469", "r470", "r471", "r472", "r473", "r474", "r541", "r589", "r674", "r675", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r429", "r469", "r470", "r471", "r472", "r473", "r474", "r587", "r588", "r589", "r674", "r675", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r545", "r547" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Amortization period" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r253", "r392" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r390", "r391", "r392", "r393", "r596", "r597" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r95", "r597" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Gross Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "A description of the entity's intent or ability to renew or extend the arrangement related to an intangible asset and how that affects expected future cash flows.", "label": "License agreement, expiration description" } } }, "localname": "FiniteLivedIntangibleAssetsIntentOrAbilityToRenewOrExtendArrangement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r90", "r94" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets [Member]" } } }, "localname": "FiniteLivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r95", "r596" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Net Book Value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign currency contracts, liability, fair value disclosure" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": { "auth_ref": [ "r188" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.", "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value", "verboseLabel": "Foreign currency forward exchange contracts not accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r549", "r551", "r553", "r555" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Loss (gain) on foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r667", "r681", "r692" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r186" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Net derivative instrument gain (loss), net of tax" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r87", "r92" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Long-Lived Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r41", "r289", "r346", "r351", "r357", "r360", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r548", "r671", "r751" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentChargeOnReclassifiedAssets": { "auth_ref": [ "r101", "r103" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.", "label": "Impairment Charge on Reclassified Assets" } } }, "localname": "ImpairmentChargeOnReclassifiedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLeasehold": { "auth_ref": [ "r61", "r102" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.", "label": "Impairment loss" } } }, "localname": "ImpairmentOfLeasehold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r290", "r517" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "U.S. operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r290", "r517" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Foreign operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r346", "r351", "r357", "r360", "r671" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfIncomeBeforeIncomeTaxesConsistOfFollowingDetails", "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r38", "r61", "r84", "r220", "r237", "r343" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Share of income of equity investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r395", "r397" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r291", "r500", "r501", "r507", "r513", "r519", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r292", "r314", "r315", "r344", "r498", "r514", "r520", "r623" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes", "terseLabel": "Total income tax expense", "verboseLabel": "Income Tax Expense (Benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/ProvisionForCurrentAndDeferredIncomeTaxExpenseBenefitConsistsOfFollowingDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r269", "r494", "r495", "r501", "r502", "r506", "r510" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r58", "r65" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r219", "r236", "r720" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r60" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r60" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r729" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Income taxes, net" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r60" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r729", "r777" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r60" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedLicenseAgreements": { "auth_ref": [ "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.", "label": "Indefinite-Lived License Agreements" } } }, "localname": "IndefiniteLivedLicenseAgreements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Member]" } } }, "localname": "IndefinitelivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Trademarks, Licenses and Other Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r88", "r93" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Trademarks, licenses and other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r206", "r223", "r273", "r340", "r568" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r281", "r284", "r285" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.", "label": "Interest Rate Derivative Liabilities, at Fair Value", "negatedLabel": "Interest rate swaps" } } }, "localname": "InterestRateDerivativeLiabilitiesAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet": { "auth_ref": [ "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of all derivatives designated as interest rate fair value hedging instruments.", "label": "Interest rate swaps" } } }, "localname": "InterestRateFairValueHedgeDerivativeAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r721" ], "calculation": { "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r260", "r665", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r249", "r259", "r328", "r378", "r379", "r380", "r594", "r668" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r722" ], "calculation": { "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials and component parts" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserveMember": { "auth_ref": [ "r734", "r735", "r736", "r737", "r738" ], "lang": { "en-us": { "role": { "documentation": "Reserve to reduce inventory to lower of cost or net realizable value.", "label": "SEC Schedule, 12-09, Reserve, Inventory [Member]" } } }, "localname": "InventoryValuationReserveMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r86", "r723" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InventoriesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterestAndDividend": { "auth_ref": [ "r45" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Interest and Dividend", "negatedLabel": "Interest and investment income", "negatedTerseLabel": "Investment Income, Interest and Dividend" } } }, "localname": "InvestmentIncomeInterestAndDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r540" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "verboseLabel": "Short-term investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Gross Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MaturitiesOfLeaseLiabilitiesSubsequentToDecember312022AreAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Operating Leases" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r216", "r234", "r694", "r731", "r745", "r774" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity [Default Label]", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r248", "r289", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r528", "r531", "r532", "r548", "r694", "r751", "r780", "r781" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r195" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r3", "r214", "r228" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of credit, maximum borrowing amount" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r214", "r231", "r428", "r442", "r674", "r675" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Loan payable" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Current portion of long-term debt", "verboseLabel": "Less current maturities" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtDescription": { "auth_ref": [ "r23", "r115" ], "lang": { "en-us": { "role": { "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.", "label": "Long term debt maturity, description" } } }, "localname": "LongTermDebtDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r111", "r294", "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-term Debt, Maturities, 2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r256" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long\u2013term debt, less current portion", "verboseLabel": "Total" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term debt, term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-Term Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r23", "r112" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtConsistsOfFollowingDetails", "http://interparfumsinc.com/role/Long-termDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Information by type of risks inherent in servicing assets and servicing liabilities.", "label": "Servicing Assets and Servicing Liabilities Risk [Axis]" } } }, "localname": "ManagingRisksInherentInServicingAssetsAndServicingLiabilitiesByTypeOfRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Customer incentives cost" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MiddleEastMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Middle East.", "label": "Middle East [Member]" } } }, "localname": "MiddleEastMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r26", "r215", "r233", "r289", "r375", "r406", "r408", "r409", "r410", "r413", "r414", "r548" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Net Income Attributable to Inter Parfums, Inc. and Transfers from the Noncontrolling Interest" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.AndTransfersFromNoncontrollingInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Ownership percentage in Interparfums SA", "verboseLabel": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r283" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r283" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r57", "r59", "r62" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r39", "r62", "r221", "r238", "r246", "r264", "r267", "r272", "r289", "r306", "r308", "r309", "r310", "r311", "r314", "r315", "r319", "r346", "r351", "r357", "r360", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r539", "r548", "r671", "r751" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income attributable to Inter Parfums, Inc.", "terseLabel": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to Inter Parfums, Inc.", "verboseLabel": "Numerator for diluted earnings per share (in dollars)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "http://interparfumsinc.com/role/ScheduleOfNetIncomeAttributableToTransfersFromNoncontrollingInterestDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r171", "r177", "r264", "r267", "r314", "r315", "r727" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Net income attributable to the noncontrolling interest", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r120", "r170", "r172" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r164", "r456", "r739", "r740", "r741" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets [Default Label]", "verboseLabel": "Long-Lived Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Nonoperating Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expenses (income):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r346", "r351", "r357", "r360", "r671" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing operating income (loss).", "label": "Operating Income (Loss) [Member]" } } }, "localname": "OperatingIncomeLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r573", "r693" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Noncash additions to operating lease assets" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r571" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r571" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liabilities, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r572", "r574" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating lease payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r570" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-use assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r576", "r693" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average cost of capital", "verboseLabel": "Operating lease, weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r575", "r693" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r261", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r254" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Total" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueAfterFifthYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "OtherCommitmentDueAfterFifthYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInFifthYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "OtherCommitmentDueInFifthYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInFourthYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "OtherCommitmentDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "OtherCommitmentDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInSecondYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "OtherCommitmentDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInThirdYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "OtherCommitmentDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/MinimumAnnualRoyaltiesAndOtherCommitmentsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r29", "r31", "r550", "r552", "r557" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "negatedLabel": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "auth_ref": [ "r27", "r32", "r550", "r554", "r564" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r85", "r275", "r558", "r563", "r565", "r610", "r618", "r725", "r726" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Other comprehensive income (loss), before tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": { "auth_ref": [ "r263", "r533" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Net derivative instrument income (loss), \u00a0net of tax" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r27" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r27", "r32", "r554", "r564" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r166", "r167", "r173", "r265", "r268" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net derivative instrument income (loss), \u00a0net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r239" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "negatedLabel": "Other loss (income)" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Receivables, other" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r54" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r54" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedLabel": "Dividends paid to noncontrolling interests" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r49" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Purchase of equity investment" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r50" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Payment for intangible assets acquired" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r51" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r280", "r766", "r767", "r768" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Purchase price, period cost" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r50" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property, equipment and leasehold improvements" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r56" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedLabel": "Purchase of subsidiary shares from noncontrolling interests" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r2", "r125", "r126", "r127" ], "calculation": { "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Retirement reserves" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r443" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r6", "r443" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.001 par value. Authorized 1,000,000 shares: none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r53" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from issuance of long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r48" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from sale of short-term investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r52", "r148" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of options", "verboseLabel": "Proceeds from stock options exercised" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InventoriesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r246", "r264", "r267", "r282", "r289", "r306", "r314", "r315", "r346", "r351", "r357", "r360", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r526", "r529", "r530", "r539", "r548", "r615", "r671", "r690", "r691", "r727", "r751" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity", "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r108", "r637", "r638", "r639" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Equipment and Leasehold Improvements" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovements" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r105", "r251" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment and leasehold improvements" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r107", "r235", "r616", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, equipment and leasehold improvements, net", "verboseLabel": "Property, Plant and Equipment, Net, Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r107", "r637", "r638" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property, Equipment and Leasehold Improvements" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of equipment and leasehold improvements" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/PropertyEquipmentAndLeaseholdImprovementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Depreciated over a range" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "auth_ref": [ "r60", "r82", "r222" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.", "label": "Lease expense" } } }, "localname": "ProvisionForLoanLeaseAndOtherLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r34", "r36" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedLabel": "Transfer of OCI into earnings" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r475", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r475", "r583", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r779" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r55" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepurchaseAgreementsCollateralPolicy": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy with regard to collateral required and collateral rights on securities sold under agreements to repurchase.", "label": "Treasury Stock" } } }, "localname": "RepurchaseAgreementsCollateralPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Package Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r119", "r232", "r628", "r630", "r694" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r243", "r303", "r304", "r305", "r307", "r313", "r315", "r376", "r489", "r490", "r491", "r511", "r512", "r537", "r625", "r627" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r337", "r338", "r350", "r355", "r356", "r362", "r363", "r366", "r465", "r466", "r595" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Net sales", "verboseLabel": "Revenue from Contract with Customer, Including Assessed Tax" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r467", "r669" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionAllowances": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for sales allowances.", "label": "Payments to Customers" } } }, "localname": "RevenueRecognitionAllowances", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionSalesReturns": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for sales returns.", "label": "Sales Returns" } } }, "localname": "RevenueRecognitionSalesReturns", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r274", "r289", "r337", "r338", "r350", "r355", "r356", "r362", "r363", "r366", "r375", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r548", "r615", "r751" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue from export sales", "verboseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "The nature of risks inherent in servicing assets and servicing liabilities." } } }, "localname": "RisksInherentInServicingAssetsAndServicingLiabilitiesTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesReturnsAndAllowancesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.", "label": "Sales Returns and Allowances [Member]" } } }, "localname": "SalesReturnsAndAllowancesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r366", "r743" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Accrued expenses consist of the following:" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r34", "r775", "r776" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "The components of accumulated other comprehensive loss consist of the following:" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r159", "r160", "r524" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "The following table summarizes cash and cash equivalents as of December 31, 2021:" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ReconciliationOfCashAndCashEquivalentsToStatementOfCashFlowsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "The provision for current and deferred income tax expense (benefit) consists of the following:" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r23", "r115", "r116", "r117", "r118", "r204", "r205", "r207", "r226", "r674", "r676", "r733" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Long-term debt consists of the following:" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Long-termDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r128", "r129", "r130", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Differences between the United States federal statutory income tax rate and the effective income tax rate were as follows:" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of fair value, assets measured on recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r90", "r94", "r596" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CommitmentsDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfTrademarksLicensesAndOtherIntangibleAssetsDetails", "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.", "label": "Schedule of trademarks, licenses and other intangible assets" } } }, "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "The components of income before income taxes consist of the following:" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r13", "r14", "r15" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "The following table sets forth information with respect to nonvested options for 2022:" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative", "http://interparfumsinc.com/role/ScheduleOfLanvinBrandNameForOurClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfEquipmentAndLeaseholdImprovementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.", "label": "Consolidated net sales to customers in major countries are as follows:" } } }, "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r40", "r81" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Consolidated net sales to customers by region are as follows:" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r37", "r81" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/InformationOnCompanysOperationsBySegmentsIsAsFollowsDetails", "http://interparfumsinc.com/role/NetSalesToCustomersByRegionAreAsFollowsDetails", "http://interparfumsinc.com/role/SegmentsAndGeographicAreasDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r78", "r79", "r80", "r87" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r78", "r79", "r80", "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Information on the Company\u2019s operations by segments is as follows:" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/SegmentsAndGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r138", "r140", "r142" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "The effect of share-based payment expenses decreased income statement line items as follows:" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "The following table summarizes additional stock option information as of December 31, 2022:" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r135", "r140", "r142" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "The following table summarizes stock option activity and related information for the years ended December 31, 2022, 2021 and 2020:" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "The assumptions used in the Black-Scholes pricing model are set forth in the following table:" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r69", "r71", "r72", "r73", "r198", "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedule of lanvin brand name for our class" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r334", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r360", "r366", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r398", "r399", "r672", "r788" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r334", "r335", "r336", "r346", "r349", "r354", "r358", "r359", "r360", "r361", "r362", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segments and Geographic Areas" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/SegmentsAndGeographicAreas" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r44" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r60" ], "calculation": { "http://interparfumsinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Noncash stock compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based compensation arrangement by share-based payment award, award vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Weighted-average dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Weighted-average expected stock-price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Weighted-average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Adjusted for stock splits (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares available for grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price of options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Intrinsic value of stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedWereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Nonvested options granted", "verboseLabel": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details", "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant Date Fair Value, granted", "verboseLabel": "Weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative", "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Aggregate intrinsic value of options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options shares under option - end of year", "periodStartLabel": "Options shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price shares under option - end of year", "periodStartLabel": "Weighted average exercise price shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price options forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Options exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Options outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average expected option life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/AssumptionsUsedInBlack-scholesPricingModelAreSetForthInFollowingTableDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r147" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate intrinsic value of options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Nonvested options - end of year", "periodStartLabel": "Nonvested options - beginning of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Nonvested options vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted Average Grant Date Fair Value, vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant Date Fair Value, end of year", "periodStartLabel": "Weighted Average Grant Date Fair Value, beginning of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsFor2022Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Fair value of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Exercise price range (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Options outstanding weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details" ], "xbrltype": "durationItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r217", "r218", "r229", "r724" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r68", "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "The Company and its Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r245", "r334", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r360", "r366", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r396", "r398", "r399", "r672", "r788" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/NetSalesToCustomersInMajorCountriesAreAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r25", "r114", "r243", "r270", "r271", "r272", "r303", "r304", "r305", "r307", "r313", "r315", "r329", "r376", "r456", "r489", "r490", "r491", "r511", "r512", "r537", "r558", "r559", "r560", "r561", "r562", "r565", "r582", "r625", "r626", "r627" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ComponentsOfAccumulatedOtherComprehensiveLossConsistOfFollowingDetails", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/InventoriesDetailsNarrative", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r303", "r304", "r305", "r329", "r595" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EffectOfShare-basedPaymentExpensesDecreasedIncomeStatementLineItemsAsFollowsDetails", "http://interparfumsinc.com/role/FollowingTableSummarizesAdditionalStockOptionInformationAsOfDecember312022Details", "http://interparfumsinc.com/role/InventoriesDetailsNarrative", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r133", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Recognized as compensation cost" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r114", "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issue" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r6", "r7", "r114", "r119", "r481" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionActivityAndRelatedInformationForYearsEndedDecember3120222021And2020Details" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r6", "r7", "r114", "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Shares adjusted for stock splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r25", "r114", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Shares issued for license acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r7", "r114", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r6", "r7", "r119", "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r25", "r114", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r83", "r694", "r731", "r745", "r774" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inter Parfums, Inc. shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r164", "r165", "r176", "r243", "r244", "r271", "r303", "r304", "r305", "r307", "r313", "r376", "r456", "r489", "r490", "r491", "r511", "r512", "r537", "r558", "r559", "r565", "r582", "r626", "r627", "r731", "r745", "r774" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets", "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r123", "r288", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r536" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r566", "r586" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r566", "r586" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r566", "r586" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary or Equity Method Investee [Line Items]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Schedule of Valuation and Qualifying Accounts" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleIi-ValuationAndQualifyingAccountsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r240", "r241", "r242", "r370", "r371", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/TrademarksLicensesAndOtherIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r24", "r121" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r24", "r121" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r24", "r121", "r122" ], "calculation": { "http://interparfumsinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost, 9,864,805 common shares on December 31, 2022, and 2021" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r74", "r75", "r76", "r330", "r331", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Management Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/CompanyAndItsSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r295", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "Charged to costs and expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r299" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "Charged to other accounts describe" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "Deductions describe" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r295", "r296", "r297", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves." } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r295", "r296", "r297", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ScheduleOfValuationAndQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/LoansPayableBanksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Stock options" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r317", "r322" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Denominator for diluted earnings per share", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r316", "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "http://interparfumsinc.com/role/StatementsOfIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=SL5742995-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2459-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569618-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13572-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13587-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.11)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r698": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r699": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r701": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r702": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r703": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r704": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r705": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r706": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r707": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r708": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r709": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r711": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r712": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r713": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r714": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r715": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r716": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r717": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 107 0001753926-23-000213-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001753926-23-000213-xbrl.zip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b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�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